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Abstract 
Walking for people with diabetes related foot neuropathy and ulceration incurs risk. This risk may 
lead to amputation of the affected limb as the ulceration becomes infected and ultimately life 
threatening. It is in reducing this risk that this thesis contributes new knowledge.  
Footwear with rocker-sole modification is routinely prescribed as a means to protect ulceration 
from walking impact pressures. However, the current experimental evidence is of limited value 
and may actually be leading clinicians to prescribe treatment detrimental to their patients. This is 
because rocker-sole efficacy to protect ulceration has not been determined for populations with 
diabetes and foot ulceration. A compounding difficulty is studies are not readily comparable as 
methodologies are not standardised and interpretation limits have yet to be defined.  
This research aimed to determine which rocker-sole shoe design was the most effective at 
protecting diabetes related foot ulceration from further injury. As a precursor, the research 
methodology was developed from an analysis of the literature, interpretation limits were defined 
by archival data analyses and it was safety tested prior to application to people with diabetes 
related ulceration. Innovative analyses were developed and showed a relationship between shoes, 
impact pressures and time.  
Statistically significant differences between in-shoe peak pressures measured on the first 
metatarsal phalangeal joint (p=0.01: 95% CI 2.83 – 25.95kPa) but not on the hallux were 
identified between sub-populations with and without diabetes related neuropathy and ulceration 
when walking in an athletic shoe. However, the plotting of the pressure-time results proved most 
clinically useful and showed that there was a different relationship with peak pressure when 
ulceration is present on the hallux compared to the first metatarsal phalangeal joint.  
Statistically significant differences were not found between in-shoe peak pressures measured on 
either first metatarsal phalangeal joint or hallux ulceration when therapeutic shoes with rocker 
sole modifications were worn. These results disagree with studies that have found peak pressure 
differences in healthy subjects when walking in these footwear styles. The results of this research 
do not support the claims from healthy subject research that beneficial reductions in peak 
pressures from walking in rocker sole shoes may also be achieved in diabetic subjects with 
neuropathy and ulceration.  
This research developed methods to plot in-shoe plantar peak pressures with time. The patterns 
formed by peak pressures in different sub-populations with and without ulceration and neuropathy 

showed that functional differences were present. These differences provide insight for future 
research and potentially clinical diagnostic outcomes. Specifically, the methods developed by this 
research provide clinicians with evidence to inform on prescribing, and a method to evaluate shoe 
therapies for maximum protective benefit for people with diabetes related neuropathy and 
ulceration. 

 
Background to the problem 
“I marvel that society would pay a surgeon a large sum of money to remove a 
patient’s leg…but nothing to save it”(p 55).  
George Bernard Shaw (1856-1950) (Shaw, 1911). 
 
The amputation of a leg is a horrific possibility that people with Type 2 diabetes mellitus1 are at 
risk to endure (Payne, 2000b). Amputation is a life saving procedure performed when the limb is 
no longer viable, often due to infiltration of infection into the body via foot ulceration (Reiber, 
2001). Ulceration is a chronic wound that affects 15 percent of people with diabetes at some time 
during their life (Reiber, 1996) and commonly occurs on the plantar forefoot due to inadequate 
protection from the normal repetitive physical microtrauma experienced during walking gait 
(American Diabetes Association, 1999). Physical microtrauma to the plantar tissues of the foot 
arises due to pressures from impact with the ground during walking. Injury from impact pressures 
is avoided in the normal foot by constant conscious and unconscious minor adjustments to the 
walking style that redistributes the stress across the foot (Sanders, Goldstein, & Leotta, 1995). 
Even though people with diabetes and a history of ulceration are nearly 50 percent less active than 
their ulceration-free and healthy counterparts (Maluf & Mueller, 2003), without sensory input 
from the injured foot, these people continue to walk without gait deviation and therefore, fail to 
protect fragile or injured tissues until skin and tissue integrity deteriorates to ulceration (Brand & 
Yancey, 1993). Eventually either the person or a carer notices the ulceration and seeks therapy 
and healing occurs, or infection infiltrates the body necessitating urgent limb and life saving 
intervention (Bild et al., 1989).  
                                                     
1Type II diabetes mellitus is abbreviated to ‘diabetes’ from this point on. 
C H A P T E R  O N E   
I N T R O D U C T I O N   
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Regular daily walking is essential to people with diabetes not only for general mobility, but also 
as a self-management practice to assist in glycemic regulation. Regulation of glycemic levels to 
within the non-diabetic range is the goal for people with diabetes, as this limits the severity of 
secondary systemic complications of diabetes, especially cardiovascular disease (Ousman & 
Sharma, 2001). Cardiovascular disease is a leading cause of mortality in people with diabetes and 
walking is the main form of prescribed exercise to limit and treat its effects on the body 
(American Diabetes Association, 1997b). Walking for mobility and exercise poses both the 
people with diabetes and their carers with a dilemma; walk to manage glycemic levels, limit 
cardiovascular disease and potentially prolong life but at the same time also increase the risk for 
the morbidity/mortality associated with pressure-induced foot injury. Clearly, this dilemma would 
diminish if the feet were protected from the stress of impact pressures during walking. 
There are many and varied forms of therapeutic footwear prescribed to people with diabetes to 
provide external foot protection and for ulceration management strategies (Coleman, 1987). 
Therapeutic footwear covers a wide range of shoes and devices that includes socks, different shoe 
styles, insoles and outsole modifications (Payne, 2000a). Socks, shoes and insoles are prescribed 
specific to the patient’s foot needs (Albert & Rhinoie, 1994), whereas there are several outsole 
modifications that are prescribed to modify walking to protect ulceration independently of 
individual foot differences (White, 1994). Even though therapeutic shoe therapy has been funded 
for diabetic patients in the USA via the Medicare Therapeutic Shoe Bill since 1989 (White, 1994), 
no conclusions on their efficacy to protect the foot could be drawn from the Health Care Finance 
Adminstrations’ Therapeutic Shoe Demonstration (Reiber, 1994). Additionally, two randomized 
controlled studies of 352 and 400 diabetic patients, respectively, did not find evidence to support 
the perceived benefit of foot protection from using therapeutic footwear with individually 
prescribed insoles (Litzelman, Marriott, & Vinicor, 1997; Reiber et al., 2002). Therefore, either, 
therapeutic footwear is not effective for non-individualised widespread use unless based on 
individual patient-efficacy evaluation (Cavanagh, Ulbrecht, Caputo, & Lemmon, 1996), or that 
the assumption that therapeutic shoes and their modifications provide protection to ulceration 
through pressure reduction, is unfounded. 
When ulceration is present on the plantar forefoot, a rocker-sole modification to the outsole of the 
shoe is often prescribed with the understanding that the pattern of pressures and resultant stresses 
on the ulceration will be minimised, therefore, allowing healing to occur (Brown, Wertsch, Harris, 
Klein, & Janisse, 2004; Chantelau, Kushner, & Spraul, 1990; Coleman, 1987; Praet & Louwerens, 
2003). The pattern of pressures is assumed to be diverted from the forefoot and ulceration by 
changing the shape and location of the rocker-sole; specifically the pivot position and toe off 
angle. These outsole changes negate the need for the forefoot to be actively involved in ‘pushing 
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off’ for the propulsion of the limb, and instead the limb passively ‘rocks’ forward following the 
shape of the out-sole (Nawoczenski, Birke, & Coleman, 1988). However, it remains an 
assumption and without experimental basis, that these modifications are effective at protecting 
ulceration from walking pressures in people with diabetes, neuropathy and plantar forefoot 
ulceration. If this assumption is incorrect, then this may explain why ulceration healing remains 
unpredictable even when these shoe modifications are used. 
Technological developments of the past three decades and large epidemiological studies have 
yielded experimental evidence that has seen great improvement in the management of the 
glycemic component of diabetes management (American Diabetes Association, 2002). However, 
even with the advent of sophisticated computerised instrumentation that measures in-shoe plantar 
(impact) pressures, clinically applicable evidence to the efficacy of shoe interventions, 
specifically rocker sole modifications, prescribed to protect forefoot plantar ulceration from 
walking impact pressures is scant. This lack of evidence leaves clinical shoe selection to be 
somewhat ad hoc, leaving clinicians to rely on their deductive reasoning and clinical experience, 
and ulceration healing is unpredictable and amputation common. Evidence is lacking for two 
main reasons. First, there is a lack of standardised protocol for dynamic in-shoe plantar pressure 
measurement, which prevents valid comparisons between studies, leaves the uncertainties of 
walking impact pressure measures undefined and prevents intervention evaluation because 
reference databases are not developed (Barnett, 1998). Second, rocker-sole shoe efficacy research 
on clinically relevant diabetic and neuropathic with ulceration patient sample populations are also 
lacking. 
 
General aim of the thesis 
This thesis aimed to test rocker-sole shoe modification designs to select the most effective design 
for protecting plantar hallux and plantar first metatarsophalangeal joint ulcerations from plantar 
pressures during walking in adults with diabetes and peripheral neuropathy. To achieve this, the 
following work was undertaken: 
Chapter Two  
This chapter reports on a review of the literature pertaining to the underlying mechanisms that 
lead to ulceration on the plantar forefoot in the presence of diabetes and the measurement of the 
effect that footwear and footwear modification designs have on these mechanisms. 

Chapter Three  
This chapter reports on the development of a standard protocol for the thesis study using analysis 
of literature and reanalyses of archival in-shoe plantar pressure measurement data. The protocol 
was developed in the chapter over two parts. 
Part I  
This part reports on a protocol analysis that was undertaken of the literature to standardise aspects 
of procedural theory for use in the thesis studies, that were incompletely addressed in the 
International Protocol Guidelines for Plantar Pressure Measurement. .  
Part II  
This part reports on analyses conducted to define the result interpretation limits for the thesis 
studies. The analyses were conducted using an archival database constructed from in-shoe plantar 
pressure measurement results of adults with diabetes, peripheral neuropathy and forefoot 
ulceration. Part II contained four sections: 
a)  A report on a method for checking mid-gait step data validity. 
b)  A report on the number of steps that was required for calculation of a reliable average step 
and its associated precision.  
c)  A report on the number of steps that was required for calculation of an average step with 
maximum practical accuracy.  
d)  A report on the selection of pressure variables for use in analyses for predicting the site of 
ulceration in the thesis studies. 
Chapter Four.  
This chapter describes the methods that are common to all thesis studies. 
Chapter Five.  
This chapter reports on one study and two bench-based experiments conducted to select the 
standard sock to be worn by the subjects in the thesis studies. 
Chapter Six.  
This chapter reports on a study using the protocol and procedures developed and described in 
chapters three and four. In this study, adults with diabetes and normal protective sensation 
(neuropathy-free) were studied while they walked in a standard athletic shoe. The results of this 
	
chapter became the non-neuropathy reference results for the following thesis chapter. Specifically 
this chapter reports on study conducted with the aim to: 
1. Ensure that subjects were not put at risk of foot injury due to the procedures in the thesis 
protocol for in-shoe plantar pressure measurement; 
2. Verify that spatial and temporal gait variables are consistent during in-shoe plantar 
pressure measurement study when subjects self-select their natural comfortable walking 
pace, and; 
3. Explore peak pressures beyond the absolute measured value, and construct and cross-
validate plots of force, mean pressure and peak pressure with 95% confidence bands 
normalised in the time-domain from 0-100% of stance. 
Chapter Seven.  
This chapter reports on a study using the protocol and procedures developed in chapters three and 
four, and tested in Chapter Six. In this study, adults with diabetes and peripheral neuropathy who 
were diagnosed with forefoot ulceration on either their plantar hallux or plantar first 
metatarsophalangeal joint were studied while they walked in a standard athletic shoe.  
Specifically, this chapter reports on peak pressure absolute values and peak pressure-stance time 
plot comparisons made to explore first, the effect of neuropathy, and secondly the difference 
between hallux and first metatarsophalangeal joint ulcerations to each other, and to the non-
neuropathic population (Chapter Six reference results).  
Chapter Eight.  
This chapter reports on a study using the protocol and procedures of Chapter Seven with 
additional subjects and different footwear designs. In this study, the subjects walked in a standard 
athletic shoe, an unmodified therapeutic shoe and therapeutic shoes with five different rocker-sole 
modifications.  
Specifically, this chapter reports on peak pressure absolute values and peak pressure-stance time 
plot comparisons made between hallux and first metatarsophalangeal joint ulcerations when 
walking in the different shoes to determine the shoe or shoe modification that was most effective 
in protecting ulceration from walking pressures.  
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Research questions 
1. Are in-shoe plantar pressure measures of walking in the adult diagnosed with diabetes, 
peripheral neuropathy and ulceration:  
a) reliable,  
b) precise,  
c) accurate, and  
d) can they identify the location of forefoot ulceration? 
2. Are in-shoe plantar pressure measurements of walking in adults with diabetes: 
a) affected by differing sock fabric, and  
b) do they impose foot injury risk? 
3. Are in-shoe plantar pressure measures of walking in the adult with diabetes, peripheral 
neuropathy and ulceration significantly different between: 
a) ulceration site,  
b) shoe type, and  
c) rocker-sole shoe modifications? 
4. Is there a particular rocker-sole shoe modification design (angle and pivot position) that 
affords the best protection from plantar impact pressures to ulcerations on the: 
a) plantar hallux and  
b) plantar first metatarsophalangeal joint? 
5. Do examinations of plots of peak pressures, as they relate to percent-normalised stance 
time, provide more clinically useful insight into walking pressures than the absolute peak 
values? 
To provide order to the overall complexity of the thesis, a specific format for directing the flow of 
inquiry was mapped with clear ties through to the desired outcome and is presented in Figure 1. 
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ulcera tion, but there  is  scant evidence o f the ir efficacy to  perform  this role
E vidence  for rocker-outso le  e fficacy is scant because dynamic
in-shoe p lantar p ressure m easurem ent is  not standard ised  and
interpreta tion bounds are  undefined
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Figure 1. Concept map that shows the flow of the thesis studies towards the required outcome 
(1MPJ = first metatarsal phalangeal joint). 

Assumptions 
The measurement of walking impact pressures using the Pedar™ system in the laboratory is a 
valid representation of impact pressures transferred to the plantar foot from the ground/shoe 
interface during general walking. 
Steps measured in the middle section of walking, that exclude any starting, stopping or turn 
around steps, are a valid representation of steps taken during general level ground walking. 
Lack of statistically significant difference from a one way paired t-test with unequal variances 
confirms the validity for pooling limbs as independent measures. 
Delimitations 
Texas Diabetes Institute (San Antonio, Texas, USA) patients were studied. 
Ulceration located on the plantar hallux or plantar first metatarsophalangeal joint anatomical 
regions were studied. 
Pedar™2 pressure insole analysis system was used for in-shoe dynamic study. 
F-scan™3 pressure insole analysis system was used for bench-based study. 
EMED™4 pressure plate system was used for un-shod dynamic sock study. 
GaitMat II™5 gait measurement system was used for subject-as-control verification study. 
Limitations 
Measures of the subjects with diabetes, neuropathy and forefoot ulceration and their walking that 
may contribute to explanation of impact pressures (velocity, step length, limb length, muscle 
flexibility and strength, joint ranges of motion) were not obtained. 
Left and right limbs were not statistically significantly different at p<0.05 and were therefore, 
treated as being independent for all analyses. 
                                                     
2
  Novel Electronics Incorporated, St. Paul, Minneapolis, USA. 
3
  Tekscan, Boston, New York, USA. 
4
  Novel Electronics Incorporated, St. Paul, Minneapolis, USA. 
5
  GaitMat II, Chalfont, Philadelphia, USA. 

Background 
The literature reviewed for this thesis was obtained initially by reading the key textbooks and 
peer-reviewed journals related to the topic of inquiry. The books included: Pain: The Gift That 
Nobody Wants, Levin and O’Neal’s: The Diabetic Foot, Diabetic Neuropathy, Diabetes Mellitus 
and the Foot and Medical and Surgical Management of the Diabetic Foot. The peer reviewed 
journals included: Diabetes Care, Diabetic Medicine, Journal of Bone and Joint Surgery, The 
Foot, Journal of the American Podiatric Medical Association, Foot and Ankle, Journal of Foot 
and Ankle Surgery, Archives of Physical Medicine and Rehabilitation, Gait and Posture, Journal 
of Prosthetics and Orthotics and Clinical Biomechanics.  
Specific research reports were located using computerised databases by imputing key words that 
were identified from the initial reading. The databases included: Pub Med, CINAHL, The 
Cochrane Library, and Academic Search Premier. The key words included: diabetes, foot 
ulceration, neuropathy, plantar pressure, footwear, therapeutic shoe, rocker-sole, diabetes and 
exercise, amputation and foot-care. 
This review of the literature will be formatted under five main headings, these being: 
• Diabetes and its complications that lead to ulceration of the foot 
• Diabetic complications and foot ulceration 
• Diabetic foot ulceration classification and prevalence 
• Footwear and ulceration 
• Footwear and foot protection from walking pressures 
C H A P T E R  T W O   
R E V I E W  O F  T H E  L I T E R A T U R E  
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Diabetes and its complications that lead to ulceration of the foot 
The epidemiology and monetary cost of diabetes mellitus (diabetes) 
Diabetes mellitus (diabetes) is a disease that may have devastating consequences that may be 
preventable and one of these is diabetes related foot and leg amputation. Epidemiology statistics 
show that the disease of diabetes is of epidemic and expanding proportions, that shows no sign of 
stabilising or abating. More than 150 million adults worldwide suffer from diabetes, a figure that 
is expected to double over the next 25 years (American Diabetes Association, 2002). The 
prevalence of diabetes varies widely between populations. Prevalence is reflected in 
environmental influences and genetic susceptibility and is a consequence of the advancing age of 
populations and the effects of modernisation of lifestyle (Dunstan et al., 2002). There are many 
reports about diabetes from the United States of America (USA). This country is estimated to 
have the largest number of people with diabetes of all the developed countries, with more than 16 
million people currently diagnosed with the disease (American Diabetes Association, 2002). The 
Asia and Pacific region (Australia) has also been found to have very high rates of diabetes. There 
are two Australian reports that show that diabetes prevalence more than doubled between the 
years of 1981 and 2002 (Dunstan et al., 2002; Glatthaar, Welborn, Stenhouse, & Garcia-Webb, 
1985). There was a prevalence of the disease of 8.0% in men and 6.8% in women in total in the 
Australian population in 2002 and an additional 17.4% of men and 15.4% of women had impaired 
glucose tolerance, which is an indicator of diabetes risk (Dunstan et al., 2002). These statistics 
suggest that approximately 2.5 million Australians have diabetes and a further 5.5 million are at 
risk of diabetes, confirming that diabetes is a disease of epidemic proportions in Australia as well 
as worldwide. 
Diabetes is an expensive disease to treat and in the USA, one in every seven dollars spent on 
medical care is related to diabetes, with an annual cost of over $US100 billion (Black, 2002). 
Modelling of the cost of treating diabetes and its complications has facilitated a monitory estimate 
based on blood glucose level over time. It suggests that a person who has been diagnosed with 
diabetes for five years without ideal glucose control will cost the health system, an average of 
$US47, 240 over a period of 30 years (Caro, Ward, & O'Brien, 2002). A major limitation of this 
model is that it optimistically assumes that many complications such as foot ulcerations are 
reversible and are “episodes” that will resolve, an assumption that is questionable such that the 
realistic per-person cost could be much higher. Part of the cost of diabetes can be clearly 
demonstrated from hospital utilisation statistics. Diabetes has been shown to account for 3 million 
hospital stays in the USA (Black, 2002), and 0.12% of all admissions and 0.41% of total bed/days 
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in New Zealand (Payne, 1997). The costs related to keeping a person with diabetes out of hospital 
would be difficult to tally, but at least 15 million physician visits are attributed to diabetes in the 
USA annually (Black, 2002). There is no doubt that diabetes poses a significant health cost 
burden with recognition as being the fifth National Health Priority Area in Australia (DHAC & 
AIHW, 1999). 
The disease of diabetes  
To more fully elucidate the problem of diabetes, it is useful at this point to outline the disease. 
Diabetes is a group of metabolic diseases that are characterised by hyperglycaemia, commonly 
referred to as high blood sugar. Hyperglycaemia is caused by the body’s inability to produce or 
effectively utilise enough insulin, a hormone that the body uses to convert food into energy 
(glucose) (Black, 2002). The main concern with diabetes is the range of acute and chronic 
complications that can be experienced in isolation and combination. The range of complications 
means that diabetes cannot be managed paternally with medical supervision and therapy alone. 
The treatment must be in partnership, with the patient taking full control of living with the 
disease, assisted by education under medical supervision. The complexity of diabetes means that 
there is interest from multiple persons in addition to the patient and the medical personnel. These 
include researchers, educators, clinicians, carers and third party payers. The American Diabetes 
Association (ADA) supports interested parties in many forms and funds committees and research 
reports and commissions position statements that focus on particular needs, not only useful to 
Americans, but also worldwide, and these readily apply to the Australian context. 
In 1997, the ADA issued a position statement that determined new diagnostic classification 
criteria for diabetes (American Diabetes Association, 1997c). The classification includes four 
clinical classes: Type 1 diabetes, Type 2 diabetes, other types (that includes; genetic defects, 
diseases of the exocrine pancreas, drug or chemical induced) and Gestational diabetes mellitus. 
Type 1 and 2 are the most common forms of the disease, with Type 1 generally being identified in 
younger people due to the severity of onset with absolute dependency on insulin injection to 
survive, and Type 2 with a more insidious onset, typified in the overweight, unfit and older aged 
person. This thesis focuses on Type 2 diabetes characterised by insulin resistance and inadequate 
beta cell insulin secretion, because these people represent more than 90% of the population 
diagnosed with diabetes (Beckman, Creager, & Libby, 2002).  
All sub-diagnoses of diabetes are determined by criteria that include the presence of classic 
symptoms of diabetes in conjunction with measurement of blood sugar level administered via a 
blood test. The classic symptoms of diabetes include excessive urination (polyuria), excessive 
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thirst (polydipsia), unexplained weight loss and raised blood glucose level (hyperglycaemia). The 
aim of diagnosis, treatment and management of diabetes is to maintain the blood glucose 
(glycaemic control) levels, measured via the glycosylated haemoglobin (HbA1C) at a three-month 
average, at less than 7% (HbA1C has a normal range of 4.2 to 7.4%). Glycaemic control success 
has been associated with reduced rates of the serious complications of diabetes. The complications 
of diabetes that are most prominent are blindness (retinopathy), kidney failure (nephropathy), and 
loss of nerve function resulting in foot injury, ulceration and amputation (neuropathy) (Boulton, 
1996). People with diabetes are also at a greater risk of cardiovascular disease and this risk can be 
reduced with intensive glycaemic control and regular exercise (Ousman & Sharma, 2001). 
Management of diabetes and the risk to the foot 
Walking is the main form of exercise prescribed to people with diabetes to maintain homeostasis 
and therefore, reduce cardiovascular disease risk (American Diabetes Association, 1997a). 
Cardiovascular risk reduction via glycaemic control is achieved when the blood glucose level is 
maintained within the non-diabetic limits. Glycaemia control is managed with diet and exercise, 
which equates to limiting the glucose put into the body (diet control), and eliminating any excess 
from their body (exercise). When sufficient control is not achieved by diet and exercise alone, 
then drug therapy is initiated. The initiation of drug therapy can assist to regulate glycaemic 
fluctuations, but unlike many diseases, drug therapy is insufficient without continued and 
carefully managed diet and exercise.  
Minor foot injuries are possible for all people who walk, especially to the plantar forefoot and the 
toes due to irritations from ill-fitting footwear and normal walking pressures. However, sensory 
and nutritional compromises limit both prevention of injury and limit protection of existing injury 
during walking. Therefore, leaving potentially minor injuries likely to progress to ulceration 
(American Diabetes Association, 1999). Foot injuries resulting in ulceration, which are cutaneous 
erosions characterised by a loss of epithelium that extends into or through the dermis to deeper 
tissue, are a ready portal for infection. If the ulceration is unresolved, infection may lead to the 
surgical removal or amputation of part of the limb (Reiber, 2001).  
An average of 2629 diabetes-related foot or leg amputations occur in Australia each year with a 
prevalence of 11.34 per 100 000 of total population (Payne, 2000b). Unfortunately, amputation is 
a likely event from poor healing or infection of the foot ulceration in patients in the 65 – 79 age 
group (Payne, 2000b), and stems in a large part from ad hoc prescription of, and inadequate 
design of injury protection footwear (Litzelman et al., 1997; Ross, 1962; Ulbrecht, Perry, Hewitt, 
& Cavanagh, 1994). Currently, clinicians and diabetes patients are in a dilemma. There is growing 
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evidence that walking daily as exercise assists in maintaining homestasis and therefore, reducing 
diabetes and cardiovascular disease severity, but at the same time, carries increased risk to injure 
the insensitive foot. Clearly, this dilemma may diminish if appropriate shoes could be prescribed 
to the diabetic patient that protected ulceration and areas of high risk of injury on the insensitive 
foot from adverse walking pressures while not limiting the benefits gained from a normal walking 
exercise regime. 
Understanding the mechanism of injury is essential before prevention and protection can be 
instigated. A foot injury is an uncommon event when the feet can detect normal sensory input 
such as temperature, pressure and pain. If injury does occur, then the source of injury is not only 
obvious, but either highly preventable or accidental and its extent is minimised by the person’s 
reaction. The person will react to both remove themselves away from the injury risk and if injury 
occurs initiate care to protect the injury and encourage healing. Injury can be denoted either as 
being specific, where the skin has been broken, or insidious where there has been sufficient 
disruption of the skin and tissue layers or cells that results in tissue ischaemia. For the skin to be 
broken, the trauma can occur if a small force is applied to a small area, such as a pin prick. 
However, for a large injury to occur a much higher force is necessary (Sanders et al., 1995). 
Hence, the area over which a force is applied is critical to the type and occurrence of the injury 
and this is quantified as pressure (Pressure = Force divided by Area). In the person with diabetes 
whose feet are insensitive to pain, they do not receive the sensory input to alert them to react to 
move away from the risk and limit further injury, or initiate care to protect the injury that has 
occurred. This places them at risk of specific and insidious injury to their feet from everyday 
events. Specifically, localised regions of high pressure have been recorded under the foot both at 
sites where ulceration commonly occur (Veves, Murray, Young, & Boulton, 1992). The presence 
of localised regions of high pressures under the foot is confirmed as a prerequisite for and 
aetiological factor in the development of ulceration in people with diabetes whose feet are 
insensate (Cavanagh, Ulbrecht, & Caputo, 2001).  
The physiological complications of diabetes and the risk to the foot 
In diabetes, two main complications have been shown to be of constant concern due to two main 
diabetic complications, angiopathy and neuropathy, and this is due to their role in potential 
ulceration occurrence and poor healing, which potentially leads to foot or leg amputation (Adler, 
Boyko, Ahroni, & Smith, 1999; Tooke & Brash, 1996). The model developed by Levin (1983) 
shows the pathways through which these complications can lead to ulceration or amputation and 
is presented in Figure 2. The model shows five main pathways, two that stem from angiopathy 
and three from neuropathy. Cardiovascular (large vessel), and peripheral vascular (small vessel) 
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disease follow the angiopathy pathways. This thesis is concerned with injury risk during walking, 
and walking is prescribed as therapeutic exercise for vascular disease and will be discussed later. 
The neuropathy pathway that describes motor neuropathy is limited in its applicability to this 
thesis. Motor neuropathy may present as foot deformities and abnormal walking or gait patterns 
that would limit therapeutic shoe interventions. The peripheral neuropathy6 pathway that exhibits 
as loss of protective sensation in the foot forms the basis for selecting the population for the thesis 
inquiry. This pathway suggests how the person with diabetes cannot identify an irritation to the 
foot or potential injury until it has occurred, nor protect an existing injury or ulceration to allow 
healing to occur. Even though Levin’s model clearly defines pathways through which the disease 
of diabetes can lead to amputation, its prevention is not readily achievable. This makes clinical 
management of this problem particularly difficult as some or all complications may be present in 
a greater or lesser degree, especially in the environment of poor blood glucose control in an 
ageing adult.  
Diabetic complications and foot ulceration 
The diagnoses of diabetes and neuropathy were first linked in the 19th century. Leval-Picquechef 
in 1855, as cited by Taylor and Dyck (1999), described the complication of neuropathy as causing 
serious symptoms and impairments, but not death. The link between insensitivity of the foot due 
to peripheral neuropathy and the need for external and artificial foot protection was then 
confirmed by Paul Brand in his work with people suffering from Leprosy (Brand & Yancey, 
1993). In his book, aptly titled: Pain the gift that nobody wants, Dr. Brand eloquently described 
his revelation into the link between insensitivity of the feet and injury, poor healing and ulceration 
(Brand & Yancey, 1993).  
                                                     
6
 Peripheral neuropathy is shortened to neuropathy from this point on. 
	
 
From: Levin, M. E. (1983). Medical Evaluation and Treatment. In M. E. Levin & L. W. O’Neal (Eds.), The Diabetic Foot. 
St Louis: C. V. Mosby Company, Figure 1.1, Page 2. 
Figure 2. Pathogenesis of diabetic foot lesions.  
In summary, Dr. Brand wrote that after carefully cleaning and bandaging a significant plantar foot 
ulceration for his friend who was diagnosed with both Leprosy and peripheral neuropathy: 
Instead of returning to my examining room, I stood and watched Sadan walk down the 
steps, cross a sidewalk,…Then for the first time I noticed something. He had no 
limp!…he was putting his full weight on the exact spot we had so carefully treated. No 
wonder the wound never healed (pp. 119-120). 
This observation directed Dr. Brand towards designing therapies for leprosy affected feet to 
provide artificial protection during walking. In the early 1970’s, Dr. Brand was invited to present 
his findings on the clinical management of leprosy to specialists in diabetes, and from this point 
on these patients too began to benefit from foot protection therapies (Brand & Yancey, 1993). 
Insensitivity of the foot to pain during walking not only leaves it vulnerable for injury and poor 
healing, but other forms of neuropathy also make injury more likely.  

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Neuropathy affects the foot in several ways and the distinctions between sensory (peripheral), 
motor and autonomic neuropathy made in Levin’s (1983) model presented in Figure 2, cannot be 
readily made. They all fall under the diagnosis of diabetic polyneuropathy. Diabetic 
polyneuropathy has been described to follow a time line where symptoms of the presentations 
described in Levin’s model can be identified. Taylor and Dyck (1999) described this time line as 
beginning with an abnormality of nerve conduction, followed by loss of ankle reflexes and 
decrease of vibration perception in the toes. Further sensory loss (peripheral neuropathy) follows 
and signs of autonomic dysfunction (autonomic neuropathy) can be seen in the legs and feet. In 
the severe cases, signs of motor dysfunction (motor neuropathy) will eventually be seen with 
weakness of toe extension, ankle dorsiflexion, and development of toe flexion deformities (Taylor 
& Dyck, 1999). Polyneuropathy is a result of nutritional deficit and affects the most distal portion 
of the longest nerves first. As nerve damage progresses proximally along the nerve, nerve 
function is lost to the toes and feet in a distribution like a sock. Once damage has extended to the 
region of the knee, then the hands also become involved in a similar distribution like a glove. 
Generally, the person with diabetes is significantly ill with multiple complications of diabetes, 
especially cardiovascular disease), before much dysfunction of the hands is noticed (Brand & 
Yancey, 1993). 
The co-occurrence of the diabetic complications of neuropathy and cardiovascular disease are 
confounding factors in using walking as exercise therapy to manage systemic severity of diabetes. 
As discussed in Chapter One, walking can reduce the severity of diabetes and cardiovascular 
disease whilst increasing the potential for incurring an injury to the insensitive foot. There is 
emphasis on managing cardiovascular disease because it is implicated as the cause of most of the 
death and much of the disability related to diabetes (Beckman et al., 2002). Cardiovascular 
disease affects the brain, heart and lower limbs in its non-specific form and in its specific form it 
occurs as microangiopathy affecting small vessels (Spittell & Brown, 1999). Atherosclerosis 
affects the whole population, but with diabetes its incidence increases to 2- to 4-fold that of the 
normal population and its clinical course is accelerated (Beckman et al., 2002). This is 
demonstrated in the increased risk from myocardial infarction that the person with diabetes incurs. 
The person with diabetes has the same risk of suffering and dying from their first myocardial 
infarction as the risk that the non-diabetic person has of dying once they suffer repeated 
myocardial infarctions (Beckman et al., 2002). Beckman et al,  reported that the five year 
mortality rate following a myocardial infarction for those with diabetes was 50%, which is at least 
double that of the non-diabetic population. The epidemiological evidence reviewed by these 
authors confirmed that the specific presentation of cardiovascular disease, namely peripheral 
vascular disease, occurred at a higher prevalence with diabetes. Additionally, the extent of 
peripheral vascular disease was related to the duration and severity of diabetes and the level of 
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glycaemic control (or rather lack of control). peripheral vascular disease either presents with 
diabetes as intermittent claudication (Brandsma et al., 1998) or occlusion of the blood vessels 
below the knee. This occlusion predisposes the limb to ischaemia7 that may result in ulceration, 
gangrene and, potentially, amputation. Unfortunately, controlling hyperglycaemia reduces the risk 
of micro-vascular (but not macro-vascular) disease, and cardiovascular disease events increase 
once the HbA1C measured is greater than 6.2% (Beckman et al., 2002). Beckman et al. also 
reported that controlling hypertension limits cardiovascular disease far more effectively than 
controlling hyperglycaemia, and this required weight loss, smoking cessation, dietary 
modification and exercise. With these life style modifications and supporting drug therapies, 
Beckman et al. recommended that supervised exercise therapy in the form of limited, but 
progressively extended distance walking, be the primary prescription issued to people with 
diabetes.  
For a person with diabetes and neuropathy, walking brings with it concerns due to their inability 
to sense impending injury. Foot insensitivity has been associated with the occurrence of foot 
ulceration by many authors (Adler et al., 1997; Armstrong, Lavery, Vela, Quebedeaux, & 
Fleischli, 1998; Boulton, Kubrusly et al., 1986; Sosenko, Kato, Soto, & Bild, 1990). Specifically, 
Sosenko et al. (1990) examined 314 people with diabetes, 91 of whom had either ulceration or a 
history of ulceration, and found both the presence of foot ulceration and a history of having had 
foot ulceration to be strongly associated with loss of protective sensation. This is in agreement 
with Boulton, Kubrusly et al. (1986) who preformed a case-control investigation and compared 86 
people with diabetes and ulceration to 49 controls who were diagnosed with diabetes but without 
ulceration or history of ulceration. Armstrong, Lavery, Vela et al. (1998) explored this 
relationship further with 30 cases (diabetic with ulceration or history of ulceration) and 85 
controls (diabetic without history of ulceration) and found that loss of protective sensation when 
confirmed by two methods was 100% sensitive for identifying diabetes patients at risk of 
ulceration. There is growing evidence that ulceration is associated with foot insensitivity and 
therefore, determines the role of therapeutic interventions in ulceration prevention and healing. 
Establishing the level of peripheral neuropathy and therefore, sensation allows the clinician to 
determine when protecting the foot during walking using external and artificial means like 
footwear becomes necessary. Clinical tests for neuropathy of the lower limb and feet are 
categorised from sensitivity criteria (Grant, O'Brien, & Dyck, 1999). Grant et al. (1999) reported 
that nerve conduction was most sensitive, neuropathy impairment score for the lower limb  
                                                     
7 Tissue ischaemia is assessed from local oxygen perfusion and is measured via the transcutaneous oxygen pressure found 
on the dorsal foot skin (Hauser, Klein, Mehringer, Appel, & Shoemaker, 1984) 
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(NISLL) questionnaire and vibration perception threshold (VPT) less sensitive, while pressure, 
temperature perception and ability to walk on the heels were the least sensitive. 
Some clinical tests to diagnose peripheral neuropathy have limitations in their practical use in the 
clinical setting and these include; nerve conduction, application of the NISLL and temperature 
sensation assessment. The ideal test for assessing vibration and touch-pressure sensations is nerve 
conduction testing because this information is conducted via the large-fibres (Bartlett, Stewart, 
Tamblyn, & Abrahamowicz, 1998). However, nerve conduction testing is not practical in the 
clinical setting because it requires the expert application of electric current to sites on the lower 
limb proximal to the foot and ankle8. The NISLL is another less applicable test, even though it is 
the gold standard for neuropathy testing (Dyck & Dyck, 1999). According to Dyck and Dyck 
(1999) the NISLL is a reliable and valid tool when conducted by neurologists but it is not 
designed for clinical use due to concern for reliability and the time required to conduct and grade 
the nine tests for foot and lower limb testing. 
Loss of temperature sensation is another diagnostic tool specifically to determine the involvement 
of the smaller peripheral nerve fibres, but its clinical usefulness is limited as it requires extensive 
testing for valid and reliable application (Sosenko et al., 1990). The methodology reports of 
Sosenko et al. (1990) and Bartlett et al. (1998) describe temperature sensation testing to be 
extremely time consuming, requiring the patient to judge perception of temperature differences 
between probes warmed or cooled initially at ten degrees Centigrade increments, progressing 
eventually to one degree increments. Clinical temperature sensation perception is unreliable due 
to the high inter-subject variability reported from a study of 148 healthy adults by Bartlett et al. 
Sosenko et al. (1990) also investigated the thresholds of vibration, pressure and temperature in 
people with diabetes with or without ulceration. They found temperature to be correlated to the 
simpler and quicker tests for vibration and pressure, and all to be associated with ulceration. 
Therefore, in the clinical setting, where time generally takes precedence over specificity, those 
tests that can quickly and reliably identify those patients at risk of ulceration are utilised.  
Peripheral neuropathy testing for foot insensitivity 
Determining a critical level of neuropathy that leaves the foot insensitive and at injury risk has 
been standardised and validated for clinical application by a number of authors under the two 
broad areas of vibration perception threshold (VPT) and cutaneous pressure sensation 
                                                     
8
 The Act of law under which Podiatry is registered and practised in most states of Australia and in several other countries, 
limits invasive tests and procedures to structures that are distal to the level of the ankle joint. 
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(Armstrong, Hussain et al., 1998; Armstrong, Lavery, Vela et al., 1998; Birke & Sims, 1986; 
Boulton, Kubrusly et al., 1986). Cavanagh and Ulbrecht (1994) reported that the accepted 
thresholds to diagnose the existence of sensation loss and potential for foot injury are based on the 
statistical analysis of clinical tests that require the patient to judge between graduated sensations 
rather than only a yes/no observation. Dr. Andrew Boulton has reported extensively on procedures 
used in studies into the health of the diabetic foot and they utilised the biothesiometer for 
determining VPT (Boulton, 1990; Boulton, 1991; Boulton, 1992; Boulton et al., 1987; Boulton, 
Kubrusly et al., 1986). The biothesiometer is an electronically controlled instrument that has a 
variable-rate vibrating tip that is controlled by a voltage input of 0 to 50 mV. The tip is placed on 
the apex of the hallux and the voltage is adjusted until the level that the patient can no longer feel 
the tip vibrating is established. The vibration resulting from 25mV has been reported to delineate 
the 90th percentile of the VPT at the hallux in healthy older adults (Bloom, Till, Sönsken, & 
Smith, 1984). While a VPT of greater than 25mV at the hallux is reported to be an effective 
predictor of foot sensory loss and ulceration risk (Boulton, Kubrusly et al., 1986; Young, Breddy, 
Veves, & Boulton, 1994). The measurement of VPT is an effective clinical indicator, but there is 
growing evidence that other sensory measurement may also be useful. 
Evidence is growing that the measurement of pressure sensation is an effective clinical indicator 
for sensory loss. Sosenko et al. (1990) and Armstrong, Lavery, Vela et al. (1998) have reported on 
the associations that both VPT determined by the biothesiometer and pressure sensation threshold 
from Semmes-Weinstein monofilaments hold with the presence of ulceration in the diabetic 
population. Semmes-Weinstein monofilaments are nylon fibres of different diameters that are 
attached to a handle. The size of the filament determines how much mass is required to make the 
filament bend. The tip of the filament is applied perpendicular to the skin at several locations on 
the foot and the patient is asked if and where they can feel the filament while their eyes are closed. 
Lack of perception of the pressure applied from a 5.07 diameter (that bends with an applied mass 
of 10 gram) monofilament is predictive of a level of neuropathy that identifies a person with 
diabetes to be at risk of ulceration (Armstrong, Lavery, Vela et al., 1998; Kumar et al., 1991). Due 
to their portability, small cost and minimal training needed, S-W monofilaments predominate as 
the clinical diabetes neuropathy-screening tool. 
Diabetic foot ulceration classification and prevalence 
The locations and prevalence of ulceration on the foot have been reported by several authors 
(Armstrong, Lavery, & Harkless, 1998; Birke & Sims, 1986; Ctercteko, Dhanendran, Hutton, & 
LeQuesne, 1981; Sosenko et al., 1990). Two of these reports specified the ulceration location 
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incidence in detail, and this is presented in Table 1. This is in agreement with other authors who 
reported the plantar hallux, 1MPJ and fifth MPJ to be the commonest sites for ulceration to occur 
(Ctercteko et al., 1981). Sosenko et al. (1990) appeared to have a similar combined hallux and 
digits ratio (45%), but their MPJ area result was much lower (12%), while their mid-foot result 
was much higher (20%). Therefore, ulcerations may occur on any part of the foot and this thesis 
will include the most prevalent ulceration locations that are the plantar hallux and 1MPJ. 
Table 1   
Foot ulceration incidence per anatomical locations reported for adults with diabetes and 
peripheral neuropathy. 
Plantar foot region Percentage of ulcerations on foot (%) 
   
 Armstrong, Lavery, & 
Harkless (1998) 
Birke & Sims (1986) 
Hallux 30 25 
Lesser digits 23 (apex: 10%, dorsum: 13%) 15 
1MPJ 22 19 
2-4 MPJ 23 18 
5 MPJ 9 15 
Midfoot 4 6 
Heel 1 2 
MPJ = metatarsal phalangeal joint 
 
The level of classification of ulceration determines the level of concern and clinical intervention 
required (Lavery, Armstrong, & Harkless, 1996). Lavery et al. (1996) developed and Armstrong, 
Lavery, and Harkless (1998) validated The University of Texas Wound Classification System to 
assist clinicians to standardise their approach to diabetes foot ulceration management and it is 
presented in Table 2. Their classification system relies on three basic questions. These questions 
are: ‘How deep is it?’, ‘Is it infected?’ and ‘Is it ischemic?’. The depth of the ulceration is then 
graded as either being 0, 1 or 2, while the infection or ischemic state of the ulceration is graded in 
four stages, being Stages A to D.  
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Table 2   
The University of Texas Diabetic Wound Classification System. 
  Grade    
  0 1 2 3 
 A Pre or post-ulcerative 
lesion completely 
epithelialized 
Superficial wound, 
not involving 
tendon, capsule, or 
bone 
Wound 
penetrating to 
tendon or capsule 
Wound 
penetrating to 
bone or joint 
 B with infection with infection with infection with infection 
Stage C with ischemia with ischemia with ischemia with ischemia 
 D with infection and 
ischemia 
with infection and 
ischemia 
with infection and 
ischemia 
with infection 
and ischemia 
From D. G. Armstrong, L. A. Lavery, and L. B. Harkless (1998) Validation of a diabetic wound classification system. 
Diabetes Care, 21(5), pp. 855-859. 
 
 
As ulcerations increase in both depth and stage, the prevalence of amputation also increases 
(Armstrong, Lavery, & Harkless, 1998). These authors further reported that ulceration which 
extended to the bone were 11 times more likely to result in amputation, and in the presence of 
infection or ischaemia, this risk increased to 90 times. Ulceration that is categorised with infection 
or ischaemia (Stage C or D), or penetrates into tendon or bone (Grade 2) requires medical 
intervention and is beyond the level of management with footwear alone and is beyond the scope 
of this thesis. Ulceration that is categorised as Grade 1 and Stage A and potential ulceration 
categorised as Grade 0 Stage A are relevant to this thesis because footwear is integral to their 
management. According to Armstrong, Lavery, and Harkless, Grade 1 and Stage A ulceration 
described 25.8% of the 300 diabetes foot ulcerations assessed by them, and a further 4.2% were 
potential ulceration (Grade 0 Stage A). Combination of these ulceration categories leaves 30% of 
ulceration to be primarily managed with footwear. Unfortunately, evidence to the efficacy of 
common footwear and footwear modifications to protect ulceration from walking pressures is 
lacking, leaving footwear as therapy prescription to be ad hoc and healing to be unpredictable. 
This thesis will address this lack of evidence, and potentially reduce the undue suffering resulting 
from poor clinical outcomes of 30% of people with diabetes, neuropathy and plantar ulceration. 
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Footwear and ulceration 
The role of footwear in foot ulceration 
Ulceration develops predominately at those sites on the foot that endure the highest pressure when 
walking and especially when a callus has formed (Edmonds & Watkins, 1999; Young et al., 
1992). Therefore, it makes sense that healing cannot occur if the injury is not adequately protected 
and mechanical trauma is ongoing (Cavanagh et al., 2001). Shoes are the primary means of 
protecting insensitive feet. When a shoe upper doesn’t fit well, then injuries will occur where the 
shoe exerts direct pressure onto the foot and tissue ischaemia results. Such sites are commonly the 
medial, lateral or dorsal forefoot and toes, or the dorsum of the foot (Coleman, 2001). It has been 
reported that 93% of ulceration in the diabetic and neuropathic population occurred in the forefoot 
(Edmonds et al., 1986). Of particular interest, Edmonds et al. reported, from a footwear 
perspective, that ulceration on the dorsal and plantar surfaces were approximately evenly 
distributed. Since dorsal ulceration are invariably shoe related, then the reported distribution 
indicates that approximately half of all ulceration could be avoided very simply by footwear that 
is appropriately sized and fitted (Cavanagh et al., 2001). The report by Uccioli et al. (1995) 
contributes to knowledge of the potential risks from everyday footwear with their study of people 
with diabetes and a history of healed ulceration. These people were assigned to wear either their 
own footwear or were supplied with well-fitted footwear with padded insoles. The results showed 
that footwear is associated with ulceration because after one year 58.3% and 27.7% reulcerated in 
the group with their own footwear and the therapeutic footwear, respectively (Uccioli et al., 
1995). Therefore, potentially, it’s the proper use of footwear will not only influence ulceration 
healing but also have a role in prevention of foot injury. 
The footwear sole and force dispersion 
Injury on the plantar surface of the foot is related to the shoe sole and insole’s ability to transfer 
pressures. Pressure transfer or dissipation is described as the cushioning ability of the shoe and is 
the protective function afforded by shoe outsoles and insoles (Cavanagh et al., 2001). Cushioning 
is a general concept that has several meanings, but mechanically it can be defined as “controlling 
the energy of a collision” (Cavanagh et al., 2001). When addressing the cushioning ability of an 
insole it is important to note that the forces of walking are only dispersed , and not altered in 
magnitude. Dispersion of the forces away from the fragile skin over prominent bony points of the 
plantar foot using different materials or different shaped insoles allows a greater area of the foot to 
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cope with the same force. Therefore, this results in a lower pressure being experienced by the 
foot, and this coping is described mechanically as damping (Cavanagh et al., 2001). Damping 
means that the pressure applied to the bony points are not met by a shoe outsole that acts as a 
spring and pushes the forces away, but is both transformed from mechanical energy into thermal 
energy and dispersed to adjacent areas. There is an abundance of data describing the damping 
properties of common insole materials (Boulton, Franks, Betts, Duckworth, & Jard, 1984; 
Brodsky, Kourosh, Stills, & Mooney, 1988; Foto & Birke, 1998).  
Another way of dissipating adverse pressure away from prominent injury sites is to influence the 
load to move differently. This relieves high pressure areas and transfers it to less vulnerable areas 
(Edmonds & Watkins, 1999). There are several approaches to transfer the load to other sites and 
these include shaped insoles or orthoses, rocker-sole modifications to therapeutic shoes and casts 
or walking devices. The most widely investigated has been the total contact cast (TCC) 
(Armstrong & Athanasiou, 1998; Armstrong & Stacpoole-Shea, 1999; Coleman, Brand, & Birke, 
1984; Guzman, Fisher, Palladino, & Stavosky, 1994; Helm, Walker, & Pulliam, 1984; Kominsky, 
1991). The TCC is applied directly and firmly to the non-weight bearing foot and leg in such a 
manner that when the cast is walked on, the cylindrical leg component bears some of the loads 
normally experienced by the foot (Armstrong & Stacpoole-Shea, 1999). There are are also 
removable forms of casting that are termed walkers and both the TCC and walkers are 
successfully utilised to heal ulceration (Armstrong & Stacpoole-Shea, 1999; Baumhauer, Wervey, 
McWilliams, Harris, & Shereff, 1997; Boulton, Bowker et al., 1986).  
The most common means to dissipate pressure away from prominent injury sites is to alter the 
weightbearing surface and this is achieved by using padded and moulded insoles or dressings 
(Armstrong, Liswood, & Todd, 1995; Holmes & Timmerman, 1990). A moulded insole is 
generally made in a sandwich manner where a cushioned material is adhered over a more rigid 
material that is moulded to the foot shape. Moulded insoles have been reported to redistribute 
pressure away from plantar foot sites and to do so far more effectively than flat insoles (Lord & 
Hosein, 1994). However, there are severe limitations on pressure study into insole efficacy due to 
individual patient and insole variations in addition to instrumental measurement uncertainties 
(Lord & Hosein, 1994). Insoles and dressings have also been indicated as the cause of foot injury 
and the paper by Armstrong and Athanasious (1998) discussed the injury risk potential if insole 
design did not adequately control load transference away from potential injury sites.  
Load transference away from potential injury sites and ulceration is affected by the use of rigid 
modifications to the shoe outsole. Outsole modifications frequently take the form of either a 
rocker or a roller sole that is manufactured to replace the normal shoe sole and are made by 
specialist shoe technicians guided by prescription from a clinician. The rigid outsole acts to 
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prevent the need for the forefoot to flex at the metatarsophalangeal joints. Reduced flexion lessens 
the prominence of the metatarsal head component of the joint and thus reduces the exposure of the 
fragile plantar skin to injury during loading (Nawoczenski et al., 1988; Schaff & Cavanagh, 
1990). The rocker-sole affects change in load transference by encouraging the foot to increase the 
midstance time (Albert & Christensen, 1994; Brown et al., 2004; Schaff & Cavanagh, 1990). 
Rocker modifications are a well-accepted method of lessening plantar forefoot loading while 
walking (Nawoczenski et al., 1988). However, little data exist to demonstrate their benefit to the 
diabetic and neuropathic population to whom they are supplied, and to select the ideal rocker 
position or angle to prescribe (Brown et al., 2004; Cavanagh et al., 2001; Peterson, Perry, & 
Montgomery, 1985). Evaluating rocker-sole efficacy to lessen plantar pressures and load timing 
on ulceration is the aim of this thesis and the evidence towards understanding the effect on 
pressures when walking in rocker-soles will be discussed in the following section. 
The responsibility to ensure proper shoe applications rests with the clinician and, in combination 
with careful instruction and education related to foot care, most people with diabetes can expect to 
avoid skin injury to their feet (Coleman, 2001). Unfortunately, even with an attentive clinician 
and compliant patient, shoes are not reliable for total ulceration management and if used in 
isolation will usually prolong the time needed to heal (Coleman, 2001) or reulceration will occur 
(Cavanagh et al., 1996). This is because most shoe modifications are prescribed as the result of 
trial-and-error experience and training that is based on the empiric findings of shoemakers of 
previous generations, and not based on experimentally derived evidence (Coleman, 2001). Even 
though evidence clearly shows that high peak pressures on discrete points of the plantar foot are 
an accepted risk for foot ulceration, there are little objective, experimentally derived data to 
support most shoe therapy (Armstrong & Lavery, 1998; Cavanagh, Simoneau, & Ulbrecht, 1993; 
Lavery, Vela, Fleischli, Armstrong, & Lavery, 1997; Schaff & Cavanagh, 1990).  
Footwear is the mainstay of Grade 1 Stage A therapeutic interventions and prevention, but its use 
as a therapeutic device must also conform to the social and fashion expectations of the patient 
(Payne, 2000a). Fashion changes over time, but Dahmen, Haspels, Koomen, and Hoeksma (2001) 
found that the ageing person may unknowing contribute to injury to their feet when they purchase 
inappropriate fashionable shoes, or continue to wear a favourite shoe-style once a change in the 
shape or size of the foot has occurred. This is in agreement with Chantelau and Gede (2002) who 
found, in a case-control study (568 older adults with diabetes and insensitive feet and 100 healthy 
age-matched controls) of the foot length and breadth, that the foot breath was wider than standard 
dress shoes in more than two thirds of those studied. In a similar study, Burns, Leese, and 
McMurdo (2002) reported that the footwear of 47 (72%) patients admitted to a general 
rehabilitation hospital ward were ill fitting. Of these patients, ten (15%) had ulceration and the 
	
shoes were of incorrect length. These studies show that patients may be using footwear un 
suitable to protect their feet, suggesting that they are potentially unaware of the risks that 
inappropriate footwear poses to their feet and ultimately, their general mobility and health. 
Dahmen et al. (2001) identified that limited communication on the part of the clinician may be a 
factor in diminished patient compliance with footwear because, in their study population, the 
rationale behind footwear selected was often unclear to both the patients and carers. The lack of 
efficacy evidence of footwear to protect ulceration prevents a standard of care approach to 
footwear selection, severely limiting the guidance for clinicians to select the appropriate footwear 
for their patients. It is not surprising therefore, that the clinician’s communications with patients 
and carers regarding footwear selection has not been clearly understood by the recipient.  
Footwear is categorised by its design (Ashry, Lavery, Murdoch, Frolich, & Lavery, 1997; 
Cavanagh et al., 2001; Chantelau & Gede, 2002; Flot, Hill, Yamada, McPoil, & Cornwall, 1995; 
Janisse, 1995; Lavery, Vela, Fleischli et al., 1997; Litzelman et al., 1997; Payne, 2000a; Reiber et 
al., 1997; Reiber et al., 2002). Payne (2000a) described the categorisation of footwear to fall under 
four major headings that relate to the therapeutic use in diabetes. The categories are; athletic 
shoes, extra-depth shoes (commonly known as therapeutic shoes), therapeutic shoes with 
modifications and custom made shoes.  
Athletic shoes are the first line of footwear prescription to the adult with diabetes according to 
Chantelau et al. (1990). They reported that athletic footwear are recommended to all people who 
exercise. Some of the features that make the athletic shoe the ideal first line choice include; the 
sole is cushioned, the upper is soft, the bindings are adjustable and secure, the toe box is deep and 
the generic insole can be replaced with a custom insole. People with diabetes may also select 
these shoes for non-therapeutic reasons such as acceptable price range and socially acceptable 
appearance.  
Athletic shoes have been reported by Lake (2000) to be unsafe for healthy people, because the 
cushioning component of the sole limits the impact experienced and felt by the person, therefore, 
they continue the activity and allow potentially dangerous high forces to be inflicted on the feet 
and limbs. However, when the foot is insensitive, Litzelman et al. (1997) reported that the limited 
impact experienced is beneficial and protective to the feet.  
According to Uccioli et al. (1995) as athletic shoes have evolved and become more readily utilised 
by the diabetic population, it has become less likely that therapeutic footwear would be 
prescribed. The message from Tennent (2002) in the Diabetes Australia –Victoria patient 
information publication suggests the regular use of athletic shoes for exercise, but falls short 
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regarding everyday street footwear selection. It states, “Wear exercise shoes such as sports shoes 
that are in good repair to reduce overuse injuries of the feet and minimise the development of 
blisters” (p 5). Flot et al. (1995) and Uccioli et al. (1995) both reported that the new generation of 
street shoes that are based on athletic shoe design hold a great appeal to people with diabetes 
because their feet are protected and appear socially acceptable. What the literature does not 
provide the clinician with is evidence regarding the efficacy, of an Oxford style therapeutic shoe 
with prescribed modifications over an athletic shoe, to transfer plantar pressure away from 
ulceration, and this thesis will address this lack of evidence.  
Therapeutic shoes were defined by Payne (2000a), as footwear specifically designed to 
accommodate and enhance the function of the foot when it’s shape cannot be accommodated in a 
standard shoe or it is not biomechanically sound. The therapeutic shoe follows the design and 
construction of the oxford shoe. The oxford style is analogous to the common laced public-school 
shoe and the typical male dress shoe. There are critical design features that take the appearance of 
an oxford style to the function of a therapeutic shoe. Flot et al (1995) reported the depth and 
squareness of the toe box and the extra depth of the shoe overall, which allows for the addition of 
a custom insole, to be important features, while several authors have stated that the rigidity of the 
mid-sole shank and heel counter to be optimal shoe features (Litzelman et al., 1997; Ulbrecht et 
al., 1994; Walsh, 1996). There is a down side with this shoe type that several authors have 
reported and it is in the overall good materials and construction that gives a long lasting and 
quality shoe, but imposes risks to the foot while the long wearing-in or softening process is 
followed through (Litzelman et al., 1997; Reiber et al., 2002; Ulbrecht et al., 1994). As discussed 
earlier, evidence is lacking to the efficacy of the therapeutic shoe to protect the foot from walking 
pressures, and therefore, it is unknown whether it is the modification of the shoe or the shoe style 
itself that provides any ulceration protective benefit and this thesis aims to contribute to 
answering this question. 
According to Ulbrecht et al. (1994) there are so many techniques and devices for modifying a 
therapeutic shoe that the process of prescribing a particular shoe and modification for a particular 
patient is ad hoc, and remains largely an art. Shoe modifications are described by the part of the 
shoe affected. These are the body of the foot affected by the shoe upper, the foot-to-shoe interface 
affected by the shoe insole and the functioning of the foot as the body link to the ground affected 
by the shoe outsole. Within these general categories there are many uses. Specifically, upper 
modifications have a role in accommodating particulars of toe or foot deformity or size, 
improving on the binding of the shoe to the foot, and purely aesthetic improvements. 
Unfortunately, Chantelau and Gede (2002) found that the aged foot is wider than the range of 
standard shoe sizes for between 35 and 93% of aged men and 56 and 90% of aged women. 
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Therefore, if we review the reports discussed earlier by Cavanagh et al. (2001) and Edmonds et al. 
(1986), where they expected that attention to shoe fitting would prevent up to half of ulceration 
events from occurring, particularly on the toes and medial and lateral forefoot, then education 
regarding appropriate footwear is required. Good fitting education is especially imperative when 
an insole or padded sock is used within the shoe. 
It is a frequent oversight in the literature that excludes the mention of the role of the sock in 
addition to using shoes to protect the diabetic foot. Padded (therapeutic) socks were found to 
provide a substantial and significant reduction in adverse walking pressures under the feet of 10 
people with diabetes and insensitive feet (Veves, Masson, Fernando, & Boulton, 1990) and eight 
healthy people (Flot et al., 1995). Veves et al. (1990) found that the pressure reduction from the 
socks was effective over the whole forefoot, and was still below the pressures of barefoot walking 
after three and six months of use. However, Flot et al. (1995) did not find the pressure reduction 
to be consistent over the forefoot, but limited to the plantar hallux and central forefoot. The study 
of Veves et al. also found a significant pressure reduction when wearing athletic socks, but this 
reduction was not as great as when wearing the therapeutic socks. They concluded that padded 
athletic socks might protect insensitive diabetic feet. There are three main limitations on the 
applicability of the results from these studies. The potential effect of shoes, measurement device 
and different populations is unknown. Veves et al. used a pressure measurement plate without 
shoes and a diabetic population, whereas Flot et al. used an insole pressure matrix in shoes in a 
healthy population.  
There needs to be an element of caution when selecting socks due to the volume that therapeutic 
socks take up in a shoe according to Murray, Veves, Young, Richie, and Boulton (1993). Their 
evaluation into the compliance and satisfaction to use therapeutic socks and shoes in 86 people 
with diabetes found ulceration arose in one subject from direct injury caused by the creasing of 
excessive sock material bulk. Even though, this is only a potential injury prevalence of less than 
two percent, this finding is in agreement with a study that found that the dorsal toe seam on a 
commercially available padded athletic sock could impose up to a ten-fold increase in localised 
pressure (Stacpoole-Shea, Walden et al., 1999). Additionally, to study therapeutic socks, 80 of the 
86 people studied by Murray et al. (1993) required therapeutic shoes to be provided because their 
own shoes did not have sufficient volume to accommodate the padded therapeutic socks. These 
studies suggest that therapeutic socks have several advantages in diabetic foot protection, but they 
also bring risks, in that the creation of a too tight shoe may be the source of potential injury risk, 
and therefore, this approach necessitates careful fitting between the sock and the shoe.  
Within the shoe, insole devices (termed insoles, inserts or orthoses) are utilised to protect 
particular sites on the plantar foot from walking pressures, to accommodate bony protrusions, 
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protect ulceration, to support the foot structure, or modify walking gait. Insoles come in three 
main forms; cushioned, semi-rigid and rigid. Insoles may be custom-made or prefabricated and 
dissipate pressures, and may also be used to locate experimental padding against the foot to avoid 
the risks associated with skin injury from adhesives (Albert, 1981; Brodsky et al., 1988; McPoil & 
Cornwall, 1992). 
Custom made insoles that makes total contact with the weight-bearing components of the foot was 
highly successful in reducing walking pressures (Janisse, 1995; McAllister et al., 1991; Mueller, 
Strube, & Allen, 1997). The debate around the evidence or primarily lack of evidence to support 
the clinical selection of either custom made cushioned, semi-rigid or rigid devices to modify and 
improve foot function has been the focus of many reports; (Ashry et al., 1997; Bennett, 
Miskewitch, & Duplock, 1996; Boulton et al., 1984; Cross, Sane, Dey, & Kulkarni, 1995; 
Holstein, Larsen, & Sager, 1976; Lemmon, Shiang, Hashmi, Ulbrecht, & Cavanagh, 1997; 
Novick et al., 1991; Reiber et al., 1997) and will indirectly be addressed by the thesis studies that 
aim to encourage the standardisation of the protocol for in-shoe walking pressure measurement.  
Shoe outsole modifications are prescribed to alter the pattern and magnitude of pressure on the 
foot, or improve inequalities in limb length during walking. The rocker-sole modification made to 
therapeutic shoes is illustrated in Figure 3and are readily prescribed yet poorly evaluated 
(Cavanagh et al., 2001). The rocker-soled shoe has a break in the contour of the outsole (pivot 
point) which means that there is little motion through the metatarsophalangeal joints during the 
push-off phase of gait (Bauman, Girling, & Brand, 1963; Cavanagh et al., 2001; Mueller et al., 
1997; Nawoczenski et al., 1988; Schaff & Cavanagh, 1990). Various forms of this modification 
have been reported to reduce the pressure borne on the plantar surfaces of the MPJ region by 20 to 
50% compared to walking in flexible soled shoes or regular dress shoes (Nawoczenski et al., 
1988; Schaff & Cavanagh, 1990). Computerised pressure measurement of in-shoe walking have 
shown that in addition to differences in pressure, that the time that weight is born on segments of 
the foot is increased in all areas of the foot except the forefoot when wearing a rocker-soled shoe 
(Cavanagh et al., 2001; Schaff & Cavanagh, 1990). These authors suggested that these changes in 
both pressure and time explain the mechanism by which a rocker-soled shoe protects the forefoot 
from pressures. Unfortunately, evidence into the efficacy of rocker-soled shoes to reduce walking 
pressures are limited in their applicability to clinical practise for two reasons. The lack of study 
and reporting standards means that reports are not comparable and the reality of the differences 
between the measures (errors and variability) are unknown, and study so far, has been conducted 
on subjects without ulceration. The thesis studies will address both these limitations by 
standardising the protocol for plantar pressure measurement and studying rocker-sole 
modifications in people with diabetes, neuropathy and plantar ulceration. 
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Figure 3. Therapeutic shoe with a full-contact insole and a rocker-sole with the pivot point 
beneath the metatarsophalangeal joints.  
The decision to prescribe a rocker-soled shoe clinically is not straight forward, as there are several 
design variables to select from. These variations include the position of placement of the break in 
the contour of the sole, and the angle that the break makes with the rear foot section of the sole. A 
number of investigations have revealed that the rocker-sole designs can influence the efficacy of 
the shoe to reduce pressures experienced by the foot during walking and the forefoot results 
reported are summarised in Table 3.  
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Table 3    
Summary of results of investigations into rocker-sole shoe design efficacy to reduce pressure on the forefoot compared to other shoes/designs. 
 
Rocker design Comparison shoe Results of % reduction in rocker from  
comparison shoe 
Population Authors 
Angle/height  Pivot point  Hallux 1MPJ Forefoot   
2.5cm high Under MPJ 1.7cm proximal to 
MPJ 
  NSD 12 adult men with 
Leprosy & 
neuropathy 
Bauman et al. (1963)  
        
30 degree Under MPJ Same unmodified PP -31* PP -16*  20 healthy adult 
men 
Nawoczenski et al. (1988)  
 50% shoe length 60% shoe length NSD NSD NSD   
        
24 degree & 
3.5cm high 
67% shoe length Same unmodified PP -63* 
PTI -1 
PP -64* 
PTI -33* 
 8 healthy adult men 
on treadmill 
Schaff & Cavanagh 
(1990)  
        
20 degree Proximal to MPJ 
residuum 
Unmodified with toe 
filler 
  PP -16* 30 adults with DM 
& forefoot 
amputation 
Mueller et al. (1997)  
        
11 degree 67% shoe length Traditional post op 
shoe 
  PP -21* 
FTI -8 
16 health adult 
women 
Fuller, Schroeder, & 
Edwards (2001)  
        
23 degree 65% shoe length Different style with 
rockers of 5 & 10 
degree at 60 & 65% 
shoe length 
  PP -32 10 adult women 
with DM & 
neuropathy 
Praet & Louwerens (2003)  
        
1.2cm high Proximal to MPJ Same unmodified PP -71*(R) 
      -75*(L) 
PTI -30*(R) 
      -41*(L) 
PP -13*(R) 
        -7*(L) 
PTI -5*(R) 
        -9*(L) 
 40 healthy adults Brown et al. (2004)  
* Significant difference reported at p=0.05, NSD = No significant difference found, R = right foot, L = left foot, PP = peak pressure, PTI = pressure-time integral 
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When prescribing a rocker-sole modified shoe the position of the pivot point is made either by 
selecting it to align with the foot structure, or at a percent of the length of the shoe. The other 
prescription decision is what degree of angle of the fore sole is required to positively affect 
forefoot pressure. Nawoczenski et al. (1988) investigated several rocker-sole designs in healthy 
young adults. The out-sole designs tested had the rocker pivot point position placed at either 50 or 
60% of shoe length and were beneath the MPJ. They reported that the 50% rocker-sole pivot point 
position effectively reduced pressure over all sites on the forefoot; whereas the rocker-sole pivot 
point position placed directly beneath the MPJ was not as effective under the fifth MPJ. It is 
difficult to interpret the clinical usefulness of these results as the authors used two measures of the 
angle that the rockers made with the sole of the shoe. One rocker pivot point shape was described 
in the standard manner using measurement of the angle that the fore-sole made with the rear-sole 
in degrees (30 degrees). The other rocker-soles were rounded at the pivot point and this was 
described in percent radius of the arc to the rear-sole of the shoe. The arcs tested were at fore-sole 
radii of 125, 75 and 60% with the rear-sole. They concluded that the 75% rocker-sole radius with 
the pivot point placed at 50% of the shoe length was the most successful at reducing forefoot 
pressures. These results do not agree with the later report by Cavanagh et al. (2001) who reported 
that the optimal rocker placement for reducing MPJ region pressures was in the region of 55 to 
60%. However, plantar hallux pressure reduction was shown to be much less in these 
computations than that reported by Nawoczenski et al. and the reason for this is not apparent.  
Even though the reports reviewed uniformly discuss the role of rocker-sole modifications on peak 
pressure reduction for forefoot ulceration management and protection, none of the reports 
investigated pressures experienced on an actual ulceration. Consequently, there is a dearth of 
experimental evidence to show that these modifications have any effect on reducing pressure and 
protecting forefoot ulceration at all. Therefore, this thesis aims to address this uncertainty and 
investigate the efficacy of various rocker-sole pivot positions and angles to reduce in-shoe plantar 
pressure measures on adults with diabetes, neuropathy and plantar forefoot ulceration.  
Regardless of the footwear modification concerned, there is a lack of standards both for in-shoe 
plantar pressure measurement in the research and clinical setting. Lack of standards leaves shoe 
selection to be ad hoc and patients’ safety when prescribed therapeutic footwear interventions 
cannot be assured (Litzelman et al., 1997; Miller, 1993). To understand the lack of evidence it is 
useful at this stage to look at the means to which footwear has been selected and evaluated 
historically in the context of diabetes. 
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Footwear and foot protection from walking pressures 
Non-computer-assisted identification of localised high pressure areas 
Therapeutic footwear usually in the form of a specific shoe type, in-sole or sole modification is 
considered inappropriate if it is directly seen as a contributing factor in the pathoaeitology of 
ulceration. A direct causal link may seem to be obvious between wearing a particular shoe and an 
ulceration event, especially when the shoe upper is concerned. Such an example is when a narrow 
shoe is worn and ulceration occurs on the medial or lateral bony prominences of the forefoot. The 
question remains to whether the shoe in- or out-sole, is appropriate when proper shoe fit has been 
assured? There are several observational methods that are employed by clinicians to make 
judgements about shoe soles. These primarily focus on signs of material damage or aging on the 
shoe. To localise a sign of shoe damage to a specific injury the least a clinician does is to mark the 
foot with a transferring substance (such as lip stick) and observes signs of the substance transfer 
to the shoe after walking. 
Objective measures of therapeutic shoe efficacy are necessary to ensure that appropriate therapy 
has been prescribed. Historically, the role of pressure in the aetiology of plantar foot ulceration 
has been observed using devices that intensify ink or an image proportional to pressures (Barrnett, 
1954; Bauman et al., 1963; Benbow, Chan, Bowsher, Williams, & Macfarlane, 1994; Elftman, 
1934; Hughes, 1993; Quaney, Meyer, Cornwall, & McPoil, 1995).The pressure sensitive sock was 
one of the first devices that could accurately identify the location of and facilitate the reporting of 
high-pressure regions on the foot within a shoe. The pressure sensitive sock contains tiny ink 
impregnated wax capsules that break under pressure and stain the sock leaving a pressure map for 
interpretation (Brand & Yancey, 1993; Coleman, 2001).  These images were clinically applicable 
for visualisation of localised pressure, but results were not quantifiable. However, the introduction 
of computer assisted devices that serve both functions, in that they produce visual images of 
pressure, as well as provide measurements for evaluation and experimental research.  
Computer-assisted identification and quantification of localised high 
pressure areas 
Experimental testing of the effect of pressures on different shoes and their materials can be 
loosely categorised into testing external to, or within a shoe. External testing takes the form of 
either bench-based machine or human subject tests (Lake, 2000). Mechanical tests involve 
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machinery, which can evaluate resistance and compressibility of materials to pressures, or employ 
weighted missiles that are dropped to test the shock attenuation properties of a material (Lake, 
2000). These non-human subject tests are necessary to control the testing conditions to gain 
accurate or preliminary data, and are especially essential for procedural testing prior to and to 
minimise risk and inconvenience to human subjects (Stacpoole-Shea, Walden et al., 1999). The 
effect that different shoe materials have on pressures experienced by the foot have primarily been 
assumed from tests conducted external to the foot-shoe environment at the shoe-ground interface 
(McPoil & Cornwall, 1992). The disadvantage with external-testing procedures is that only 
assumptions, and not actual evidence, can be derived from the data about the effect on the foot-
shoe interface.  
Several different computer-assisted instruments are available to quantify foot pressure either on 
the floor surface or within the shoe during walking. These have primarily been limited to the 
realm of the research laboratory because of high cost and the skill and time required for their 
accurate use. However, with the advances in computer assisted technologies, reducing cost and 
growing computer literacy, pressure measurement is available more widely and this has translated 
to include the clinical setting. Traditionally, clinical applications of pressure measurement have 
been limited to barefoot walking measured via a pressure plate housed in the floor over which the 
patient walks. The relevance, accuracy and reliability of this data has been questioned due to it not 
measuring the gait from both limbs or footsteps in sequence, and that barefoot walking is unusual 
for most people, and prohibited for the diabetes population (Alexander, Chao, & Johnson, 1990; 
Arcan & Brull, 1976). However, it is still the primary means of both clinical and experimental 
pressure measurement due to its ease of use and lower cost than in-shoe pressure measure devices.  
In-shoe pressure measurement takes two main forms. These are discrete sensors placed relevant to 
a specific site on the foot or shoe, or matrices of sensors placed in the shoe in the form of an 
insole. These instruments have been the focus of many reports describing their relevance, 
usability, and technical limitations (Abu-Faraj, Harris, Abler, & Wertsch, 1997; Ahroni, Boyko, & 
Forsberg, 1998; Bauman, Krabbe, & Farkas, 1992; Brown, Rudicel, & Esquenazi, 1996; 
Cavanagh, Hewitt, & Perry, 1992; Davis, Perry, Neth, & Walters, 1998; Franks, Betts, & 
Duckworth, 1983; Kernozek, LaMott, & Dancisak, 1996; Luo, Berglund, & An, 1998; McPoil, 
Cornwall, & Yamada, 1995; Sarnow et al., 1994; Stacpoole-Shea, Shea, & Lavery, 1999; 
Wertsch, Webster, & Tompkins, 1992; Woodburn & Helliwell, 1996a; Zhu et al., 1990). Their 
application to shoe study and diabetic gait has yet to be standardised. The lack of standards limits 
the usefulness of research reports as variations in the applications of the technologies and 
treatments of data prevents the accurate comparison of results or an understanding between what 
are valid measurements and interpretations (Amos, McCarty, & Zimmet, 1997).  
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Reducing plantar pressure to non-adverse levels 
When a point of high pressure is measured on the foot of a person with diabetes and peripheral 
neuropathy, with or without ulceration, then the aim of therapy will be to lower the pressure. 
However, without standardisation of pressure measurement instrumental use, an absolute 
threshold value for ulceration risk has yet to be agreed upon (Cavanagh et al., 1992; Cavanagh, 
Perry, Ulbrecht, Derr, & Pammer, 1998; Cavanagh et al., 2001). The existence of a threshold 
pressure for ulceration has also not been established because agreement on the variables of 
measurements of pressure that are useful for ulceration assessment have not been established 
(Barnett, 1998). Primarily reports present the absolute or peak pressure measured, but this has 
varying interpretations dependant on sensor type, size, location and conditions of use (Ahroni et 
al., 1998; Kernozek et al., 1996) and there is not consensus regarding the units of pressure used 
for reporting (Barnett, 1998). Influence of pressures during the stance time of the foot during 
walking gait has been proposed as potentially more useful than absolute values for determining 
ulceration risk (Duckworth, Boulton, Betts, Franks, & Ward, 1985; Schaff & Cavanagh, 1990). 
There is a dearth of literature specifically to direct experimental study using pressure measures 
(Barnett, 1998) and this is especially critical due to the growing extent to which these measures 
are being applied to therapy selection in the diabetic and neuropathic population. This thesis will 
examine the absolute pressure and pressure-time values in the presence of ulceration in people 
with diabetes and neuropathy to determine their usefulness for experimental study into shoe 
therapies. 
Foot and shoe plantar pressure measurement 
Differences between the pressure measurement results obtained from pressure plates and in-shoe 
pressure measurement systems led to in-shoe systems being recommended for all evaluations 
involving the feet of people with diabetes and neuropathy (Schaff & Cavanagh, 1990). This 
recommendation places in-shoe pressure testing at the foot-shoe interface during walking as the 
mainstay of scientific enquiry into design and efficacy of protective shoes for prescription to the 
diabetic population (Bauman et al., 1992; Linge, 1996). The usefulness, however, of study to 
clinical practice for shoe selection is limited due to the lack of a standard protocol for data 
acquisition and analysis for this type of measurement instrument. A lack of standardisation means 
that studies are not comparable, severely limiting their translation into clinical standards of care.  
Computer assisted in-shoe plantar pressure measurement systems began discrete pressure 
measuring sensors that acted as timing switches. Foot specific sensor technology has developed 
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inline with electronic and computer technologies so that not only can the time that loading occurs, 
but also the magnitude of pressure can be measured (Alexander et al., 1990). This has been 
successfully utilised to both assist the individual patient clinically and experimentally validate the 
assumption that high pressures are experienced at sites of diabetic ulceration (Barrett & Mooney, 
1973; Birke, Franks, & Foto, 1995; Boulton et al., 1987). However, the rapid advancement in the 
technology has brought with it a lack of basic testing that would have not only established 
procedural standards, but also baseline data to which researchers and clinicians may refer (Finch, 
1999; Mueller & Strube, 1996). This thesis will address the lack of baseline in-shoe dynamic 
plantar pressure measures from the population of people with diabetes, neuropathy and plantar 
forefoot ulceration from archival and new data analyses based on experimentally derived standard 
procedures. These standardised, baseline data will not only allow the efficacy of therapeutic 
rocker-sole modifications to be established, but also allow repetition of these procedures for 
ongoing critique and contribution to the body of knowledge in this field. 
Practicalities and measurement uncertainties 
Computer assisted in-shoe pressure measurement has the practical advantage of being applicable 
to both the research and clinical environment. In particular, the computer reports on many specific 
variables obtained from multiple sensors that measure over the plantar surface of the foot 
simultaneously (Finch, 1999; Mueller & Strube, 1996). For research applications these variables 
and data can be data-mined to assist in answering specific questions. However, the matter of 
which variables are useful to the clinical investigations of the diabetic foot has not been 
satisfactorily established. The literature has reports on peak and mean pressures, pressure-time 
integrals, peak and mean forces, force-time integrals and variations on timings. This is far below 
the capabilities of these computerised in-shoe pressure measurement systems. For example, the 
Pedar™ system supplies data that can be analysed within the Novel-win Group Mask 
Evaluation™9 computer program to provide twenty-one individual pressure variable reports for 
every site selected on each foot (Novel Electronics Incorporated, 1998a). This thesis will address 
the uncertainty regarding whether all or a few of the multiple variables obtained from standard 
reports from in-shoe dynamic pressure measurement are useful for determining the efficacy of 
footwear to protect ulceration on the foot of people with diabetes from walking impact pressures. 
Clinically, whilst in-shoe pressure measurement is applicable, it is not always practical, due the 
purchase and maintenance cost of the systems and the personnel time required to analyse and 
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 Novel Electronics Incorporated, St. Paul, Minneapolis, USA. 
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report on the data. With standardised procedures, technician training for data collection and 
analysis could also be standardised and thus facilitate time efficient building of standardised 
databases. Trained assistance and standardised databases would free the clinician to focus on 
individual patient interpretation and therapeutic intervention efficacy investigation. Cavanagh et 
al. (1996) reported testing and retesting the one patient when walking in different interventions 
and based on their positive clinical outcomes, they recommended that all patients with diabetes 
and insensitive feet have access to this type of test. However, provision of trained assistants, in 
addition to the purchase cost of the instrumentation currently makes testing unlikely due to third-
party insurance companies and health management organisations refusing to, or severely 
restricting, reimbursement for this clinical test. Reimbursement is limited due to the lack of 
efficacy evidence, standards of care and the emphasis that both government and health 
management organisations place on treatment of injury or illness rather than prevention (Finch, 
1999). . Therefore, this thesis will conduct clinically relevant research into footwear currently 
prescribed with the assumption that it protects ulceration from walking pressures. The results 
from the thesis studies are expected to provide clinicians with guidance to select the most 
effective rocker-sole shoe design when individual in-shoe assessment is either unavailable or 
impractical. 
There are some practical disadvantages to collecting in-shoe pressure data that require careful 
procedural considerations. The ability to gain data from sensors inside the shoe has the practical 
limitation of needing a cable connection between the sensor and the collection device. This 
physical presence of the tethering to the collection device is problematic in itself and can 
contravene Kelvin’s Law10 (Finch, 1999). Collection devices can either be in a form that is 
worn/carried by the subject, or tethered by a longer wire to a stationary desk unit. The device that 
is worn/carried by the subject has the advantage of allowing data collection away from the 
constraints of the laboratory, but has the disadvantage of preventing examination of preliminary 
data at the same time as data collection. The device that requires the sensors and subject to be 
tethered have the disadvantage of limiting the subject to walking within the laboratory but allow 
continual on-line data monitoring. The imposition of the sensors within the shoe needs careful 
procedural consideration in addition to their tethering for data collection. The placement of the 
sensors into the shoe under the foot appears to ideally provide insight to the foot shoe interface, 
but the validity of the data has been questioned because the sensors are flat and does not conform 
to the shape of the foot or insole (Cavanagh et al., 1992; Finch, 1999).  
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 Kelvin’s Law states that the act of measurement or observation should not affect the quantity being measured or the 
behaviour being observed (Cavanagh et al., 1992). 
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The most practical disadvantage to collecting in-shoe pressure data is the subject of inquiry itself; 
the human. The foot being the point of interaction between the earth and the walking person 
means that the data collected is limited by the consistency of human movement. Human footsteps 
have been anecdotally described to be ‘as variable as snowflakes’ and it is common practice in 
human gait analysis to collect at least two walk repetitions and use the average of the two in the 
final analysis (Craik & Dutterer, 1995). However, there is no consensus to how many step 
repetitions are required for analysis of in-shoe plantar pressure measures. As little as only one step 
have been reported by Conti, Martin, Chaytor, Hughes and Luttrel (1996), while four hundred 
steps were reported by Brown, Wertsch et al. (2004). Kernozek et al. (1996) addressed this 
question for healthy individuals tested while walking on a motorized treadmill. They reported that 
at least eight steps were required for excellent reliability for analysis of peak pressure and 
pressure-time integrals. However, the applicability of these recommendations for the patient 
population with diabetes, neuropathy and plantar forefoot ulceration is unknown and will be 
addressed by this thesis. 
The consistency, or lack of it, in the walking and in-shoe plantar pressure measurement of the 
diabetes person with insensitive feet and ulceration has as yet not been adequately addressed. It is 
accepted that the insensitive foot lacks the sensory input to vary its movements on the ground and 
therefore, subjects localised sites on the plantar foot to repetitive stresses resulting in ulceration. 
However, Cavanagh, Perry, Ulbrecht, Derr and Pammer (1998) reported that the walking gait of 
people with diabetes and insensitive feet was not less variable than healthy walking. Further study 
is needed to clarify this point due to this result being contrary to the clinical assumption, and 
limitations in the generalisability of these results from the study’s small sample size and lack of 
subjects with ulceration (i.e. 13 subjects with diabetes and neuropathy but without ulceration) 
Once in-shoe pressure data is collected, standard procedures are lacking for data analysis and 
transformation for presentation and interpretation of the results. These standard procedures 
include ensuring that all data included in analyses are valid, and there are sufficient repeated 
walking steps for the measurement to be stable and reliable, and the accuracy of the measures is 
known so that valid conclusions can be drawn. Without standard procedures based on these 
concepts, the pressures during walking for the population of people with diabetes, neuropathy and 
plantar forefoot ulceration cannot be determined. Without these baseline figures being expressed 
within the understandings of the above mentioned conceptual constraints, the actual difference 
between walking in several shoes cannot be confidently differentiated from normal variability or 
systematic error. This thesis will address the concerns for standard procedures for measurement 
and uncertainties of analysis and reporting of in-shoe plantar pressure measures that were raised in 
this review of literature in the following chapter.
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The concept map of the thesis presented in Chapter One indicates that clinical ulceration 
protection using shoe modification is not evidence-based. This may result in unpredictable ulcer 
healing and, too commonly, surgery is required to amputate the ulcerated limb. This chapter 
addresses the lack of standardisation of in-shoe plantar pressure measurement and describes 
development of the in-shoe plantar pressure measurement protocol used for data collection and 
definition of the limits for result interpretation for the studies contained in this thesis. The 
protocol developed incorporates results from a protocol analysis of in-shoe pressure measurement 
reports, and measurement uncertainties were defined from analyses of archival data. 
Rationale and purpose 
Physical health can be narrowly defined as the absence of discrete pathology, and health 
practitioners rely upon the classification and measurement of bodily function to determine the 
appropriate treatment to return the body to health (Finch, 1999). The need to measure the function 
of the unhealthy foot has lead to the development and refinement of the technology behind in-
shoe plantar pressure measurement systems. In 1998, International Protocol Guidelines For 
Plantar Pressure Measurement (IPGPPM) were reported because many aspects regarding foot 
pressure measurement procedures had not been standardised (Barnett, 1998). Even though 
procedural standards and therefore, measurement limits are yet to be defined and published, a 
relationship between plantar ulceration and dynamic pressures under the foot has been confirmed 
in the population with diabetes and foot insensitivity (Cavanagh et al., 1993; Cavanagh et al., 
1996). Clinically, the visual representations of the foot-shoe interface provided by the plantar foot 
pressure measurement systems are viewed on a monitor or in print form and assist in confirming 
clinical opinion, patient education and therapy marketing. However, procedures for their use, both 
in research and clinical practice have not been standardised, thus the variability of protocols used 
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prevents accurate comparison of and evaluation of the results reported (Barnett, 1998; Redmond, 
Lumb, & Landorf, 2000). The greatest limitation is in the inability to define results as normal or 
abnormal due to the lack of a definition of acceptable and threshold measurement values for 
normal dynamic human foot pressures (Cavanagh et al., 1996). Normal and threshold 
measurement value definitions are also lacking because any values would be dependant upon the 
protocol and the instrument used. This is further complicated because different instruments 
produce different measures of the same foot due to the size, resolution and characteristics of the 
sensor employed (Cavanagh et al., 1993).  
The IPGPPM, which are reproduced in Appendix A, are contained in a report by Barnett in 1998 
that was compiled from group discussions of plantar pressure measurement system users who 
attended the Fourth Footpressure Special Interest Group Meeting held in 1997. The IPGPPM are 
in the form of suggestions, comments, questions and some specific recommendations. To achieve 
consistency in usage of and reporting from these systems, specific and systematic evidence-based 
protocol guidelines are required for the procedures. Such procedures are; subject accommodation, 
footwear type and usage, data collection volume, data analysis and filtering and results reporting. 
Thus the purpose of this chapter is to develop a standardised protocol for application of the 
studies in this thesis and to identify the limitations for application of the results in respect to 
reliability, precision, accuracy and which variables to select for thesis study into ulceration. 
Chapter outline 
Specifically, Chapter Three examines Research Question One (a – d) and, in so, doing determines 
procedures to standardise collection, analysis and reporting of dynamic in-shoe plantar pressure 
measures relevant to shoe study in the diabetic population. This is achieved through protocol 
analysis of research reports in Part I and analyses applied to archival in-shoe plantar pressure data 
in Part II (a-d). The aims and approaches used in Parts I and II are described as followed:  
Part I  
In this section the IPGPPM have been refined by eliciting of procedural theory through protocol 
analysis of research reports. 
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Part II: This section utilised archival data and is in four parts: 
Part II (a)  
This part described and demonstrated a method for checking data obtained from dynamic in-shoe 
plantar pressure measurement to confirm mid-gait step data validity. 
Part II (b)  
This part examined Research Question One (a) and (b) and defined the reliability and precision 
obtained from repeated steps. Specifically, these analyses determined a priori how many steps 
were required for the calculation of a reliable average step and its associated precision for 
utilisation in the thesis studies.  
Part II (c)  
This part examined Research Question One (c) and defined the number of repeated steps required 
for maximum practical accuracy. Specifically, this analysis determined a priori how many steps 
were required for the calculation of an accurate average step for utilisation in the thesis studies. 
Part II (d)  
This part examined Research Question One (d) and determined which dynamic in-shoe plantar 
pressure measurement variables and at which anatomical regions for use in analyses for ulceration 
identification in the thesis studies. 
Operational definitions 
Anatomical regions abbreviations 
Unless otherwise stated, the anatomical regions on the plantar foot are defined and abbreviated as 
follows; hallux (Hallux), second to fifth toes-digits (Di), first metatarsophalangeal joint region 
(1MPJ), second to fifth metatarsophalangeal joints region (2-5MPJ), midfoot (Mf), Heel (Heel) 
and whole plantar foot-total (Total foot). 
Ulceration location and abbreviations 
Unless otherwise stated, ulcerations are categorised by the anatomical region that they occur in. 

Gait cycle terminology and timing 
The gait cycle is presented in Figure 4. Stance phase for each limb occurs over 60% of the total 
gait cycle, and is defined as 100% of the stance phase for that limb. 
 
 
From Trew, M. (1997) Function of the lower limb. In M. Trew & T. Everett (Eds.), Human movement An introductory text 
(3rd ed., p. 158) New York: Churchill Livingstone Trew, 1997. 
Figure 4. Terminology and timing of the gait cycle.  
 
Definitions of in-shoe plantar pressure variables 
Peak pressure 
The highest pressure in kilopascal experienced by any one active sensor within an operator-
defined plantar foot region. 
Mean pressure 
The average pressure in kilopascal experienced by active sensors within an operator-defined 
plantar foot region. 
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Area 
The area in centimetre squared of the mean pressure image that is contained within an operator-
defined plantar foot region.  
Time 
The time in milliseconds that any one sensor was active within an operator-defined plantar foot 
region. 
Force 
Force is derived from the pressure measured from sensors of known area using the formula: 
Force  =  Pressure  x  Area 
The total force is a sum of all tangential forces acting on the foot and these forces are described in 
Figure 5. 
Force-time integral 
A measure in newton-second of the area under the force-time graph calculated using finite 
analysis with the sum of the peak force obtained at each time interval (50 Hertz) multiplied by the 
number of time intervals. 
Pressure-time integral 
A measure in kilopascal-second of the area under the pressure-time graph calculated using finite 
analysis with the sum of the peak pressure obtained at each time interval (50 Hertz) multiplied by 
the number of time intervals. 
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From: Uccioli, L., Caselli, A., Giacomozzi, C., Macellari, V., Giurato, L., Lardieri, L. et al, (2001) Pattern of abnormal 
tangential forces in the diabetic neuropathic foot. Clinical Biomechanics, 16, 446-454 (Figure 1 p 448)   
Legend: Tangential forces acting on an elementary area corresponding to a single pressure sensor; fxi and fyi contribute to 
the global tangential forces Fx (anteroposterior force) and Fy (mediolateral force), respectively; fMi (free tangential force) 
contributes to the moment that acts about a vertical axis passing through the centre of pressure (C.O.P.) of the total foot. A 
is a hypothetical area on which we may desire to compute the resultant tangential forces. 
 
Figure 5. The total force is a sum of all tangential forces acting on the foot. 
Variable abbreviations, units of measurement and significant figures 
Unless otherwise stated the variables will be denoted in tables and figures by the abbreviation, 
unit of measurement and significant figures as follows:  
Variables that are measured to whole numbers (no decimal places) are: 
• peak pressure (PP) in kilopascal (kPa),  
• time (T) in millisecond (ms),  
• pressure instant at peak occurrence (PPms instant) in millisecond (ms), 
• loading time (LT) in millisecond (ms) 
Variables that are measured to two decimal places:  
• area (A) in centimetre squared (cm2),  
• pressure-time integral (PTI) in kilopascal second (kPa s) ,  
• force (F) in newton (N),  
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• force-time integral (FTI) in newton second (N s), 
• begin of loading time (LT begin) in percent of the stance phase of gait (%), 
• end of loading time (LT end) in percent of the stance phase of gait (%), 
• loading time (LT) in percent of the stance phase of gait (%), and 
• pressure instant at peak occurrence (PP instant) in percent of the stance phase of 
gait (%)  
Data processing definitions 
Average step 
The value derived from the addition of the data result from several single steps divided by the 
number of single steps included in the calculation. 
Mask or Box 
The method of defining the anatomical region of interest (Mask: Pedar™ system, Box: F-scan™ 
system). 
Procedures for dynamic in-shoe plantar pressure measurement with the 
Pedar™ system  
Description of the Pedar™ system 
The Pedar™ system is a computerised insole sensor system that is used to record and evaluate 
dynamic and static real time vertical pressure distribution inside the shoe and under the foot. The 
sensors are formed into an insole that is 2 mm thick and is semi-flexible. The matrix configuration 
of the sensors provides for identification of each sensor for location and timing of the occurrence 
of the pressure. Each insole has 85 sensors that operate on the principle of capacitance and exhibit 
a resolution of approximately 0.5 sensors/cm2. The maximum sampling frequency when using 
both insoles is 50 Hertz.  
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The main advantage of the Pedar™ system is in the use of capacitance-based sensors for pressure 
measurement. The capacitance sensors are not significantly affected by the physical effects of 
testing such as creep and temperature (McPoil et al., 1995). The Pedar™ sensors have a reported 
accuracy of at least plus or minus five percent within the normal use temperature range of 10 to 40 
degrees Centigrade (Novel Electronics Incorporated, 1998b). 
There are two hardware related limitations of this system. The main limitation is the insole sizes. 
The sensor matrix is made into the shape of an insole, which means that only the length of the 
insole can be readily fitted to the participants’ foot. This may leave some of the medial and lateral 
forefoot overlapping the insole and limits investigations into the medial and lateral forefoot in 
some individuals. Insoles are available in multiple sizes and widths, however, cost limits the 
number of insoles in the laboratory setting. The other limitation is the potential affect on free and 
natural walking from the physical presence of the wires that connect the data logger, worn at the 
subject’s waist, to the insoles and the cable connection from the data logger to the computer. 
However, a wireless data logger that removes the cable connection has reduced this limitation 
since the completion of data collection for the thesis studies.  
There are two main data application related limitations of this system. The first limitation is the 
sensor resolution (Cavanagh et al., 1992), which equates to the sensors in some instances being 
larger than some components of measurement (eg. digits) and anatomical points of interest may 
fall at the junction between sensors and therefore, be missed. The second limitation is that the 
sensors only measure vertical pressures and not horizontal or shear forces and these forces are 
hypothesised to contribute to ulceration formation in the diabetic and neuropathic foot (Armstrong 
& Athanasiou, 1998; Davis, 1993). This limitation is a focus of technological investigation and it 
is expected that measurement of shear forces between the foot and the shoe will one day be 
incorporated into in-shoe pressure measurement (Davis et al., 1998). 
Collection of raw Pedar™ data 
The procedures, including calibration for dynamic in-shoe plantar pressure-testing using the 
Pedar™ system were conducted as described in the Users Manual [Novel Electronics 
Incorporated, 1998 #2868] in addition to those procedures determined from the analyses that 
follow in this chapter. The specific procedures for data collection for the thesis studies are 
discussed in detail in Chapter Four. 
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Processing of raw Pedar™ data  
Processing of raw Pedar™ data begins with the selection and transformation of the walking trial 
into individual left and right steps. The Pedar-Filter™11 software provides a graphical 
representation of the force-time data for the entire trial from which individual steps can be 
visually identified. The software automatically eliminates the first and last steps and minimises 
data noise errors with the use of a force filter with a default of five percent of the mean peak 
force. If the timing of stepping is critical to the research question under investigation, then a 
minimum and maximum time can also be set to filter out steps. This feature was not employed as 
variable time has been reported to be a normal component of mid-gait walking (McPoil, 
Cornwall, Dupuis, & Cornwell, 1999).  
To determine steps to select or eliminate for analysis, the consistency of mid-gait stepping is 
visually identified from the cyclical pattern of the force-time plots. Step data is selected by 
deleting all other steps All mid-gait steps retained while the starting, ending and distinctly 
different steps are deselected. Following the selection of mid-gait steps, each force-time graph 
representing a single selected step is converted by a standard software function into an individual 
data file and exported into the Novel-win analysis software.  
Each step data was visualised on the monitor and the plantar foot was divided into areas of 
interest for analysis using the Novel-win Multi-mask™ software according to the method reported 
by Cavanagh, Rodgers and Iiboshi (1987). A separate mask file is defined for each subject and the 
left and right feet. The Mask file is saved and applied to each of that subject’s steps to ensure 
consistency. Visual inspection is performed for the mask of each subject, and small alterations are 
made if necessary to ensure that the correct anatomical structures are in the appropriate masks. 
Consistent application of the masking regions over all steps for each subject is possible because of 
the in-shoe nature of the experiment where the movement of the foot relative to the shoe is 
minimal. The Novel-win data is saved in an ASCII format for exporting into Excel where the 
variables are labelled and an appropriate spreadsheet built for exporting into SPSS Release 8.0 for 
statistical analyses. 
                                                     
11
 Novel Inc. St Paul USA 
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Part I: Refinement of international protocol 
guidelines for plantar pressure measurement 
Rationale and purpose 
Standardisation for conducting investigations and reporting on gait measures is an ongoing 
process, as measurement systems develop to ensure that reports can be readily understood and 
allow for straightforward comparisons. It has become the role of special interest groups or 
specialist committees to initiate and propose recommendations through discussion papers towards 
standardisation (Wu & Cavanagh, 1995). The IPGPPM is such a discussion paper and does not 
actually provide guidelines for in-shoe plantar pressure measurement as the title suggests, but 
rather identifies areas of agreement and disagreement between users, and proposes areas that need 
clarification. Therefore, to determine and standardise the protocol for thesis studies of in-shoe 
plantar pressure measurement, an analysis of archival research reports was undertaken and the 
procedural theory underlying the variety of protocols applied to these measures were tabulated. 
Source of protocols for analysis of in-shoe plantar pressure measurement 
procedures 
Research reports that utilised in-shoe plantar pressure measurement were identified by analysing 
journals that included reports related to gait analysis and diabetes including: Diabetes Care, 
Diabetic Medicine, The Foot, Journal of the American Podiatric Medical Association, Foot & 
Ankle, Foot & Ankle International, Journal of Foot & Ankle Surgery, Archives of Physical 
Medicine and Rehabilitation, Journal of Bone and Joint Surgery, Gait and Posture, Journal of 
Prosthetics and Orthotics, Physical Therapy and Clinical Biomechanics. Retrieved reports were 
manually searched in addition to computerised searching by inputting key words into Proquest 
and Medline. Computerised searching were limited to the English language, peer reviewed 
publications and full papers, but were not limited by year. The key words used to further limit the 
search were: diabetes, foot ulceration, plantar pressure, footwear, insoles, orthoses, total contact 
cast, gait analysis and foot-care.  
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
Data analysis  
A total of 129 reports were obtained and screened for inclusion in the protocol analysis. Reports 
were selected for inclusion in the analysis if they utilised in-shoe plantar pressure measurement 
and tested more than one subject. Reports were excluded if they reported on force or pressure 
plate/mat measurement of plantar pressure of outside the shoe or of a bare foot, were review 
articles, clinical case discussions or single-case studies.  
Twenty-seven research reports published between 1992 and 2004 met the criteria for protocol 
analysis and the reports are cited in Appendix B. The protocols within each report were analysed 
for content within defined categories, their range and frequency to gauge possible deficiencies in 
the selected reports. The following categories were coded for analysis: 
• Category: Subjects  
Group size, gender, adult or child, diabetes, and other disease or health status.  
• Category: Pre-data collection protocol  
Instrument used, standardisation procedures for in-shoe measurement including socks or 
shoes, and if a baseline sock or shoe was used. 
• Category: Data collection protocol 
Speed of walking (treadmill, metronome or self selected pace), number of trials 
conducted, number of steps retained for analysis, and method of step selection. 
• Category: Data analysis protocol 
Regions of the plantar foot defined for analysis, variables analysed, reliability or accuracy 
testing, and units of reporting. 
Even though all but six of the reports selected were published before or in the same year that the 
IPGPPM were published, they will be discussed in view of the recommendations of the 
guidelines.  
Results  
The subjects reported were either homogenous with respect to health status or were within 
homogenous groups. The number of subjects investigated in each study is presented in Table 4. 
Of the 12 reports that included diabetic subjects, there were less than ten in five reports, between 
10 and 15 in four reports, and 25, 44 and 51 each in single reports. Both genders were included in 
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all but one report of males only, all reports were of adults and, apart from the diabetic reports, one 
involved subjects with rheumatoid arthritis while all other reports involved healthy people.  
The socks used during testing were standardised in nine reports and of these, seven reports stated 
that standard socks were provided and two reports stated that the subject wore their own socks. 
Standardised shoes were provided for testing in 15 reports, while seven reports stated that the 
subject wore their own shoes and three reports tested therapeutic devices such as plaster casts. 
Five reports stated that both shoes and socks were standardised together. Eight reports stated that 
a standardised shoe measure was obtained as a baseline measure to make comparisons to another 
shoe or footwear therapy such as insoles.  
Fifteen reports stated that the subject was prepared prior to testing. Subject preparation included 
statements in singular reports of ten, five or one minute walking to warm up, five reports had 
practice trials, one report stated the subject took ten steps prior to data collection, while another 
report stated that the subject wore the testing shoes for four hours prior to data collection. 
Fourteen reports stated the number of trials that were conducted during testing. These included 
five trials in three reports, three trials in six reports, two trials in two reports, four trials in one 
report, while only one trial was conducted in two reports. Twenty-five reports stated the number 
of steps that were used in the analysis of each limb of each subject and these are presented in 
Table 4. The step data selected for analysis was stated as mid-gait or middle in six reports, while 
one report each stated either “a representative step”, “acceptable steps”, all steps, the first four 
steps, the first eight steps, the third step or randomly selected steps were analysed. 
Regional analyses of the plantar foot were stated in all but one report, but there was a definite lack 
of standardisation with 22 different defined foot regions analysed, and these are presented in 
Table 5. 
The mean peak or maximum pressure variable was reported in all but one report. The other 
variables reported were: pressure-time integral and peak force (five reports each), contact time 
(three reports), area (three reports) and the instant of peak force or pressure were reported once 
each. The reliability of the data obtained was tested and described in 11 of the 27 reports.  
The units of pressure measurement were reported in all but two reports. The kilopascal was the 
most common unit (15 reports). The other units reported were: pounds per square inch (four 
reports), kilogram per centimetre squared (two reports), Newton per centimetre squared (two 
reports) and a single report used gram per centimetre squared.  
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Table 4    
Sample size and number of steps analysed per subject’s limb investigated for in-shoe plantar pressure measurements protocols analysed. 
Sample size Steps analysed Instrument Walking Control  Study 
4 6 Pedar™ Treadmill McPoil, Cornwall & Yamada (1995) 
5 50 Pedar™ N/R Shaw, Hsi, Ulbrecht, Norkitis, Becker & Cavanagh (1997) 
6 3 Fscan™ Self determined Lord & Hosein (1994) 
8 40 Pedar™ Self determined Lavery, Vela, Ashry, Lanctot & Athanasiou (1997) 
8 5 Fscan™ Self determined Albert & Rhinoie (1994) 
9 N/R Fscan™ Self determined Martin & Conti (1996) 
10 12 Fscan™ N/R Brown, Rudicel & Esquenazi (1996) 
10 1 Fscan™ Self determined Conti, Martin, Chaytor, Hughes & Luttrel (1996) 
10 8 Fscan™ N/R Mueller & Strube (1996) 
10 N/R Fscan™ Self determined Novick, Stone, Birke, Brasseaux, Broussard, Hoard et al. (1993) 
10 3 Fscan™ Self determined Randolph, Nelson, Akkapeddi & Levin (2000) 
10 20-32 Footscan™ Self determined Praet & Louwerens (2003) 
11 6 Fscan™ N/R Lavery, Lavery & Quebedeax-Farnham (1995) 
11 3 Fscan™ N/R Rose, Feiwell & Crachiolo (1992) 
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Table 4 continued. 
Sample size Steps analysed Instrument Walking Control  Study 
12 16-24 Pedar™ Self determined Rozema, Ulbrecht, Pammer & Cavanagh (1996) 
13 4 Fscan™ Self determined Mueller, Sinacore, Hoogstrate & Daly (1994) 
22 14 Pedar™ Self determined Redmond, Lumb & Landorf (2000) 
25 40 Pedar™ Self determined Lavery, Vela, Lavery & Quebedeaux (1997) 
25 10 Pedar™ Treadmill Kernozek, LaMott & Dancisak (1996) 
30 12 Pedar™ Self determined VanZant, McPoil & Cornwall (2001) 
35 5 Fscan™ Self determined Mandato & Nester (1999) 
39 50 Pedar™ Self determined Cavanagh, Perry, Ulbrecht, Derr & Pammer (1998) 
39 11-15 Pedar™ Self determined Perry, Ulbrecht, Derr & Cavanagh (1995) 
40 400 Interlink™ Self determined Brown, Wertsch, Harris, Klein & Janisse (2004) 
51 4 Fscan™ N/R Ahroni, Boyko & Forsberg (1998) 
109 3 Fscan™ N/R Sarnow, Rosenblum, Veves, Chrzan, Giurini & Habershaw (1994) 
144 5 Fscan™ Self determined Woodburn & Helliwell (1996b)  
Legend: N/R Not reported 
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Table 5    
Anatomical regions of the plantar foot defined for analysis from in-shoe plantar pressure 
measurements.  
Plantar foot region Anatomical regions defined for analysis Number of reports 
Whole foot Whole foot 
Site of highest pressure on whole foot 
5  
3  
Digits All digits 
Hallux 
2nd toe 
3-5 digits   
2-5 digits  
3  
8  
2  
1  
3  
Forefoot Forefoot  
All MPJ  
Medial forefoot  
Lateral forefoot  
1MPJ  
2MPJ  
3MPJ  
3-5MPJ  
2-5MPJ  
7  
2  
2  
2  
10  
4  
1  
4  
2  
Midfoot Midfoot  
Medial midfoot  
Lateral midfoot  
10  
1  
1  
Heel Heel  
Medial heel  
Lateral heel  
16  
2  
1  
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Discussion  
As expressed in the IPGPPM, the results of the current analysis confirm a lack of standardised 
protocol for in-shoe plantar pressure measurement (Barnett, 1998). In-shoe plantar pressure 
measurement is especially ideal for study into the effect on pressures from therapeutic shoe 
interventions experienced by the insensitive diabetic foot. This is reflected by diabetic subjects 
being the focus of 40 percent of the reports that met the criteria for analysis. The lack of 
standardisation of the procedures conducted means that there is limited scope for comparability 
between these studies. Therefore, clinical footwear therapy and shoe prescription has little solid 
evidence to treat or prevent ulceration and lower limb amputation in the diabetic population. The 
same lack of standardisation and result comparability for the large volume of healthy subjects’ 
data is a primary limitation in the development of this analysis as a clinical tool. For clinical 
applicability, the IPGPPM confirmed that there needs to be well-defined average measures and 
confidence limits for the healthy population. It is from a healthy population data set that true 
differences can be identified that represent the effect of the disease on plantar pressures, and from 
which appropriate therapeutic and preventative interventions can be developed and prescribed. 
Four in-shoe plantar pressure measurement systems were utilised in the reports and the IPGPPM 
acknowledged that different systems require specific standardised protocols for calibration, data 
collection, analysis and reporting. Separate protocols are required, as differences exist in the 
sensor size and type, and the methods of data smoothing employed by the software (Graf, 1993; 
Young, 1993). The IPGPPM require that the manufacturer’s protocols be acknowledged and 
understood, and it be stated that the protocols have been adhered to in any report produced. This 
received only a cursory comment in several reports. No reports discussed procedures for the 
establishment of the uncertainties associated with the measures and variables obtained from this 
analysis. Nonetheless, these statements do not improve the comparability between reports due to 
the lack of documentation of the inherent errors, variability, reliability and precision that can be 
expected. Without knowledge of these uncertainties, the study of diabetic footwear efficacy would 
lack scientific rigour and be of limited clinical usefulness, and resolving these issues is the focus 
of Part II of this chapter. 
The standardisation of the socks and shoes used during data collection in over a quarter of the 
reports is in agreement with the IPGPPM (Barnett, 1998). The issuing of socks and shoes to 
subjects is supported by the IPGPPM, as it provides scientific rigour to limit the differences found 
in the results of the dependent variable under investigation. However, the use of each subject’s 
socks and shoes is supported by the IPGPPM, if the purpose of the investigation is to provide 
clinical information on the change in a individual subject’s gait pre and post intervention (Barnett, 
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1998). The shoe sole has been reported to affect plantar pressure measures (Rose et al., 1992) and 
therefore, a standard shoe was used for preliminary or baseline data collection in a quarter of the 
reports. Other than Brown (1996), who stated that their subjects wore their new shoes for four 
hours as preparation prior to data collection, any potential effects from shoe age lacked 
clarification. The standard shoe was generally described as being a minimal effect shoe (examples 
are the canvas oxford and the boat shoe) or were an unmodified form of the test shoe. However, 
wearing an unprepared minimal effect shoe may not be in compliance with the IPGPPM, that 
states that the shoes used during testing should reflect real-life footwear (Barnett, 1998). The 
selection of the standard sock is another protocol weakness identified, as it was not described in 
any report. As sock material has been shown to affect plantar pressure measures (Veves et al., 
1990), the selection of the standard sock for in-shoe plantar pressure measurement in this thesis 
was determined experimentally and is described in Chapter Four. 
Sixty percent of the reports reviewed conformed with the IPGPPM recommendation with regard 
to the subject walking at their normal comfortable pace. Speed was only verified instrumentally 
and visually in one report each, but as speed has been reported not to affect plantar pressure 
measures (Kernozek et al., 1996), then the lack of confirmation is acceptable. Even though the use 
of a treadmill is not representative of normal overground walking, its use to control the walking 
speed in three reports ensured consistency to answer specific speed related and reliability 
questions.  
In 13 reports there were six different subject preparation procedures stated. The IPGPPM provide 
limited guidance in this area other than to report that; the researcher must control the inserting of 
the sensors into the shoe, and for bedding in time be allowed for the foot-sensor-shoe environment 
(Barnett, 1998). This procedural weakness could affect the validity of the data obtained especially 
for the F-scan™ system due to time and temperature dependant limitations of the resistive ink 
sensor components (Ahroni et al., 1998; Luo et al., 1998; Sumiya, Suzuki, Kasahara, & Ogata, 
1998; Woodburn & Helliwell, 1996a). Additionally, the cables that connect the in-shoe sensors to 
a data collection device (leg cables), and this device to the computer (umbilical cables), may also 
invalidate data due to potential gait changes made to accommodate for them (Finch, 1999; Walsh, 
1994). A simple procedure to ensure minimal intrusion of the cables is to observe the subject’s 
gait with and without the leg cables and adjust them until visual consistency is ensured, and for an 
assistant to walk behind the subject holding the umbilical cables to minimise their drag. These 
procedures were utilised for all studies in this thesis, but since their completion these procedures 
are of less concern as some cables have become redundant and replaced with wireless technology.  
The number of trials conducted and the number of steps retained for analysis from each trial is 
another weak procedural area. The ten reports that utilised data from at least three trials and used 
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the mean value calculated from these trials in their analyses are following standard procedures for 
anthropometric laboratory measurement (Pederson & Gore, 1994). Recording several trials 
ensures that there is adequate data obtained for minimising error, but also ensures against total 
loss of subject data in the case of instrumentation error or malfunction. Additionally, if a rest 
period occurs between trials, then the physical effects of fatigue and the sensor effects from 
temperature and time can be minimised. The two reports that obtained data from only one trial, 
and the 12 reports that did not state how many trials were conducted, should be reviewed with 
caution because without repeated data collection trials, errors cannot be identified or reliability 
assumed, potentially resulting in invalid conclusions being drawn. Ideally, once protocols are 
standardised, inconsistencies within the measurement will be determined and external verification 
of gait laboratories, systems and procedures will bring this analysis method into line with other 
clinical laboratory standard requirements. 
Using the criterion of a minimum of nine repeated steps, collected in a series, being required for 
calculation of an average step with acceptable reliability from in-shoe pressure measurement 
(Kernozek et al., 1996), only eleven studies could be assumed to have utilised sufficient steps. 
Without adequate data to ensure reliability, the reader cannot have confidence in the conclusions 
drawn from 16 of the reports analysed. Additionally, the eleven studies that analysed between 12 
and 400 steps may have imposed excessive physical burdens on the subjects and added time and 
analysis burden on to the investigators without notable gain. These reports with more than 12 
steps analysed could be assumed to have ensured reliable data based on the mathematical fact that 
by the inclusion of more values, the true central measure will be exposed as opposing positive and 
negative values will cancel each other out (Portney & Watkins, 1993). A further question arises 
from these results, and this is how the number of steps included, influences the reliability of the 
data. Eleven reports stated that their data were ‘reliable’, even though they encompassed the full 
range of steps (2-400 steps), included both healthy and diseased subjects and were conducted with 
both in-shoe plantar pressure systems. This suggests that reliability of in-shoe plantar pressure 
measurement may not be influenced by step volume analysed, subject health nor by different 
systems used for data collection. Without knowledge of the validity, accuracy, reliability and 
precision of plantar pressure measures for specific healthy and diseased sample populations, the 
general applicability of these studies is unknown and, as suggested by the IPGPPM, this thesis 
investigated the inconsistencies of these measures (See Part II of this chapter)  
The IPGPPM stated that the step data should be selected from the mid-gait section of a trial; 
however, only seven reports made a statement that confirmed that they complied with this 
requirement. Selection of mid-gait steps makes not only logical sense for limiting the type of 
walking steps that are analysed, but also ensures consistency between subjects within a protocol. 
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The reports that stated selecting “a representative step’, “acceptable steps” or “randomly selected” 
steps for analysis bring into question their results and conclusions for three reasons. Firstly, due to 
the lack of definition of step selection and therefore, lack of scientific rigour; and secondly the 
lack of definition of the gait phase that was studied limits the general applicability. Finally, these 
selection methods also bring into the analysis the possibility of investigator bias, and the questions 
of ‘representative of what?’, ‘acceptable to whom?’ and ‘what method of randomisation?’ need to 
be asked. The reports that used all steps or the first three or four steps, limit their usefulness to 
understanding different walking gaits, as they are actually analysing accelerating and decelerating 
walking steps mixed in with mid-gait steps, and are therefore, measuring a variable other than, 
and are not generally applicable to, mid-gait walking. Other than selecting only steps from the 
middle section of each walking trial, only one report stated that they checked the data visually for 
consistency after each trial and repeated the trial if inconsistencies were found (Praet & 
Louwerens, 2003). There was no reported method of confirming the validity of each subject’s 
steps selected as being consistent mid-gait steps. The validity of mid-gait steps for this thesis was 
confirmed with a method of filtering steps based on consistent measures of the area of the plantar 
foot and is described in Part II of this chapter. 
The definition of anatomical plantar foot regions for analysis as described by the IPGPPM was 
not utilised in any reports, including those published after 1998; a deficiency that exacerbates the 
lack of reference standards. Potentially, the authors were either unaware of the guidelines or did 
not find the defined anatomical regions to be suitable to address their research question. Ideally, 
software modifications could be provided that would allow investigators to both address their 
specific question, and compute the IPGPPM defined regional analyses for contribution to a 
reference database. The validity of the definition of the anatomical plantar foot regions was not 
confirmed in any reports and further research should be encouraged to facilitate rapid and accurate 
identification of regional plantar foot anatomical regions. A simple identification procedure for 
the 1MPJ was utilised for the thesis, and is described in Chapter Four. 
Only eight pressure, force, area or time variables were stated in the reports. This is surprising as 
the Novel-win software that is used to analyse the data obtained from the Pedar™ system 
automatically calculates 14 variables for each operator-defined region on the plantar foot. 
Unfortunately, variable exclusion reasoning was not discussed and potential explanations for this 
observation could be that that the investigators had found that the other variables were of no value 
to answer their question, or that the other variables have been ignored for time efficiency. The 
IPGPPM confirmed that the effect of the many variables supplied on gait requires investigation. It 
is also stated that the variables specifically affected by ulceration and useful for investigation of  
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the site of ulceration need investigation and this thesis addresses selection of useful variables in 
Part II of this chapter.  
Although all reports stated their results in numbers to two decimal places, this may not be 
appropriate in regard to significant figures. This is especially a concern for the Pedar™ system 
that reports raw pressure data and time variables as a whole figure (no decimal places) and also 
reports its accuracy as five percent, which is once again a whole number. Two decimal places are 
acceptable for the calculated Pedar™ variables as they are reported with this detail. A thorough 
investigation of the validity of the variables measured and calculated by the Pedar™ system are 
beyond the scope of this thesis and in discussion of the thesis studies validity is assumed. In 
regard to appropriate significant figures, the variables of pressure and time will be reported as 
whole numbers (no decimal places), but other calculated variables will be reported with two 
decimal places.  
The IPGPPM was published in 1998 and it is pertinent at this point to compare the protocols of 
the six reports analysed that were published in following years and these are summarised in Table 
6. All six reports were of the study of healthy adults and the only procedure that was uniformly 
standardised in accordance with the IPGPPM was the selection of middle trial steps for analysis. 
All six studies could be assumed to have analysed reliable data due to selecting greater than nine 
steps for each subject for analysis. 
Conclusion of Part I 
The protocol analysis of reports that used in-shoe plantar pressure analysis has found that a 
standardised protocol is lacking. Additionally, where the IPGPPM are clear in defining a 
procedure, other than selection of mid-gait steps, these have not been universally applied since its 
publication in 1998. Therefore, for this thesis, where the IPGPPM are not clearly defined, a 
default position was adopted based on the considered assessment of the results of this protocol 
analysis and this is presented in Table 7. 
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Table 6    
Summary of protocol procedures reported since publication of IPGPPM in 1998. 
Study n  Preparation procedure Footwear standardisation Trials Selection of steps   Unit 
  Instrument Subject Shoes Socks  (number)  
Mandato & Nester (1999)  35 Calibration after 3min for 
temperature equilibration 
N/S  N/S N/S 1 Middle (10) psi 
         
Randolph, Nelson, Akkapeddi &  
Levin (2000)  
10 Calibration after 5min for 
temperature equilibration 
N/S Own shoes N/S 3 Not S/S (9) psi 
         
Redmond, Lumb & Landorf 
(2000)  
22 N/S Minimal  
acclimation time 
Standard  
athletic 
N/S 3 Not S/S/turning  
(14) 
kPa 
         
VanZant, McPoil & Cornwall 
(2001)  
30 Calibration 2 practice trials Standard  
sport 
Standard  
cotton 
3 Middle (12) kPa 
         
 
Praet & Louwerens (2003) 10 Calibration Acclimation  
time 
Standard 
therapeutic 
N/S 2 Midgait consistency  
checked (N/S) 
N/cm2 
         
Brown, Wertsch, Harris, Klein & 
Janisse (2004) 
40 Calibration 10-15 minute 
 acclimation 
Standard therapeutic N/S 1 Continuous walking  
(400) 
kPa 
N/S: Not state; S/S: Starting or stopping steps of each trial.       
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Table 7    
Summary of the protocol for in-shoe plantar pressure measurements compiled from the protocol analysis.  
Protocol for in-shoe plantar pressure measurements 
The sensors are calibrated as per the manufacturers specifications 
The shoes and socks worn are standardised and the type are reported 
The same shoe and sock is retained for that subject for all trials 
Subjects are trained and practice to acclimate to testing procedures and warm-up the sensors 
Subjects rest for a defined and reported time between trials to minimise fatigue and discomfort/pain 
Data collection sessions are conducted to minimise subject boredom and burden 
Interventions tested are randomised to minimise a learned or practice effect 
The first trial is rejected and not analysed 
Three to five data collection trials are conducted to achieve more than eight mid-gait steps from each limb tested 
The starting, stopping and turn around steps are rejected and not analysed 
The method for step selection and validity checking is based on a quantifiable variable and is reported 
The repeated steps data are averaged to form a representative step for each limb for statistical analyses 
The unit of pressure measurements is kPa 
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Part II: Archival analysis of in-shoe plantar 
pressure measurements 
The overall purpose to the studies in this part of the thesis is to test Research Question One (a – d) 
and determine the reliability, precision, and accuracy of results and to select the variables for 
study investigation into ulceration in the population of people with diabetes, neuropathy and 
forefoot ulceration. Each study within this part has a specific purpose and these will be stated as 
each study is introduced. 
Source of archival data  
The data set was compiled from the archives of research data collected and analysed under the 
supervision of Associate Professor Lawrence Lavery DPM MPH in the Department of 
Orthopedics, Podiatry Service at the University of Texas Health Science Center at San Antonio, 
Texas USA12. The data were the result of in-shoe plantar pressure measurements using the 
Pedar™ system on people with diabetes, neuropathy and forefoot ulceration while they walked 
overground at their normal comfortable pace. All procedures were carried out at the University of 
Texas Health Science Center (UTHSC) at San Antonio, Department of Orthopedics, Podiatry 
Service Biomechanics Laboratory in Texas, USA with the approval of the UTHSC and University 
Health System Institutional Review Boards and the informed consent of the subjects. The results 
of the studies are reported in the literature:  
Lavery, L., Vela, S., Fleischli, J., Armstrong, D. & Lavery, D. (1997). Reducing plantar pressure 
in the neuropathic foot – A comparison of footwear. Diabetes Care, 20(11), 1706-10. 
Lavery, L., Vela, S., Lavery, D. & Quebedeaux, T. (1997). Total contact casts: Pressure reduction 
at ulcer sites and the effect on the contralateral foot. Archives of Physical Medicine and 
Rehabilitation, 78(11), 1268-1271. 
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 Data were collected by the Research Fellows: Steven Vela, John Fleischli, David Armstrong or Terri Quebedeaux. 
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Subjects  
The archival sample contained data from 39 subjects (30 males) aged 52.82 (SD 9.74) years who 
were diagnosed with Type 2 diabetes mellitus over a duration of 14.23 (SD 10.37) years and who 
were obese (BMI mean 30.27, SD 4.70 kg/m2). All subjects were diagnosed with peripheral 
neuropathy and this was confirmed by their hallux being insensitive to the application of 25 mV 
induced vibration during a biothesiometer test. Their feet were insensitive to pain with a vibration 
perception threshold above 25 mV (mean 39.77, SD 13.04). Thirty-four subjects had a single 
ulceration per foot and five subjects had a single ulceration on both feet. The distribution of 
ulceration is presented in Table 8. 
Table 8    
The number of diagnosed plantar forefoot ulcerations per location. 
Plantar forefoot ulceration location Number of ulcerations 
First metatarsophalangeal joint (1MPJ) 17 
Hallux inter-phalangeal joint (Hallux) 14 
2-5 metatarsophalangeal joint region (2-5MPJ) 13 
Total number of ulcerations 44 
Total number of feet 78 
 
Procedures utilised for the collection of the archival data13 
The subjects were fitted with appropriately sized canvas oxford sneakers with thin rubber soles 
(Reebok) for baseline measures of walking. These shoes were new and selected due to the large 
range of sizes available in this model for both men and women. They had soft uppers that were 
deemed not to have injury risk potential to the skin and the thin and flexible soles would not 
require or be affected by ‘wearing in’. The socks worn during testing were the subject’s own and 
were consistently used through out testing. The Pedar™ insole sensor of the appropriate size was 
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 The procedures are reported in the literature (Lavery, Vela, Fleischli et al., 1997; Lavery, Vela, Lavery et al., 1997) and 
confirmed by personal communication with Associate Professor Lawrence Lavery and his Research Fellow, Mr. Steve 
Vela. 
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placed into the shoes between the sock and the shoe’s insole for measuring dynamic plantar foot 
pressure. The sensors were tethered to a backpack unit that was also tethered by a 10 m cord to a 
Pentium 20014 desktop computer. Prior to testing, the sensors were calibrated over a range of 0 to 
600 kPa using a pneumatic pressure vessel as per the User’s Manual [Novel Electronics 
Incorporated, 1998 #2868]. To minimise intrusion of the leg cables on the subject’s gait, the chief 
investigator observed the subject’s gait from parallel and perpendicular angles during a practice 
trial with and without the cables. The cables were adjusted accordingly and the practice trial 
repeated. To minimise gait effects from the cable dragging behind the subject, an assistant walked 
approximately two metres behind the subject holding and taking the tension off the cable. Once 
prepared and fitted to the device and appropriate shoe, the subject walked at least three 
preparatory trials along the 10 m walkway in the shoes and equipment to accommodate to the 
testing equipment, area and procedures before data collection began.  
Data collection and processing 
The walking gait data were collected at 50 Hertz using the Pedar™ on-line software from four 
trials where the subject was instructed to walk at their normal and comfortable pace. The walking 
trial was visually monitored for disturbance from consistent stepping and speed. The middle eight 
steps were selected from the 12 remaining steps after the starting and stopping steps had been 
automatically eliminated. A total of 32 steps for each limb were evaluated. 
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Part II(a) Data checking to ensure the validity of 
normal ‘mid-gait’ walking steps 
Rationale and purpose 
Part I described how for in-shoe plantar pressure measurements, multiple steps are collected, from 
which some steps are selected to create a mean step value from each limb to be used for data 
analysis and hypothesis testing. Unless the steps included in the average step calculation are from 
consistent mid-gait walking, the step data will not be reproducible, leaving the investigator less 
able to make valid conclusions and generalisations about their investigation’s contribution to 
understanding mid-gait walking.  
Defining inconsistency of data to instigate data validity checking may have clinical implications. 
What are seen as irregular or outliers by the researcher may be clinically insightful. The risk of 
altering the data and reducing clinical implications during the checking process was minimised by 
the researcher being an experienced senior clinician. 
To ensure a data set of consistent and valid mid-gait steps, three procedures were applied. Firstly, 
the subjects practiced and became consistent at the testing activity prior to data collection. 
Secondly, visual monitoring of trials for mid-gait irregularities allowed those trials to be 
eliminated and repeated. Thirdly, starting and stopping steps were eliminated from the steps 
collected from each limb and trial. The resulting data set was checked to ensure that it did not 
contain inconsistent steps. If so these steps were removed. Inconsistent steps that were undetected 
during visual checking contributed to inconsistent step data.  
Data set checking methods, mainly semi-automated, for mid-gait step consistency ensure high 
quality data sets but represent considerable processing time. Unfortunately, data checking 
methods for in-shoe plantar pressure data have not been reported and are another area that lacks 
protocol standardisation and therefore, limits the general applicability of these data.  
To reduce the processing time cost of data checking for inconsistent steps, a method of steps 
consistency identification based on the variable of the (total) area of the plantar foot (TAF) is 
proposed. The TAF was chosen to identify step consistency as it is influenced by altered function 
during the gait cycle (Cavanagh, Sims, & Sanders, 1991) and therefore, is sensitive to inconsistent 
steps. A change in TAF is reflected by a higher or lower value than the majority of the steps 
measured because more or less sensors were activated in that footstep than during consistent mid-
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gait steps. Therefore, the consistency of the TAF must be confirmed in addition to following the 
three current procedures to ensure valid conclusions about in-shoe pressure measures of mid-gait 
walking are made.  
Inconsistent mid-gait steps are defined as those steps with TAF that are outliers or extreme 
outliers according to the box plot function (SPSS Incorporated, 1998). Outliers and extreme 
outliers are defined as data that are more than one and a half or three times the inter-quartile range 
above or below the third or first quartile, respectively. Descriptively the box plot function places a 
‘box’ around the middle 50 percent of the data with the 25th and 75th percentile being represented 
by the upper and lower edges of the box. Whiskers identify the highest and lowest values 
excluding outliers and extreme outliers.  
To detect inconsistent steps in the data set, two approaches are considered; the semi-automated 
method using the semi-automated (box plot) with visual crosschecking methods, or the fully 
automated method using algorithmic methods. The first approach is extremely time consuming 
because it requires the production of a box plot for each individual limb within which inconsistent 
steps are visually identified as outliers and extreme outliers following which they are located in 
the data set for deletion. The second approach is to use automatic tools, which use an algorithm to 
mathematically detect and delete the steps identified as inconsistent according to the same rules of 
the box plot function, without the production of and visual checking of the box plot graph.  
A fully automated method with the option of checking using graphing was investigated by 
Bisquay, Freulon, de Fouquet and Lajaunie (1999) when data checking geostatistical data from 
oceanography studies. They used automated detection of inconsistent data that could be confirmed 
via graphical means prior to deletion by an operator and this method was found to keep a good 
balance between the processing time and the quality of validation. 
The purpose of this study is two fold: firstly, to propose that data checking be conducted using the 
TAF measure, and secondly, to evaluate if fully automated deletion of inconsistent steps can 
replace the more time consuming semi-automated graphical production with visual checking and 
deletion method. 
Data analysis 
For this analysis the subjects who had ulceration to both feet were not included as they were 
assumed not to be representative of the target population for the thesis studies, and three subjects 
who had incomplete data were excluded; leaving 31 subjects and 62 limbs for analysis.  
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To examine the data to detect inconsistent steps using the semi-automated method, the TAF data 
from each limb were graphed using the box plot function provided in SPSS. This resulted in 62 
graphs for visual interpretation and cross-referencing to the data spreadsheet for the investigator 
to detect and delete inconsistent steps.  
The fully automated method rapidly shortcut the semi-automated process by flagging the 
inconsistent steps directly in the data spreadsheet, which were then checked by the investigator to 
validate the automation, in the same manner as the semi-automated method. 
All data were examined for and confirmed as being normally distributed using Proportion 
probability (P-P) plots with the proportion estimated using the Rankit formula. In a P-P plot, if the 
data are from a normal distribution, then the plot points will cluster around a straight line  (SPSS 
Incorporated pp 431-435). The calculation of a two tailed t-test with unequal variances was 
performed to test if the pre-validity checked and post-validity checked sample data were 
representative of the same population (Portney & Watkins, 1993; SPSS Incorporated, 1998).  
Results and discussion 
Seventy-eight (4.22%) steps within the 1848 steps in the data set were flagged as inconsistent by 
both the semi-automated and automated methods. The box plot of the data from limb three is 
presented in Figure 6 and demonstrates the presence of inconsistent steps data (an outlier and an 
extreme outlier). Figure 6 shows a shaded box that encapsulates the limits of the 25th and 75th 
percentiles, and bars extending away from the box (whiskers) representing the highest and lowest 
values excluding extreme outliers (asterisk) and outliers (circle) The box plot shows that the 
outlier step is very close to the consistent mid-gait step values, but the extreme outlier step is quite 
different. In this example, the outlier step (circle) is slightly bigger than the consistent mid-gait 
steps and would have resulted from an altered step that activated more in-shoe plantar pressure 
sensors and, therefore, a larger measured TAF. The extreme outlier step, however, is much 
smaller than the consistent mid-gait steps and would have resulted from an altered step that 
activated fewer in-shoe plantar pressure sensors and therefore, a smaller measured TAF. These 
inconsistent steps are visible in Figure 7 where the unchecked measured values for this limb are 
displayed. 
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Figure 6. Box plot graph result from the variable of total area of the foot (TAF) of limb number 
three showing one outlier (shown as a circle outside the whiskers) and one extreme outlier (shown 
as an asterisk outside the whiskers) step data point.  
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Figure 7. The total area of foot (TAF) variable for each step for limb number three was plotted 
and outliers and extreme outliers are highlighted with an asterisk. Step 8 (extreme outlier) was 
much smaller and step 30 (outlier) was slightly bigger than the other steps and therefore, 
inconsistent and inconsistent mid-gait steps.  
 
The effect on the variable of Peak pressure TOTAL for limb three after elimination of inconsistent 
steps is shown in Figure 8 and demonstrates the improved consistency in the data set with the 
checking process.  
* 
* 
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 (a) Before validity checking of data from limb three  
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(b) After validity data checking and cleaning of data from limb three 
Figure 8. The measures from the variable of peak pressure over the whole foot (Total) of each 
step was plotted for limb three before and after validity checking and cleaning. 
 
The elimination of inconsistent step data from limb three is reflected in reduced variability as 
demonstrated in the descriptive statistics calculated before and after validity checking and 
presented in Table 9. Three two-tailed t-tests of equality of means with unequal variances were 
performed on the variables of peak pressure-total, pressure-time integral-total and TAF for the 
data set. The alpha values presented in Table 9 confirmed that the pre- and post-validity checked 
data sets were from the same population and therefore, the validity of the data set had not been 
compromised by the checking for and elimination of inconsistent steps.  
 
= 
= 
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Table 9    
The descriptive statistics results for limb number three calculated before and after mid-gait 
validity checking. 
Variable Checking stage Mean SD Min Max alpha 
Before 149.50 12.49 87.0 169.0  Area-total 
After 151.07 8.73 130.0 169.0 p=0.99 
Before 541.3 45.8 340.0 610.0  Peak pressure-total 
After 544.5 38.0 440.0 610.0 p=1.0 
Before 218.6 27.3 50.5 255.9  Pressure-time interval-total  
After 221.2 16.3 193.8 255.9 p=1.0 
 
 
Conclusion 
The purpose of this analysis was to propose a method to standardise mid-gait consistency 
checking of in-shoe pressure data using the TAF. Data checking using TAF was found to be 
necessary as inconsistent steps were identified in the data set that was created using the current 
procedures for ensuring consistent mid-gait steps. 
The use of box plots of each limb’s TAF step measures were found useful to detect inconsistent 
mid-gait step data. However, the use of automated inconsistent steps detection was found to be a 
more time effective approach and will be utilised to ensure consistent mid-gait steps in the thesis 
studies.
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Part II(b) Reliability and precision of in-shoe 
plantar pressure measurements 
Rationale and purpose 
Reliability of in-shoe plantar pressure measures for healthy adults who were walking on a 
treadmill, are reported by Kernozek et al. (1996) for the Pedar™ system, to be dependent on the 
number of repeated step measures included in the average step calculation, and independent of 
speed. The purpose of this analysis is to test Research Question One (a and b) and utilise the study 
design of Kernozek et al. to determine a priori the number of steps required for the reliable 
average step calculation for adults with diabetes, neuropathy and forefoot ulceration during 
normal walking. In addition, the study aims to determine the clinical usefulness of reliable 
measures by calculation of the associated precision (Van Gheluwe, Kirby, Roosen, & Phillips, 
2002) for each variable measured on defined anatomical plantar foot regions. The coefficient of 
variation (CV%) is an index that describes variability expressed as a percentage and reduces the 
difficulty inherent in making comparisons across variables of different measurement units(McPoil 
et al., 1999). 
Data analysis 
The validity-checked data set described in Part II(a) was exported into Excel and new average 
step variables were calculated that included increasing numbers of steps (4-24 steps) for the 
average step calculation. Twenty-four steps was the maximum number of steps that were available 
for all limbs after inconsistent steps had been removed. A paired t-test with unequal variances was 
performed between the left and right limbs for each variable to determine if the left and right 
limbs data could be pooled. The t-test showed that left and right limbs were not significantly 
different (p=0.464) and therefore, the limbs were pooled resulting in 62 limbs for analysis. 
Pooling of both limbs of data would violate statistical assumptions if an out come from the 
measurement was sort. However, as the following analyses are for the purpose of understanding 
the nature of the data and not an outcome measurement, statistical violation was accepted. These 
data were imported into SPSS Release 8 for statistical analyses. 
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Statistical analysis 
A series of intra-class correlation coefficients (ICC (3,k)), where 3 denotes the model of ICC and 
where k denotes the number of raters15; were performed using a repeated measures design 
(Eliasziw, Young, Woodbury, & Fryday-Field, 1994; McPoil & Cornwall, 1998). The ICC Model 
3 is chosen when the results of interest are from a single rater, and in this study it was the Pedar™ 
in-shoe pressure measurement system. Therefore, the resulting ICC used was Model 3 with a 
single rater (ICC(3,1))The alpha statistic obtained from the ICC(3,1) determines the level of 
reliability between the average of the successive steps data for each limb, variable and anatomical 
location as obtained from the single rater (the Pedar™ system) The ICC(3,1) alpha is a 
dimensionless reliability coefficient that ranges from zero to one, where perfect reliability is 
defined by the ICC(3,1) alpha equalling one and acceptable reliability is above 0.80 (Eliasziw et 
al., 1994).  
The Standard Error of Measurement (SEM) is a statement of statistical precision and was 
calculated to provide the clinically useful 95% confidence interval (95% CI) in the units of 
measure of the variable (Portney & Watkins, 1993). The SEM is derived from the standard 
deviation (SD) of the set of measures obtained and the reliability coefficient using the following 
formula: 
ICCSDSEM −= 1
 
In addition, the 95% CI is calculated using the following formula: 
SEMmeasureCI *96.1%95 ±=
 
The coefficient of variation (CV%) is a statement of variability and it is calculated from the 
precision values to allow comparison between variables of different units. The CV% is calculated 
using the standard deviation (SD) and mean ( X ) in the following formula:  
100*%
X
SDCV =  
Reduced variability of the precision values and therefore, high precision, is shown by a low CV%. 
Acceptable variability for plantar pressure measures has not been reported for measures of adults 
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  All clinical measurements require that a human observer, or rater, is part of the measurement system (Portney & 
Watkins, 1993) pp 60. 
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diagnosed with diabetes, neuropathy and ulceration. This study will contribute towards the 
suggestion made by McPoil (1999) that less than 15% be acceptable  
Results  
The number of steps required for inclusion in the reliable calculation of the average step results 
for variables measured over the whole foot, those variables requiring the greatest number of steps 
and peak pressure will be discussed as follows, while the complete results are presented in 
Appendix C. 
The number of steps required for inclusion in the calculation of the average step results for 
variables measured over the whole foot to achieve acceptable reliability and their associated 
precision are presented in Table 10. Calculations of reliability and precision are not applicable 
when the measure value is constant and this applies to the variables that measure the limits of time 
in percent of the whole foot, but are included in Table 10 for completeness. Other than the 
variable measuring pressure instant of peak (%), variables that measured the whole foot were 
reliable with only two steps included in the calculation of the average step. 
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Table 10  
The number of steps required to calculate the average step for variables measured over the whole 
foot (Total foot) to reach acceptable reliability (ICC> 0.80) and their associated precision (95% 
CI) 
Variable (Total foot) 
(n=62 limbs) 
Number of steps for  
reliable average step 
(ICC > 0.80) 
Precision  
(95% CI in variable unit) 
Area (cm2) 2 0.72 
Force (N) 2 1.19 
Force-Time Integral (N s) 2 3.65 
Loading Begin (%) Not applicable*: 0% Not applicable* 
Loading End (%) Not applicable*: 100% Not applicable* 
Loading Time (%) Not applicable*: 100% Not applicable* 
Loading Time (ms)  2 61.67 
Pressure Instant of Peak (%)  5 15.56 
Pressure Instant of Peak (ms)  2 163.16 
Peak Pressure (kPa) 2 41.40 
Pressure-Time Integral (kPa s) 2 10.90 
*Not applicable because calculations are not possible on constant values, such as zero or 100 percent. 
 
The average step calculation reached acceptable reliability for the majority of variables measured 
on defined anatomical regions with either two or three steps included in the calculation. However, 
seven variable measures on defined anatomical regions required between four and eight steps to 
be included in the calculation of the average step, to achieve acceptable reliability, and these are 
presented with their precision in Table 11. 
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Table 11  
Variables measured on defined anatomical regions that required more than three steps to be 
included in the calculation of the average step to reach acceptable reliability (ICC > 0.80) and 
their associated precision (95% CI) 
Variable 
(n=62 limbs) 
Anatomical 
region 
Number of steps for  
reliable average step 
(ICC > 0.80) 
Precision  
(95% CI in variable unit) 
Force (N) 1MPJ 4 5.16 
Force-Time Integral (N s) 1MPJ 4 1.30 
Loading begin (%) 1MPJ 4 4.86 
Loading end (%) 1MPJ 7 0.45 
Loading Time (%) 1MPJ 6 3.65 
Pressure Instant of Peak (%) 2-5MPJ 8 7.40 
Pressure Instant of Peak (%) Hallux 4 4.87 
 
 
The variable peak pressure as measured over defined anatomical regions is most commonly 
reported in the literature as shown earlier in this chapter, and the results for reliability and 
precision are specifically presented in Table 12. 
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Table 12  
The reliability and precision of the variable of peak pressure per anatomical region. 
Variable 
(n=62 limbs) 
Anatomical 
region 
Number of steps for  
reliable average step 
(ICC > 0.80) 
ICC alpha Precision 
(95% CI in kPa) 
Peak Pressure 1MPJ 2 0.87 70.6 
(kPa) 2-5digits 2 0.93 9.1 
 2-5MPJ 2 0.96 35.3 
 Hallux 2 0.92 16.8 
 Heel 2 0.96 30.8 
 Midfoot 2 0.87 25.0 
 
 
The average precision per variable (all anatomical regions combined) as expressed in variable 
units and CV%, is presented in Table 13. The variability of the measures were unacceptably high 
(44 to 139%) (acceptable CV%<15% (McPoil et al., 1999)) and therefore, precision was low. 
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Table 13  
The average precision in variable units is shown against the average variability in CV% per 
reliable variable (all anatomical regions combined). 
Variable (all anatomical regions combined)  
(n=62 limbs) 
Average precision  
in variable unit 
Average variability 
in CV% 
Area (cm2) 0.93 81.38 
Force (N) 2.36 82.71 
Force-Time Integral (N s) 1.94 81.87 
Loading Begin (%) 4.64 58.50 
Loading End (%) 2.18 139.49 
Loading Time (%) 4.82 53.32 
Loading Time (ms)  52.79 61.46 
Pressure Instant of Peak (%)  7.39 52.69 
Pressure Instant of Peak (ms)  63.19 75.16 
Peak Pressure (kPa) 32.70 61.10 
Pressure-Time Integral (kPa s) 12.20 44.46 
 
Discussion 
The results of the reliability analysis are in agreement with Kernozek et al. (1996) and indicate 
that a high level of reliability for in-shoe plantar pressure variables can be obtained using the 
Pedar™ system. Therefore, these results suggest that the same number of repeated steps can 
reliably be utilised to calculate the average step for both healthy and diabetic, neuropathic and 
ulcerated sample populations whether walking normally or on a treadmill. The similarity in 
reliability between the two study populations is also supported by the report by Cavanagh et al. 
(1998), who reported that the variability of plantar pressure measures did not differ between the 
diabetic and normal populations.  
The majority of variables exhibited acceptable reliability coefficients after only three steps. 
However, at least eight steps were needed to achieve acceptable reliability in all variables for all 
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anatomical regions of the foot. Therefore, at least eight repeated steps are required for reliable 
calculation of the average step if all in-shoe plantar pressure variables are utilised in analyses of 
the population of adults with diabetes, neuropathy and forefoot ulceration. 
The protocol analysis from Part I of this chapter showed that peak pressure was the most 
commonly reported variable from in-shoe plantar pressure-based research reports and this analysis 
showed that it was reliable for all anatomical regions with only two repeated step measures 
utilised in the average step calculation. Even though few of the reports analysed in Part I reported 
their reliability, it can be assumed to have been acceptable because their analyses included at least 
two or more steps.  
The precision varied substantially between variables and anatomical regions suggesting that even 
though few steps are required to calculate a reliable average step, these measures are not clinically 
useful due to the poor precision. These results are in agreement to other such measures, including 
the goniometric measurement studies of Van Gheluwe et al. (2002) , who found that although 
measures were reliable, they were not clinically useful due to the large SEM (and therefore, 95% 
CI) associated with the measures. 
The clinical application of the measures of precision can be demonstrated from the reliable 
variable measures of peak pressure. The precision varied from reliable measures of ±9.1 kPa on 
the 2-5 digits to ±70.6 kPa on the first MPJ. To put these results into context, the average reliable 
measure for the first MPJ region was 361.3 kPa and its precision was 70.6 kPa. These results 
translate that the clinician can be 95% confident that the true measure of peak pressure on the 
1MPJ was between 290.7 and 431.9 kPa (mean ± 70.6 kPa) Therefore,, if the condition of 
measurement was changed, for instance to see the effect of a different shoe on the patient 
population, the treatment measure would need to be less than 290.7 kPa or more than 431.9 kPa at 
the first MPJ, before the clinician could confidently know that the treatment was influential on the 
first MPJ.  
The low precision found across all variables as measured on the combined areas of the plantar 
foot shows that, even though variables can be reliably measured with only a few steps, they are 
highly variable and therefore, of limited clinical usefulness. Hence, if investigations using in-shoe 
plantar pressure measurements are to be clinically useful, then sufficient step data must be 
included in the average step calculation to improve precision and ensure accurate conclusions are 
drawn. The accuracy of these measures are unknown, and whether the inclusion of additional 
steps will result in advantageous accuracy and therefore, precision improvements to warrant extra 
step data collection and analysis is also unknown. 
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Conclusion 
The first purpose of the study was to address Research Question One (a) and determine the 
number of repeated steps that were required for inclusion for the calculation of the average step to 
be reliable for the population of adults with diabetes, neuropathy and forefoot ulceration. To 
achieve acceptable reliability, then at least eight repeated step measures were required when 
conclusions were to be drawn from all variables available from the Pedar™ system. When 
measures of peak pressure were only of interest, then only two repeated steps were required for 
acceptable reliability to be achieved. The second purpose of study was to test Research Question 
One (b) and determine the precision associated with a reliable average step. At the level that the 
average step was reliable, then precision was very low and did not reach acceptable variability 
(CV < 15%).  
When data are reliable, then its’ usefulness for study on a clinical population is dependant on the 
precision and accuracy. Therefore, the following study will determine the number of repeated step 
measures required for inclusion in the average step calculation to achieve the maximum practical 
improvement in accuracy and their associated clinically useful precision limits. 
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Part II(c) Accuracy of in-shoe plantar pressure 
measurements 
Rationale and purpose 
The previous section showed that in-shoe plantar pressure measurement is reliable when very few 
repeated steps are included in the calculation of the average step, but with these few steps comes 
low precision. Data cannot be properly interpreted without estimates of reliability, precision and 
accuracy for each variable and each anatomical location. For thesis study, the knowledge of the 
number of step data required for maximum practical accuracy to be achieved in the average step is 
required. Specifically, knowledge of the accuracy of these data would be useful to decide whether 
extra data collection above the number of steps required for reliable data is warranted.  
Additionally, for comparability of expected variability across variables, the calculation of the 
coefficient of variation is made. Therefore, to address Research Question One (c), the purposes of 
this section are two fold: first, to determine the critical number of repeated steps for optimum 
accuracy using the statistical methods of Besser, Kmieczak, Schwartz, Snyderman, Wasko and 
Selby-Silverstein (1999) and second, to determine the variability associated with repeated steps 
and compare this across variables, using the statistical method of Sekiya, Nagasaki, Ito and 
Furuna (1997). 
Data analysis 
The mid-gait consistency checked data set used in the previous study was utilised for these 
analyses. 
Statistical analysis 
The method described by Besser et al. (1999) was performed to obtain the error in percent 
(accuracy). The method utilises the 95% CI and expresses it as a percent of the mean measured 
value for each average step (including two to 24 steps), variable and anatomical region. The 95% 
CI were obtained from a series of two-way analysis of variance (ANOVA) functions, with the two 
factors being the average of two to 24 steps and the variable for each limb and the series being  
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each anatomical region. The accuracy results for each limb were averaged and formatted in Excel 
and then imported into SPSS.  
At low step numbers, the validity of the average step cannot be assumed to contain sufficient data 
to reflect the true average step due to the mathematical fact that, by the inclusion of more values, 
the true central measure will be exposed as opposing positive and negative values will cancel each 
other out (Portney & Watkins, 1993). To check the validity of the accuracy of the averaged step 
data, especially at a low number of steps, a series of regression curve fitting functions were 
performed. A natural log based curve was found to best fit the data. An accuracy curve was 
calculated using this formula for the average step values for each variable and anatomical region 
(SPSS Incorporated, 1998). The formula for the natural log based curve was calculated as follows: 
)/1(1 tbbYLog on +=  
where Y is the calculated value on the vertical axis, b0 and b1 are the function coefficients to fit 
the measured data, and t represents the number of steps (two to 24 steps) included in the average 
step (SPSS Incorporated, 1998). 
The first differential (change in accuracy over change in number of steps (dA/dS)) of the accuracy 
curve was calculated for each variable and anatomical region to identify the maximum practical or 
optimal number of repeated steps required in the average step calculation until further steps 
resulted in less than one percent improvement in accuracy. Additionally, extrapolation was 
performed to assess the potential accuracy that would be achieved if 50 repeated steps16 were 
included in the analysis. The number of repeated steps that achieved accuracy to within 5%17 of 
50 steps was also determined. To avoid the problems caused by the infinite series generated when 
differentiating natural log functions, iteration with an accuracy of 0.001%was performed 
(Dobinson, 1969). Of critical importance is to note that the accuracy determined here, is the 
accuracy inherent in the measurement, and not in the instrument. The Pedar™ system has a 
documented accuracy of at least 5%.Therefore, each accuracy value determined must then have 
±5% added to account for instrument error (Novel Electronics Incorporated, 1998b). In order to 
evaluate the inherent variability within and across different variables the coefficient of variation 
(CV%) (Portney & Watkins, 1993) was calculated for each limb using the formula described in 
the previous study. 
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 Fifty steps was selected as this was the maximum number of steps reported from the Pedar™ from studies of adults with 
diabetes analysed in the protocol analysis (See Part I of Chapter Three).  
17
 Five (±)  percent was chosen as this is the reported accuracy of the Pedar system (Novel Electronics Incorporated, 
1998b). 
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The CV% for each individual limb, for each variable and anatomical region, were added together 
and divided by the number of limbs to obtain the average CV%. As introduced in the previous 
study, an acceptable CV% and CV% range for in-shoe plantar pressure variables per anatomical 
region has not been established, but McPoil et al.(1999) selected CV% values less than 15% to 
indicate reduced variability. 
Results 
As was expected, the accuracy for all variables and anatomical regions, improved as more mid-
gait steps were included in the calculation of the average step. The regression curve fitting 
function fitted the results to a natural log based curve with an r-squared level that was above 0.97 
for all variables and anatomical regions, and these were significant (p<0.001) for all variables and 
anatomical regions.  
The protocol analysis in Part I of this chapter showed that the peak pressure was the most 
commonly reported variable from in-shoe plantar pressure analyses and this variable, as measured 
over the whole foot (peak pressure-total), will be used to demonstrate the analysis method and 
results. The regression curve-fitting plot for the variable of peak pressure-total is presented in 
Figure 9 and the SPSS output is presented in Table 14. 
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Figure 9. Fit of the natural log curve from the regression equation to the results of the accuracy 
(error %) versus the number of steps included in the calculation of the average step for the peak 
pressure-total variable. 
 
Table 14  
SPSS output for regression curve fitting analysis for the analysis of the inclusion of 24 steps in the 
calculation of the average step from the peak pressure-total variable. 
Dependent variable r-squared Degrees freedom F-stat  p-value b0 b1 
Peak pressure-total 0.994 23 3415.89 <0.001 1.1816 5.9510 
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The number of repeated steps included in the average step calculation was plotted against the 
accuracy (error %) for peak pressure-total and is presented in Figure 10. The number of repeated 
steps included in the average step calculation was obtained at two points where dA/dS (0.5 and 
1.0) was considered virtually flat and these results are presented in Table 15 and Appendix D. 
When dA/dS was equal to 0.5, it corresponded to 8.69 steps (nine repeated steps) and when dA/dS 
equalled 1.0 it corresponded to 6.88 steps (seven repeated steps) steps. Additionally, the minimum 
number of repeated steps required for the calculation of the average step to be within 5%18 of that 
calculated to be likely at 50 steps was 6.08 (seven repeated steps) The accuracy associated with 
nine steps was ±6.31 % and at seven steps was ±7.63 %, while at 50 steps it was ±3.67 %.  
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Figure 10.  The accuracy (error %) for peak pressure-total and the associated number of repeated 
steps included in the calculation of the average step. 
                                                     
18
 As the accuracy of the Pedar™ system is reported to be five (±) percent, the accuracy potentially available within five 
percent of fifty steps is not achievable. 
// 
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Table 15 
The number of steps required for inclusion in the calculation of the average step and the accuracy 
achieved for the regression line to be within 1 and 5% of flat, and the number of steps and 
accuracy achieved within 5% of the accuracy achievable with 50 steps included in the average 
step calculation. 
dA/dS<1% dA/dS<0.5% dA/dS50-5% Variable 
n=62 limbs 
Anatomical 
region 
Steps Accuracy Steps Accuracy Steps  Accuracy 
50 steps 
Accuracy  
1MPJ 9 12.17 12 10.29 10 11.38 7.03 
2-5digits 8 11.57 11 9.59 9 10.72 6.49 
2-5MPJ 7 8.11 9 6.82 7 8.11 4.15 
Hallux 9 12.87 12 10.94 10 12.06 7.54 
Heel 7 7.61 9 6.32 7 7.61 3.71 
Midfoot 9 13.59 12 11.53 10 12.73 7.92 
Peak 
pressure 
(kPa) 
Total foot 7 7.63 9 6.31 7 7.63 3.67 
1MPJ 10 13.27 13 11.52 11 12.55 8.14 
2-5digits 10 14.64 13 12.89 11 13.92 9.42 
2-5MPJ 8 10.85 11 8.90 8 10.85 5.89 
Hallux 10 15.22 13 13.37 11 14.46 9.71 
Heel 8 11.19 11 9.28 8 11.19 6.29 
Midfoot 10 13.18 12 11.94 10 13.18 8.22 
Pressure-
time integral 
(kPa s) 
Total foot 7 6.91 9 5.76 6 7.91 3.42 
 
 
The variability results for in-shoe plantar pressure measurements (CV%) for the variable peak 
pressure-total are presented in Figure 11 and show that this variable has an average relative 
variability of 8.81% (SD=6.04%: range 0.04 to 43.88%) and does not improve markedly after 
approximately nine steps are included in the average step calculation. Practically, these results 
mean that with nine steps included in the calculation of the average step for peak pressure-total, 
that we are 95% confident that the true mean value is within ±6.31% of our measured mean value 
which incorporates data variability of 8.81%. Therefore, the overall uncertainty (percent error) of 
the measure of peak pressure-total includes the measurement percent error of ±6.31% plus the 
documented instrument accuracy of ±5% which results in ±11.31% overall percent error.  
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Other variables and anatomical regions required more or less steps to calculate the average step. 
The highest number of steps required were 14 and this was determined for the variables of force-
time integral (2-5Digits), loading begin (%) (1MPJ) and pressure instant of peak (ms) (Midfoot). 
The highest average variability was associated with the variable pressure-time integral, which 
ranged from CV% of 14.54 at the 2-5MPJ to 22.81 at the 2-5 digits. The lowest average 
variability was associated with the variable area, which ranged from CV% of 0.66 at the heel to 
9.20 at the 2-5 digits.  
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Figure 11.  The variability (CV%) of peak pressure-total per number of repeated steps included in 
the average step calculation. 
  
 

Discussion 
Two methods that both relate to the inherent variability within in-shoe plantar pressure data were 
calculated. The percent error provided a value for the residual uncertainty around the mean value 
attributed to the average step, and this uncertainly was used to determine the critical number of 
repeated steps. The CV% provided a value for the spread of the data around the mean value 
attributed to the average step, but the criterion of 15% is not uniformly appropriate for all 
variables and anatomical regions in the population of adults with diabetes, neuropathy and 
forefoot ulceration. Both methods show that there is little gain in reducing the uncertainty and 
variability associated with the average step once at least nine steps are included in the calculation 
for the variable peak pressure-total (percent error = ±11.31% (±6.31% measurement error + ±5% 
instrument error)). 
A limitation to the general applicability of these results is the lack of external verification. It is 
unknown whether these results would apply to another sample of people with diabetes, 
neuropathy and forefoot ulceration, and even if these results would hold if the data were acquired 
on the same sample, but in a different laboratory. However, as both the archival data and the 
thesis study data were collected and analysed in the same laboratory, this limitation is assumed 
consistent. 
Conclusion 
The aim of this study was to address Research Question One (c), and determine the number of 
steps required to be included in the calculation of the average step for maximum practical 
accuracy to be achieved and to determine the variability associated with this accuracy. To achieve 
the maximum practical accuracy and minimal variability, then at least 14 steps were required to be 
included to calculate the average step if all variables and anatomical regions were under 
investigation. However, if only the peak pressure-total was of interest, then the inclusion of at 
least nine steps in the average step calculation results in a mean value that can be interpreted with 
an overall accuracy (percent error) of ±11.31%.  
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Part II(d) Selection of in-shoe pressure variables 
useful for location-specific ulceration 
exploration19 
Rationale and purpose 
The preceding studies of this chapter have demonstrated that the measures obtained from in-shoe 
plantar pressure analyses using the Pedar™ system are reliable and their associated precision and 
accuracy is maximised when sufficient steps are included in the average step calculation. 
Additionally previous research reviewed in Chapter Two demonstrated that measures of in-shoe 
pressures under the foot of a person with diabetes and neuropathy are elevated at the site of 
ulceration. Therefore, the key to the safe and effective prescription of therapeutic interventions 
and enhancement of their role in ulceration management is the identification and modification of 
specific sites with high pressures. The current challenge to the clinician and researcher when 
examining the complex pressure-time data generated from the Pedar system is to decide which 
information it provides is useful for location specific ulceration identification and pressure 
modification. Part one of this chapter demonstrated that most research reports based on these 
measures only discuss the peak pressure results at the site of their interest. There are, however, 13 
other variables automatically generated by the standard software and all variables are also 
calculated for each anatomical region defined on the plantar foot. Some variables can be 
automatically excluded from analyses, as they are a constant number, for example the beginning 
of loading on the foot as a percent of the stance time is always zero while the ending of loading 
time as a percent is always 100. The archival data set utilised in this chapter contains 72 variables. 
Therefore, the purpose of this section was to address Research Question One (d) and identify 
which variables were useful to identify the location of known forefoot ulceration.  
Data analysis 
The mid-gait consistency checked data set used the previous section was utilised for these 
analyses. 
                                                     
19
 This study has been published: Stacpoole-Shea, S., Shea, G. & Lavery, L., (1999) An examination of plantar pressure 
measurements to identify the location of Diabetic forefoot ulceration. The Journal of Foot and Ankle Surgery 38(2), 109-
115 (Stacpoole-Shea, Shea et al., 1999). 
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Statistical analysis  
The steps data from each subject were treated as replications and were averaged to calculate a 
mean and standard deviation for each variable. The Levene's test for homogeneity of variance was 
performed as an aid to determine the statistical method to be used for the post hoc analysis for the 
analysis of variance (ANOVA) function. An alpha level of 5% was selected as the threshold for 
significance for all analyses unless stated otherwise. The Levene's test results revealed that the 
equality of group variances could not be assumed due to skewness in some variables. Therefore, a 
Dunnett's T3 test was selected as being appropriate for the post hoc analysis due to it not requiring 
the assumption of equality of variances to be met (SPSS Incorporated, 1998).  
In order to evaluate that the significantly different variables were not different measures of the 
same variable, a Pearson's product correlation coefficient (r) was calculated. An r-value of one 
indicates that there is a perfect relationship and that the two variables are measuring the same 
variable. An r-value that is closer to zero indicates a weaker relationship and therefore, the two 
variables are not measures of the same variable. Linear regression was performed to provide the r2 
values. The r2 value is a measure of how much of the change in one variable can be attributed to 
or predicted by the change in the other variable.  
Discriminant analysis using Fisher’s liner discriminant functions was used to determine 
classification function coefficients that were calculated for each ulceration location category20 
using the variables determined from the ANOVA post hoc analysis. The classification function 
coefficients produced for each variable were multiplied against the measured value for the 
variable for each subject and these results were summed for each potential ulceration location. 
The sum value was adjusted with the constant provided by the analysis, and the ulceration 
category with the highest result was the most likely site for the ulceration to be present for that 
subject. 
Sensitivity and specificity formulas were applied to the correctly and incorrectly identified 
classification results. Sensitivity is the likelihood that someone with a target condition, in this case 
ulceration on a particular forefoot location, is correctly identified as having ulceration at that 
location and is defined by the formula (Dorland, 2003):  
Sensitivity = true positive/(true positive + false negative) 
                                                     
20
 Unless otherwise stated, ulceration are categorised by the anatomical region that they occur in. 
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Specificity is the likelihood that someone without the target condition/ulceration, is correctly 
identified as being target condition/ulceration-free and is defined by the formula (Dorland, 2003):  
Specificity = true negative/(false positive + true negative) 
Results  
Timing variables were not found to be significantly different between ulceration categories, but 
the gait variables are presented to describe the population. The population walked with a mean 
cadence of 125.8 (SD 18.2) steps per minute, stance time of 0.59 (SD 0.02) seconds, stride time of 
0.96 (SD 0.03) seconds and time in double limb support time of 0.12 (SD 0.01) seconds. 
Five variables were found from the ANOVA and post hoc analysis to be significantly different 
between ulcerations, and these were peak pressure on the 1MPJ and 2-5MPJ and pressure-time 
integral on the whole foot (total), 1MPJ and 2-5MPJ. The descriptive results are presented in 
Table 16, the ANOVA results are presented in Table 17 and the post hoc results that showed 
significant differences are presented in Table 18. 
Pearson's product correlation coefficients (r) were calculated and the r-value results indicate that, 
while most of the different variables are related they are not identical and the results are presented 
in Table 19. The closer the correlation or r value is to 1, the higher the likelihood that the two 
variables are measures of the same thing. This is demonstrated in the variables that are correlated 
at the p = 0.01 level or equal to 1. The smaller the r value the less likely that the variables are 
measures of the same thing and this is evident in the r values of the variables that are correlated at 
the p ≥ 0.05.  
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Table 16  
The results for peak pressure and pressure-time integral per ulceration category and anatomical 
region. 
Dependent 
Variable 
Anatomical 
region 
Ulceration 
category* 
Mean SD Min Max 
Peak pressure Total foot 1MPJ 501.95 113.57 329.80 680.00 
(kPa)  2-5MPJ 504.24 106.16 281.30 677.00 
  Hallux 431.33 81.00 264.40 546.90 
 Hallux 1MPJ 196.97 125.46 39.10 426.90 
  2-5MPJ 215.40 77.92 98.30 383.40 
  Hallux 233.74 95.41 74.40 392.30 
 1MPJ 1MPJ 471.93 144.10 181.90 680.00 
  2-5MPJ 369.42 102.74 190.70 540.60 
  Hallux 285.24 95.40 162.20 526.50 
 2-5MPJ 1MPJ 343.04 114.58 149.00 544.70 
  2-5MPJ 463.98 126.36 226.30 677.00 
  Hallux 386.23 91.84 169.40 535.60 
Total foot 1MPJ 164.71 32.20 113.20 236.40 
 2-5MPJ 174.89 29.62 134.60 223.20 
 Hallux 141.14 30.43 90.30 192.10 
Hallux 1MPJ 27.96 22.19 3.10 80.10 
 2-5MPJ 35.88 20.45 7.10 72.70 
 Hallux 38.94 21.80 7.10 72.70 
1MPJ 1MPJ 114.52 34.79 48.60 179.80 
 2-5MPJ 85.45 20.67 45.30 112.80 
 Hallux 72.46 24.28 28.70 130.30 
2-5MPJ 1MPJ 86.08 20.44 50.10 116.90 
 2-5MPJ 121.68 33.66 61.90 177.60 
Pressure-time  
integral (kPa s) 
 Hallux 93.73 24.53 52.80 142.70 
*Ulceration category populations are 17 for 1MPJ, 13 for 2-5MPJ and 16 for Hallux. 
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Table 17  
The ANOVA results that showed significant differences between ulceration groups for peak 
pressure and pressure-time integral. 
Dependent 
Variable 
Anatomical  
region 
Groups Sum of 
Squares 
Degrees  
freedom 
Mean Square F Sig. 
Peak pressure 1MPJ Between 288620.89 2 144310.44 10.42 <0.00 
(kPa)  Within 595403.42 43 13846.59   
  Total 884024.30 45    
 2-5MPJ Between 108641.36 2 54320.68 4.42 0.02 
  Within 528164.69 43 12282.90   
  Total 636806.05 45    
        
Total foot Between 8932.45 2 4466.23 4.68 0.01 
 Within 40996.61 43 953.41   
 Total 49929.06 45    
1MPJ Between 15279.43 2 7639.71 9.86 <0.00 
 Within 33332.07 43 775.16   
 Total 48611.50 45    
2-5MPJ Between 9972.36 2 4986.18 7.32 <0.00 
 Within 29306.54 43 681.55   
Pressure-time  
integral (kPa s) 
 Total 39278.90 45    
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Table 18  
Dunnett's T3 post hoc analysis results that showed significant differences between ulceration 
groups for peak pressure and pressure-time integral. 
Dependent  
Variable 
Anatomical  
region 
Ulcer 
group 1 
Ulcer 
group 2 
Mean 
Difference 
(ulcer 
group 1-2) 
Std. 
Error 
Sig. 95% CI 
Lower 
limit 
 
Upper 
limit 
Peak pressure (kPa) 1MPJ 1MPJ Hallux 186.69 40.99 <0.00 79.55 293.84 
 2-5MPJ 1MPJ 2-5MPJ -120.94 40.83 0.04 -235.03 -6.86 
Total foot 2-5MPJ Hallux 33.75 11.53 0.02 5.27 62.23 
1MPJ 1MPJ 2-5MPJ 29.06 10.26 0.02 3.17 54.95 
1MPJ 1MPJ Hallux 42.06 9.70 <0.00 15.79 68.32 
Pressure-time  
integral (kPa s) 
2-5MPJ 1MPJ 2-5MPJ -35.61 9.62 0.01 -63.15 -8.07 
 
 
Table 19  
Pearson's product correlation coefficients (r) of variables that are significantly different between 
ulceration locations (PP: Peak pressure (kPa) and PTI: Pressure Time-Integral (kPa s)) 
  PP 1MPJ  PP 2-5MPJ PTI 1MPJ PTI 2-5MPJ Total foot PTI 
 r      
PP 1MPJ  1 0.271* 0.821** 0.143 0.546** 
PP 2-5MPJ   1 0.160 0.725** 0.447** 
PTI 1MPJ    1 0.342** 0.653** 
PTI 2-5MPJ     1 0.695** 
Total foot PTI      1 
*Correlation is significant at the 0.05 level (2-tailed) 
**Correlation is significant at the 0.01 level (2-tailed) 
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As an extension of the Pearson’s product correlation coefficients, linear regression (r2) was 
performed to show how much the change in one of the paired variables was attributed to, or 
predicted by the change in the other paired variable and are presented as follows: 
• The peak pressure on the 1MPJ is explained by 67.3% of the pressure-time integral on the 
same location.  
• The pressure time integral at the 2-5MPJ is explained by 48.3% of the pressure-time 
integral of the whole foot.  
• The peak pressure at the 2-5MPJ is explained by 52.5% of the pressure-time integral at 
the 2-5MPJ. 
Discriminant analysis was performed using the five variables determined from the ANOVA post 
hoc analysis to provide a mathematical model for determining the most likely location of 
ulceration on the forefoot. The prior probabilities for each ulceration category were assumed equal 
and the classification function coefficients results are presented in Table 20. The value for each 
variable for each subject is multiplied against the classification function coefficient and the results 
for each variable summed and the sum value is adjusted by the constant provided. The ulceration 
category with the highest value is the most likely site for ulceration to be present on that subject. 
 
Table 20  
Classification function coefficients results for the mathematical model to determine most likely 
ulceration location. 
Variable Anatomical region Classification function coefficients  
for ulceration categories 
  1MPJ 2-5MPJ Hallux 
Peak pressure (kPa) 1MPJ 0.02 0.04 -0.13 
 2-5MPJ 0.19 0.18 0.29 
Pressure-time integral Total foot 1.28 1.41 1.25 
(kPa s) 1MPJ 0.61 -0.05 0.55 
 2-5MPJ -0.31 0.33 -0.40 
Constant -17.55 -20.06 -13.88 
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The model was found to accurately determine the location of the ulceration in 69.6% of subjects 
and the classification results are presented in Table 21 
Table 21  
The classification results showing numbers of subjects and their correctly and incorrectly 
predicted ulceration category membership. 
 Ulceration category Predicted ulceration category membership Total 
  1MPJ 2-5MPJ Hallux  
Count 1MPJ 12* 1 4 17 
 2-5MPJ 2 10* 1 13 
 Hallux 1 5 10* 16 
 Uncategorised cases 10 13 13 36 
      
% 1MPJ 70.59* 5.88 23.53 100 
 2-5MPJ 15.38 76.92* 7.69 100 
 Hallux 6.25 31.25 62.5* 100 
 Uncategorised cases 27.78 36.11 36.11 100 
* Correctly classified 
 
Subjects who were placed in a predicted ulceration category membership different from their true 
ulceration category are incorrectly classified. The correct and incorrect classification results were 
utilised to calculate the sensitivity and specificity of identifying ulceration using in-shoe pressure 
measurement and these results are presented in Table 22. 
Discussion  
The analysis did not find evidence to suggest that ulceration location was related to walking gait 
variables. The population walked at a rate that is comparable to normal healthy adults even though 
being neuropathic means that they lack both local and spatial sensory feedback to control their 
gait (Courtemache et al., 1996; Zhu, Wertsch, Harris, & Alba, 1995). The average overground 
walking cadence of the data set (125.77 steps per minute) compared favourably with the treadmill 
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Table 22  
Specificity and sensitivity results from application of the discriminate analysis model. 
Ulceration category Specificity (%) Sensitivity (%) 
1MPJ 71 90 
2-5MPJ 87 85 
Hallux 69 83 
 
 
walking study of people with diabetes by Walker, Helm and Lavery (1997) (126.86 steps per 
minute). There was smaller variability in the cadence in this population as demonstrated by a 
standard deviation of 18.17 steps per minute as compared to the 31 steps per minute reported by 
Walker et al. (1997). This difference may be potentially explained by differences between 
treadmill and overground walking or because the subjects of Walker et al. were interrupted by an 
auditory signal when they walked on their ulceration. Doing higher cognitive tasks has been 
shown to interfere with walking (Mueller, Minor et al., 1994). The population’s cadence (125.77 
(SD 18.17) steps per minute) was faster than the studies of people with diabetes reported by 
Courtemache (1996) of 102.5 and Mueller (1994) of 106.3 (SD 8.0) steps per minute. Stride time 
measured in both studies (Courtemache et al., 1996; Mueller, Minor et al., 1994) (1.15 (SD 0.09) 
sec) and our population were comparable (1.04 (SD 0.08) sec). As step length was not measured 
in our population it is assumed that the subjects’ higher cadence may be due to their taking shorter 
steps to maintain their comfortable speed. 
As the peak pressure and pressure-time integral were significantly related in the location of 
ulceration, the result that loading time was definitely not related to ulceration presence suggests 
that the pressure component within pressure-time interval is most relevant. Timing of the 
application of peak pressures on ulcerated and ulceration-free feet were found to have an alpha 
value equivalent to choosing random numbers (p=0.5). The apparent randomness of the timing 
values can be explained by the high variability of these measures described earlier in this chapter 
and by Kernozek et al. (1996). 
It was expected that, if the peak pressures had a highly statistically significant relationship to 
ulceration presence, then the peak forces would also be important due to their mathematical 
relationship. However, this was not the case and these results support the clinical assumption that 
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it is the area over which the force is applied that is a factor in ulceration presence on the forefoot 
rather than the overall force applied. This assumption can be conceptualised using the analogy of 
a large rock or a needle. If the same force is applied to the foot, the needle will rupture the skin, 
while the rock will not. Therefore, the implication is that area is critical. 
The results of this analysis are in agreement with the growing body of literature that supports the 
fact that ulceration measured on the 1MPJ and 2-5MPJ regions exist with high pressures during 
walking (Armstrong, Peters, Athanasiou, & Lavery, 1998; Katoulis, Boulton, & Raptis, 1996; 
Lodewick, 1993; Murray, Young, Hollis, & Boulton, 1996). However, the analysis did not explain 
a clear relationship between hallux ulceration and pressure on the hallux and implies that there 
may be other structural or functional factors involved. Limitation in extension of the 1MPJ has 
been reported to be an aetiological factor in ulceration of the plantar hallux (Birke, Cornwall, & 
Jackson, 1988). The limitation of the joint, either by structural damage to the joint itself or 
functional restrictions from adjacent soft tissues, is reported to alter the smooth forward 
progression of the limb over the forefoot during the terminal stage of gait (Payne & Dananberg, 
1997). Theoretically, joint limitation may make the hallux function as a rigid lever during toe off 
(Dananberg, Phillips, & Blaakman, 1996) and as body weight transfers forward it may trap the 
skin of the hallux against the ground/shoe shearing the skin from the deeper structures resulting in 
ulceration (Armstrong & Athanasiou, 1998; Landsman, Meaney, Cargill, Macarak, & Thibault, 
1995).  
To identify the actual location of the ulceration, the optimal diagnostic level of specificity and 
sensitivity was obtained when the five variable results were combined even though they were not 
all significantly different for each ulceration category site. To put these results into clinical 
context, a specificity of 69% meant that 31% of patients could have been misdiagnosed as having 
ulceration when they did not. A sensitivity of 83%, however, meant that only 17% of patients who 
had ulceration would have been missed and their ulceration left undiagnosed.  
When implementing a clinical screening tool, the acceptability of the levels of sensitivity and 
specificity are taken into account (Portney & Watkins, 1993). Sensitivity, to some extent is 
irrelevant to this screening test because it would be likely that a visual examination would be part 
of the test, even if only cursory as a result of assisting the person to don the standardised socks, 
sensors and shoes, and the error would be quickly identified. To decide if the level of specificity is 
acceptable, then the consequences of incorrectly and therefore, over diagnosing people with 
specific ulceration when their ulceration is in another location is the issue. Clearly, if the test 
identified ulceration, then the person would naturally be referred to a clinician. The clinician faced 
with seeing ulceration in one location and test results that suggested an ulceration-free location to 
be ulcerated, would then have the opportunity to prescribe an intervention that protected both 
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regions, therefore, protecting the existing ulceration and hopefully preventing potential ulceration. 
Specificity however, becomes an issue when resources are limited and potentially ulceration 
protective interventions are prescribed to ulceration-free individuals. Such an instance would 
likely see the clinician attempt to convince the resource managers to the value of protecting a foot 
at risk of ulceration and therefore, preventing the later high resource consumption that would be 
required to manage ulceration. 
Conclusions 
The purpose of this analysis was to test Research Question One (d) and identify which plantar 
pressure measurement was useful to identify the location of known forefoot ulceration. The 72 
variables calculated by the Novel-win software were analysed and five variables were found to be 
useful in correctly predicting the location of ulceration from three possible ulceration sites. The 
variables were: peak pressure on the 1MPJ and 2-5MPJ and the pressure-time integral on the 
1MPJ, 2-5MPJ and whole foot. Therefore, on the basis of these results, only these five variables 
identified were selected a priori for statistical analyses in further thesis studies.  
Chapter summary 
This chapter addressed Research Question One (a, b, c and d) and demonstrated that standardised 
procedures for application of this research and clinical tests are lacking in the literature and, even 
though dynamic in-shoe plantar pressure measures in people with diabetes are reliable and 
accurate, they are highly variable and precision is low. Additionally, the analysis complexity of 
the clinical testing of in-shoe pressures has been limited with the identification of only five of the 
72 potential variables as being clinically useful towards interpretation of the data for 
investigations of forefoot ulceration.  
The next three chapters will address; the methods that are common to the thesis studies, the 
selection of the standard testing sock, and the safety and consistency of walking when using this 
protocol.
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Procedures 
The protocol developed in Chapter Three will be utilised for all studies in addition to the 
procedures described in this chapter. 
Description of footwear used for baseline testing 
In accordance with the international protocol guidelines for (in-shoe) plantar pressure 
measurement (IPGPPM), the shoes, insoles and socks were standardised for all testing procedures. 
The baseline-test shoe was a canvas laced up oxford style athletic shoe with a thin rubber sole 
(Nike, Beaverton, Oregon, USA). The baseline-test shoe was specifically selected based on its 
upper being secured with laces, their initial ease of wearing due to the soft canvas upper and thin 
flexible rubber sole, and the assumption that the thinness of the sole would provide minimal shock 
absorption to ensure that plantar pressure measures were representative of the subjects’ normal 
walking. The baseline sock was a SmartKnit™. This sock was specifically selected due to the lack 
of leg constriction afforded by the suspender band construction and the knitted seam that 
potentially posed less injury risk to the digits (Stacpoole-Shea, Walden et al., 1999). 
Anatomical region verification for in-shoe plantar pressure analyses 
Specific anatomical regions of the plantar foot are defined for analysis of in-shoe plantar pressures 
measured during dynamic gait. Identification of these sites can be problematic as the location of 
each anatomical site may not be obvious from the pressure image obtained. A simple pre-testing 
procedure was developed that allowed for identification of the centre of each anatomical region of 
interest. One-cent coins were taped over the sock onto the centre of the anatomical point and a 
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single data collection was conducted for each foot as the subject stood, with the assistance of a 
chair, in single limb stance. Attention was made to ensure that the coins remained located under 
the determined site. The raw data were processed using the Pedar Filter™ and Pedar-
EMEDlink™ software and a single left and right foot data were obtained. These data were 
exported into the Novel-win Creation of Any Mask™ software in which masks were drawn 
around the anatomical region with the assistance of the coin image. This mask file was saved 
ready for use with analyses of the study data. An example of a single foot data at each stage is 
shown in Figure 12. 
 
 
Figure 12.  Identification of anatomical regions for mask drawing on the image of localised high-
pressure areas associated with weight bearing on coins. 
Data collection 
The procedures, including calibration for dynamic in-shoe plantar pressure testing using the 
Pedar™ system were conducted as described in the Users Manual with the addition of those 
procedures determined from the analyses in Chapter Three.  
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Upon arriving at the laboratory, the subject was introduced to the laboratory staff and an 
explanation of the study given prior to informed and written consent being obtained. The subject 
blindly selected a card on which a subject identification code number was written. This code 
ensured confidentially provisions of the Institutional Review Boards. The code was recorded and 
the subject details were retained under lock and key in the laboratory.  
The subject removed their shoes and socks, and the Chief Investigator inspected the feet and 
debrided any callus (Potter & Potter, 2000; Young et al., 1992), and then a new pair of standard 
socks was donned. The anatomical region site identification procedure was then conducted as 
described previously. The subject blindly selected the order of shoe or insole testing by selecting 
from a set of index cards. The sensors were fitted to the first testing shoe with testing insole and 
then to the subject and this set up was checked by encouraging the subject to walk around the 
laboratory. A trial practice session followed that achieved three aims; to accommodate the subject 
to walking within the constraints of the umbilical cord and trial method, to warm up the sensors, 
and to accommodate the subject to the testing shoes. The subject was instructed to walk at their 
own normal pace as if they were walking in the street.  
In order to minimise the effect of internal shoe pressures, a zeroing process was conducted in 
accordance with the User’s Manual, which determined the sensing threshold above which the 
pressure exerted from the foot onto the sensor during non-weight bearing was excluded. 
One trial was conducted during which data were not collected and where system checks and 
subject comfort were made. Data were then collected from three trials, between which the subject 
rested while the data were saved onto the computer. A trial was defined as a walk to the end of the 
laboratory (eight metres), turn around and return to the starting point without incident. At the 
completion of the trials, the subject rested while a preliminary survey of the raw data were made 
using Pedar Filter™ software. At the end of testing, the feet were examined by the author to check 
for injury and any questions that the subject had were answered. Subjects were reminded to 
inspect their feet that night and daily in accordance with good diabetes self-management practice 
and to report any irregularities to the clinic nurse. The standard socks used during testing were 
retained by the subject, as was a copy of the consent form.  
After data analysis was completed, to comply with subject participation incentives, a clinical 
report was made available to the subject’s doctor and an appropriate pair of either insoles or shoes 
given to the subject. Original consent forms were filed in the subject’s medical file as per 
Institutional Review Board requirements, while remaining shoes and insoles were made available 
for clinical prescription to financially-stricken patients of the High Risk Diabetic Foot Clinic. 
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Data processing  
The raw in-shoe plantar pressure data were processed ready for analysis by following three stages 
within the Pedar™ system software package. The stages were: 
1. Removal of unwanted step data from a trial, specifically starting, stopping and turn 
around steps - Pedar Filter™ software. 
2. Transformation of trial data into individual step data - Pedar-EMEDlink™ software. 
3. Definition of anatomical regions of interest on step data - Novel-win Multimask 
Evaluation™ software. 
Two formats of processed step data were available ready for analysis. The formats are the 
measures of force, pressure (peak and average) and area from each time interval during the stance 
phase of the steps within each trial and the absolute value measured for each variable during each 
step. Within these formats are subsets of processed data divided into the defined anatomical areas 
of interest (masks). 
Data analysis  
The processed pressure data from each step was imported into Excel where it was labelled and the 
sample data set was formatted ready for mid-gait validity checking as described in Chapter Three 
prior to exportation into SPSS for statistical analyses. 
Measures of subjects 
Body mass index 
Measures of the participants’ stature and mass were standardised to Body mass index (BMI). BMI 
is the stature in metre squared divided by the mass in kilogram (Zeman, 1991). The stature was 
measured as the participant stood without shoes with their back against the wall alongside a 
measure chart. The chart device was aligned on the top of the participant’s head and the adjacent 
value was recorded as their stature in metres. Body mass was measured while the subject stood in 
their clothes, but without shoes, on the electronic clinic bodyweight scale and the number 
registered by the scale was recorded as their mass in kilograms. Mass was measured by the scale 
to two decimal places. 
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Peripheral neuropathy diagnosis confirmation 
As described in Chapter Two, peripheral neuropathy is diagnosed to be present on the feet, when 
protective sensation is lost. Loss of protective sensation was confirmed by establishment of the 
vibration perception threshold using a biothesiometer. The vibrating head of the biothesiometer 
was placed on the apex of each subject’s hallux and the vibration slowly decreased via a dial until 
the subject could no longer feel vibration. The vibration was controlled by adjustment of voltage 
to the device through a range from 0 to 50 mV. The vibration perception threshold (VPT) is stated 
as the highest voltage recorded from the dial from which the subject continued to feel vibration. 
The diagnosis of peripheral neuropathy was confirmed and the test stopped when the VPT 
exceeded 25 mV. 
Shoe size 
Shoe size was obtained to determine the appropriate shoe or insole required for testing. Shoe size 
was measured using a male or female Branick device. The device consists of fixed heel and lateral 
foot placement barriers and two adjustable levers to put against the most distal and medial 
portions of the foot. The levers are positioned against the foot while the subject stands on the 
device. The measurement is read where indicated by the position of the distal and medial levers. 
The distal lever gives the value of the shoe size while the medial lever gives the value of the shoe 
width. The actual value of shoe size and width is arbitrary as it is not consistent across different 
shoe and insole designs and manufacturers. Therefore, the measure is used as an indicator for 
initial selection and then the shoe, insole and sensor are compared against the Branick device prior 
to fitting to the subject. 
Statistical analysis 
All analyses were performed using SPSS Release 8.0 for Windows. All data were examined for 
and confirmed as being normally distributed using Proportion probability (P-P) plots with the 
proportion estimated using the Rankit formula. In a P-P plot, if the data are from a normal 
distribution, then the plot points will cluster around a straight line (SPSS Incorporated, 1998). The 
inferential statistics used for each thesis study will be described in each respective chapter. 
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One study and two bench experiments were conducted due to concerns around the selection of a 
standard testing sock. The study and experiments were designed to address Research Question 
Two (a) and specifically determine the influence on pressure measurement from the sock material. 
The chapter also aimed to verify the anecdotal risk of increased localised pressure associated with 
sock seams and substantiate the extent of increased localised pressure associated with sock seams 
through a range of pressures.  
 
Does the fabric of a sock affect pressures 
measured under the foot? 
Rationale 
Socks in which the fabric is thicker or padded are recommended for use when walking, as they 
have been reported to significantly reduce the pressures experienced under the regions of the 
plantar foot in healthy subjects and those with diabetes and neuropathy (Flot et al., 1995; Veves et 
al., 1990). However, another aspect of safety that relates to therapeutic socks is the constriction 
that the sock suspender band has on venous vascular drainage of the leg and two socks that are 
constructed so that this risk is minimised are marketed specifically to the diabetic population. The 
Circulation Sock (Red Robin, Melbourne, Australia) is constructed to minimise leg constriction 
and has a thicker plantar fabric resulting in a thick sewn toe seam. Although the SmartKnit sock 
(KnitRite Inc., Kansas, USA) does not have either a tight sock suspender band or thicker plantar 
fabric, it does not have the thick toe seam that is associated with a thicker sock. Even though 
therapeutic socks are recommended to people with diabetes due to their specialised construction, 
this construction limits their general use due to their significant purchase cost (approximately 
$AUD 12-35 per pair). The cheaper, supermarket available sports sock is an alternative sock  
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frequently worn by the general population, including those with diabetes (approximately $AUD 1-
5 per pair, Sport Gear (Fruit of the Loom, Mt. Airy, USA)) 
Purpose 
The purpose of this experiment was to determine if the fabric in the sole of selected therapeutic 
socks had an effect on dynamic plantar pressures and whether the sock used during in-shoe 
plantar pressure testing should be standardised. 
Subjects 
A convenience sample of 16 subjects was sought who were diagnosed with diabetes but without a 
history of peripheral neuropathy or forefoot ulceration to volunteer to take part in the study. 
Potential subjects were informed about the study via a presentation about foot health and diabetes 
that was given by the Chief Investigator at a diabetes education session in the Dietetics 
Department at the Texas Diabetes Institute. The Institutional Review Boards of the University of 
Texas Health Science Center and the University Health System gave approval for the study, and 
informed consent was obtained from all subjects prior to their participation. 
Subjects were included if they were an adult with diabetes and were able to walk unassisted. 
Subjects were excluded if they had a history of peripheral neuropathy, foot ulceration, major 
trauma to the lower limbs or lower back, surgery to the feet, or if they had concurrent disease 
processes such as Parkinson’s disease that limited their ability to walk consistently. All subjects 
who volunteered were eligible and consented to participate in the study and their positive decision 
was influenced by two incentives. The first incentive was that they would receive plantar pressure 
assessment that was normally reserved for surgical assessment and they would receive it free of 
charge. The second was that they would receive the therapeutic and supermarket socks worn 
during testing, and these would be free of charge.  
The sample of 16 subjects (eight men and eight women), ranged in age from 32 to 75 years (mean 
53.31, SD 12.01), height of 1.52 to 1.98 m (mean 1.71, SD 0.13) and mass of 80.91 to 154.55 kg 
(mean 104.80, SD 23.22). Body mass index (BMI) ranged from 24.59 to 51.80 (mean 35.80, SD 
7.25), classifying three subjects as overweight (BMI 25-30) and 13 as obese (BMI>30) (Zeman, 
1991). 
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Method 
To eliminate the effect on plantar peak pressures from a shoe, the EMED™ in-floor pressure plate 
was used to collect and measure pressure data. All procedures, including calibration, were 
conducted in accordance with the User’s Manual. The pressure plate was mounted flush with the 
floor midway along an 8 m walkway. It is a capacitance mat transducer system, with a platform 
dimension of 420 x 417 mm and a sensor dimension of 360 x 190 mm. Data were acquired from 
foot strikes to the platform composed of 2,736 individual sensors with a resolution of four per 
square centimetre at the default sampling rate of 50 Hertz.  
The mid-gait method (Meyers-Rice, Sugars, McPoil, & Cornwall, 1994) of data collection was 
used and the subjects were instructed to walk at their normal comfortable pace along the flat 
linoleum path that included the pressure plate. To minimise the potential inconsistentation of the 
data from the subject targeting the plate, they were instructed to look at and walk towards a head 
high marker. Practice walks were conducted with the starting position being adjusted until the 
subject’s right foot successfully landed within the surface area of the pressure plate sensor area 
during the walk. A chair was placed at the starting position and the subjects were instructed to sit 
between trials to minimise fatigue while the trial data were saved. 
Peak pressure data obtained from the EMED™ system has been reported to be reliable when at 
least three steps are included in the calculation of the average step for each condition in healthy 
subjects (Hughes, Pratt, Linge, Clark, & Klenerman, 1991). However, Chapter Three showed that 
the variability of in-shoe peak pressure data did not become stable until at least eight steps were 
included in the calculation of the average step. Therefore, due to the dearth of reports to determine 
the number of steps required until pressure plate data variability becomes stable, it was considered 
that at least the in-shoe criterion should be applied. Ten successful right foot hits were obtained 
for each subject for each of the sock conditions and the stocking, which represented a bare foot. In 
accordance with the incentives for subject participation, three successful left foot hits were 
recorded in the stocking and a report was produced for inclusion in the subject’s medical file. 
The subject blindly selected labelled cards to randomise the order of sock testing. The subject’s 
feet were inspected by the author prior to testing and any plantar was callus removed (Young et 
al., 1992), and the feet were inspected again prior to the subject being discharged from the testing 
laboratory. Subjects were reminded to inspect their feet that night and daily in accordance with 
good diabetes self-management practice and to report any irregularities to the clinic nurse. The 
subject retained the three pairs of socks used during testing and the clinical report was made 
available to their doctor. 
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Data analysis 
The peak plantar pressures for each of the ten right foot strikes were exported into Novel-win 
Multimask Evaluation™ software for regional analysis. The plantar foot was divided into analysis 
regions that represented the total foot, hallux, first and second to fifth metatarsophalangeal joints 
and the heel. The results obtained for each region from the ten steps were treated as repetitions 
and summed and divided by ten to calculate an average step for each sock tested yielding the 
sample mean and standard deviation. The variability of the results from each subject were 
determined using the coefficient of variation (CV%) using the formula presented in Chapter Three 
and the variability of the sample average (mean CV%) and standard deviation (SD CV%) were 
determined.  
Results and discussion 
The peak pressure results for each region of the plantar foot and each sock condition are presented 
in Table 23. The average stocking foot pressures were highest for the regions of the total foot, 1 
MPJ and 2-5 MPJ, but not for the hallux or the heel. The lowest average pressure was not 
attributed to a sock material. These results agree with Flot et al. (1995) who reported that the 
cushioning effect of sock fabric was not consistent across all regions of the plantar foot, but 
disagree with the report of consistency of the cushioning effect from Veves et al. (1990).  
There were only small differences between the sock conditions, including the stocking, but these 
differences are within the limits of the variability (mean CV%) of the data. Therefore, no true 
difference was found and inferential statistics were not calculated. Peak pressure measures over 
the whole foot (Total foot) were the least variable (mean CV% range 9.4 to 11.5%, SD CV% 
range 5.0 to 8.6%), while other anatomical regional measures had similarly higher variability 
(mean CV% range 14.4 to 22.2%). These results were unexpected considering that significant 
differences had been reported between sock conditions in the two reports mentioned previously 
(Flot et al., 1995; Veves et al., 1990). The pressure reducing claims from these two reports have 
been widely acknowledged resulting in the wearing of padded socks being encouraged by health 
professionals as a routine part of the diabetes self-education message (Tennant, 2002).  
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Table 23  
Peak pressures obtained from each region of the foot for each sock condition. 
Variable Anatomical region Sock Mean  SD  Mean CV% 
Peak pressure  Whole foot Circulation Sock# 898.9 48.2 9.4 
(kPa)  SmartKnit+ 831.4 41.5 10.0 
  Sport Gear8 916.4 77.8 9.5 
  Stocking 920.8 62.4 11.5 
 Hallux Circulation Sock# 524.6 99.4 20.9 
  SmartKnit+ 553.3 48.5 18.4 
  Sport Gear8 578.1 103.4 18.1 
  Stocking 499.5 72.1 19.8 
 1MPJ Circulation Sock# 721.7 70.4 17.0 
  SmartKnit+ 651.3 69.8 18.4 
  Sport Gear8 724.7 144.8 22.2 
  Stocking 748.1 96.0 20.5 
 2-5MPJ Circulation Sock# 619.9 81.3 16.4 
  SmartKnit+ 625.1 66.6 18.2 
  Sport Gear8 611.2 118.8 21.3 
  Stocking 659.1 63.0 17.6 
 Heel Circulation Sock# 475.5 52.0 17.8 
  SmartKnit+ 527.0 40.5 14.4 
  Sport Gear8 552.8 103.7 18.2 
  Stocking 484.6 33.4 19.2 
#Red Robin, Melbourne Australia, +KnitRite, Kansas USA, 8 Fruit of the Loom Mt. Airy USA 
 
These claims may have been made based on the significant differences obtained from the 
statistical calculations without consideration of the inherent variability of the data analysed. To 
investigate this point, the mean and standard deviation results for peak pressure at the 1MPJ 
region that were reported by Veves et al. (1990) were used by the author to calculate their data’s 
variability (CV%) and these results are presented in Table 24. The variability results calculated 
are limited due to their being calculated from the sample mean and standard deviation results 
instead of each subject and then averaged, but still give an indication that the results reported are 
so variable (CV% range of 55.1 to 67.2%). This result brings into question the validity of the 
conclusions drawn. The magnitude of the difference between the variability of the thesis study 
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and that calculated from Veves et al. (1990) may potentially be explained by the different 
instruments used for data collection (capacitance versus optical pedobarography), but this cannot 
be verified and warrants further investigation. 
 
Table 24  
Results reported by Veves et al. (1990) with CV% calculation and units conversion (from kg.cm2 
to kPa) by the author. 
Variable Anatomical region Sock condition Mean* SD* CV%+ 
Peak pressure  1MPJ Barefoot 715.7 480.4 67.2 
(kPa)  Experimental socks 617.6 343.1 55.1 
  High density socks 617.6 392.2 63.6 
  Medium density socks 656.9 392.2 58.9 
* Reported by Veves et al. (1990), + Calculated by the author. 
 
The study reported by Perry et al. (1995) are from data collected from a sock of similar material 
and thickness (Adler Jogger socks) to the Sport Gear (Fruit of the Loom, Mt Airy USA) sock 
tested in the thesis study. The studies are comparable in respect to subjects, instrument and sock, 
but differ in the method of data collection and the results are presented in Table 25. The study by 
Perry et al. measured pressures while the subjects walked with the first-step data collection 
method as opposed to the mid-gait method used for thesis data collection. The different method of 
data collection may explain why the peak pressure results reported by Perry et al.  are nearly half 
in the mean result while having similar standard deviation compared to the thesis study result. The 
variability of the results from Perry et al.  are similar to the thesis results for the lateral 
metatarsophalangeal joints and heel region, but are nearly double the thesis study results for the 
hallux and 1MPJ regions. Once again, the different method of data collection may explain this 
difference. It would not be unexpected to find more variability in the loading of the forefoot in the 
first step of data compared to mid-gait steps, because expected higher variability underlies the 
elimination of the first (and last) steps during walking when measuring pressure for in-shoe 
analyses.  
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Table 25  
Results reported by Perry et al. (1995) with CV% calculation and units conversion (from N.cm2 to 
kPa) by the author. 
Variable Anatomical region Sock condition Mean* SD* CV%+ 
Peak pressure  Hallux 307 128 41.69 
(kPa) 1MPJ 
Adler Jogger socks 
326 140 42.95 
 2 MPJ + 3-5 MPJ  390 97.5 24.61 
 Heel  304 72 23.68 
 
 
Conclusion 
The results from this thesis study show that there is no clinically applicable difference between 
sock material and ‘barefoot’ for dynamic plantar pressures measured at a resolution of four 
sensors per square centimetre. Therefore, for dynamic in-shoe plantar pressure measurement at the 
lower resolution of two sensors per square centimetre, the selection of the standard sock can be 
based on clinical logic and not sock fabric. To minimise the potential risk to the leg from 
constriction from the suspension band, a suspension band-free sock was chosen for the standard 
sock. However, if the plantar material is to be discounted, then the choice becomes between the 
construction methods of securing the toe seam of the socks; sewn or knitted. The anecdotal 
potential for irritation and skin injury risk from the bulk of a sewn seam is unverified and is the 
focus of the following experiment. 
 
Verification that sock seam bulk is associated with 
localised high pressure21 
Rationale 
Irritation from footwear is one of the most readily preventable factors leading to ulceration in the 
high-risk diabetic foot (Burns, Leese, & McMurdo, 2002; Chantelau & Gede, 2002). Irritation 
from the sock fabric being trapped between the foot and the shoe has been confirmed in one case 
and anecdotally in others as being a causative factor in ulceration (Murray, Veves, Young, Richie, 
& Boulton, 1993). The role of socks has received substantially less attention than shoes and 
insoles in their potential role in causing foot ulceration. Experimental evidence has not been 
reported to verify whether the bulk of the fabric in a sock seam could exert sufficient localised 
pressure to compromise the skin integrity of the diabetic and neuropathic foot. Naturally, it would 
be unethical to conduct experiments to verify this assumption in humans without first establishing 
sound laboratory-bench based evidence. Therefore, a laboratory-bench test was designed to test 
the assumption that an increase in pressures of greater than 40% in the laboratory could suggest 
that a sock seam trapped between the foot and shoe could potentially be of sufficient pressure 
magnitude for the skin of the diabetic and neuropathic foot to be at risk of injury. 
Purpose 
The purpose of study was two-fold; first, to determine in the laboratory, if a sock seam could form 
a measurable and identifiable local focus of high pressure and, secondly, to verify any difference 
in localised pressure between the seam and no-seam areas of socks made of different fabrics. 
Method 
The two socks with sewn seams (seamed socks) used in the previous experiment (Sport Gear: 
Fruit of the Loom, Mt. Airy, USA and Circulation Sock: Red Robin, Melbourne Australia) were 
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compared against the sock with a knitted seam (seamless sock) (SmartKnit: Knit-rite Inc., Kansas 
City, KS). The F-scan™ In-sole Pressure Analysis System was selected to measure pressure in the 
experiment because its high resolution of four sensors per centimetre was found during pre-testing 
to be sufficient to identify the location of the seam. The Pedar™ system’s sensor resolution of two 
sensors per centimetre was found during pre-testing to be insufficient to identify the location of 
the seam on the sock-seam sample. 
The image of raw pressure data from the sock sample with a sewn seam compressed in the 
apparatus obtained during pre-testing using the F-scan™ software is presented in Figure 13 and 
the seam area is clearly visible in the image. The F-scan™ sensors have been reported to have 
limitations on pressure measurement and that the limitations are temperature and time dependant 
due to the resistive ink method of sensor construction (Luo et al., 1998; Sumiya et al., 1998). 
However, due to the temperature stability afforded by the laboratory environment and procedural 
minimisation strategies to limit sensor activation time, these limitations were assumed negligible. 
A protocol error of 10% was accepted as a limitation of the unit of measures. 
Procedures 
A new sensor was utilised for each sock condition tested to take advantage of the standardisation 
achieved through factory equilibration. The system was calibrated and all software procedures 
were conducted as described in the User’s Manual. 
The socks were prepared for testing by removing their plantar surface therefore, exposing the 
seam freely for placement against the sensor and removing the material bulk of the upper sock 
portion. The sensor and the sock sample were ‘sandwiched’ between two flat and non-compliant 
3mm thick metal plates and the apparatus is presented diagrammatically in Figure 14. Two non-
compliant surfaces were utilised due to the assumption that the inner of a shoe and bony 
prominences on the foot are non-compliant. A 65 kg mass applied vertical mass to the apparatus22. 
Sixty-five kilograms was selected to represent the applied force of an adult body mass. Sensor 
data were captured using the default sensing thresholds from five trials of eight seconds each at 
the default sampling frequency of 50 Hertz for each sock condition.  
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Figure 13.  Image of raw pressure data as obtained from a sock sample under load using the F-
scan™ system and software. 
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Figure 14.  Diagram of the sock sample testing apparatus. 
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Data analysis 
The seam area and a non-seam area of each sock sample were identified and were ‘boxed’ to 
create an object file for analysis. To facilitate identification of the knitted seam a preliminary data 
collection was carried out with a matchstick placed adjacent to the seam. Peak pressure data were 
analysed over a standardised area using the F-scan™ 4.1123 software at three time points from the 
eight seconds of continuous data collected for each trial and exported into Excel for spreadsheet 
preparation and calculation of descriptive statistics. 
 
Results and discussion 
The results support the anecdotal clinical evidence that a sock seam can lead to a focus of high 
pressure. Sewn seams were found to form a region of high localised pressure as demonstrated in 
the raw data image shown in Figure 13 and the three dimensional image provided by the F-scan™ 
software and shown in Figure 15. The magnitude of the pressure measured at the sewn seam was 
found to be 1000% (ten times) that measured at the non-seam areas of the socks and this is shown 
in Figure 16. The pressure measured at the sewn seams was slightly higher on the therapeutic 
sock compared to that of the supermarket sock and this is attributed to the physically thicker 
material and seam of the therapeutic sock. The pressure measured at the knitted-seam region was 
found to be equivalent to the non-seam areas of the socks. The level of pressure measured under 
load at the seam (438.2 and 394.4 kPa) is less than was reported to correspond with known peak 
pressures on the plantar foot in persons with neuropathy and diabetes (700 kPa) (Armstrong, 
Peters et al., 1998). Whether the level of pressure recorded at the seam is sufficient to cause 
ulceration to the foot remains unknown and further in-shoe pressure testing of the dorsal and 
lateral foot is recommended. 
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Figure 15.  Three-dimensional image of the magnitude of localised pressure measured at the 
seamed area of the sample when the sock was under load. 
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Figure 16.  Pressure measured at the seam and sock regions of two therapeutic and one 
supermarket socks. 
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Conclusion 
The results of this experiment verify that the bulk of a sewn sock seam can form a region of 
localised high pressure and that this pressure is of the magnitude of ten times that afforded by the 
sock material and a knitted seam. Even though the results provide sufficient evidence to logically 
suggest that the standard sock for in-shoe testing should be seam-less, the experimental design 
limits the general applicability of these experimental results to the foot-shoe environment due to 
two main factors. The first factor is the loading of the sample with a single and constant mass and, 
the second factor is the measurement obtained from between two rigid and non-compliant 
surfaces as opposed to the realistic environment being one non-compliant (shoe) and one soft or 
compliant surface (foot). Therefore, to more realistically determine any potential effect on 
pressures from a sock seam, these limitations are minimised in the following experiment. 
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Localised pressure and sock seams under 
increasing applied loads 24 
 
Rationale and purpose 
For a sock seam to form a localised area of high pressure on the foot, it would need to be firmly 
trapped against the skin, and a firm shoe would generally provide the trap. The firmness of the 
trap provided by the shoe would be likely to vary depending on the action of the foot during 
different phases of the gait cycle and due to the seam being absorbed into the soft (semi-
compliant) flesh of the foot when trapped against the firm (non-compliant) shoe. The previous 
experiment was limited in its general applicability for making inferences to the injury potential 
role of the sock seam on a foot within a shoe due to testing a single sustained pressure and 
utilising two non-compliant surfaces. Therefore, the purpose of this experiment was to explore the 
limitations of the previous experiment by applying incremental pressures to seam and seamless 
sock samples compressed between a semi-compliant and a non-compliant surface.  
Method 
A bench-based test was designed to address the purpose of study. 
Socks were eligible for inclusion if they were marketed as therapeutic to the diabetic population. 
Four socks were eligable for inclusion in the study. Three socks with sewn seams (seamed socks) 
(Sport Gear, Fruit of the Loom, Mt. Airy USA; BlisterGuard, PTFE, New York USA & 
TheraSock-Double sock system, TheraFoot Technologies, Kansas USA) were compared against a 
sock with a knitted construction (seamless sock) (SmartKnit, Knit-Rite Inc., Kansas USA). The 
Sport Gear and SmartKnit socks were of similar and the thinnest fabric composition, the 
BlisterGuard were the thickest, while the TheraSock-Double sock system were a similar thickness 
and composition to Sport Gear and SmartKnit socks but had two layers sewn together. The 
BlisterGuard and TheraSock-Double sock system socks had the thickest seams, the Sport Gear 
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(2000, March) What are the effects of incremental pressures on the pressure exerted from sock seams? Poster session 
presented at The Diabetic Foot, Conference of the Australian Podiatry Council, Sydney, Australia. 
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sock had the thinnest seam, while the Smart Knit sock seam was indiscriminatable to the 
surrounding fabric.  
Instrumentation and procedures 
Pressure was measured with the F-scan™ In-sole Pressure Analysis System 4.12 as described in 
the previous experiment. Four sock samples were dissected as previously described and placed 
with a pressure sensor between a non-compliant and a semi-compliant surface associated with a 
mechanically driven and controlled compressed air pressure Trublu25 device, and the testing 
apparatus and set up is shown in Figure 17. The semi-compliant material was 1.5 mm of PPT26, 
which is described as an open cell polyurethane foam (McPoil & Cornwall, 1992). PPT was 
selected as it readily utilised in therapeutic footwear interventions to protect diabetic foot 
ulceration [McPoil, 1992 #1569]. Three trials were conducted with each sock sample under 
applied loads in increments of 100 kPa from 100 to 500 kPa. Each load was applied and 
maintained while the previous trial’s data were labelled and then data collected to standardise the 
time that the sensor was active to minimise creep. These loads were chosen as they were the 
minimum increments available on the Trublu27 device. Data were collected for eight seconds for 
each trial. The samples were placed in the device such that the inner sock and seam were directly 
against the pressure sensor and then the semi-compliant surface. This arrangement was intended 
to mimic a sock seam pressed against the foot (semi-compliant surface) within the shoe (non-
compliant surface) A protocol error of 10% was accepted as a limitation of the unit of measures 
and study design. 
Data analysis 
Areas of the midfoot (baseline) and forefoot encompassing the distal sock and sock seam of each 
sock’s image data were identified for pressure measure analysis. Peak pressure data were analysed 
over a standardised area with the F-scan™ 4.12 software from the midpoint from the eight 
seconds of data collected for each trial and exported into Excel for presentation.  
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Figure 17.  Testing set up utilising a mechanically driven and controlled compressed air pressure 
Trublu™ device, the pressure sensor insole matrix and the sock sample (the semi-compliant 
material is not shown in the photograph) 
Results 
The results are presented in Figure 18 and it shows that the pressures measured at the seam and 
no-seam area increased proportionally as the applied pressure was also increased. The sock with 
the knitted seam, and therefore, no detectable increase in fabric bulk, showed minimal difference 
at the seamed and non-seamed site at each incremental rise in applied pressure. The Sport Gear 
sock that was made of the thinnest fabric showed a difference in pressure at the lowest applied 
pressures, but this difference dissipated at the higher pressures. Both the TheraSock double system 
sock and the BlisterGuard sock showed a difference between the seam and the non-seamed areas 
at each of the incremental pressures, with the seam area consistently showing a higher pressure.  
 
The percent difference between the seam and no-seam areas during testing did not reach above 
60% and the highest difference was found at the lowest pressure (100kPa) for the TheraSock 
Double system sock. 
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Legend: Sport Gear, Fruit of the Loom, Mt. Airy USA; SmartKnit, KnitRite, Kansas USA; TheraSock double system, 
TheraFoot Technologies, Kansas USA; Blister Guard, PTFE, New York USA. 
Figure 18.  Peak pressure as measured on each sock condition at each applied load. 
 
Discussion 
The results of this experiment at low pressures are in agreement with the previous study, except 
that the pressure difference between seamed and non-seamed areas in seamed socks was 
substantially less. The lower difference is most likely explained by the change in the experimental 
design that included the semi-compliant material. The semi-compliant material provided 
cushioning which was sufficient to accommodate the seam-bulk and the compliant material fully 
embedded the seam after 300kPa of applied pressure in the seamed sock with the thinnest fabric. 
However, the semi-compliant material was insufficient to embed the thicker seams in the thicker 
fabric socks (BlisterGuard and TheraSock double sock) and their seams formed an area of 
localised higher pressures throughout the range of pressures applied. The TheraSock double 
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system sock showed the densest seam (being four layers of fabric sewn together) and was the least 
embedded by the cushioning thus showing the highest percent difference of all sock conditions 
and pressures tested. 
The absorption of the seam by the semi-compliant material provides insight into the potential 
effect that the trapping of a seam against the compliant tissue of the foot by a shoe would have. 
The results of this experiment raise questions to the validity of the current sock prescription and 
education practises for people with diabetes and further study is warranted. 
Conclusion 
This experiment showed that having one semi-compliant surface rather than two non-compliant 
surfaces reduced the severity of the pressure increase at the seam to less than 60% more than the 
non-seam area compared to the 1000% increase found in the previous experiment. Different 
applied pressures also influence the pressures measured on different seams and fabrics. 
 
Chapter summary 
The use of padded socks as a cushioning device to protect the plantar foot from high plantar 
pressures is unsubstantiated when the results of the thesis study are viewed in light of the 
uncertainty analysis results found in Chapter Three. The results of this chapter did not find 
evidence to agree with Research Question Two (a). However, the consequences of the practice of 
educating people with diabetes to wear padded socks to protect their feet may in fact potentially 
lead to injury if the thick sewn seam became trapped between the foot and the shoe. The results of 
the two experiments on sock seams, especially suggest that a sock seam trapped against a foot by 
a shoe (non-compliant) is more of a concern over bony prominences (non-compliant) than other 
more fleshy parts of the foot (semi-compliant). Therefore, until pressure threshold levels are 
identified at which skin integrity becomes compromised and these results can be verified, 
potentially feet may be being placed at risk by wearing padded (thick fabric) socks with sewn 
seams. Consequently, to minimize potential risk to the subjects who participate in the thesis 
studies, the seamless sock was selected as the standard-testing sock. 
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Rationale and purpose 
This chapter reports the results of the initial investigation into in-shoe plantar pressure 
measurement during walking gait in adults with diabetes. The study was designed to test Research 
Question Two (b) and address three aims. The first aim was to test the in-shoe pressure 
measurement protocol for foot safety, because if the procedures were to pose a foot injury risk, 
and were utilised in a neuropathic population, then the subjects could potentially incur injury that 
could begin the sequelae towards ulceration, infection, limb amputation and even death. Foot 
injury risk was defined as interruption to the skin, that would take the form of blistering, abrasion 
or cut. 
The second aim was to verify that walking gait spatial and temporal measurement variables were 
consistent for the population when subjects self-selected and controlled their comfortable walking 
gait during the in-shoe plantar pressure measurement procedures. The Pedar™ system does not 
contain instrumentation to verify the distance travelled during testing and therefore, the 
consistency of spatial and temporal gait measures is not known. Lack of verification of spatial and 
temporal gait measurement variables during in-shoe plantar pressure measurement is indirectly 
supported by the literature. Specifically, pressure measure’s reliability was not affected by speed 
when controlled by a treadmill (Kernozek et al., 1996), variability in temporal variables was a 
normal component of mid-gait walking (McPoil et al., 1999), and gait velocity variation was 
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acceptable within ± 10% in people with diabetes and neuropathy (Cavanagh et al., 1998). 
However, investigation to validate the assumption that walking gait temporal and spatial variables 
are consistent when the subject self-selects their comfortable walking pace during in-shoe plantar 
pressure measurement procedures was conducted for good practice. 
The third aim explored in-shoe plantar pressures beyond the absolute value convention to define 
the pressures measured as a function of stance time. Chapter Three Part I showed that it is the 
convention that in-shoe plantar pressure results are described in terms of the peak absolute value 
recorded during each step without regard to time. There is ample literature that concurs with the 
assumption that high peak pressures are associated with forefoot ulceration. However, an absolute 
peak pressure threshold value, above which ulceration will occur, has not been established, 
suggesting that measures other than the peak, may be related to ulceration occurrence (Armstrong, 
Peters et al., 1998).  
Data presentation and description conventions from other gait analysis tools, specifically kinetic, 
kinematic and electromyographic methods, differ from plantar pressure analysis, in that rather 
than compare the absolute peak values, their results are often graphed as they relate to time. These 
results are co-plotted to enable comparisons to be made with reference data, which is generally 
from a baseline or healthy population (for example see (Craik & Dutterer, 1995; Winter, 1991)) 
Recently, the pattern that peak plantar pressure results as related to stance time has provided 
insight into pressure with neuropathy and ulceration (Maluf & Mueller, 2003). Therefore, the 
pattern of peak plantar pressure as it relates to stance time was defined and for cross-validation 
with the literature, plots of measures of the pattern of force and mean pressure were produced. 
Subjects 
A convenience population of eight subjects who were diagnosed with diabetes, but without 
peripheral neuropathy or a history of plantar forefoot ulceration volunteered to take part in the 
study. Potential subjects were informed about the study via a presentation about foot health and 
diabetes that was given by the author at a diabetes education session in the Dietetics Department 
at the Texas Diabetes Institute. Subjects who volunteered were briefly screened for inclusion at 
the end of the session and then an appointment time was made to confirm their eligibility. The 
Institutional Review Boards of the University of Texas Health Science Center and the University 
Health System gave approval for the study, and informed consent was obtained from all subjects 
prior to their participation. 
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Subjects were included if they were an adult with diabetes and were able to walk unassisted. 
Subjects were excluded if they had peripheral neuropathy as defined in Chapter Four; a history of 
foot ulceration, major trauma to the lower limbs or lower back, surgery to the feet, or if they had 
concurrent disease processes such as Parkinson’s disease that limited their ability to walk 
consistently. All subjects who volunteered were eligible and consented to participate in the study 
and their positive decision was influenced by two incentives. The first incentive was that they 
would receive in-shoe plantar pressure assessment that was generally reserved for surgical 
patients and they would receive it free of charge. The second was that they would receive free of 
charge a pair of walking shoes.  
The population of eight subjects (two men and six women), ranged in age from 43 to 60 years 
(mean 52, SD 6), height of 1.51 to 1.73 m (mean 1.62, SD 0.06) and mass of 65.91 to 113.64 kg 
(mean 94.09, SD 17.81). Body mass index (BMI) ranged from 26 to 50 (mean 36, SD 7), 
classifying three subjects as overweight (BMI 25-30) and five as obese (BMI>30) (Zeman, 1991). 
Procedures 
Data collection and processing 
In-shoe plantar pressure measurement 
Procedures for subject treatment, in-shoe plantar pressure measurement trial practice, data 
collection and processing and subject discharge that were developed in Chapter Three and those 
described in Chapter Four were conducted.  
The subjects wore appropriately sized SmartKnit seamless socks and the standard Nike canvas 
shoes during testing. 
External verification of spatial and temporal gait variables consistency when the 
subject controls for self selected natural walking  
The subjects were fitted for in-shoe plantar pressure measurement and trials were practised and 
conducted where the subjects walked away from the data collection device over the laboratory 
floor beside the GaitMatt II™ (E. Q. Incorporated, Chalfont, PA) walkway for the distance 
allowed by the Pedar™ system umbilical data collection cord. For spatial and temporal gait 
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variable testing, the subject then returned to the starting point by walking over the GaitMat II™ 
walkway.  
GaitMat II™ is a system for measuring the spatial and temporal variables of gait. It consists of a 
walkway with pressure sensitive switches embedded in its surface. The system recorded steps 
while the subject walked on the walkway. At least two left and two right steps were recorded for 
each subject for each trial. Five trials were conducted and by convention the first trial was not 
included in the analysis (Pederson & Gore, 1994). The investigator visually observed each trial 
and any trials that included irregular steps or a stumble were repeated. All steps recorded were 
included in the analysis.  
The default sampling interval of five milliseconds (frequency = 200 Hz) was selected for 
measurement of gait variables. The variables and their measurement units were step length, stride 
length and support base in metres (m), and step time, swing time, stance time, single support time 
and double support time in milliseconds (ms), and average velocity in metres per second (ms-1). 
The GaitMatt II™ output that defines the measurement of the spatial variables is presented in 
Figure 19. The GaitMatt II™ output that defines the measurement of the temporal variables are 
presented in Figure 20 and Figure 21. Average velocity (ms-1) was calculated by the following 
formula: 
Velocity = (last contact distance - first contact distance) / (last contact time - first contact time) 
 
Statistical analysis  
Absolute value analyses 
The peak pressure and pressure-time integral absolute values measured for each step and for each 
limb obtained from in-shoe plantar pressure measurement with the Pedar™ system and the spatial 
and temporal gait variables obtained from each trial from the GaitMat II™ system were examined 
for and confirmed as being normally distributed using proportion probability (P-P) plots with the 
proportion estimated using the Rankit formula. Descriptive statistics were calculated for the in-
shoe plantar pressure measurement variables of peak pressure and pressure-time integral for the 
whole foot and the anatomical regions of the hallux, 1MPJ and 2-5MPJ and heel regions. Even 
though the not all of these variables were identified as useful for ulceration location identification 
in Chapter Three, they are included to allow comparison of the study results with the reported 
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literature. Descriptive statistics were also calculated from each trial for the spatial and temporal 
measurement variables of step length, stride length, support base, step time, swing time, stance 
time, single support time, double support time, and average velocity. The GaitMatt II™ variable 
means were examined for between-trial differences using a one-way analysis of variance 
(ANOVA) for repeated measures (3,1) function, and post hoc analyses were conducted using the 
Dunnett’s T3 test. Dunnett’s T3 test was chosen for post hoc analyses as it does not require the 
assumption of equal variances to be met as already discussed in Chapter Three (SPSS 
Incorporated, 1998). 
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Figure 19.  The definition of the calculation of the spatial variables as measured by GaitMatt II™. 
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Figure 20.  Definitions of the temporal variables of step, swing and stance time as measured by 
GaitMatt II™. 
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Figure 21.  Definitions of the temporal variables of single and double support time as measured 
by GaitMatt II™. 
 
Pressure-time analyses 
The in-shoe plantar pressure absolute values measured for force, mean pressure and peak pressure 
at each 200 Hz data point of the percent-normalised stance phase of each step for each limb were 
averaged to create a representative step for graphical exploration. The average values (means) 
from the representative step were presented graphically bounded by their corresponding 95% 
confidence limits. Graphs were developed for three of the variables beginning with force to 
facilitate comparison with and validate the graphical result patterns of the present study with the 
reported literature. The graphs of the mean pressure were then produced and used to describe the 
influence on the result patterns from the standardised area defined for each anatomical region. 
Finally the graph of the peak pressure was produced to describe the patterns that reflected the area 
defined by an individual sensor and therefore, potentially ulceration. 
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Confidence limits for continuous data are generally constructed using the joining of Gaussian 
theory based point-to-point confidence intervals, generally calculated from the 95% confidence 
interval of each mean value for each time point using the formula (Portney & Watkins, 1993  
p646): 
SDzXCI )(95% ±=  
However, the point-to-point statistical methods appropriate for the analysis of less complex single 
point measure data are inappropriate when applied to continuous curves of gait data. These 
methods ignore the fact that the curve is a series of related (not independent) points and these 
points are being considered simultaneously (Lenoff et al., 1999). To utilise single point statistical 
methods for examination of continuous data presented over percentage-normalised stance phase 
(with 100 time points), then a Bonferroni correction to the magnitude of 100 is required (Portney 
& Watkins, 1993,  pp 406-407). However, a Bonferroni correction of that magnitude would result 
in the confidence limits being so broad as to be of little interpretative value (Lenoff et al., 1999).  
A method for calculation of confidence bands appropriate for continuous curves of data is the 
bootstrap (Lenoff et al., 1999). The bootstrap is a re-sampling with replacement procedure that is 
applicable for continuous, or gait curve data from which prediction and confidence bands can be 
constructed and these are advocated for use for evaluating gait data curves (Davison & Hinkley, 
1997; Efron & Tibshirani, 1993; Lenoff et al., 1999).  
To calculate confidence bands using the bootstrap method, the data were ranked and replications 
of the ranked data values were repeatedly generated and means calculated (Zhu, 1997). All 
bootstrap calculations were performed in Excel and for each calculation, 1000 iterations of 
sampling with replacement were performed. The results of the calculations provided a pseudo 
population of 1000 cases closely representing the original data set and a curve was determined for 
each variable where only 2.5% (25) of the graphs crossed the curve at any point (Efron & 
Tibshirani, 1993). As the bootstrap method is dependant on random number generation, the 
validity of Excel random number generation was tested. The validity of 200,000 random integers 
(range 1-10) that were generated were analysed by SPSS using a one-way ANOVA with post hoc 
comparison (SPSS Incorporated, 1998). The random integers were not significantly different at 
the p<0.05 level (The smallest p-value determined by any post hoc comparison was 0.18 (std error 
10.024)).  
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Results 
Foot injury risk from in-shoe pressure measurement procedures 
There were no instances of foot injury, discomfort or symptoms of potential foot injury reported 
by the subjects during data collection, nor reported to the clinic nurse in the two days after the 
data collection. There were no signs of injury or potential injury identified by the author during 
the foot inspection at subject discharge.  
Verification of spatial and temporal variable consistency when the subject 
controls for self selected natural walking 
The descriptive statistic results for spatial measurement variables per trial are presented in Table 
26, while the temporal measurement variables per trial are presented in Table 27. The descriptive 
statistic results show, and the lack of statistical significance (p<0.05) shown by the ANOVA and 
post hoc analyses confirm, that the walking gait of this sample population was highly consistent. 
For all variables, the means of each trial were consistent and did not vary greater than ±10%. 
 
In-shoe plantar pressure measurement 
Absolute value analyses 
The absolute values measured for the variables of peak pressure and pressure-time integral over 
the whole foot and defined anatomical regions were examined descriptively for each limb and the 
population results are presented in Table 28. 
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Table 26 
Results for spatial measurement variables from four trials. The ‘trial number’ represents all steps 
for all subjects (n=8) for that trial. 
 
Variable & 
ANOVA significance 
Trial number* Mean SD Min Max 
Step length (m) 2 0.57 0.07 0.41 0.68 
p=0.34 3 0.58 0.06 0.43 0.68 
 4 0.59 0.06 0.43 0.68 
 5 0.60 0.06 0.44 0.70 
Stride length (m) 2 1.13 0.13 0.84 1.33 
p=0.30 3 1.15 0.12 0.87 1.33 
 4 1.17 0.12 0.90 1.37 
 5 1.20 0.11 0.94 1.38 
Support base (m) 2 0.26 0.05 0.15 0.34 
p=0.70 3 0.27 0.04 0.18 0.33 
 4 0.25 0.05 0.16 0.34 
 5 0.25 0.06 0.15 0.38 
*By convention, the first trial was excluded from analysis, leaving trials numbered two to five for analysis (Pederson & 
Gore, 1994). 
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Table 27 
Results (n=8) for temporal measurement variables from four trials . 
Variable & 
ANOVA significance 
Trial number* Mean SD Min Max 
Step time (s) 2 0.55 0.06 0.45 0.64 
p=0.99 3 0.55 0.05 0.44 0.64 
 4 0.55 0.06 0.44 0.66 
 5 0.55 0.04 0.46 0.61 
Swing time (s) 2 0.37 0.04 0.29 0.44 
p=0.85 3 0.38 0.05 0.26 0.44 
 4 0.38 0.06 0.27 0.46 
 5 0.38 0.04 0.28 0.44 
Stance time (s) 2 0.73 0.07 0.63 0.86 
p=0.71 3 0.73 0.06 0.59 0.83 
 4 0.71 0.07 0.61 0.83 
 5 0.71 0.06 0.61 0.81 
Single support time (s) 2 0.37 0.04 0.29 0.44 
p=0.85 3 0.38 0.05 0.26 0.44 
 4 0.38 0.06 0.27 0.46 
 5 0.38 0.04 0.28 0.44 
Double support time (s) 2 0.18 0.03 0.14 0.24 
p=0.12 3 0.17 0.02 0.14 0.23 
 4 0.16 0.02 0.12 0.20 
 5 0.16 0.03 0.12 0.22 
Velocity (ms-1) 2 1.01 0.11 0.85 1.21 
p=0.08 3 1.05 0.12 0.89 1.27 
 4 1.08 0.10 0.92 1.21 
 5 1.10 0.12 0.92 1.27 
*By convention, the first trial is excluded from analysis, leaving trials numbered two to five for analysis (Pederson & Gore, 
1994). 
 
Table 28  
Results from absolute value analyses for peak pressure and pressure time integral (n=8). 
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Variable  Anatomical region Mean SD Min Max 
Peak pressure (kPa) Total foot 339.85 36.86 252 405 
 Hallux 313.64 37.89 223 379 
 1MPJ 230.26 37.52 156 302 
 2-5MPJ 223.99 25.58 155 266 
 Heel 207.50 18.71 164 244 
Pressure-time integral Total foot 123.40 8.52 106 143 
(kPa s) Hallux 72.10 13.08 48 100 
 1MPJ 61.44 10.60 42 85 
 2-5MPJ 64.76 7.29 47 80 
 Heel 56.11 7.60 43 78 
 
 
Pressure-time analyses 
Graphs were plotted for the force, mean pressure and peak pressure over percentage-normalised 
stance time. The means and the 95% confidence limits derived from the point-by-point and the 
bootstrap methods are presented on the same graphs to illustrate the two methods. The result for 
peak pressure-total over percentage-normalised stance time for limb 13 was erroneous due to a 
processing error and was discarded leaving 15 limbs for analysis. The variability between 
individual limb results are presented using the force-total for all limbs in Figure 22 and for the 
sample mean in Figure 23. The mean results calculated using the point-by-point and the bootstrap 
methods are very similar, leaving the plots of these curves indistinguishable and presents as a bold 
continuous central line, which is in fact two lines (a dashed and a continuous line) very slightly 
offset. For all graphs, the 95% confidence point-by-point limits are shown in the outer dashed 
lines and the bootstrap bands are shown in the continuous outer lines. In both Figure 22 and 
Figure 23, the bootstrap bands are larger (and therefore, wider) than the point-by-point limits, 
which confirm that the bootstrap method provides a more conservative estimate of the 95% 
confidence limits than the point-by-point method. 
 
The variability in the pattern of foot loading between limbs is shown in Figure 22 and this 
variability is reflected in the width of the point-by-point limits and bootstrap bands plotted on the 
mean from each time point that is shown in Figure 23. 
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Figure 22.  The 16 individual limbs (n=8) results for force over the whole foot (total) during 
percentage-normalised stance time shows the variability associated with individual subjects when 
walking. 
 
The graph of force on the whole foot (total) over percentage-normalised stance time presented in 
Figure 23 shows the double hump shape that is typically expected (Craik & Dutterer, 1995; 
Winter, 1991). The first hump represents the higher deceleration force that arrises from the limb 
impacting the ground at the end of swing phase, the following dell represents the lower force that 
relates mainly to body mass and gravity, while the second hump represents the higher acceleration 
force that arrises from the limb pushing off the ground. The 95% confidence limits and bands 
show that with 95% surety, the population mean will fall within approximately plus or minus 200 
Newtons of the calculated mean through midstance phase, and that the limits and bands are 
narrower at the initiation and termination of gait than during midstance. 
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Figure 23.  The means and confidence bands calculated using both the point-by-point (PbP) and 
bootstrap (Bstrap) methods for force over the whole foot (total) (n=8). 
 
The force graphs over percentage-normalised stance time in Newtons for the means (PbP and 
Bstrap) and 95% confidence point-by-point limits and bootstrap bands for the defined anatomical 
regions are presented in Figure 24. These graphs illustrate the shapes formed from the results of 
the means and confidence limits for forces when measured over each anatomical region during 
percentage-normalised stance time. These results are presented to describe the forces that are 
measured over the defined anatomical regions of the plantar foot as they relate to time.
Mean (PbP)   95% confidence limits (PbP) 
Mean (Bstrap)   95% confidence bands (Bstrap) 
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Figure 24.  The means and 95% confidence point-by-point (PbP) limits and bootstrap (Bstrap) bands for force on the hallux, 1MPJ, 2-5MPJ and 
heel over percentage-normalised stance time (n=8). 
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The force on the hallux shows that even though the hallux would not be on the ground, there is a 
small force is measured there at the initiation of stance phase immediately after the heel contacts the 
ground. This small force is most likely due to force on the foot from the shoe rather than from the 
ground and alerts the author to the limitation of describing the specific origin of the results when 
using the in-shoe plantar pressure measurement tool. However, being cognisant of this limitation, the 
force can be seen to very gradually increase until after midstance when more body weight is 
transferring from the rearfoot to the forefoot. The force peaks following heel lift and then rapidly 
reduces as the foot leaves the ground at the termination of stance phase. 
The force on the 1MPJ region shows that the pattern of force through the 1MPJ region follows a 
similar pattern to the hallux but peaks and begins to reduce slightly sooner as the medial forefoot 
accepts maximum body weight for push off and termination of stance phase occurs. 
The force on the 2-5MPJ region once again follows a similar pattern to both the hallux and 1MPJ 
except that the load increases at a higher and more constant rate from initiation until it peaks for push 
off and termination of stance phase. 
The force on the heel shows that the force rapidly rises after stance phase is initiated. The force peaks 
after ten percent of stance phase and remains loaded until 25 percent when heel lift has begun and 
body weight begins to transfer from solely the heel to include the forefoot. The forces gradually 
reduce after this time until only a small amount remains after 70 percent of stance phase, which is 
most likely from the shoe rather than the ground. 
The following figures illustrate the shape and confidence limits for mean pressures measured on each 
anatomical region over percentage-normalised stance time. The mean pressure-time points relate to 
the force-time points mathematically by the formula:  
Force/AreaPressure =  
The mean pressure-time graphs for the means (PbP and Bstrap) and 95% confidence point-by-point 
limits and bootstrap bands for the whole foot and the defined anatomical regions over percentage-
normalised stance time are presented in Figure 25 and Figure 26. The defined anatomical regions are 
standardised for area and therefore, the mean pressure-time graphs can be directly compared to the 
force-time graphs. Overall, the mean pressure-time graphs can be seen to follow similar patterns, 
although they are flatter than the force-time patterns. 
 
The graph of mean pressure on the whole foot (total) over percentage-normalised stance time 
presented in Figure 25 shows a similar double hump shape to that of the force. The main difference is 
that the first hump of the mean pressure is lower than the second. This is due to the large area of the 
heel, and therefore, higher number of sensors that are included in the average calculation process. The 
dell between the humps dips lower for the mean pressure than the force due to the large sensor area 
(whole foot) over which the force is divided by during midstance. The 95% confidence limits and 
bands show that with 95% surety, the population mean will fall within approximately plus or minus 
20 kPa of the calculated mean through midstance phase, and that the limits and bands are narrower at 
the initiation and termination of gait than during midstance. 
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Figure 25.  The means and 95% confidence point-by-point (PbP) limits and bootstrap (Bstrap) bands 
for mean pressure over the whole foot (total) over percentage-normalised stance time (n=8). 
 
The mean pressure graphs presented in Figure 26 show similar patterns to those of the force, with 
variations due to the large sensor area included in the average calculation process as discussed 
previously.
Mean (PbP)   95% confidence limits (PbP) 
Mean (Bstrap)   95% confidence bands (Bstrap) 
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Figure 26.  The means and 95% confidence point-by-point (PbP) limits and bootstrap (Bstrap) bands for mean pressure on the hallux, 1MPJ, 2-
5MPJ and heel over percentage-normalised stance time (n=8). 
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The peak pressure graphs for the means (PbP and Bstrap) and 95% confidence point-by-point limits 
and bootstrap bands for the whole foot and the defined anatomical regions over percentage-
normalised stance time are presented in Figure 27 and Figure 28. These figures illustrate peak 
pressures as they relate to time and are constructed to form baseline patterns for utilisation in time-
relative discussion in this and future studies of clinical populations. The peak pressure-time patterns 
differ from mean pressure-time patterns due to their relativity to specific sensors (sensor with the 
highest or peak measure) rather than being an average of several sensors. This site specificity can 
therefore, be utilised as baseline data to provide diagnostic insight into future studies of clinical 
populations with plantar foot ulcerations. 
As shown earlier, once again the peak pressures over the whole foot shows the double hump pattern, 
as did the force and mean pressure results, except that the first hump is much lower than the second. 
This result reflects the lower peak pressure measured on individual sensors that are due to padded 
nature of the heel, which dissipates pressures over a larger area and thus more sensors. The second 
hump is higher relative to the first hump, due to the smaller and more prominent bony (MPJ and 
digits) areas over which pressure is measured. It is important to be cognisant of the fact that the 
pressures measured on the sensors is not different between the mean pressure and the peak pressure 
results, rather that the highest (peak) pressure measured by any one sensor is recorded as the measure 
rather than this result being tempered by the average (mean) pressure calculation process. 
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Figure 27.  The means and 95% confidence point-by-point (PbP) limits and bootstrap (Bstrap) bands 
for peak pressure on the whole foot (total) over percentage-normalised stance time (n=8). 
 
Once again the peak pressures on the hallux, 1MPJ, 2-5MPJ and heel follow similar patterns to the 
force and mean pressure, however due to their relativity to specific sensor recordings, they provide 
greater insight into the peak pressures actually experienced on the sites of the foot that are at risk of 
pressure related injury and ulceration. 
The peak pressure plots presented in Figure 28 show that there is pressure experienced on all regions 
of the foot throughout the whole of stance phase. The pressure on the hallux peaked at approximately 
300 kPa, which is higher than the 1MPJ and 2-5MPJ that peaked at approximately 200 kPa and higher 
again from the heel, which peaked at approximately 175 kPa. The hallux results showed that the 
sample mean was within ±75 kPa with 95% surety, between 80 and 90 percent of stance phase, while 
the 1MPJ and 2-5MPJ means were within ±50 kPa and the heel mean was within approximately ±25 
kPa.  
Mean (PbP)   95% confidence limits (PbP) 
Mean (Bstrap)   95% confidence bands (Bstrap) 
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Figure 28.  The means and 95% confidence point-by-point (PbP) limits and bootstrap (Bstrap) bands for mean pressure on the hallux, 1MPJ, 2-
5MPJ and heel over percentage-normalised stance time (n=8). 
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Discussion 
Protocol safety 
The in-shoe plantar pressure measurement procedures as described in Chapters Three and Four 
was established as not posing a foot injury risk to a population of adults with diabetes. This 
sample was sought and tested due to their ability to self-detect both injury risk and potential. Even 
though shown to not pose an injury risk, these results cannot be generalised to the neuropathic 
population, because there may be injury risk that remains undetected and clinician test supervision 
is required. 
Verification of spatial and temporal variable consistency when the subject 
controls for self selected natural walking  
Gait temporal and spatial variables measured for this sample population were found to be highly 
consistent between trials and confirmed the assumption that gait is consistent when the subjects 
self-select their own comfortable pace during in-shoe plantar pressure measurement procedures. 
The present study population walked at the same velocity (Mean 1.06 ms-1), but with a slightly 
smaller standard deviation (SD 0.11 ms-1) during in-shoe plantar pressure measurement 
procedures than that reported by Muellar, Minor et al. (1994) (SD 0.19 ms-1) for a diabetic 
population during kinematic study procedures. The present study population also walked with a 
stride length comparable to, but slightly less variable as reflected in the smaller standard deviation 
(Mean 1.16m (SD 0.12m) than that reported by Muellar, Minor et al. (Mean 1.20m (SD 0.23m)). 
Based on the plus or minus ten percent velocity variation that was reported to be acceptable for 
the diabetic population studied by Cavanagh et al. (1998), the results from the present study 
procedures are acceptable. Therefore, external verification of temporal and spatial gait variables 
was not added to the procedures conducted for the studies to follow in this thesis. 
In-shoe plantar pressure measurement 
Absolute value analyses 
Comparison between study reports in the literature is fraught with difficulty due to the lack of a 
standardised protocol, however, other than the different foot wear styles used, the population and 
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methods reported by Perry et al. (1995) are comparable to the present study and are therefore, 
utilised to cross validate the present study. Absolute value results from the present study and those 
reported by Perry et al. (1995) are presented for comparison in Table 29. 
 
Table 29  
Comparative mean (standard deviation) peak pressure absolute value results (kPa) from in-shoe 
plantar pressure analysis of adults with diabetes, but without neuropathy. 
 Present study result n=8  
(16 limbs: both feet data) 
Perry, Ulbrecht, Derr & Cavanagh (1995) 
n=13 (13 limbs: right foot only data) 
Anatomical region Canvas oxford shoe Running shoe Leather oxford shoe 
Heel region 207.50 (18.71) 187 (24) 304 (45) 
1MPJ region 230.26 (37.52) 292 (86) 392 (148) 
Hallux region 313.64 (37.89) 180 (60) 274 (130) 
 
 
Comparisons between the results from the two studies presented in Table 29 are made whilst 
being cognisant of the fact that different shoes were tested and the anatomical regions defined are 
not standardised. However, with these limitations in mind, the peak pressures measured on the 
heel region appear logical with the highest peak pressure being reported in the firm shoes (leather 
oxford), the lowest recorded in the padded shoes (running shoe) and the canvas oxford shoe, being 
soft but not padded, peak pressure measure falling between the other shoes.  
The differences found between the mean results from the other two regions (1MPJ and hallux) 
reported by Perry et al. (1995) and the present study cannot be explained. The larger standard 
deviations reported by Perry et al. (1995) than the present study, potentially suggest that there are 
either true differences in the procedures for data collection or analysis between the studies, or that 
the populations are not homogeneous. Large standard deviations suggest that there is high 
variability within the data and the lack of a data validity checking procedure by Perry et al. 
(1995), as proposed in Chapter Three and utilised in the present study, would increase the 
variability of the data if inconsistent data were included in the final analyses. Alternatively, large 
standard deviations may also reflect highly skewed data, but the authors did not report testing for 
skewness.  
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Even though there are differences between Perry et al. (1995) and the present study that remain 
unexplained, there are similarities within the methods and results that support cross validation. 
Therefore, with cross validation support for the absolute value results from the present study, the 
same results measured relative to time are assumed to be valid for discussion. 
Pressure-time analyses 
Both the means derived from the standard point-by-point and the bootstrap methods were graphed 
together in Figure 23 to provide a crosscheck between the methods. Both the point-to-point and 
bootstrap means overlay, confirming the methods are comparable. The statistical predictive range 
of the 95% confidence bands (bootstrap) are wider than those derived from the point-by-point 
method as shown in Figure 23 which confirms that the bootstrap method bands are more 
conservative (Lenoff et al., 1999). More conservative bands, translates to greater surety that the 
sample mean is representative of the population mean and can be used as a basis for clinical 
evaluation (Portney & Watkins, 1993). 
To facilitate the comparison of, and therefore, cross validation of the present study results with 
that of Uccioli et al. (2001), their force-time graphs are reproduced in Figure 29. The force-time 
graphs from the present study follow comparable shapes to and are therefore, cross validated by 
those of the above authors. Both the total force results graphed by the present study and that of 
Uccioli et al. follow the double hump pattern that is widely accepted (Winter, 1991) and is a 
vector sum of the varying forces through the regional contact areas of the foot during stance phase 
(%). 
As alluded to earlier, the classic representation of the force imparted onto the ground through the 
weight bearing foot during stance phase is confirmed by Figure 29 and can be roughly described 
as following the shape of a stylised capital ‘M’. Therefore, the first hump formed by the plot of 
the mean in the graph describes the large decelerating force imparted onto the ground through the 
heel. The trough formed by the mean in the graph describes the smaller force imparted onto the 
ground as the body moves forward over the whole foot with the swinging of the other limb. The 
second hump, formed by the mean in the graph, describes the large acceleration force imparted 
onto the ground through the forefoot (1MPJ and 2-5MPJ) and ends as the hallux leaves the 
ground.  
 
 
 	
 
 
The dotted circle indicates the force values when other parts of the foot beyond the heel come in contact with the sensitive 
surface of the platform: the heel force curve shows no lack of continuity: From Uccioli, L., Caselli, A., Giacomozzi, C., 
Macellari, V., Giurato, L., Lardieri, L. et al, (2001) Pattern of abnormal tangential forces in the diabetic neuropathic foot. 
Clinical Biomechanics, 16, 446-454: Figure 5 p453. 
Figure 29.  An example of the ground reaction force under the foot of a healthy subject during 
percent-normalised stance phase. 
 
 
The regional force-time graphs follow the patterns related to their loading during the stance phase. 
The heel force-time graph showed a large force as the heel contacted the ground and then the 
force petered off as the load transferred to the forefoot. The force-time graphs for the forefoot 
components also describe their action. The 2-5MPJ region showed that it initially accepted a small 
force while the full force continued to be born through the heel. As the 2-5MPJ accepted more 
force, the 1MPJ began to accept force until the hallux and toes were fully loaded with the 
movement of the body to over the foot. The full force of acceleration was then experienced by the 
forefoot, with the force petering off firstly with the 2-5MPJ region followed by the 1MPJ and 
finally the hallux as the foot left the ground. 
Reports of mean pressure-time graphs have not been identified, therefore, the results of mean 
pressure-time for the present study were produced for cross validation by their relationship to the 
force-time graph patterns. The mean pressure-time graph results are comparable to the results of 
the force-time graphs because they are calculated from the same measures. Cross validation was 
confirmed by the similarity of the shapes formed from the two variable graphs. However, as 
ulcerations are generally smaller than the defined anatomical region in which they occur, the 
Stance phase (%) 
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mean pressure over the region is not as useful for investigating ulceration than the sensor specific 
peak pressure results. Therefore, to provide a reference graph of a neuropathy- and ulceration-free 
diabetic population, peak pressures over percentage-normalised stance time for future study 
application to other diabetic populations, the present study’s peak pressure-time graphs need cross 
validation.  
To facilitate the comparison and cross validation of the present study with the literature, the 
pressure-time graphs reported by Duckworth, Betts, Franks and Burke (1982) and Quesada and 
Rash (2000) are reproduced in Figure 30 and Figure 31, respectively. The total peak pressure-
time graph patterns from both the reported studies and the present study show a lower first hump, 
which may be due to the structure of the large heel pad as already discussed (large area and 
shock/force absorbing padding) as compared to their MPJ regions and hallux (smaller areas and 
less padding). The instrument and method of Quesada and Rash is comparable to the present 
study and both the present study’s 1MPJ and 2-5MPJ and the combined MPJ region peak 
pressure-time patterns show similar concave loading shapes. 
The present study’s peak pressure-time pattern from the hallux shows a later, more concave and 
steeper loading than that of Duckworth et al. (1982) and this observation is repeated in the present 
study’s 1MPJ graph. The present study’s peak pressure-time pattern on the heel follows this same 
observation except that it is in the reverse. The present study’s peak pressure on the heel remains 
loaded until approximately 80% of stance phase as compared to approximately 60% reported by 
Duckworth et al. The differences in loading may be due to instrumental differences between the 
studies because the present study used in-shoe pressure measurement of midgait walking, while 
Duckworth et al. collected peak pressure data by the subject taking a single barefoot step onto a 
raised pressure platform.   
The variability of the data from the present study and that reported by Quesda and Rash (2000) 
are comparable and show similar limits that closely relate to the mean. The limits on the graph 
from these authors are one standard deviation and approximately 10 kPa, while the present study 
are 95% confidence limits which are at least two standard deviations and are approximately 25 
kPa for the similar region. However, the variability graphed by Duckworth et al. (1982) differs 
from both the present study and that of Quesda and Rash and show wide percentile curves. The 
width of the percentiles, once again, may be due to instrumental or method differences, but may 
also be due to differing populations tested by their inclusion of very young children with 
immature gait in the population tested (ages one to 43 years old). 
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From Duckworth, T., Betts, R. P., Franks, C. I., & Burke, J. (1982) The measurement of pressures under the foot. Foot & 
Ankle, 3(3), 130-141: Figure 8 p137. 
Figure 30.  Peak pressure percentile curves obtained from 50 control measurements28.  
 
 
                                                     
28
 The peak pressures are expressed in kilogram per square centimetre which are approximately one tenth of the values if 
expressed in kPa. 
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In Quesada, P. M., & Rash, G. S. (2000) Quantitative assessment of simultaneous capacitive and resistive plantar pressure 
measurements during walking. Foot & Ankle International, 21(11), 928-934: Figure 2 p929. 
Figure 31.  Example of mean ± standard deviation curves for a single subject's peak plantar 
pressure.  
 
Conclusion 
This study was conducted to address Research Question Two (b). The protocol developed for in-
shoe plantar pressure analysis in Chapter Three and methods of Chapter Four were tested and 
found to be safe and not pose any specific foot injury risk in adults with diabetes and normal 
sensation. Additionally, the study verified that temporal and spatial variables of gait were 
consistent during in-shoe plantar pressure measurement procedures when subjects self-controlled 
their walking gait. The addressing of these two aims confirmed that the in-shoe plantar pressure 
measurement procedures developed for the thesis study were not likely to impose risk to the 
subjects or significantly modify their gait and were therefore, adopted for future thesis studies.  
The in-shoe plantar pressure measurement results were analysed firstly using the common 
absolute value method and found to be comparable to the published literature within the 
constraints of the lack of a standard protocol, methods and standard footwear. The results were 
further explored graphically and relative to time using the data point-to-data point and the 
continuous data bootstrap methods. Patterns formed by graphing the mean results from both 
methods were so similar in that the method means overlayed. Additionally, the method means of 
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the total force results showed patterns that were similar to and therefore, cross-validated by those 
in the literature. The bootstrap method was found to be comparable to, but slightly more 
conservative than the standard point-to-point method and graphs of force, mean pressure and peak 
pressure at defined anatomical regions of the foot were produced. The peak pressure results, as 
they related to time graphs, provided information especially relevant to showing the pattern of 
pressure on an anatomical region and specific sensors more so than the absolute value results. A 
change in the patterns rather than a change in the absolute measured value of peak pressure over 
an anatomical region or specific sensor could hypothetically provide clinically useful insight into 
the gait-related aetiology of pressure related injury and ulceration in the population of people with 
diabetes, neuropathy and ulceration. Therefore, further exploration of this results-presentation 
method in a clinical population is required and will be conducted in the following chapter.
 	
 
Rationale and purpose 
The previous chapter demonstrated that pressure-time graphs of in-shoe plantar pressure measure 
variables form patterns that are comparable to the literature. A graph of peak pressure on the 
forefoot over stance time reportedly differs between diabetic sub-populations with and without 
neuropathy and a history of forefoot ulceration (Maluf & Mueller, 2003). However, potential 
differences between peak pressure-time graphs for defined anatomical regions of the plantar foot 
in diabetic sub-populations with and without neuropathy are unknown. Additionally, potential 
differences between these graphs for diabetic and neuropathic sub-populations with ulcerations on 
either the hallux or 1MPJ are also unknown. Knowledge of if, where and how peak pressure-time 
graphs differ with neuropathy and differ between hallux and 1MPJ ulcerations will be useful to 
assess and design interventions to encourage ulceration healing and eventually be an aid to 
prevent ulceration occurrence.  
Therefore, the purpose of the present study was two fold. First, the present study will investigate 
potential differences between in-shoe plantar pressures when neuropathy is present by comparing 
diabetic sub-populations with and without neuropathy. Secondly, the present study will address 
Research Question Three (a) and investigate potential differences in in-shoe plantar pressures 
when ulceration is present on either the hallux or the 1MPJ and by comparisons of the same, but 
not ulcerated regions in the diabetic sub-population without neuropathy or ulceration. For all 
analyses, investigation into potential differences will be conducted using the common absolute  
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method that will allow comparisons to be made with the reported literature, but also the 
usefulness of analysing peak pressure as a function of stance time will be conducted. 
Subjects 
The academic staff, residents and fellows of the Podiatry Service in the Department of 
Orthopedics at the University of Texas Health Science Center were enlisted to identify subjects 
for this and the following shoe out-sole study. A PowerPoint assisted presentation was made at 
the weekly education forum to describe the background and aims of both this and the shoe out-
sole study, and the inclusion and exclusion criteria for subject selection. All patients who attended 
the “At-risk Diabetic Foot Clinic” at the Texas Diabetes Institute in late 1998 and until mid-1999 
were screened for inclusion. The Texas Diabetes Institute High-risk Diabetic Foot Clinic is a 
teaching clinic of the University of Texas Health Science Center, Department of Orthopedics, and 
Podiatry Residency Program and is staffed by Podiatry residents under the supervision of 
academic staff. Patients generally attend this clinic due to their lack of health insurance and low 
socio-economic status, which limits their access to other health care facilities. Subjects who met 
the inclusion criteria were identified to the author who confirmed their eligibility prior to inviting 
them to participate in the study. The Institutional Review Boards of the University of Texas 
Health Science Center and the University Health System gave approval for the study, and 
informed consent was obtained from all subjects prior to their participation. 
Subjects were included if they met the criteria for one of two groups. The first population was that 
described previously in Chapter Six, and the volunteers were adults with diabetes, but without 
peripheral neuropathy nor plantar forefoot ulceration. The second population criteria required that 
the volunteer be an adult with diabetes, peripheral neuropathy, plantar forefoot ulceration either to 
the plantar hallux or the plantar 1MPJ and were able to walk unassisted. Subjects were excluded if 
they had a history of major trauma to the feet, legs or lower back, surgery to the feet, or if they 
had concurrent disease processes such as Parkinson’s disease that limited their ability to walk 
consistently. The exclusion of subjects that had had surgery to their feet severely limited the 
number of suitable subjects. This was because podiatric surgical residents who could provide the 
patients with ready access to subsidised surgery staffed the clinic. All invited subjects consented 
to participate in the study and their positive decision was influenced by the incentive that they 
would receive free of charge in-shoe plantar pressure assessment that was normally reserved for 
surgical assessment. 
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Twenty-eight subjects were identified who met the inclusion criteria for the ‘ulcerated group’. 
There were 19 men and nine women in the study population. The population were aged between 
32 and 64 years (mean 52.04, SD 8.75), weighed between 63.64-136.36 kg (mean 86.67, SD 
15.27), height was between 1.52-1.90 m (mean 1.71, SD 0.10) and body mass index (BMI) ranged 
from 19.78 to 41.38 (mean 29.03, SD 4.84). Eleven subjects were classified as overweight (BMI 
25-30) and another eleven were classified as obese (BMI>30) (Zeman, 1991). The population 
were diagnosed with Type 2 diabetes for between six months and 37 years (mean 11.48 years, SD 
9.34). Sixteen subjects managed the hyperglycaemia component of their diabetes with oral 
hypoglycaemic medication (tablets), ten subjects used insulin injections, while one subject was 
taking both tablets and insulin injections and another did not require hypoglycaemic medication 
due to a successful pancreas transplant. The demographic results for the population per ulceration 
site are presented in Table 30.   
 
Table 30  
Sub-population demographic results. 
Ulceration 
site 
Age 
(years) 
Weight (kg) Height (m) BMI Years DM 
(years) 
None 52 (43-60) 94.09 (65.91-113.64) 1.62 (1.51-1.73) 36 (26-50) Not recorded 
Hallux  48 (32-62) 83.66 (63.64-134.09) 1.74 (1.52-1.98) 28 (20-38) 10 (0.5-37) 
1MPJ  56 (45-64) 87.85 (68.18-104.54) 1.70 (1.55-1.86) 31 (23-41) 14 (1-30) 
 
Procedures 
All subjects underwent the protocol that was developed in Chapter Three, the methods described 
in Chapter Four and tested for safety in Chapter Six. The subjects wore appropriately sized 
SmartKnit seamless socks (KnitRite, Kansas, USA) as previously described in Chapter Five. The 
shoes worn for baseline data collection were Nike canvas shoes (Nike, Beaverton, Oregon, USA) 
as previously described and used for data collection in Chapter Six.  
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Data analyses 
Data analysis was conducted as previously described in chapters three, four and six. 
Data from the two populations were categorised into sub-population groups based on neuropathy 
and ulceration, status and location, and presented in Table 31. 
 
Table 31  
Sub-population categorisation process. 
Diabetic Neuropathic Ulceration Sub-population category Abbreviation 
Yes No No Non-neuropathic-no ulceration NoN NoU 
Yes Yes No Neuropathic-no ulceration N NoU 
Yes Yes Yes – Hallux Neuropathic-hallux ulceration N HalluxU 
Yes Yes Yes – 1MPJ Neuropathic-1MPJ ulceration N 1MPJU 
 
Statistical analyses 
Absolute value analyses 
Absolute value analyses were conducted as this is the current results presentation method and 
these results will enable the present study results to be compared to those in the literature. Both 
the absolute value results for peak pressures and pressure-time integrals per anatomical region 
will be analysed as these variables were found in Chapter Three have a statistically significant 
relationship to ulceration location. 
All absolute value analyses were performed using SPSS Release 8 for Windows. Results were 
examined for and confirmed as being normally distributed using proportion probability (P-P) plots 
with the proportion estimated using the Rankit formula. The variable means of sub-populations 
were compared using the one-way analysis of variance for repeated measures (ANOVA) function, 
and post hoc analyses were conducted using the Dunnett’s T3 test. Dunnett’s T3 test was chosen 
for post hoc analyses as it does not require the assumption of equality of variances to be met as 
already described in Chapter Three (SPSS Incorporated, 1998). 
 	
 
Pressure measures as they relate to stance time 
The results of peak pressure over percent-normalised stance time were plotted, along with the 
respective 95% confidence bands. These plots describe the pattern of pressure and are expected to 
provide clinically useful insight into the aetiology of pressure-related injury and ulceration in the 
clinical population with diabetes, neuropathy and ulceration. 
Peak pressure-time analyses were performed using Excel 2000 for Windows. Bootstrap means 
and 95% confidence bands were calculated and graphed as previously described in Chapter Six. 
Results 
Absolute values analyses 
At the time of data collection, two subjects were found to have developed both a hallux and 1MPJ 
ulceration on one foot and these limbs were excluded from future analyses, leaving 54 limbs in 
the neuropathic and ulcerated population. The descriptive statistics for the variables of peak 
pressure and pressure-time integral per each anatomical region and each ulceration sub-population 
are presented in Table 32.  
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Table 32  
Descriptive analysis of absolute value results per variable (a. peak pressure and b. pressure-time 
integral) and anatomical region and sub-population.  
a) Peak pressure absolute value results 
Variable Anatomical 
region 
Ulceration sub-
population* 
Mean SD Min Max 
Total foot N-1MPJU 417.1 99.0 304.3 578.7 Peak pressure 
(kPa)   N-HalluxU 361.5 88.8 220.0 576.7 
   N-NoU 369.5 96.1 210.0 543.0 
   NoN-NoU 339.9 73.0 203.7 466.0 
 Hallux N-1MPJU 247.8 127.6 69.3 513.3 
   N-HalluxU 289.3 109.5 98.0 460.0 
   N-NoU 246.6 120.6 83.8 496.0 
   NoN-NoU 313.6 105.6 119.7 466.0 
 1MPJ N-1MPJU 374.2 113.3 220.7 578.7 
   N-HalluxU 274.7 119.2 131.3 576.7 
   N-NoU 296.8 113.1 54.0 543.0 
   NoN-NoU 230.3 74.8 116.3 352.3 
 2-5MPJ N-1MPJU 292.8 105.3 122.7 531.3 
   N-HalluxU 243.5 64.5 146.7 374.3 
   N-NoU 281.9 74.2 135.3 443.3 
   NoN-NoU 224.0 66.4 118.7 363.3 
 Heel N-1MPJU 246.9 47.0 186.7 326.7 
   N-HalluxU 214.4 68.4 71.4 292.7 
   N-NoU 239.8 70.7 123.8 429.3 
   NoN-NoU 207.5 38.5 160.3 273.3 
*Sub-population groups are: n=11 for N-1MPJU, n=17 for N-HalluxU, n=26 for N-NoU and n=16 for NoN-NoU. 
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Table 32 continued 
b) Pressure-time integral absolute value results. 
Variable Anatomical 
region 
Ulceration sub-
population* 
Mean SD Min Max 
Total foot N-1MPJU 160.1 42.1 109.7 252.8 Pressure-time 
integral (kPa s)  N-HalluxU 136.4 33.1 77.0 221.9 
   N-NoU 152.3 48.7 65.8 294.0 
   NoN-NoU 123.4 26.0 76.7 156.4 
 Hallux N-1MPJU 57.3 22.6 10.3 94.2 
   N-HalluxU 70.2 27.6 24.8 111.7 
   N-NoU 62.8 25.8 24.1 125.0 
   NoN-NoU 72.1 35.4 15.1 132.1 
 1MPJ N-1MPJU 107.4 48.7 48.6 189.3 
   N-HalluxU 79.2 39.0 43.6 197.6 
   N-NoU 95.7 42.8 9.5 189.8 
   NoN-NoU 61.4 22.8 20.2 98.9 
 2-5MPJ N-1MPJU 85.6 33.1 18.8 137.8 
   N-HalluxU 72.6 29.4 22.6 131.4 
   N-NoU 9.27 3.13 2.98 15.62 
   NoN-NoU 6.48 2.01 3.42 9.58 
 Heel N-1MPJU 7.75 3.45 4.65 16.88 
   N-HalluxU 6.31 2.17 0.71 10.45 
   N-NoU 7.92 3.52 2.06 18.97 
   NoN-NoU 5.61 1.77 2.91 8.70 
*Sub-population groups are: n=11 for N-1MPJU, n=17 for N-HalluxU, n=26 for N-NoU and n=16 for NoN-NoU. 
 
The ANOVA results from comparing the variable means of peak pressure and pressure-time 
integral per anatomical region grouped by ulceration sub-population are presented in Table 33. 
There were significant differences between means of the ulceration sub-populations for the 1MPJ 
and 2-5MPJ anatomical regions for both peak pressure and pressure-time integral. The means of 
the ulceration sub-populations for pressure-time integral for the anatomical regions of total foot 
and the heel approached significance at the p<0.05 level (0.06 and 0.05, respectively).  
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Table 33  
ANOVA table showing significant differences (p<0.05) between means of absolute values per 
variable and anatomical region grouped by ulceration sub-population. 
Variable Anatomical 
region 
Groups Sum of  
squares 
Degrees 
freedom 
Mean 
square 
F Sig. 
Peak pressure 1MPJ Between  1399.95 3 466.65 4.06 0.01 
(kPa)  Within  7595.40 66 115.08     
   Total 8995.35 69       
 2-5MPJ Between  495.90 3 165.30 2.86 0.04 
  Within  3813.89 66 57.79     
  Total 4309.79 69       
1MPJ Between  178.59 3 59.53 3.86 0.01 
 Within  1017.08 66 15.41     
Pressure-time 
Integral 
(kPa s)  Total 1195.67 69       
 2-5MPJ Between  92.08 3 30.70 3.67 0.02 
  Within  552.37 66 8.37     
  Total 644.45 69       
 
 
The results of the post hoc analyses that showed significant differences (p<0.05) between 
ulceration sub-populations are presented in Table 34. These results show that there were 
significant differences between peak pressures on the 1MPJ region when 1MPJ ulceration and 
neuropathy was present (N-1MPJU) compared to when neither neuropathy nor ulceration are 
present (NoN-NoU). There were also significant differences between pressure-time integral 
results on the 1MPJ, 2-5MPJ and heel regions between neuropathy and neuropathy-free (NoN-
NoU and N-NoU sub-populations). 
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Table 34  
Post hoc analyses that showed significant differences (p<0.05) between ulceration (ulcer) sub-
populations (I and J) per variable and anatomical region. 
Dependent 
Variable 
Anatomical 
region 
Ulcer Sub-
pop  
(I) 
Ulcer Sub-
pop 
(J) 
Mean 
Dif. 
(I-J) 
Std. 
Error 
Sig. 95% CI 
Lower 
Limit 
  
Upper 
Limit 
Peak pressure 
(kPa) 
1MPJ N-1MPJU NoN-NoU 14.39 4.20 0.01 2.83 25.95 
1MPJ N-NoU NoN-NoU 3.42 1.25 0.01 0.62 6.23 
2-5MPJ N-NoU NoN-NoU 2.80 0.92 0.01 0.61 4.98 
Pressure-time 
integral  
 (kPa s)  Heel N-NoU NoN-NoU 2.31 0.92 0.04 0.04 4.58 
 
The pressure-time graphs for the four ulceration sub-populations are divided into two sections. 
The first section presents the effect of neuropathy on pressure-time patterns. Comparisons are 
made between the sub-populations: neuropathic and ulceration-free and non-neuropathic and 
ulceration free. The second section presents the effect of ulceration position on pressure-time 
patterns. Comparisons are made between the sub-populations: neuropathic with 1MPJ and 
neuropathic with hallux ulceration. 
The effect of neuropathy: Neuropathic and ulceration-free sub-population compared to 
non-neuropathic and ulceration-free sub-population 
The graphical results of peak pressures from the sub-populations with and without neuropathy and 
without ulceration (NoN NoU and N NoU) are presented per anatomical region in Figure 32 
through to Figure 36. The graphical results from these sub-populations describe differences in 
peak pressure (kPa) that occurred during stance phase with and without neuropathy.  
The graph in Figure 32 shows that when neuropathic, the peak pressure over the whole foot (Total 
kPa) has a more gentle rise, followed by less unloading during midstance and a ten percent earlier 
and slightly lower peak when compared to the non-neuropathic sub-population. The respective 
lower and upper confidence bands (bootstrap) of the sub-populations differ between 
approximately 70 and 95 percent of stance phase. 
 
 	
0
100
200
300
400
500
0 20 40 60 80
Stance phase %
Pe
ak
 
pr
es
su
re
 
-
 
To
ta
l k
Pa
N NoU
N NoU 95%CI Bands
NoN NoU
NoN NoU 95%CI Bands
 
Figure 32.  The means and 95% confidence bands (Bstrap) for peak pressure over the whole foot 
(total) per sub-population. 
 
The graph in Figure 33 shows that when neuropathic, the peak pressure on the hallux peaks 
approximately 10% earlier in stance phase at approximately 15 kPa less than the non-neuropathic 
sub-population. The respective lower and upper confidence bands (Bstrap) of the sub-populations 
differ between approximately 80 and 95%of stance phase. 
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Figure 33.  The means and 95% confidence bands (Bstrap) for peak pressure-Hallux per sub-
population.  
 
The graph in Figure 34 shows that when neuropathic, the peak pressure on the 1MPJ is 
consistently approximately five kPa higher and peaks slightly earlier at 75% of stance phase when 
compared to the neuropathy-free sub-population. The respective lower and upper confidence 
bands (Bstrap) of the sub-populations clearly differ in the first 20% and then are aligned on a 
parallel path from 20% until 60% of stance phase. 
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Figure 34.  The means and 95% confidence bands (Bstrap) for peak pressure-1MPJ per sub-
population. 
 
The graph in Figure 35 shows that when neuropathic, the peak pressure on the 2-5MPJ is higher 
initially and then consistently five kPa higher from 20% of stance phase until it peaks at 
approximately 10% earlier in stance phase than the neuropathy-free sub-population. The 
respective lower and upper confidence bands (Bstrap) of the sub-populations overlap throughout 
stance phase suggesting that the peak pressures in kPa do not differ between the sub-populations. 
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Figure 35.  The means and 95% confidence bands (Bstrap) for peak pressure-2-5MPJper sub-
population. 
 
The graph in Figure 36 shows that when neuropathic, the peak pressure on the heel rises at the 
beginning of stance phase at a slightly lower rate and peaks approximately 5% after the 
neuropathy-free sub-population. The mean peak pressure is approximately ten kPa higher from 
approximately 40% to the end of stance phase. The 95% confidence bands (Bstrap) aligned from 
80%, and then clearly differed in the final 5% of stance phase. 
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Figure 36.  The means and 95% confidence bands (Bstrap) for peak pressure-heel per sub-
population. 
 
The effect of neuropathy and ulceration: Hallux or 1MPJ ulceration with neuropathy 
and neuropathy sub-populations compared to ulceration-free sub-population 
The graphical results of peak pressures from the sub-populations that are non-neuropathic and 
with out ulceration, neuropathic with ulceration-1MPJ and ulceration-Hallux during stance time 
per anatomical region are presented in Figure 37 through to Figure 41. The graphs from these 
sub-populations describe differences in the pattern of peak pressures that occurred during stance 
phase on hallux or 1MPJ ulcerations when compared to each other and the ulceration and 
neuropathy-free sub-population. 
The graph in Figure 37 shows that with ulceration, the peak pressure over the whole foot (Total) 
was slightly elevated during the middle, 20 to 70%, of stance phase when compared to the 
ulceration and neuropathy-free sub-population. During this time, the hallux ulceration group were 
very slightly, but consistently higher than the 1MPJ ulceration group. Hallux ulceration peaked 
approximately 5% earlier but lower than 1MPJ ulceration and the ulceration and neuropathy-free 
sub-populations. The 95% confidence bands (Bstrap) overlapped throughout stance phase 
suggesting that peak pressures over the whole foot (Total) were not different between the three 
sub-populations.  
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Figure 37.  The means and 95% confidence bands (Bstrap) for peak pressure-Total foot per sub-
population. 
 
The graph in Figure 38 shows that during the first 65% of stance phase, that the peak pressure on 
the hallux is consistently lower with 1MPJ ulceration than with Hallux ulceration or when 
neuropathy and ulceration-free. From approximately 70% of stance phase, during push off, 1MPJ 
ulcerations peaked ten kPa lower, and hallux ulcerations peaked approximately seven kPa lower 
than when neuropathy and ulceration-free. The hallux ulceration lower 95% confidence band 
(Bstrap) was lower than the other sub-populations through out stance phase suggesting that the 
lower range peak pressures over the hallux were different between the three sub-populations. 
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Figure 38.  The means and 95% confidence bands (Bstrap) for peak pressure-Hallux per sub-
population. 
 
The graph in Figure 39 shows that the peak pressure on the 1MPJ is slightly, but consistently 
higher when ulceration is present. During push off, with 1MPJ ulceration the pressure peaked 
slightly higher and earlier, whereas with hallux ulceration the pressure peaked at the same time as, 
but ten kPa higher than when neuropathy and ulceration-free. The 95% confidence bands (Bstrap) 
overlapped and were of comparable widths throughout stance phase suggesting that the peak 
pressures over the 1MPJ were not distinctly different between the three sub-populations. 
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Figure 39.  The means and 95% confidence bands (Bstrap) for peak pressure-1MPJ per sub-
population. 
 
The graph in Figure 40 shows that with ulceration, that the peak pressure on the 2-5MPJ shows 
that the relationships between sub-populations for peak pressure on the 2-5MPJ closely resemble 
those of the peak pressure on the 1MPJ. Once again, during push off, 1MPJ ulceration and 
neuropathy and ulceration-free sub-populations are very similar, wheras hallux-ulceration is 
elevated, approximately five kPa, when compared to the other two sub-populations. The 95% 
confidence bands (Bstrap) are similar to those of the 1MPJ and overlapped and were of 
comparable widths through out stance phase suggesting that the peak pressures over the 2-5MPJ 
were not distinctly different between the three sub-populations. 
 
 

0
100
200
300
400
500
0 20 40 60 80
Stance phase %
Pe
ak
 
pr
es
su
re
 
-
 
2-
5M
PJ
 
kP
a
N 1MPJU
N 1MPJ 95%C Bands
NoN NoU
NoN NoU 95%C Bands
N HalluxU
N HalluxU 95%C Bands
 
Figure 40.  The means and 95% confidence bands (Bstrap) for peak pressure-2-5MPJ per sub-
population. 
 
The graph in Figure 41 shows that the peak pressure over the heel is elevated approximately 20 
kPa from 40 to 70 percent of stance phase with ulceration when compared to when neuropathy 
and ulceration-free. The lower limits of the 95% confidence bands from the ulceration sub-
populations are also elevated above the mean for the neuropathy and ulceration-free from 40 to 70 
percent of stance phase, suggesting a trend to load the heel more during this time, but as the other 
bands overlap the sub-populations were not distinctly different.  
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Figure 41.  The means and 95% confidence bands (Bstrap) for peak pressure-heel per sub-
population.  
Discussion 
Absolute values analyses 
Even though significant differences were found between the means of the sub-populations the 
actual differences were small and were less than the measurable accuracy established for the 
device in Chapter Three. Therefore, actual differences between the sup-populations are so small to 
not be of any clinical usefulness.  
In Chapter Five, the study results for the population with diabetes but without neuropathy or 
ulceration (NoN NoU sub-population) were discussed with comparable study results reported by 
Perry et al. (1995). Once again, comparable results for discussion of the present study sub-
population with diabetes and neuropathy, but without ulceration (N NoU) and that reported by 
Perry et al. (1995) together with that reported by Maluf and Mueller (2003) are presented in Table 
35. The following comparisons are made whilst being cognisant of the limitations of making 
comparisons without a standardised protocol, methods, footwear and anatomical region 
definitions, as discussed previously in Chapter Five. 
The results from the present study are higher than the running shoe results and lower than the 
leather oxford shoe results reported by Perry et al. (1995), but the highest forefoot region of the 
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present study is very similar to the forefoot peak result reported by Maluf and Mueller (2003). 
The differences between the present study results and Perry et al. are plausible due to the logical 
differences expected between a cushioned sole running shoe (lower peak pressures), firm sole 
leather oxford shoe (higher peak pressures) and the present study’s minimally-cushioned flexible 
soled shoe (moderate peak pressures). Other than the peak pressure result from the leather oxford 
shoe on the heel region that was higher, all other results from Perry et al. and all results from 
Maluf and Mueller are contained within plus or minus one standard deviation of the present 
study’s results; providing cross validation and confirmation that the present study results are from 
a comparable population to these other studies. This comparison between study results obtained 
from using different shoes aptly shows the importance of the strict adherence to standardisation of 
footwear discussed in Chapter Three, and without standardisation, valid comparisons and 
conclusions cannot be drawn.  
 
Table 35  
Comparative mean (standard deviation) results of peak pressure absolute value measures (kPa) 
from in-shoe plantar pressure analysis of adults with diabetes and neuropathy, but without 
ulceration (N-NoU) (N/R = not reported). 
  Present study* Maluf & Mueller 
(2003)** 
Perry, Ulbrecht, Derr & 
Cavanagh (1995)*** 
Variable Anatomical 
region 
Canvas oxford 
shoe 
Subject’s own 
shoes with/without 
custom inserts 
Running 
shoe 
Leather 
oxford shoe 
Heel  239.8 (70.7) N/R 186 (24) 324 (65) 
2-5MPJ  281.9 (74.2) N/R N/R 
1MPJ  296.8 (113.1) 236 (55) 306 (80) 
Peak 
pressure 
(kPa) 
Hallux  246.6 (120.6) 
Forefoot combined  
307 (99) 
191 (60) 325 (172) 
2-5MPJ 9.27 (3.13) N/R N/R 
1MPJ 95.7 (42.8) N/R N/R 
Pressure-
time 
integral 
(kPa s) 
Hallux 62.8 (25.8) 
Forefoot combined  
94 (23) 
N/R N/R 
* n=26 limbs: both feet data (ulceration-none-contralateral sub-population) 
** n = 10 subjects: number of limbs used was not reported  
*** n=13 limbs: right foot only data 
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To provide results to cross validate and discuss the present study results from the sub-populations 
with diabetes, neuropathy and ulceration (NHalluxU and N1MPJU), the results reported by Maluf 
and Mueller (2003) are presented in Table 36. The present study’s peak pressure results from the 
highest peak forefoot region for both sub-populations are much higher than that reported by Maluf 
and Mueller (2003). A potential explanation for this difference is due to the subjects in Maluf and 
Mueller wearing their own custom therapeutic shoes with custom inserts compared to the present 
study subjects who wore standardised shoes without inserts during testing. It is logical and 
expected that measures of peak pressures would be lower when custom therapeutic shoes and 
inserts are worn as this footwear is prescribed with the aim to reduce localised areas of high 
pressure (Litzelman et al., 1997). However, due to the extent of the differences between the 
studies, the present study results for these sub-populations cannot be cross validated with Maluf 
and Mueller.  
The pressure-time integral result from the forefoot reported by Maluf and Mueller (2003) is 
similar to the present study result measured on hallux ulceration but higher than on 1MPJ 
ulceration. The lack of reporting of the actual forefoot ulceration locations, in addition to the 
wearing of therapeutic footwear by Maluf and Mueller as already discussed, prevents accurate 
explanation of the differences between the studies. However, the present study’s pressure-time 
integral results are within one standard deviation of Maluf and Mueller, confirming the study 
results as being from a comparable population. 
The ANOVA results presented in Table 33 confirm the results from the archival analysis in 
Chapter Three and show that the peak pressures and pressure-time integral measures on the 1MPJ 
and 2-5MPJ are significantly different between ulceration locations. 
The post hoc results presented in Table 34 did not find that pressure measures could differentiate 
between ulcerations located on the hallux and 1MPJ, but instead found that there were significant 
differences between the neuropathic with 1MPJ ulceration (N1MPJU) and neuropathy and 
ulceration-free (NoNNoU); and neuropathic (NNoU) and non-neuropathic with out ulceration 
(NoNNoU) sub-populations. These results show that pressure measures are different between 
these stages of diabetes, and therefore, warrant further exploration for potential clinical screening 
tool development. Of note is with there being significant differences between measures of peak 
pressures and pressure-time integral, these results also confirm the opinion of Cavanagh, Ulbrecht 
and Caputo (2001) that time is a factor in the relationship between ulceration and peak pressures.  
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Table 36  
Comparative mean (standard deviation) results of peak pressure absolute value measures (kPa) 
from in-shoe plantar pressure analysis of adults with diabetes, neuropathy and ulceration (N-
HalluxU or 1MPJU sub-populations). 
  Present study* Maluf & Mueller 
(2003)** 
Variable Anatomical 
region 
Hallux 
ulceration 
1MPJ 
ulceration 
Forefoot 
ulceration 
2-5MPJ 243.5 (64.5) 292.8 (105.3) 
1MPJ  274.7 (119.2) 374.2 (113.3) 
Peak pressure 
(kPa) 
Hallux  289.3 (109.5) 247.8 (127.6) 
Forefoot 
combined  
189 (99) 
2-5MPJ 72.6 (29.4) 85.6 (33.1) 
1MPJ 79.2 (39.0) 107.4 (48.7) 
Pressure-time 
integral 
(kPa s) Hallux 70.2 (27.6) 57.3 (22.6) 
Forefoot 
combined  
81 (36) 
* n=26 limbs: both feet data (N-Hallux U or 1MPJU sub-populations)  
** n = 10 subjects: number of limbs used was not reported  
 
The present study results are supported by Caselli, Pham, Giurini, Armstrong and Veves (2002), 
albeit the studies differ in their methodology: barefoot stepping over a pressure plate versus in-
shoe procedures. The present study results show that there were significant differences between 
the 1MPJ and 2-5MPJ, and the heel in the ulceration-free sub-populations with and without 
neuropathy (NoNNoU and NNoU). This is comparable to that of Caselli et al. who reported that 
there was a higher forefoot to heel peak pressure ratio in severe neuropathy when compared to 
moderate, mild or no neuropathy. Once again, the present study’s result showing differences in 
pressure-time integral measures suggests that if time is a factor in the severity stages of diabetes, 
and there is a forefoot to heel ratio change shown by Caselli et al., then further investigation is 
indicated to explore any functional changes to the foot structure or gait that could explain 
ulceration occurrence and risk. 
Links between absolute values analyses and pressure-time comparisons 
The peak pressure (kPa) on the 1MPJ over stance time graph for hallux and 1MPJ ulcerations and 
neuropathy and ulceration-free sub-populations presented in Figure 39 agrees with the absolute 
value analysis presented in Table 34. The peak pressure-time graph shows that 1MPJ ulceration 
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peaks at least ten kPa higher than the neuropathy and ulceration-free sub-populations, whereas the 
post hoc analysis shows that there is a mean difference of 14.39 kPa between these sub-
populations. However, even though there is a distinct difference between the means on the 
pressure-time graph at 80% of stance phase, the 95% confidence bands of these means overlap 
which suggests that the sub-populations are not distinctly different and arise from the same 
population. This finding is a useful example of where statistically significant differences between 
the absolute value mean results may not be as clinically useful as graphical comparisons of the 
peak pressure-time means and 95% confidence bands (Portney & Watkins, 1993). 
Pressure-time comparisons 
Comparing the pressure-time graphs between the ulceration-free neuropathic and non-neuropathic 
sub-populations, the results over the whole foot (total) suggest that with neuropathy the timing of 
the pattern of pressure varies and the gentle lead in to an earlier peak in the neuropathic sub-
population results suggests a prolonged double limb support phase. In order for the slopes to be 
gentle, the other limb must still be carrying body weight. Also, for the forefoot to peak earlier, 
then the other limb must be ready to accept body weight. It may be hypothesised that if both feet 
continue to maintain acceptance of body weight, then they may experience pressure, even at low 
levels from a prolonged period each step. Prolonged even low-level pressure may be detrimental 
to the tissues due to resulting tissue ischaemia and hypoxia (Sanders et al., 1995). Further 
investigation utilising instrumentation that can provide bilateral gait timing is suggested to 
determine any role that bilateral foot function and timing has in potential injury or injury risk to 
the neuropathic foot. 
The graphical results suggest that there is a more shuffling gait when neuropathic. This is evident 
from the hallux graph that shows an earlier but less pressure peak during push off, which suggests 
a more flat-footed and less propulsive push off phase. The 1MPJ and 2-5MPJ graphs show that 
the forefoot accepts load and peaks sooner and higher when neuropathic. This would be expected 
if body weight was passively moving forward over the foot and the pressures are a result of 
compression into the ground rather than during transfer into the digits at toe off phase.  
Alternatively, the higher peak pressures on the 1MPJ and lower peak pressures on the hallux 
graphs could also suggest that the foot was abducted from the direction of progression with 
neuropathy, therefore, negating the loading of the hallux at toe off to some extent. The extent that 
the gait is a shuffle, abducted and/or double limb stance time prolonged could readily be 
quantified using a gait-timing mat, suggesting that potentially, first line screening for gait changes 
for foot injury risk identification could be conducted with inexpensive gait analysis devices.  
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The study results presented in Figure 34 agree with the figure reported by Maluf and Muellar 
(2003), which is reproduced in Figure 42. Both graphs show that, although not significantly 
different, peak pressures on the 1MPJ are slightly higher (about five kPa) when comparing non-
neuropathic and neuropathic ulceration-free populations. The study results, however, do not agree 
with Maluf and Muellar that peak pressures are significantly lower on the 1MPJ when there is 
ulceration on the forefoot. On the contrary, the study results presented in Figure 39 show peak 
pressures on the 1MPJ to be higher, when ulceration is present on the forefoot, than without 
neuropathy or ulceration. 
 
 
 
CON = Control (non-diabetic) population (n=10),  
DMPN = Diabetic and neuropathic (without ulceration (n=10)),  
DMPN + U = Diabetic, neuropathic and recurrent ulceration (n=10)  
In Maluf, K. S., & Mueller, M. J. (2003), Comparison of physical activity and cumulative plantar tissue stress among 
subjects with and without diabetes mellitus and a history of recurrent plantar ulcers. Clinical Biomechanics, 18, 567-575 
Figure 42.  Peak pressure in the forefoot region plotted as a function of time during stance phase 
(group mean and SE). 
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Comparisons of pressure-time graphs 
The major limitation in the absolute value analyses has been the lack of insight that they provide 
to look further to modify or change the peak pressures to provide optimal foot protection and nor 
do they show how the pressure experienced by the foot has varied from a normal or safe level. 
The pressure-time graphs have the potential, when based on a larger sample size, to show the 
range of pressure patterns that the normal foot experiences. Although there are few definite 
differences found between sub-populations seen in the pressure-time graphs from the present 
study, the graphs show that during the stance phase some variations in the pattern of pressure 
through the anatomical region occur. The variation in pressures between sub-populations in the 
present study is supported by the work of Uccioli et al. (2001), who showed that the direction of 
tangential forces varied with neuropathy and ulceration. With knowledge that kinetic variations do 
occur and the additional knowledge of when they occur, further investigation could provide links 
to be made with established kinematic functions of the foot, limb and body, and specific multi-
functional therapeutic interventions be designed and tested. 
The effect of neuropathy: Neuropathic and ulceration-free sub-population compared to 
non-neuropathic and ulceration-free sub-population 
Comparing the pressure-time graphs between the ulceration-free neuropathic and non-neuropathic 
sub-populations, the results over the whole foot (total) suggest that with neuropathy the timing of 
the pattern of pressure varies and the gentle lead in to an earlier peak in the neuropathic sub-
population results suggests a prolonged double limb support phase. In order for the slopes to be 
gentle, the other limb must still be carrying body weight. Also, for the forefoot to peak earlier, 
then the other limb must be ready to accept body weight. It may be hypothesised that if both feet 
continue to maintain acceptance of body weight, then they may experience pressure, even at low 
levels from a prolonged period each step. Prolonged even low-level pressure may be detrimental 
to the tissues due to resulting tissue ischaemia and hypoxia (Sanders et al., 1995). Further 
investigation utilising instrumentation that can provide bilateral gait timing is suggested to 
determine any role that bilateral foot function and timing has in potential injury or injury risk to 
the neuropathic foot. 
The present study results from the defined anatomical area graphs suggest that there is a more 
shuffling gait when neuropathic. This is evident from the hallux graph that shows an earlier but 
lower pressure peak during push off, which suggests a more flat-footed and less propulsive push 
off phase. The 1MPJ and 2-5MPJ graphs show that the forefoot accepts load and peaks sooner and 
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higher when neuropathic. This would be expected if body weight was passively moving forward 
over the foot and the pressures are a result of compression into the ground rather than during 
transfer into the digits at toe off phase.  
Alternatively, the higher peak pressures on the 1MPJ and lower peak pressures on the hallux 
graphs could also suggest that the foot was abducted from the direction of progression with 
neuropathy, therefore, negating the loading of the hallux at toe off to some extent. The extent that 
the gait is a shuffle, abducted and/or double limb stance time prolonged could readily be 
quantified using a gait-timing mat, suggesting that potentially, first line screening for gait changes 
for foot injury risk identification could be conducted with inexpensive gait analysis devices.  
 
The effect of neuropathy and ulceration: Hallux or 1MPJ ulceration with neuropathy 
and neuropathy sub-populations compared to ulceration-free sub-population 
The results from the present study show that there is a different relationship with peak pressure 
between hallux and 1MPJ ulcerations. This is particularly notable in the pressure-time graphs of 
the hallux and 1MPJ anatomical regions. Specifically, when there is ulceration on the hallux, then 
hallux pressures are somewhat higher than the other sub-populations throughout stance. However, 
when there is ulceration on the 1MPJ, then 1MPJ pressures are similar to the other sub-
populations until the later of stance phase when they peak higher, but remain lower than the 
pressures from the hallux ulceration sub-population. These graphs supports earlier discussions, 
that further investigation utilising kinematic instrumentation is suggested to explore potential 
functional links that may exist between pressure and foot, limb and body actions. 
Conclusion 
This chapter has cross validated the results of the present study to the literature, and has 
demonstrated that the method of utilising pressure-time graphs provides greater insight into and 
confirms that there are differences and similarities between sub-populations with and without 
neuropathy, and ulcerations on the 1MPJ and hallux than does the absolute value method. What 
remains unknown and is the overall aim of this thesis and the focus of the next and final 
investigation, is whether the intervention with shoe therapy, namely rocker-soled shoe 
modifications to therapeutic shoes, have positive protective effects on existing ulceration and 
what is the ideal rocker-sole modification design. 
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Background 
Therapeutic shoes with rocker-sole modifications are routinely prescribed (see Chapter Two, p 
34) with the aim to protect the ulceration from adverse plantar pressures so that healing can occur. 
Of concern is that experimental evidence from the study of people with ulceration is lacking and 
the efficacy to which these modifications provide protection to ulceration is unknown. 
Consequently, shoe design features, devices and techniques for shoe modification and shoe 
prescription are based on conflicting opinions (Litzelman et al., 1997), are ad hoc and remain 
largely an art (Ulbrecht et al., 1994). Of concern, is that without experimental evidence to support 
this intervention’s efficacy, these therapeutic footwear may be included in the footwear-related 
pivotal events that were implicated as leading onto half of the eventual limb amputations reported 
in people with diabetes (Reiber, 1994; Reiber et al., 2002). 
Rocker-sole shoes are designed using various fore sole angles placed at various anteroposterior 
pivot positions relative to the distal metatarsophalangeal joints line. Based on an extensive review 
of the literature, Schaff and Cavanagh (1990) reported that there was no consensus of opinion 
concerning the angle of the rocker-sole and the anteroposterior position of the rocker. 
Experimentally, the techniques used to construct rocker-sole modifications have not been 
standardised for the angle or placement of the pivot point (Nawoczenski et al., 1988).  
C H A P T E R  E I G H T   
T H E  E F F I C A C Y  O F  T H E R A P E U T I C  
F O O T W E A R  W I T H  A N D  W I T H O U T  
R O C K E R - S O L E  M O D I F I C A T I O N S  T O  
P R O T E C T  U L C E R A T I O N  
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Purpose 
The purpose of the present study is to address research questions three (b) and four. That is, the 
purpose is to define the peak pressures experienced on the plantar foot when walking in a 
therapeutic shoe when compared to an athletic shoe, and to determine the efficacy of commonly 
prescribed rocker-soled shoe modifications of different angles and pivot point positions to protect 
ulceration on the hallux and 1MPJ during walking.  
To this end the study has three aims:  
1. To define the effect on walking pressures under hallux and 1MPJ ulceration when 
wearing therapeutic shoes compared to athletic shoes,  
2. To define the effect that adding various rocker-sole modifications to therapeutic 
shoes has on walking pressures measured under hallux or 1MPJ ulceration, and  
3. To determine the most beneficial shoe or rocker-sole modification that is useful to 
protect hallux or 1MPJ ulceration from walking pressures.  
Subjects 
The academic staff, residents and fellows of the Podiatry Service in the Department of 
Orthopedics at the University of Texas Health Science Center were enlisted to identify subjects 
for the study. A PowerPoint assisted presentation was made at the weekly education forum to 
describe the background and aims of the study, and the inclusion and exclusion criteria for subject 
selection. All patients that attended the “At-risk Diabetic Foot Clinic” at the Texas Diabetes 
Institute in late 1998 and until mid-1999 were screened for inclusion. The Texas Diabetes Institute 
High-risk Diabetic Foot Clinic is a teaching clinic of the University of Texas Health Science 
Center, Department of Orthopedics, and Podiatry Residency Program and is staffed by Podiatry 
residents under the supervision of academic staff. Patients generally attend this clinic due to their 
lack of health insurance and low socio-economic status, which limits their access to other health 
care facilities. Subjects who met the inclusion criteria were identified to the author who confirmed 
their eligibility prior to inviting them to participate in the study. The Institutional Review Boards 
of the University of Texas Health Science Center and the University Health System gave approval 
for the study, and informed consent was obtained from all subjects prior to their participation. 
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Subjects were included if they were an adult with diabetes, peripheral neuropathy, plantar forefoot 
ulceration either to the plantar hallux or the plantar first metatarsophalangeal joint and were able 
to walk unassisted. Subjects were excluded if they were unable to walk consistently and 
unassisted. Specifically they were excluded if they had a history of major trauma to the feet, legs 
or lower back, surgery to the feet, or if they had concurrent disease processes such as Parkinson’s 
disease. The exclusion of subjects that had had surgery to their feet severely limited the number of 
suitable subjects. This was because podiatric surgical residents who could provide the patients 
with ready access to subsidised surgery staffed the clinic. All invited subjects consented to 
participate in the study and their positive decision was influenced by two incentives. The first 
incentive was that they would receive free of charge in-shoe plantar pressure assessment that was 
normally reserved for surgical assessment. The second was that they would receive free of charge 
the footwear with rocker-sole modification ($US 600 dollars per pair) that was assessed to be 
most beneficial to protect the ulceration on their foot.  
Thirty-three subjects were identified that met the inclusion criteria and many of these subjects 
participated in the previous study. There were 23 men and ten women in the study population. 
The population were aged between 32 and 64 years (mean 52.39, SD 8.33), weighed between 
63.64-136.36 kg (mean 87.71, SD 16.94), height was between 1.52-1.98 m (mean 1.72, SD 0.11) 
and body mass index (BMI) ranged from 19.78 to 41.38. Fourteen subjects were classified as 
overweight (BMI 25-30) and twelve were classified as obese (BMI>30) (Zeman, 1991). The 
population were diagnosed with Type 2 diabetes for between six months and 30 years (mean 
11.83, SD 9.14). Nineteen subjects managed the hyperglycaemia component of their diabetes with 
oral hypoglycaemic medication (tablets), 12 subjects used insulin injections, while one subject 
was taking both tablets and insulin injections and another did not require hypoglycaemic 
medication due to a successful pancreas transplant. Thirty subjects had ulceration on one foot (19 
subjects had plantar hallux ulceration and 11 subjects had plantar 1MPJ ulceration) while four 
subjects had a plantar ulceration on both feet (hallux ulceration on one foot and 1MPJ on the other 
foot).  
Procedures 
All subjects underwent the protocol developed in Chapter Three and tested in Chapter Six and the 
methods described in Chapter Four. The subjects wore appropriately sized SmartKnit socks 
(KnitRite, Kansas, USA) as described in Chapter Five. The shoes worn for baseline data 
collection were the Nike canvas shoes (Nike, Beaverton, Oregon, USA) as described in Chapter 
Six.  
 
The therapeutic shoes worn for testing were Sequoia Therapeutic shoes (San Antonio Shoes, San 
Antonio, Texas, USA). Their style is the oxford design with specific additional features for 
accommodating the needs of diabetic foot therapies. These features include a firm and supportive 
leather shoe vamp with a soft nylon and Lycra dorsal section designed to minimise dorsal pressure 
on clawed or retracted toes. Other features include extra depth throughout the shoe and removable 
insoles for accommodation and replacement with customised insoles or therapeutic devices and a 
non-textured EVA (ethyl vinyl acetate) sole suitable for outsole additions (for example: rocker-
soles, metatarsal bars and leg lengthen components).  
The therapeutic rocker-sole modifications tested were of differing take-off angles and pivot point 
positions. The rocker-sole angles and positions to be tested were selected based on consultation 
with Certified Pedorthotists at the Texas Diabetes Institute and a review of the literature. The 
rocker take-off angles tested were 15, 20 and 25 degrees and are presented in Figure 43. The pivot 
point position for these rocker angles was determined from the line made between (level with) the 
most distal points of the first and fifth metatarsophalangeal joints (1-5MPJ line) measured from 
standardised anterior-posterior weight bearing radiographs that were obtained from the subject’s 
medical file. The rocker take-off positions tested were one centimetre proximal to, distal to and 
level with the 1-5 MPJ line. The rocker take-off positions formed 20 degrees fore-outsole angle to 
the rear-outsole. Five rocker-soled shoe conditions were tested because the ‘20 degree rocker’ and 
the ‘level with the 1-5 MPJ line position outsole’ were the same shoe. All footwear were modified 
by the same Certified Pedorthotist at the Texas Diabetes Institute. 
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Figure 43.  Therapeutic shoes with rocker-sole modifications of 15, 20 and 25 degree fore-outsole 
angle with pivot point at the 1-5 MPJ line (top to bottom respectively). 
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Seven shoe conditions were tested in random order and they were labelled as follows;  
• athletic (Nike canvas athletic shoe),  
• therapeutic (Sequoia shoe unmodified),  
• 15 degree rocker (therapeutic shoe with 15 degree fore-outsole angle level with 
the 1-5 MPJ line),  
• 20 degree rocker (therapeutic shoe with 20 degree fore-outsole angle level with 
the 1-5 MPJ line),  
• 25 degree rocker (therapeutic shoe with 25 degree fore-outsole angle level with 
the 1-5 MPJ line),  
• distal rocker (therapeutic shoe with 20 degree fore-outsole angle 1 cm distal to 
the 1-5 MPJ line), and  
• proximal rocker (therapeutic shoe with 20 degree fore-outsole angle 1 cm 
proximal to the 1-5 MPJ line). 
All shoes were new at the beginning of testing. However, the athletic shoes were reused between 
subjects, while a separate set of new therapeutic shoes, appropriately sized with rocker 
modifications were individually modified for each subject. The therapeutic shoes were unable to 
be reused due to the specific and individual nature of the modifications made for each individual. 
Insoles other than the standard shoe inlay were not placed in the shoes during testing due to the 
inability to separate the effects of rocker-sole modification design from those due to insole 
composition on results obtained (Schaff & Cavanagh, 1990). Testing overtime was not conducted 
due to the lack of evidence to ensure that during testing the ulceration would not be at risk of 
further pressure-related injury. 
At the conclusion of testing the subjects retained the SmartKnit socks worn during testing, while, 
after data analyses were completed, the therapeutic shoes/with rocker-sole modification that 
measured the lowest peak pressure on the subject’s ulceration was gifted to each subject. All other 
therapeutic shoes/with rocker-sole modification were made available for issue to suitable patients 
who attended the Texas Diabetes Institute High-risk Diabetic Foot Clinic, San Antonio, Texas 
USA. 
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Data analyses 
Data were analysed, as developed and described in chapters three, four and six. 
Statistical analyses 
Absolute value analyses 
All analyses were performed using SPSS Release 8 for Windows. All data were examined for and 
confirmed as being normally distributed using Proportion probability (P-P) plots with the 
proportion estimated using the Rankit formula. One way repeated measures analysis of variance 
(ANOVA) function was utilised to screen the pressure and pressure-time integral variables per 
anatomical regions across ulceration locations and shoes for variables of statistical significance. A 
p-value of less than or equal to 0.05 was selected for screening for statistically significant 
variables and post hoc analyses using Dunnett’s T3 (SPSS Incorporated, 1998) were performed.  
Pressure measures as they relate to stance time 
All analyses were performed using Excel 2000 for Windows. Bootstrap means and 95% 
confidence bands were plotted as described in Chapter Five. 
 
Results 
The results are presented in two sections. The first section presents the results from the hallux 
ulceration sub-population, and the second section presents the results from the 1MPJ ulceration 
sub-population. Within each section the results are presented; first, comparing the athletic shoe to 
the therapeutic shoe, and second, comparing the therapeutic shoe to the therapeutic shoe with 
rocker-sole shoe modifications. 
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The effect on hallux ulceration peak pressures with change of footwear 
Box plots showing the hallux sub-population median absolute value results and distribution of 
step-to-step variation in peak pressure (kPa) and pressure-time integral (kPa s) for the hallux 
anatomical region (ulceration) are presented in Figure 44 (for an explanation of the box-plot 
function and presentation see Chapter Three Part II(a)). Within each plot, the effects of shoe type 
and rocker-sole modification design are shown. Box plots are a useful means to provide a 
subjective impression of the effects of shoe type and intervention design (Cavanagh et al., 1998). 
It is apparent from these plots that the median results and step-to-step variability in peak pressure 
and pressure-time integral appears to be broadly similar on hallux ulceration across all shoes 
tested.  
Overall, the ulceration bore a median peak pressure of approximately 300 kPa and pressure-time 
integral of approximately 80 kPa s during walking. There was wide variation in the peak pressure 
(less than 100 kPa to nearly 600 kPa) and pressure-time integral (nearly zero to less than 200 kPa 
s) for all shoes. 
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Figure 44. Box plots showing the median and distribution of the step-to-step variation as 
described by the peak pressure (kPa) and pressure-time integral (kPa s) absolute value results on 
the hallux ulceration for the hallux ulceration sub-population per shoe. 
Hallux ulceration: Athletic shoe versus therapeutic shoe 
Absolute value analyses 
The descriptive statistic results for the absolute value analyses are presented for the hallux 
ulceration sub-population in Table 37.  
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Table 37  
Results for hallux ulceration sub-population per shoe (n=15 hallux ulcerations). 
Variable 
Anatomical  
region Shoe type Mean SD Min Max 
Peak pressure (kPa) total Athletic 355.68 67.07 220.00 466.00 
  Therapeutic 378.05 65.09 279.00 504.67 
 hallux Athletic 301.87 109.85 98.00 460.00 
  Therapeutic 286.83 95.10 72.00 417.33 
 1MPJ Athletic 258.89 95.73 131.33 398.57 
  Therapeutic 268.12 129.41 80.00 504.67 
 2-5MPJ Athletic 243.23 58.05 164.00 374.29 
  Therapeutic 193.93 60.11 93.00 292.00 
 heel Athletic 211.09 69.67 71.43 292.67 
  Therapeutic 275.21 106.74 100.67 436.67 
Pressure time-integral total Athletic 132.45 25.74 77.04 169.61 
(kPa s)  Therapeutic 144.50 32.13 75.27 201.31 
 hallux Athletic 74.27 26.75 24.84 111.71 
  Therapeutic 73.69 26.01 14.00 105.12 
 1MPJ Athletic 73.67 24.75 43.63 126.64 
  Therapeutic 71.19 31.35 20.94 137.61 
 2-5MPJ Athletic 74.99 28.12 43.11 131.37 
  Therapeutic 56.89 20.43 26.57 93.76 
 heel Athletic 63.90 23.00 7.06 104.49 
  Therapeutic 80.41 34.25 15.93 175.96 
 
In the hallux ulceration sub-population, the athletic shoe had a lower peak pressure over the whole 
foot (total) (23 kPa lower) and the heel (64 kPa lower) when compared to the therapeutic shoe. 
The peak pressures were similar between the shoes on the hallux and the 1MPJ (within 15 kPa). 
Whereas the peak pressures on the 2-5MPJ in the therapeutic shoe were lower (50 kPa lower) than 
the athletic shoe. The pressure-time integral was similar (within 18 kPa s) and not clinically 
different between shoes over the whole foot (total), hallux, 1MPJ, 2-5MPJ and heel regions. 
The ANOVA results that showed significant differences between shoes at the p ≤ 0.05 level are 
presented for the hallux ulceration sub-population in Table 38. There were significant differences 
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between shoes on only the 2-5MPJ region. Statistical significance was just outside the p < 0.05 
level for the pressure-time integral on the 2-5MPJ for the hallux ulceration sub-population. 
 
Table 38  
The ANOVA results significant at p≤0.05 for the hallux ulceration sub-population per shoe group 
(Athletic versus Therapeutic shoes). 
Variable Anatomical  
region 
Groups Sum of  
Squares 
Degrees 
 of 
freedom 
Mean  
Square 
F Sig. 
Peak pressure  2-5MPJ Between 182.23 1 1822.28 5.22 0.03 
(kPa)  Within 977.55 28 349.13   
  total 1159.78 29    
Pressure time 2-5MPJ Between 24.56 1 245.58 4.07 0.05 
integral  (kPa s)  Within 169.13 28 60.40   
  total 193.69 29    
 
Pressure-time comparisons 
The graphical results of peak pressures measured from the hallux ulceration sub-population are 
presented for the whole foot (total) in Figure 45, the hallux region in Figure 46 and the 2-5MPJ 
region in Figure 47. The other regional graphs are presented in Appendix E as they are ancillary 
to and not of direct relevance to the research question. These graphical results describe differences 
in peak pressure that occurred during stance phase with the athletic and therapeutic shoe when 
ulceration was present on the hallux.  
The graphical results of the peak pressure over the whole foot (Figure 45) shows that peak 
pressures are approximately ten kPa higher in the therapeutic shoe compared to the athletic shoe 
during the forefoot loading phase, from ten to 40 percent, of stance phase in the hallux ulceration 
sub-population.  
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Figure 45.  The means and 95% confidence bands (Bstrap) (the outer lines) for peak pressure-total  
for the hallux ulceration sub-population per shoe type. 
 
The graphical results of the peak pressure on the hallux (Figure 46) show that peak pressures are 
only slightly higher in the therapeutic compared to the athletic shoe from heel lift through to push 
off phase, 55 to 90 percent, of stance phase in the hallux ulceration sub-population. 
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Figure 46.  The means and 95% confidence bands (Bstrap) (the outer lines) for peak pressure-
hallux for the hallux ulceration sub-population per shoe type. 
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The graphical results for peak pressure on the 2-5MPJ region (Figure 47) show that the peak 
pressures are higher in the athletic compared to the therapeutic shoe during midstance through to 
toe off phases, 45 to 100 percent of stance phase, for the hallux ulceration sub-population. The 
athletic shoe was significantly higher than the therapeutic shoe when hallux ulceration was 
present (p = 0.03) and the peak pressure on the 2-5MPJ peaked, and this occurred at 
approximately 80 percent of stance phase. The athletic shoe was also significantly higher than the 
therapeutic shoe (p = 0.05) for the pressure-time integral of the 2-5MPJ region when hallux 
ulceration was present. 
0
100
200
300
400
0 20 40 60 80
Stance phase %
Pe
ak
 
pr
es
su
re
 
-
 
2-
5M
PJ
 
kP
a
Athletic shoe
Therapeutic shoe
 
Figure 47.  The means and 95% confidence bands (Bstrap) (the outer lines) for peak pressure-2-
5MPJ for the hallux ulceration sub-population per shoe type. 
 
Hallux ulceration: Therapeutic shoe versus therapeutic shoe with rocker-sole angle 
and pivot position modifications  
Absolute value analyses 
The descriptive statistic results for the absolute value analyses are presented for the hallux 
ulceration sub-population in Table 39 and Table 40. 
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In the hallux ulceration sub-population, the peak pressure was slightly lower in the rocker-sole 
modifications over the whole foot (total), hallux and the 2-5MPJ regions when compared to the 
therapeutic shoe. However, the differences were small and were less than the measurable accuracy 
established for the device in Chapter Three. All shoes had similar peak pressures on the 1MPJ and 
heel regions. All shoes had similar pressure-time integrals in all anatomical regions. 
 
Table 39  
Results for hallux ulcerations per shoe (n=15) for peak pressure and pressure-time integral as 
measured over the whole foot (Total). 
Variable Shoe type Mean SD Min Max 
Peak pressure-Total  Therapeutic 378.05 65.09 279.00 504.67 
(kPa) 15 degree rocker 358.71 74.09 237.33 525.71 
 20 degree rocker 370.81 104.00 237.33 622.86 
 25 degree rocker 359.83 102.32 217.33 509.33 
 Distal rocker 369.70 85.40 225.33 542.00 
 Proximal rocker 369.93 89.39 230.00 540.00 
Pressure time-integral-Total Therapeutic 144.50 32.13 75.27 201.31 
(kPa s) 15 degree rocker 140.70 36.47 77.83 211.11 
 20 degree rocker 146.04 37.86 75.73 204.49 
 25 degree rocker 140.11 39.28 59.08 196.33 
 Distal rocker 143.76 36.86 70.76 204.91 
 Proximal rocker 147.72 34.63 94.24 210.44 
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Table 40  
Results for hallux ulcerations per shoe (n=15) per variable a) peak pressure and b) pressure-time 
integral. 
a) Peak pressure (kPa)      
Anatomical region Shoe type Mean SD Min Max 
Hallux Therapeutic 286.83 95.10 72.00 417.33 
 15 degree rocker 262.45 92.55 97.14 414.00 
 20 degree rocker 277.91 101.63 106.00 533.33 
 25 degree rocker 274.98 105.05 129.29 500.00 
 Distal rocker 281.94 97.58 116.67 444.67 
 Proximal rocker 272.65 110.47 128.67 448.67 
1MPJ Therapeutic 268.12 129.41 80.00 504.67 
 15 degree rocker 270.43 123.49 100.00 525.00 
 20 degree rocker 265.33 147.49 84.29 622.86 
 25 degree rocker 256.90 131.89 93.57 498.00 
 Distal rocker 271.39 134.73 88.67 542.00 
 Proximal rocker 275.62 133.84 80.00 537.33 
2-5MPJ Therapeutic 193.93 60.11 93.00 292.00 
 15 degree rocker 169.42 73.76 62.00 302.00 
 20 degree rocker 156.94 64.46 59.33 270.00 
 25 degree rocker 163.93 73.82 74.67 272.67 
 Distal rocker 169.65 68.19 64.67 284.67 
 Proximal rocker 177.86 66.51 67.69 274.00 
Heel Therapeutic 275.21 106.74 100.67 436.67 
 15 degree rocker 256.29 103.18 114.67 439.33 
 20 degree rocker 253.58 94.22 112.00 436.67 
 25 degree rocker 255.18 103.10 100.67 489.33 
 Distal rocker 257.39 99.89 110.67 442.00 
 Proximal rocker 267.33 105.14 109.33 448.00 
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Table 40  continued 
b) Pressure-time integral (kPa s) 
Anatomical region Shoe type Mean SD Min Max 
Hallux Therapeutic 73.69 26.01 14.00 105.12 
 15 degree rocker 73.35 29.74 21.16 115.05 
 20 degree rocker 82.44 41.73 22.77 164.51 
 25 degree rocker 76.24 26.86 31.30 126.09 
 Distal rocker 76.14 27.36 29.93 121.21 
 Proximal rocker 74.74 27.86 24.89 112.00 
1MPJ Therapeutic 71.19 31.35 20.94 137.61 
 15 degree rocker 73.11 29.09 33.01 123.79 
 20 degree rocker 71.29 33.02 34.39 134.22 
 25 degree rocker 72.14 34.87 30.67 151.28 
 Distal rocker 72.73 33.43 28.16 139.49 
 Proximal rocker 78.06 34.10 19.97 137.88 
2-5MPJ Therapeutic 56.89 20.43 26.57 93.76 
 15 degree rocker 58.14 38.66 15.67 178.25 
 20 degree rocker 55.13 37.90 18.16 172.69 
 25 degree rocker 56.89 34.21 21.35 152.84 
 Distal rocker 58.86 33.65 18.96 153.09 
 Proximal rocker 60.60 32.56 27.76 157.56 
Heel Therapeutic 80.41 34.25 15.93 175.96 
 15 degree rocker 75.79 33.19 17.92 167.56 
 20 degree rocker 74.94 27.47 20.07 145.09 
 25 degree rocker 77.22 27.90 16.13 129.99 
 Distal rocker 75.99 29.70 18.95 159.23 
 Proximal rocker 83.18 32.37 27.73 175.09 
 
 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In the hallux ulceration sub-population, the peak pressures are slightly lower in the rocker-soled 
modifications compared to the therapeutic shoe over the whole foot (total), hallux, 2-5MPJ and 
heel regions. However, the differences were small and were less than the measurable accuracy 
established for the device in Chapter Three. The pressure-time integral was similar in all shoes for 
all anatomical regions.  
In the hallux ulceration sub-population, there were no significant differences found from the 
ANOVA and post hoc analyses(p < 0.05) in any of the rocker-soled shoe modifications when 
compared to the therapeutic shoes.  
 Pressure-time comparisons 
The graphical results of peak pressures measured from the hallux ulceration sub-population are 
presented for the whole foot (total) in Figure 48 and the hallux region in Figure 49. The other 
regional graphs are presented in Appendix F as they are ancillary to and not of direct relevance to 
the research question. These graphical results describe differences in peak pressure that occurred 
during stance phase with the therapeutic shoe with and without the rocker-sole modifications 
when ulceration was present on the hallux.  
The graphical results of the peak pressure over the whole foot (Figure 48) shows that peak 
pressures are slightly higher in the therapeutic shoe compared to the same shoe with rocker-sole 
modifications until 80% of stance phase in the hallux ulceration sub-population. Other than the 15 
degree rocker-sole modification that shows a slightly lower peak pressure over the whole foot 
after 80% of stance phase, there are no distinct differences between rocker-sole modifications in 
the hallux ulceration sub-population. 
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Figure 48.  The means and 95% confidence bands (Bstrap) (the outer dashed lines) for peak 
pressure-total for the hallux ulceration sub-population per shoe type. 
The graphical results of the peak pressure on the hallux (Figure 49) shows that peak pressures 
were slightly higher in the therapeutic shoe compared to the same shoe with rocker-sole 
modifications until 90% of stance phase in the hallux ulceration sub-population. Other than the 15 
degree and proximal rocker-sole modifications that shows a slightly lower peak pressure on the 
hallux after 80% of stance phase, there are no distinct differences between rocker-sole 
modifications in the hallux ulceration sub-population. 
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Figure 49.  The means and 95% confidence bands (Bstrap) (the outer dashed lines) for peak 
pressure-hallux for the hallux ulceration sub-population per shoe type. 
 
The effect on 1MPJ ulceration pressures with change of footwear 
Box plots showing the 1MPJ ulceration sub-population median absolute value results and 
distribution of step-to-step variation in peak pressure (kPa) and pressure-time integral (kPa s) for 
the 1MPJ anatomical region (ulceration) are presented in Figure 50 (for an explanation of the 
box-plot function and presentation see Chapter Three Part II(a)). Within each plot, the effects of 
shoe type and rocker-sole modification design are shown. As discussed earlier, box plots are a 
useful means to provide a subjective impression of the effects of shoe type and intervention 
design (Cavanagh et al., 1998). It is apparent from these plots that the median results and step-to-
step variability in peak pressure and pressure-time integral appears to be broadly similar on 1MPJ 
ulceration across all shoes tested.  
Overall, the ulceration bore a median peak pressure of less than 400 kPa and pressure-time 
integral of approximately 100 kPa s during walking. There was wide variation in the peak 
pressure (150kPa to 650kPa) and pressure-time integral (zero to more than 200 kPa s: excluding 
outliers) for all shoes.
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Figure 50. Box plots showing the median and distribution of the step-to-step variation as 
described by the peak pressure (kPa) and pressure-time integral (kPa s) absolute value results on 
the 1MPJ ulceration for the 1MPJ ulceration sub-population per shoe. 
1MPJ ulceration: Athletic shoe versus therapeutic shoe  
Absolute value analyses 
The descriptive statistic results for the absolute value analyses are presented for the 1MPJ 
ulceration sub-population in Table 41. 
In the 1MPJ ulceration sub-population, the peak pressures on the 1MPJ and the heel were lower (-
41 kPa and –30 kPa respectively) in the athletic shoe compared to the therapeutic shoe. The peak 
pressures were similar between the shoes over the whole foot (total) and hallux. Whereas the peak 
pressure was lower (-81 kPa) in the therapeutic shoe on the 2-5MPJ region. The pressure-time 
integral on the 2-5MPJ was lower (-21 kPas) in the therapeutic shoes compared to the athletic 
shoes, whereas the pressure-time integral was similar (within 14 kPas) between shoes over the 
whole foot (total), hallux, 1MPJ and heel regions. 
The ANOVA results that showed significant differences between shoes are presented for the 
1MPJ ulceration sub-population in Table 42. There were significant differences in peak pressure 
and pressure-time integral between shoes on only the 2-5MPJ region for the 1MPJ ulceration sub-
population.  
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Table 41  
Results for 1MPJ ulceration sub-population per shoe (n=9 1MPJ ulcerations). 
Variable 
Anatomical  
region Shoe type Mean SD Min Max 
Peak pressure (kPa) total Athletic 409.07 88.77 304.29 559.33 
  Therapeutic 405.58 53.82 332.00 489.33 
 hallux Athletic 246.40 139.98 69.33 513.33 
  Therapeutic 236.94 104.12 56.43 340.67 
 1MPJ Athletic 358.69 99.80 220.71 527.33 
  Therapeutic 399.68 58.75 326.67 489.33 
 2-5MPJ Athletic 303.14 96.74 202.67 531.33 
  Therapeutic 222.93 57.93 105.71 286.00 
 heel Athletic 250.31 45.95 191.33 320.63 
  Therapeutic 280.57 37.99 215.00 330.67 
Pressure time-integral total Athletic 160.04 44.26 109.73 250.84 
(kPa s)  Therapeutic 172.60 52.46 111.76 288.76 
 hallux Athletic 56.97 24.09 10.33 94.24 
  Therapeutic 62.43 31.17 9.68 110.19 
 1MPJ Athletic 111.51 49.96 48.59 190.91 
  Therapeutic 120.23 42.95 75.37 220.03 
 2-5MPJ Athletic 87.33 21.63 62.27 125.44 
  Therapeutic 66.75 17.70 39.90 98.71 
 heel Athletic 81.03 35.93 50.63 165.94 
  Therapeutic 95.95 37.86 47.01 171.35 
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Table 42  
The ANOVA results significant at p≤0.05 for the 1MPJ ulceration sub-population per shoe group 
(Athletic versus Therapeutic shoes). 
Variable Anatomical  
region 
Groups Sum of  
Squares 
Degrees  
of 
freedom 
Mean  
Square 
F Sig. 
Peak pressure  2-5MPJ Between 289.57 1 2895.71 4.55 0.05 
(kPa)  Within 1017.18 16 635.74   
  total 1306.75 17    
Pressure time- 2-5MPJ Between 19.06 1 190.59 4.88 0.04 
Integral (kPa s)  Within 62.50 16 39.06   
  total 193.69 29    
 
Pressure-time comparisons 
The graphical results of peak pressures measured from the 1MPJ ulceration sub-population are 
presented in kPa for the whole foot (total) in Figure 51, the 1MPJ region in Figure 52 and the 2-
5MPJ region in Figure 53, while the other regions are presented in Appendix G. These graphical 
results describe differences in peak pressure that occurred during stance phase with the athletic 
and therapeutic shoe when ulceration was present on the 1MPJ.  
The graphical results of the peak pressure over the whole foot (Figure 51) shows that peak 
pressures are at least 50 kPa higher in the therapeutic shoe compared to the athletic shoe from 
forefoot loading though to heel lift phases, from 20 to 80 percent, of stance phase in the 1MPJ 
ulceration sub-population. 
The graphical results of the peak pressure on the 1MPJ (Figure 52) show that peak pressures are 
less than ten percent higher in the therapeutic compared to the athletic shoe from heel lift through 
to push off phase, 40 to 90 percent, of stance phase in the 1MPJ ulceration sub-population. 
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Figure 51.  The means and 95% confidence bands (Bstrap) (the outer lines) for peak pressure-total 
for the 1MPJ ulceration sub-population per shoe type. 
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Figure 52.  The means and 95% confidence bands (Bstrap) (the outer lines) for peak pressure-
1MPJ for the 1MPJ ulceration sub-population per shoe type. 
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The graphical results for peak pressure on the 2-5MPJ region (Figure 53) show that the peak 
pressures are higher in the athletic compared to the therapeutic shoe from after midstance through 
to toe off phases, 60 to 90 percent, of stance phase for the 1MPJ ulceration sub-population. The 
athletic shoe was significantly higher than the therapeutic shoe when 1MPJ ulceration was present 
(p = 0.05) and the peak pressure on the 2-5MPJ peaked, and this occurred at approximately 80 
percent of stance phase. The athletic shoe was also significantly higher than the therapeutic shoe 
(p = 0.04) for the pressure-time integral on the 2-5MPJ region when 1MPJ ulceration was present. 
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Figure 53.  The means and 95% confidence bands (Bstrap) (the outer lines) for peak pressure-2-
5MPJ for the 1MPJ ulceration sub-population per shoe type. 
 
1MPJ ulceration: Therapeutic shoe versus therapeutic shoe with rocker-sole angle 
and pivot position modifications  
Absolute value analyses 
The descriptive statistic results for the absolute value analyses are presented for the 1MPJ 
ulceration sub-population in Table 43 and Table 44. 
 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Table 43  
Results for !MPJ ulcerations per shoe (n=9) for peak pressure and pressure-time integral as 
measured over the whole foot (Total). 
Variable Shoe type Mean SD Min Max 
Peak pressure-Total Therapeutic 405.58 53.82 332.00 489.33 
(kPa) 15 degree rocker 387.74 74.23 294.00 528.00 
 20 degree rocker 398.95 77.22 296.15 540.00 
 25 degree rocker 374.06 75.30 288.00 524.67 
 Distal rocker 404.78 66.37 303.57 546.00 
 Proximal rocker 397.09 66.29 322.67 514.00 
Pressure time- Therapeutic 172.60 52.46 111.76 288.76 
integral- Total 15 degree rocker 166.82 44.66 100.95 246.76 
(kPa s) 20 degree rocker 170.54 51.18 119.14 279.58 
 25 degree rocker 163.79 40.62 117.37 250.75 
 Distal rocker 173.87 42.72 118.32 253.71 
 Proximal rocker 169.81 49.40 122.73 289.33 
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Table 44 
Results for 1MPJ ulcerations per shoe (n=9) per variable a) peak pressure and b) pressure-time 
integral. 
a) Peak pressure (kPa) 
Anatomical region Shoe type Mean SD Min Max 
Hallux Therapeutic 236.94 104.12 56.43 340.67 
 15 degree rocker 223.74 95.24 64.67 328.00 
 20 degree rocker 222.03 94.98 70.67 326.00 
 25 degree rocker 222.03 97.39 48.67 331.43 
 Distal rocker 210.93 90.54 82.00 317.33 
 Proximal rocker 217.41 96.06 66.67 342.22 
1MPJ Therapeutic 399.68 58.75 326.67 489.33 
 15 degree rocker 382.70 76.30 294.00 528.00 
 20 degree rocker 386.41 82.02 283.08 540.00 
 25 degree rocker 360.32 83.92 267.86 523.33 
 Distal rocker 394.75 70.62 299.29 546.00 
 Proximal rocker 374.27 71.02 281.33 514.00 
2-5MPJ Therapeutic 222.93 57.93 105.71 286.00 
 15 degree rocker 201.20 42.72 144.62 279.33 
 20 degree rocker 200.77 58.16 126.00 317.33 
 25 degree rocker 202.55 47.31 128.46 280.00 
 Distal rocker 192.03 41.46 138.67 265.71 
 Proximal rocker 200.08 61.42 120.00 325.00 
Heel Therapeutic 280.57 37.99 215.00 330.67 
 15 degree rocker 278.51 45.45 208.67 330.67 
 20 degree rocker 300.50 53.50 204.00 384.00 
 25 degree rocker 287.36 35.29 236.00 335.33 
 Distal rocker 301.13 64.70 215.38 416.67 
 Proximal rocker 310.41 75.69 212.00 465.00 
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Table 44 continued 
b) Pressure-time integral (kPa s) 
Anatomical region Shoe type Mean SD Min Max 
Hallux Therapeutic 62.43 31.17 9.68 110.19 
 15 degree rocker 59.13 25.99 12.96 89.31 
 20 degree rocker 65.72 30.40 13.47 101.77 
 25 degree rocker 64.85 32.31 15.92 107.57 
 Distal rocker 60.55 33.85 13.71 112.44 
 Proximal rocker 59.02 28.30 11.97 103.82 
1MPJ Therapeutic 120.23 42.95 75.37 220.03 
 15 degree rocker 112.01 36.64 73.09 173.59 
 20 degree rocker 118.87 46.54 73.00 201.45 
 25 degree rocker 107.63 30.92 66.41 151.68 
 Distal rocker 118.87 36.65 78.20 176.65 
 Proximal rocker 109.85 39.88 68.43 207.28 
2-5MPJ Therapeutic 66.75 17.70 39.90 98.71 
 15 degree rocker 65.14 17.80 48.66 100.57 
 20 degree rocker 62.84 12.66 41.57 80.28 
 25 degree rocker 64.38 15.94 38.97 98.65 
 Distal rocker 63.09 19.43 47.20 109.71 
 Proximal rocker 63.46 13.82 37.64 80.83 
Heel Therapeutic 95.95 37.86 47.01 171.35 
 15 degree rocker 88.54 38.60 30.12 164.26 
 20 degree rocker 95.31 37.90 48.43 175.23 
 25 degree rocker 96.89 37.17 56.64 178.81 
 Distal rocker 102.95 41.02 45.76 168.51 
 Proximal rocker 99.94 40.04 56.81 182.57 
 
There were no significant differences in peak pressure and pressure-time integral from the 
ANOVA and post hoc analyses measured under the 1MPJ ulcerations in any of the rocker-soled 
shoe modifications when compared to the therapeutic shoes.  
 
Pressure-time comparisons 
The graphical results of peak pressures measured from the 1MPJ ulceration sub-population are 
presented for the whole foot (total) in Figure 54 and the 1MPJ region in Figure 55, whereas the 
other regions are presented in Appendix H. These graphical results describe differences in peak 
pressure that occurred during stance phase with the therapeutic shoe with and without the rocker-
sole modifications when ulceration was present on the 1MPJ. 
The graphical results of the peak pressure over the whole foot (Figure 54) shows that peak 
pressures are slightly higher in the therapeutic shoe compared to the same shoe with rocker-sole 
modifications from 40% of stance phase in the 1MPJ ulceration sub-population. The upper 
confidence band is different for the therapeutic shoe compared to the rocker-sole modifications in 
that it does not reduce during the midstance phase, but continues to gradually raise until it peaks 
after 85% of stance phase. There are no distinct differences between rocker-sole modifications for 
peak pressure over the whole foot (total) for the 1MPJ ulceration sub-population.  
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Figure 54.  The means and 95% confidence bands (Bstrap) (the outer dashed lines) for peak 
pressure-total for the 1MPJ ulceration sub-population per shoe type. 
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The graphical results of the peak pressure on the 1MPJ (Figure 55) shows that peak pressures 
were slightly higher in the therapeutic shoe compared to the same shoe with rocker-sole 
modifications from 40% percent of stance phase in the 1MPJ ulceration sub-population. There are 
no distinct differences between rocker-sole modifications for peak pressure over the whole foot 
(total) for the 1MPJ ulceration sub-population. 
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Figure 55.  The means and 95% confidence bands (Bstrap) (the outer dashed lines) for peak 
pressure-1MPJ kPa for the 1MPJ ulceration sub-population per shoe type. 
 
In light of the non-result gained from the ulceration sub-populations, analyses into selection of the 
shoe with the maximum benefit for protection from walking pressures for hallux and 1MPJ 
ulceration, a sample of individual subjects’ results were examined and are presented in Figure 56 
to Figure 59. These individual subjects’ results were selected as they demonstrated differences 
between shoes in the absolute value analyses. With differences evident in the absolute value 
analyses, the potential further insight gained from the pressure-time patterns can be theorised. 
Once again box plots are a useful means to provide a subjective impression on the effects of shoe 
type and intervention design. Within each plot, the effects on each individual subject’s limb with 
ulceration of shoe type and rocker-sole modification design are shown. The figures show the
 
different information that is obtained from analysis of the absolute values compared to the 
pressure-time graphs. For the individual limb results analysed, confidence bands could not be 
calculated due to the export limitations of the PedarTM system. However, it is apparent from the 
box plots that the effect on ulceration from different shoe types and rocker-sole modifications is 
specific to individual limbs. Importantly, these plots confirm the sub-population analyses and 
show that there is not one rocker-sole modification design that provides maximum protective 
benefit to either ulceration groups when walking.  
The box plots in Figure 56 show that for Subject 29, that wearing the Athletic shoe afforded the 
maximal protective benefit to their 1MPJ ulceration when walking. The shoe with the maximum 
protective benefit is defined by the lowest peak pressure and lowest pressure-time interval 
absolute value results. The peak pressure-stance time plots provide more information and show 
that both the Athletic shoe and the Therapeutic shoe with the 25 degree rocker-sole modification 
afforded similar low maximum peak pressures at the toe-off phase of stance phase. However, the 
25 degree rocker-sole modification effected an earlier maximum peak during toe off. It remains 
unknown if changing of the timing, in addition to, or lowering of the peak pressure alone, that 
may be most useful in ulceration protection. 
The box plots show and the peak pressure-time plots presented in Figure 57 confirm that for 
Subject 28, neither the athletic shoe nor the unmodified therapeutic shoe were useful for 
protecting their 1MPJ ulceration from high pressures during walking. For this subject, the 
therapeutic shoes with both the 20 and the 25 degree rocker-sole modifications showed 
comparable protection to the ulceration from high peak pressures. However, it is apparent from 
both the box plots and the pressure-time plots that relocating the rocker-pivot point had an effect 
on the timing of the peak pressures experienced on the ulceration when walking in these shoes. 
Consequentially, this subject’s results confirm that rocker-sole pivot position placement is an 
essential factor for effective clinical intervention and ulceration protection, but once again the 
importance of the timing of the maximum peak pressure for achieving maximum ulceration 
protection remains unknown. 
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Figure 56. Peak pressure and pressure-time integral absolute value box plots of individual steps 
and peak pressure-time per percentage-normalised stance time plot mean results for Subject 29 
measured on their 1MPJ ulceration per shoe. 
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Figure 57. Peak pressure and pressure-time integral absolute value box plots of individual steps 
and peak pressure-time per percentage-normalised stance time plot mean results for Subject 28 
measured on their 1MPJ ulceration per shoe. 
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The box plots show and the peak pressure-time plots presented in Figure 58 confirm that for 
Subject 2 the unmodified therapeutic shoe provided the maximum protective benefit on their 
hallux ulceration from high pressure during walking. Importantly, this subject’s results confirm 
that the correct placement of the rocker-sole pivot point is critical and if poorly placed, and in this 
case too far distal from the metatarsophalangeal joint line, may be detrimental to ulceration 
protection. Of most interest, are the very low peak pressure results on this subject’s ulceration 
compared to the other individual cases. Such a low peak pressure result may suggest that little 
force or effort goes into the push- or toe-off phase of gait and suggests a shuffling style of gait. 
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Figure 58. Peak pressure and pressure-time integral absolute value box plots of individual steps 
and peak pressure-time per percentage-normalised stance time plot mean results for Subject 2 
measured on their hallux ulceration per shoe (The pressure-time plot for the 15 degree rocker-sole 
modification is unavailable for this subject due to a processing error). 
The distinct differences between the athletic shoes and the therapeutic shoes, specifically that with 
the 15 degree rocker-sole modification shown for Subject 15 in Figure 59 appears to support the 
assumption that a rigid soled shoe, that does not bend at the metatarsophalangeal joint is useful for 
ulceration protection.
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Figure 59. Peak pressure and pressure-time integral absolute value box plots of individual steps 
and peak pressure-time per percentage-normalised stance time plot mean results for Subject 15 
measured on their Hallux ulceration per shoe. 
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Discussion 
Athletic shoe versus therapeutic shoe 
The descriptive statistic results suggest, and the ANOVA results confirm, that there were 
significant differences in peak pressure or pressure-time integral per ulceration between the 
athletic and the therapeutic shoes for the 2-5MPJ region. These differences at the 2-5MPJ regions 
in both ulceration sub-populations suggest that a functional change occurs in ulcerated feet when 
walking in the athletic versus the therapeutic shoe. The graphs of the peak pressure on the 2-5MPJ 
over stance time provide insight into the time those differences between the shoes occurred. With 
this knowledge, the likely actions of the foot, limb and body during walking could be correlated. 
The change in the function during walking in the different shoes could then be hypothesised and 
investigated using three-dimensional gait analysis tools.  
In the graph of the peak pressure on the 2-5MPJ region for the hallux ulceration sub-
population, it can be seen that the peak pressures begin to differ between the shoes from 30% 
of stance phase. From this time, the forefoot is on the ground and begins to accept body 
weight in preparation for the other foot to push off. The change in function between the shoes 
may be a result of the firmer shoe construction and thicker and stiffer sole of the therapeutic 
shoe. The shoe and sole stiffness would likely provide resistance to foot movement and with 
this, lower pressures are experienced on the 2-5MPJ region when walking. Potentially, the 
lower pressure on the lateral forefoot in the therapeutic shoe may change the balance of 
pressure flow through the forefoot and may increase ulceration risk to the 1MPJ and/or 
hallux. Specific sole stiffness has been reported to be an essential requirement for forefoot 
ulceration protection using footwear (Dahmen, Haspels, Koomen, & Hoeksma, 2001; Fuller, 
1994; Janisse, 1995). However, the present study found that the stiffer sole shoe did not 
translate into protecting the hallux ulceration from higher peak pressures and in fact, the 
graph of the hallux (ulceration) region (Figure 46) shows that the ulceration bore slightly 
higher peak pressure when walking in the stiffer therapeutic shoe when compared to the 
athletic shoe. These results suggest that it may be necessary to prescribe a cushioning insole 
to be used with the therapeutic shoe to offset the higher pressures experienced by the 
ulceration when walking in the stiffer therapeutic shoe. 
When the graphs of the 1MPJ ulceration sub-population are examined, the therapeutic shoe 
can also be seen to provide protection from high peak pressures on the 2-5MPJ region when 
compared to walking in the athletic shoe, but not until later in stance phase than when 
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ulceration is present on the hallux. The change in peak pressure and foot function in the 1MPJ 
ulceration sub-population occurs from 50% of stance phase. From this time, the foot is 
bearing full body weight while the other limb is non-weight bearing and swinging level with 
the weight-bearing limb. Once again, the study found that the protection for the 2-5MPJ 
region did not translate to protection to the 1MPJ ulceration and as with the graph of the 
hallux (ulceration) region, the graph of the 1MPJ (ulceration) region (Figure 52) shows that 
the ulceration bore slightly higher peak pressure when walking in the therapeutic shoe when 
compared to the athletic shoe. Once again, these results suggest that a cushioning insole may 
be required in a therapeutic shoe to offset the higher pressures experienced by the ulceration 
when walking in the stiffer therapeutic shoes. 
The descriptive statistic study results for the hallux ulceration sub-population agree with 
Lavery, Vela, Fleischli et al.(1997) that peak pressure on hallux ulceration is slightly lower 
when walking in a therapeutic shoe compared to a athletic shoe. However, the peak pressures 
reported on hallux ulcerations by Lavery, Vela, Fleischli et al.  were much lower (211 (110) 
kPa compared to 301.87 (109.85) kPa for this study) and they found a 9.0 percent difference 
between the shoes as compared to 4.9 percent for the present study. However, the present 
study descriptive statistic results for the 1MPJ ulceration sub-population disagree with 
Lavery, Vela, Fleischli et al. in that they reported that peak pressure on 1MPJ ulceration was 
28.6% lower, whereas the present study found peak pressure to be 11.42% higher, when 
walking in the therapeutic shoe compared to athletic shoe. The differences between results 
from the 1MPJ ulceration sub-populations may be due to differences in the shoe types, or may 
suggest that both samples were of insufficient size to be representative of this population. 
Therapeutic shoe versus therapeutic shoe with rocker-sole modifications 
The descriptive statistic, ANOVA and post hoc results showed that there were no differences 
in absolute values for the hallux or 1MPJ sub-populations when walking in therapeutic shoes 
with and without rocker-sole modifications. These results were confirmed by the pressure-
time graphs. However, the graphs do suggest that there are slightly higher but not clinically 
different pressures on the ulceration when walking in the unmodified therapeutic shoes for 
both the hallux and the 1MPJ ulceration sub-populations.  
The results of the present study are in opposition to the body of literature that has drawn 
conclusions from their positive peak pressure reduction results from rocker-soled shoe 
modifications in non-ulcerated populations to mean that there will be positive reduction and 
protective benefits on populations with ulcerations. Additionally, the results of the present 
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study do not support the anecdotal but extensive clinical experience-based evidence that 
rocker-soled shoes are effective in healing ulceration and preventing re-ulceration due to 
lowering peak pressures during walking. Technological advances into instrumental 
measurements of shear forces are expected to provide insight into a causative relationship 
between peak pressures and ulceration. Already peak pressures and peak shear forces were 
found to co-occur on the same anatomical regions of the foot in neuropathic individuals, 
although at slightly different times (Perry, Hall, & Davis, 2002). The confirmation from the 
present study that pressure-time pattern provides more insight into potential differences 
between ulcerations than the absolute peak pressure value may be more clinically useful for 
shoe design development and selection when shear force data can be simultaneously 
compared. 
If the extensive positive pressure reduction benefits from reports of rocker-soled shoes worn 
by healthier populations are valid, then potentially the mechanism by which peak pressures 
reduce when walking may not apply once foot ulceration has occurred. Alternatively, the 
anecdotal clinical evidence to the protective benefit that rocker-soled shoe modifications have 
on ulceration, may relate to the success of individuals prescribed these modifications specific 
to their foot presentation by an experienced clinician. Further investigation using additional 
structural and functional measures in combination with in-shoe plantar pressures is required 
to provide further insight into the aetiology of rocker-sole modification efficacy. 
 
Individual subject results measured on their ulceration in all shoes 
There was a large diversity in individual response to both the absolute value and over stance 
time peak pressure results as demonstrated by the wide ranges (minimum to maximum 
values) and broad upper and lower 95% confidence bands that limit the sub-population 
means. High individual variation and the lack of a most beneficial sub-population-wide 
rocker-sole shoe modification to protect either ulceration found in the present study points to 
the conclusion that shoe therapy is individual and therefore, requires individual assessment. 
Praet and Louwerens (2003) (from their study of ten diabetic women with ulceration) 
supports this conclusion, and their concluding statement is also apt for the present study: 
Predicting the effect of therapeutic footwear on an individual scale remains difficult. 
Therefore, for certain individual patients, in-shoe pressure measures seem to be 
necessary for evaluating an individual therapeutic shoe prescription (p 444). 
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The individual results presented in Figure 56 to Figure 59, showed that shoe selection for 
ulceration protection was specific to each individual. The pressure protection achieved on the 
ulceration ranged from small to large gains by changing from an athletic to therapeutic shoe 
or adding a rocker-sole modification. Over all, though these results confirm the population 
results that there was not one shoe or modification for routine prescription to protect 
ulceration by lowering of peak pressures. Even with the rigor of the application of the method 
for this study, the box plots showed large variability in the peak pressure and pressure-time 
integral results on ulceration. To note, is that when the whiskers of the box plots overlapped 
between shoes, this meant that there were not true differences between these shoes. 
Conversely the opposite is true and there were distinct and true differences between several 
shoes seen in the individual results that do not agree with the population results. Of most 
importance, there were specific shoes or rocker-sole modifications that provided some 
individuals with protection to ulceration from high plantar pressures. Consequently, with 
individual assessment-based shoe prescription using the methods developed for this research, 
patients could achieve positive outcomes without limitations being placed on their ability to 
walk. 
The pressure-time graphs for the individuals with 1MPJ ulceration showed that by changing 
shoes, the peak pressure on the ulceration also changed in both the absolute peak value (by 
about 200kPa) and also the timing that the peak occurred. In both cases it can be seen that 
these results agreed with the population mean and pressure-time graphs and showed that the 
25 degree rocker modified shoe afforded the best protection due to having the lowest peak 
pressure when compared to the other shoes. The individual pressure-time graphs however, 
showed the 25 degree rocker modified shoe peaking earlier and lower that the other shoes and 
it remains unknown whether either or both a change in the absolute peak value or the time in 
the stance phase in which the peak occurs may be useful for ulceration protection.  
The pressure-time graphs for the individuals with hallux ulceration showed a similar response 
to that of the 1MPJ ulceration examples for absolute peak value change with shoe change, 
except that the range of change in peak pressures is much higher (about 100 kPa change in 
Subject 2 and about 300 kPa in Subject 15). Of interest is that in Subject 2, all shoes peak at 
the same time (90 percent of stance phase), while in Subject 15 the shoe peaks occur earlier at 
between approximately 70 and 85 percent of stance phase. The low peak and the consistency 
of the timing for Subject 2 could suggest that the subject’s gait was of a shuffling style. 
Rocker-sole modification would not be useful and indeed contraindicated with a shuffling 
type gait due to potentially destabilizing the subject’s gait and putting the subject at risk of 
falling. The gait style and its positive or negative influence on clinical decision to prescribe 
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rocker-sole modification for ulceration protection was not identified as a contraindication in 
any of the literature reviewed for this research, and is an important avenue for future 
investigation. 
Conclusion 
Several studies have tested the effect on peak pressures during walking in therapeutic shoes 
with rocker-sole modifications but none included people with actual ulceration (Brown et al., 
2004; Fuller et al., 2001; Nawoczenski et al., 1988; Peterson et al., 1985; Schaff & Cavanagh, 
1990). These reports concluded that rocker-sole shoe modifications reduced peak pressures in 
their study populations. They then generalised that this same protective reduction in peak 
pressure would be afforded to ulceration. This thesis makes a significant contribution to 
knowledge by testing the efficacy of these shoe modifications to protect the ulceration. The 
population results of the present study do not support the generalised conclusions reported in 
the literature. Instead, the present study found that peak pressures on ulceration were lower in 
the flexible athletic shoe and that all rocker-sole modifications provided slight pressure relief 
on ulceration when compared to the stiffer therapeutic shoe, but the extent of protection 
afforded to the population was not clinically significant. Therefore, no single shoe or rocker-
sole modification was found to be effective for routine prescription to protect hallux or 1MPJ 
ulceration in patients with diabetes and neuropathy. 
A small sample of individual results were examined and they were found to have different 
responses to different shoes, including the extent and the timing of peak pressure experienced 
on their ulceration. In some individual subjects there were specific shoes or rocker-sole 
modifications that provided effective protection to their ulceration from high peak pressures. 
At the same time though, there were shoes and rocker-sole modifications that had no effect or 
were detrimental and increased the peak pressures born on the ulceration. Consequentially, 
unless individual in-shoe plantar pressure assessment is available to evaluate shoe 
intervention efficacy, then prescription should be made with caution. 
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Limitations of the thesis studies design 
Sample bias 
The archival dataset was created from study databases created several years prior to this thesis 
and the data were collected and analysed by research staff that have since resigned from the 
study institution. Although the procedures are published in the literature (Lavery, Vela, 
Fleischli et al., 1997; Lavery, Vela, Lavery et al., 1997) and were confirmed orally with the 
principal investigator, the stringency by which subjects were recruited, the data collected and 
analysed cannot be verified. However, as the aim for utilising archival data was to determine 
the protocol and procedures for further thesis study, if the data were less stringent, then the 
limits defined would be expected to be broader and more conservative. Specifically, this 
limitation would have the most effect on the calculation of the measurement accuracy. The 
accuracy determined was ± 11.31 percent, and as the mean differences in the thesis studies 
that were found to be statistically significant were always well short of this figure, then 
conservative accuracy was considered to be an acceptable limitation. 
The subjects with diabetes but without neuropathy that were recruited for the sock selection 
and protocol safety study were people that attended a general and public diabetes education 
presentation given by the author on foot health and diabetes. It is therefore, likely that these 
volunteers were more aware of their disease and healthier than the greater population with 
diabetes. The provision of the incentive of providing plantar pressure assessment for 
participation in the studies may have also biased the population towards the more aware and 
healthier population. However, as study of these subjects were utilised to determine potential 
risks to future studies of neuropathic subjects, than subjects with heightened awareness of 
their disease would be expected to provide useful feedback.  
C H A P T E R  N I N E  
C O N C L U S I O N S  
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The three-hour duration of testing, the lack of transport to and from the testing session, the 
lack of cash payment for participation and no reimbursement for expenses, may have limited 
the number of subjects willing to participate in the studies. The duration of testing and lack of 
transport may especially have biased the sample population away from the frail, elderly or 
financially limited and towards the more independent and healthy subjects. The lack of cash 
payment for subjects may have biased against participation as an artefact of the setting of the 
research. In the large American city and corporate support-university medical school context 
in which the data were collected, patients were inundated with advertising alerting them to the 
fact that willing subjects could expect cash payment for research participation, in addition to 
reimbursement for travel and bonus items (meals, prescription medication, wound dressing 
materials, and gifts). Unfortunately, as subjects that met the studies’ inclusion criteria were 
invited to meet with the author by their treating clinician, the actual impact that lack of cash 
payment, transportation and reimbursement had on subjects willing to participate is unknown. 
The decision to limit the population of study for the shoe studies to those with only two 
plantar ulcerations and an absence of foot surgery, severely limited the sample size available 
for study. This decision was made, to provide results that were applicable to hallux and 1MPJ 
diabetic ulceration knowledge, rather than more generally to diabetic foot knowledge. 
Laboratory not ‘real-life’ testing environment 
The laboratory based study design severely limits the applicability of the results to the actual 
environment in which patients generally walk or use the therapeutic footwear investigated and 
this is especially true of the sock data that was collected without wearing shoes. However, as 
the thesis aimed firstly to define the limits of the protocol and procedures to enable 
comparisons to be made between interventions, then it was necessary to rigorously limit any 
environmental influences on the measure of interest, that is, pressure.  
The use of new footwear during testing limits the applicability of the results to the actual 
clinical circumstances in which they are prescribed and therefore, relates only to the first few 
hours of the experience of the therapeutic intervention. Generally, when prescribed a 
therapeutic footwear intervention, the patient is encouraged to limit the use of the footwear to 
small but regular time slots over a period of weeks to facilitate the wearing in and softening of 
the shoe and allow gradual acclimatisation and modification of the gait/foot to occur. It is 
therefore, plausible that differences would emerge dependant on the duration of the therapy. 
However, such differences would require careful research design that included individual  
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assessment and shoe use monitoring to determine whether changes had taken place in the 
person or the footwear and to ensure that the ulceration did not incur further injury. 
Physical test exclusion 
The exclusion of a battery of physical tests limits insight that may have been gained into 
explanation for the high variability found within the pressure measure variables. The large 
variability may have most likely been due to the failure to define the sub-populations into 
further groups based on physical characteristics. However, a far larger sample size than that 
obtained for the thesis studies would be required to explore this possibility further. Physical 
tests that may have been useful are joint range of motion measurements of the foot and ankle 
(Birke et al., 1988), flexibility (Katoulis et al., 1996) and strength (Mueller, Minor et al., 
1994) of major lower limb muscle groups, and balance (Menz, Lord, Fitzpatrick, & St 
George, In Press). 
Strengths of the thesis study design 
Archival analyses for protocol development 
The major strength of the thesis studies is in the thorough development, testing and 
refinement of the protocol and procedures prior to study. Using archival analysis ensured that 
data collection methods utilised for the thesis studies were rigorous and adequate to meet the 
aims of, and allow valid conclusions to be drawn from, each study. Additionally, the archival 
analyses have made, and will make, a significant contribution to the literature, because the 
uncertainties associated with in-shoe plantar pressure measurement have been unknown for 
the population of people with diabetes, neuropathy and forefoot ulceration.  
Stringent inclusion and exclusion criteria  
The selection of subjects without foot deformity or a history of foot surgery provided general 
applicability to the studies on several fronts. The exclusion of foot deformity ensured that 
subjects could wear standard but appropriately sized ‘off-the-shelf’ footwear, which enabled 
strict standardisation of the athletic and therapeutic shoe styles. Standard footwear also meant 
that standard sized in-shoe sensor matrices could also be employed across all tests, limiting 
variability in the data obtained due to sensor numbers and size variations incurred from using 
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different sensor sizes. The exclusion of foot surgery ensured that the anatomical regions of the 
foot could be standardised across subjects and studies, limiting potential variability inherent 
from foot-structure and function modification from surgery. 
The exclusion of subjects with multiple foot ulcerations and inclusion of only plantar hallux 
and plantar1MPJ ulcerations for testing provided general applicability to enable clear 
comparisons and definite conclusions to be drawn between sub-populations and footwear 
interventions. In particular, with the aim to investigate ulceration protection efficacy from 
rocker-sole modified shoes, then the hallux and 1MPJ ulcerations tested are the most logical 
sites of ulceration to be prescribed these footwear. 
Correct statistical tests 
The testing for normal distribution status in central limit theory and selection of the 
appropriate statistical tests for repeated measures analyses of the absolute value results would 
not be expected to be stated as a strength of a study, but rather be assumed to have been done. 
However, it is unfortunate to find that few published studies reported their reasoning for 
selection of the statistical test conducted, nor checking for normal distribution status. 
Therefore, strength in the thesis studies is not only the checking for and selection of the 
appropriate statistical tests, but also the results from the archival analyses that enabled 
discussion of significant differences found in reference to the limits of the measurement 
method. 
Although the calculation of the 95 percent confidence bands using the appropriate bootstrap 
methods for continuous data, showed only slightly wider bands than the point-by-point 
method, they ensured that there was no doubt to the high variability of the data and therefore, 
unlikelihood that there were true clinical differences between the sub-populations and 
interventions tested.  
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Overview of major findings 
Guidelines for a standard protocol for in-shoe plantar pressure 
measurement were produced. 
A standardised protocol for in-shoe plantar pressure analyses was not identified from a 
thorough analysis of the published literature. The IPGPPM (Barnett, 1998) were an attempt to 
rectify this lack of standardisation. However, other than the selection of ‘mid-gait’ steps, their 
recommendations have not been universally adopted. Therefore, without a published 
standardised protocol to follow for future thesis studies, a default position was developed and 
guidelines produced based on the results from the protocol analysis and good practice. 
A method for mid-gait walking validity checking was produced and 
tested. 
Even though the validity of mid-gait stepping is assumed by ensuring that the subjects 
practise and become consistent with the testing activity, and an investigator visually monitors 
each trial, the resulting data set needs to be checked to ensure that any inconsistent steps are 
removed. Inconsistent steps were identified by screening for inconsistencies in the total area 
of the foot measure. Both a manual-visual and a computerised-algorithmic method of 
screening were evaluated and both were found to identify inconsistent steps. It was found that 
the computerised-algorithmic method was the more time effective of the two methods. 
Screening for, and removal of, inconsistent steps reduced the variability of the dataset, but did 
not compromise the validity of the original data set. 
The reliability, precision and accuracy limits of in-shoe plantar 
pressure measurement were defined. 
The number of repeated steps necessary for inclusion in the calculation of a reliable and 
precise average step had not been established for the population of people with diabetes, 
neuropathy and ulceration. For reliable analysis using the peak pressure variable, then only 
two steps were found to be required for inclusion in the average step calculation. Other 
variables ranged from two to eight steps. Precision was expressed unit-less so as to allow 
comparisons across variables. All in-shoe variables were imprecise and were outside the 
limits of acceptable variability (15%). 
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The number of repeated steps required for inclusion in the average step calculation to achieve 
maximum practical accuracy was unknown. For the variable peak pressure measured over the 
whole foot, its variability did not improve markedly beyond ±8.8 percent after nine steps were 
included in the average step calculation. This variability was found to be associated with 
measurement uncertainty of ±6.31 percent while the documented instrument accuracy is ±5%. 
Therefore, the overall maximum practical uncertainty associated with nine steps included in 
the average step calculation of peak pressure over the whole foot was ±5 percent (instrument 
error) plus ±6.31 percent (measurement error) resulting in ±11.31 percent error. If other 
variables were to be included in the analysis, then at least 14 steps were required to be 
included in the average step calculation to reach the minimum practical uncertainty. 
The variables of peak pressure and pressure time-integral were found 
most useful for ulceration identification from in-shoe plantar pressure 
measurement. 
The archival data set contained 72 variables and which of these variables were most useful in 
investigations of location specific ulceration were unknown. The peak pressure and pressure-
time integral variable measures were found to be the most useful in localised ulceration 
identification. A combination of five variables were found to produce a model that correctly 
identified ulceration locality in 69.6% of subjects with a sensitivity range of 83 to 90% and a 
specificity range of 69 to 87%. The five variables identified were peak pressure on the 1MPJ 
and 2-5MPJ and the pressure-time integral over the whole foot and on the 1MPJ and 2-5MPJ 
regions. 
Sock fabric did not affect in-shoe plantar pressure measures outside of 
measurement limits. Sock seams may pose an injury risk. 
The literature shows that the wearing of socks made from padded fabric can provide 
significant cushioning benefits to the foot via reduction of peak pressures. To determine the 
most suitable sock for standardised use in in-shoe plantar pressure analyses, socks of different 
fabrics and thickness were compared. Once the high variability and accuracy of the peak 
pressure measurements were taken into account, then in opposition to the published literature, 
there were no significant differences found in peak pressures due to sock fabric. Additionally, 
further experimentation revealed that the toe seam associated with the joining of the thick 
fabric to manufacture the sock could pose a significant injury risk to the foot, if trapped 
within a constrictive environment (shoe) due to the creation of a localised region of high 
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pressure. Standard sock selection was therefore, based on removal of the injury risk posed by 
a toe seam and a seamless sock was selected. 
Procedures for in-shoe plantar pressure measurement did not pose an 
injury risk to adults with diabetes. 
The literature anecdotally and repeatedly states that in-shoe plantar pressure measurement 
prior to and for intervention selection could prevent and heal ulceration in people with 
diabetes. However, there was a dearth of acknowledgement of or checking for the safety to 
the foot from the measurement procedures. The standard protocol developed for in-shoe 
plantar pressure analysis of walking for the thesis studies was tested under normal laboratory 
conditions and found not to pose an injury risk to adults with diabetes and was therefore, 
adopted for future study.  
Pressure-time graphs provide more useful information than do 
absolute peak pressure values. 
The peak pressure results were explored beyond the common absolute value method to graph 
their relationship to time. Graphs of peak pressure as it related to percentage-normalised 
stance time were constructed to conform to the presentation and description conventions of 
other gait analysis instruments. The mean and its 95 percent confidence limits were calculated 
firstly using the force, then mean pressure and finally peak pressure results to facilitate 
comparisons with and therefore, cross validation, with the published literature.  
The peak pressure-time graphs were constructed using both the commonly used, but 
inappropriate point-by-point method for calculation of the mean and 95 percent confidence 
limits and compared with the bootstrap method appropriate for use with continuous data. 
These graphs provided far more information especially relevant to showing the pattern of 
pressure related to time on an anatomical region and specific sensors than the absolute value 
results. A change in the pattern rather than a change in the absolute measured value of peak 
pressure over an anatomical region or specific sensor is therefore, anticipated to provide 
clinically useful insight into the aetiology of pressure related injury and ulceration in the 
population of people with diabetes, neuropathy and ulceration. The graphs constructed were 
utilised as baseline patterns against which future studies of diabetic foot complications and 
interventions could be compared. 
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There are tendencies towards different trends in peak pressures 
during walking when neuropathic. 
Significant differences were found in the absolute values measured for pressure-time integral 
on the 1MPJ, 2-5MPJ and heel regions for the population of adults with diabetes when 
walking with neuropathy compared to neuropathy-free. However, these differences were less 
than the uncertainty associated with instrumental and measurement error and are therefore, 
not of routine clinical use.  
The pattern of peak pressure as it relates to stance time during walking with neuropathy was 
established. Although the pattern of peak pressure varied between the two conditions, distinct 
differences were only found in the later 15 percent of stance phase, where neuropathic peak 
pressures were lower than when neuropathy-free. Regionally, the hallux experienced lower, 
while the 1MPJ region experienced higher, peak pressures when neuropathic compared to 
when neuropathy-free. Peak pressure was higher on the heel with neuropathy and 
inconsideration of the other regions, the differences lead to the posturing that neuropathic gait 
may be of a shuffling style. 
There are tendencies towards different trends in peak pressures 
during walking when neuropathic with ulceration on the hallux or the 
1MPJ 
Significant difference was found in the absolute values measured for peak pressure on the 
1MPJ region when the population of adults with diabetes walked with 1MPJ ulceration and 
neuropathy compared to the neuropathy-free population. However, these differences were less 
than the uncertainty associated with instrumental and measurement error and are therefore, 
not of routine clinical use. No distinct differences were found in the results between hallux 
and 1MPJ ulcerations, or between hallux ulcerations and neuropathy-free analyses. 
The pattern of peak pressure as it relates to stance time during walking with hallux and 1MPJ 
ulcerations compared each other and to the neuropathy-free reference data were established 
and the three sub-population results were found to differ. Specifically, when there was 
ulceration on the hallux, then hallux peak pressure pattern was lower than ulceration and 
neuropathy-free, but higher than 1MPJ ulceration results. However, when there was 
ulceration on the 1MPJ, then 1MPJ peak pressure pattern was the same as ulceration and 
neuropathy-free results, but much lower than hallux ulceration results.  
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There are tendencies towards different trends in peak pressures 
during walking when neuropathic with ulceration on the hallux or the 
1MPJ in therapeutic shoes 
Absolute value analyses show that there were no significant differences in peak pressure or 
pressure-time integral per hallux or 1MPJ ulceration between the flexible athletic and the 
therapeutic shoes. However, the differences found on the 2-5MPJ regions on both ulcerations 
suggest that a functional change occurs in ulcerated feet when walking in the different shoes. 
The pattern of peak pressure as it relates to stance time during walking with hallux or 1MPJ 
ulcerations show that the ulceration sites bore higher peak pressures when walking in the 
stiffer therapeutic shoe compared to the flexible athletic shoe. Therefore, prescription of a 
cushioning insole may be required with therapeutic shoes to offset and protect the ulceration 
from the higher pressures experienced on the ulcerations when walking in therapeutic shoes. 
Alternatively, an athletic shoe may have therapeutic benefits and a therapeutic shoe and insole 
may not be necessary. 
There are tendencies towards different trends in peak pressures 
during walking when neuropathic with ulceration on the hallux or the 
1MPJ in therapeutic shoes with rocker-soled shoe modifications 
Absolute value analyses of the population results show that there were no significant 
differences in peak pressure or pressure-time integral per hallux or 1MPJ ulceration when 
walking in any of the rocker-sole shoe modifications compared to the unmodified therapeutic 
shoe. There was not a specific rocker-sole modification design found that could routinely be 
prescribed to this population to protect either hallux or 1MPJ ulceration sites from high peak 
pressures. However, there were distinct differences found for individual subjects and 
assuming that reductions in peak pressures are therapeutic, then with individual in-shoe 
plantar pressure measurement, patients could be prescribed particular shoes and their 
ulceration be protected without limitations being placed on their ability to walk. 
The pattern of peak pressure as it relates to stance time during walking with hallux or 1MPJ 
ulcerations show that pressures are slightly lower on the ulcerations in all rocker-sole shoes 
when compared to the unmodified therapeutic shoe. However, the differences were very 
slight and well within the 95 percent confidence bands, confirming that there was not a 
rocker-sole modification design for effective routine clinical use. 
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Rocker-soled shoe modifications were not found to routinely protect ulceration by the 
lowering of peak pressures as had been assumed from clinical experience-based evidence and 
hypothesised in reports of experimental evidence obtained from ulceration-free and healthy 
populations. Additionally, the contradictory thesis results compared to the experimental 
literature from ulceration-free and healthy populations suggest that either the positive peak 
pressure reduction protective benefit afforded by walking in rocker-soled shoes is lost once 
ulceration is present, or else protection is afforded by another variable. This also raises the 
question to whether there is a change in neuropathic foot function when ulceration is present, 
which negates the effect of the rocker-sole modification. Alternatively, is there a change in 
neuropathic foot function that results in ulceration and is it this change that negates the 
rocker-sole modification effect? It may be likely that the person with diabetes, neuropathy 
and ulceration has developed gait strategies to ensure stability and prevent falling, and that 
these strategies negate the protective influence from the rocker-sole modification. 
Indications for further research 
The methods described in this thesis provide a useful model for future studies of in-shoe 
plantar pressure measurement. Aspects of the thesis results have identified particularly useful 
points for research and these will be outlined as follows. 
Physical and gait tests with in-shoe plantar pressure 
The high variability within the results and the lack of clinically useful and statistically 
significant differences found in peak pressure absolute values and pressure-time graph 
patterns between disease status and therapeutic interventions suggests that there may be other 
physical tests necessary to define the physical population and gait. Particularly useful may be 
the correlation and synchronisation between dynamic kinematic and electromyographic 
studies and in-shoe plantar pressure analysis. Pilot study results from preliminary 
synchronisation studies are being examined. 
Prospective ulceration analysis 
The natural flow on from the thesis is to repeat the rocker-sole shoe studies over time to 
determine whether there is an adaptation in the gait/foot of the subject from the shoe 
intervention. In addition, it would be useful to include video gait analysis methods in 
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combination with further in-shoe pressure measurement studies. These analyses could 
determine whether the subject’s gait was actively propulsive and if the rocker-sole component 
of the shoe was utilised. The time line would need to be short, due to the morbidity, 
amputation and mortality that occurred within the first year following the study for the 
majority of the thesis subjects.  
Prospective in-shoe plantar pressure assessment in ulceration-free 
with neuropathy in newly diagnosed (pre-neuropathic-pre-ulceration) 
The high morbidity and mortality of the subjects as described in the prior point emphasises 
the necessity to determine the usefulness of evaluating in-shoe plantar pressures and 
prescribing effective interventions to subjects that are at high risk of ulceration (neuropathic) 
and newly diagnosed (generally pre-neuropathic) prior to ulceration occurrence.  
Determine the pressure protective efficacy afforded to ulceration from 
commonly prescribed cushioned and functional insoles 
As cushioning and functional modification insoles are routinely prescribed to people with 
diabetes with and without therapeutic modified shoes, then potentially, it may be the pressure 
protective efficacy afforded by the insole that led to the clinical experienced-based evidence 
that supports ulceration management with therapeutic footwear with rocker-soled shoes rather 
than the shoes. Preliminary investigations have been completed and are currently under 
analysis into the pressure protection efficacy afforded to newly diagnosed (pre-neuropathic) 
adults with diabetes. 
Determine the safety of walking for exercise in diabetic population at 
difference stages of disease 
The point where protective footwear becomes paramount is for use when newly diagnosed 
(pre-neuropathic) adults with diabetes walk daily for exercise as part of their self-
management of their obesity and cardiovascular risk factors. Preliminary investigation into 
the stability of pressures measured during a 20 minute walking exercise has been completed 
and is currently under analysis. 
 

Define ‘normal-healthy’ and expand sample size of thesis pressure-
time patterns database 
Definition of any differences in pressure-time graph patterns between disease statuses could 
be clinically useful to guide selection and evaluation of appropriate foot protective 
interventions. The formation of an ideal baseline pressure pattern towards which to aim an 
intervention, would be the healthy adult pattern. Such as pattern, as well as other defined 
disease state patterns, could be integrated into the in-shoe pressure analysis software for 
development of a clinical test, and the standardised protocol produced for this thesis lends 
itself ideally for the establishing a healthy baseline as well as other patterns, including 
potentially dangerous ones. 
Conclusions 
The analyses, experiments and studies presented in this thesis provide a major contribution to 
understanding the usefulness, uncertainties and limits of walking plantar pressures at different 
stages of diabetic foot disease and in different footwear. With reference to the thesis research 
questions, the following conclusions can be made: 
1. When in-shoe plantar pressure measures of walking in the adult with diabetes, 
peripheral neuropathy and ulceration are filtered to confirm for midgait stepping 
validity, they are:  
a. Reliable (ICC(3,1)>0.80) when at least two steps are included in the average step 
calculation of the peak pressure variable, and if all in-shoe pressure variables are to 
be included in an analysis then eight steps are required. 
b. Imprecise and all variables exceeded the minimum criterion of CV<15% (Peak 
pressure over the whole foot CV = 61.10%). 
c. Accurate to ±11.31% (±6.31% measurement + ±5% instrument error) when at least 
nine steps were included in the average step calculation for peak pressure, and  
d. Useful for ulceration identification. A combination of five of the 72 in-shoe plantar 
pressure measurement variables correctly identified the specific location of forefoot 
ulceration in 69.9% of adults with diabetes, peripheral neuropathy and ulceration, 
with a sensitivity range of 83 to 90% and a specificity range of 69 to 87%. 
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2. In-shoe plantar pressure measurement of walking in adults with diabetes: 
a. Was not affected by different sock fabrics beyond the limits of the inherent variability 
of the measurement (Range: 9.4 to 22.2% CV), and  
b. Did not pose any specific foot injury risk from the protocol and procedures developed 
for the thesis. 
3. In-shoe plantar pressure measures of walking in the adult with diabetes, peripheral 
neuropathy and ulceration are not significantly affected by: a) ulceration location, b) 
shoe type or c) rocker-sole shoe modifications. 
Significant differences were not found in peak pressure absolute values between 
hallux and 1MPJ ulcerations. However, significant differences were found between 
the 1MPJ ulceration sub-population and the neuropathy-free population. 
Significant differences were not found in peak pressure absolute values between 
therapeutic shoes compared to athletic shoes when measured on the ulceration site. 
However, significant differences were found between shoes on measures of the 2-
5MPJ region.  
Significant differences were not found in peak pressure absolute values between 
rocker-sole shoe modifications and an unmodified therapeutic shoe. 
 
4. A particular rocker-sole shoe modification design (angle and pivot position) was not 
found that afforded more protection from peak pressures to ulcerations on the plantar 
hallux nor the plantar first metatarsophalangeal joint. 
 
5. Examinations of plots of peak pressures as they relate to percentage-normalised 
stance time provide more clinically useful insight into the pattern of pressures during 
walking than the absolute peak values. Different trends in pressure patterns are useful 
as they can potentially be correlated with likely or measured foot, limb and body 
actions that may describe the effect on walking from disease stage and footwear 
change. Trends towards potential differences were seen in: 
• Walking with neuropathy and ulceration on both the hallux and 
1MPJ compared to the neuropathy-free sub-population. 
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• Walking in the therapeutic compared to the athletic shoes. 
• Walking in the therapeutic shoe compared to the five different 
rocker-sole shoes. 
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Appendices 
Appendix A:  International Protocol Guidelines Plantar Pressure 
Measurement 
Appendix A   
Barnett, S. (1998). International protocol guidelines for plantar pressure measurement. The 
Diabetic Foot, 1(4), 137-140.  
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Appendix B:   Protocol Analysis 
Appendix B   
Citations of reports from in-shoe plantar pressure measurement studies evaluated for the 
protocol analysis. 
 
(Ahroni et al., 1998;  
Albert & Christensen, 1994;  
Albert & Rhinoie, 1994;  
Brown et al., 2004;  
Brown et al., 1996;  
Cavanagh et al., 1998;  
Conti et al., 1996;  
Kernozek et al., 1996;  
Lavery et al., 1995;  
Lavery, Vela, Ashry et al., 1997;  
Lavery, Vela, Fleischli et al., 1997;  
Lavery, Vela, Lavery et al., 1997;  
Lord & Hosein, 1994;  
Mandato & Nester, 1999;  
Martin & Conti, 1996;  
McPoil et al., 1995;  
Mueller, Sinacore et al., 1994;  
Mueller & Strube, 1996;  
Novick et al., 1993;  
Perry et al., 1995;  
Praet & Louwerens, 2003;  
Randolph et al., 2000;  
Redmond et al., 2000;  
Rose et al., 1992;  
Rozema et al., 1996;  
Sarnow et al., 1994;  
Shaw et al., 1997;  
VanZant et al., 2001;  
Woodburn & Helliwell, 1996b)
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Appendix C:   Reliability and Precision 
Appendix C    
The number of steps required to calculate the average step for variables measured over the 
whole foot (Total) to reach acceptable reliability (ICC > 0.80) and their associated reliability 
(ICC alpha) and precision (95% CI range). 
 Anatomical  
region 
Number  
of steps 
Reliability 
ICC alpha 
Precision 
95% CI range 
Area (cm2) 1MPJ 2 0.91 1.03 
 2-5digits 2 0.94 0.85 
 2-5MPJ 2 0.98 0.08 
 Hallux 2 0.96 0.46 
 Heel 2 0.97 0.87 
 Midfoot 2 0.96 2.48 
Force (N) 1MPJ 4 0.86 5.16 
 2-5digits 2 0.93 1.19 
 2-5MPJ 2 0.92 1.29 
 Hallux 2 0.95 0.76 
 Heel 2 0.96 5.23 
 Midfoot 2 0.96 1.73 
Force-Time Integral (N s) 1MPJ 4 0.84 1.30 
 2-5digits 3 0.91 0.59 
 2-5MPJ 3 0.89 4.59 
 Hallux 2 0.93 0.33 
 Heel 2 0.93 1.79 
 Midfoot 2 0.97 1.36 
Loading begin (%) 1MPJ 4 0.86 4.86 
 2-5MPJ 2 0.87 3.81 
 Hallux 3 0.92 8.49 
 Heel 3 0.96 2.37 
 Midfoot 3 0.96 1.36 
 2-5digits 3 0.84 6.96 
Loading end (%) 1MPJ 7 0.86 0.45 
 2-5 digits 2 0.87 1.08 
 Hallux 3 0.94 0.40 
 Heel 2 0.93 1.41 
 Midfoot 3 0.87 7.57 
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 Anatomical  
region 
Number  
of steps 
Reliability 
ICC alpha 
Precision 
95% CI range 
Loading Time (%) 1MPJ 6 0.90 3.65 
 2-5digits 3 0.85 5.74 
 2-5MPJ 2 0.89 3.30 
 Hallux 2 0.89 8.71 
 Heel 2 0.93 1.41 
 Midfoot 2 0.89 6.11 
Loading Time (ms) 1MPJ 2 0.87 81.14 
 2-5digits 3 0.87 27.03 
 2-5MPJ 2 0.95 43.78 
 Hallux 2 0.88 9.92 
 Heel 2 0.95 41.10 
 Midfoot 2 0.90 104.89 
1MPJ 3 0.82 6.27 Pressure Instant of Peak (%) 
2-5digits 2 0.85 4.69 
 2-5MPJ 8 0.84 7.40 
 Hallux 4 0.91 4.87 
 Heel 3 0.89 4.52 
 Midfoot 3 0.86 8.40 
1MPJ 2 0.94 24.16 Pressure Instant of Peak 
(ms) 2-5digits 2 0.92 50.38 
 2-5MPJ 3 0.90 48.94 
 Hallux 2 0.93 77.03 
 Heel 2 0.89 26.63 
 Midfoot 2 0.89 52.08 
1MPJ 3 0.82 22.10 Pressure-Time Integral (kPa 
s) 2-5digits 2 0.95 4.00 
 2-5MPJ 2 0.86 12.10 
 Hallux 2 0.91 10.40 
 Heel 2 0.93 11.50 
 Midfoot 2 0.91 14.40 
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Appendix D:   Limits of measurement accuracy 
Appendix D   
The accuracy results per variable and anatomical regions. The number of repeated steps 
included in the average step calculation was obtained at two points where dA/dS (0.5 and 1.0) 
was considered virtually flat (see Figure 10). Additionally, the minimum number of repeated 
steps required to calculate the average step to be within 5% of that calculated to be likely at 
50 steps was calculated.  
 
dA/dS<1% dA/dS<0.5% dA/dS50-5% Variable 
n=62 
limbs 
Anatomical  
region Steps Accuracy Steps Accuracy Steps  Accuracy 
50 steps 
Accuracy  
1MPJ 5 3.20 6 2.62 4 4.31 1.09 
2-5digits 7 8.48 9 7.27 6 9.52 4.67 
2-5MPJ 4 1.78 5 1.35 3 2.80 0.51 
Hallux 6 4.39 7 3.82 5 5.32 1.88 
Heel 4 1.18 4 1.18 3 2.01 0.27 
Midfoot 7 7.56 9 6.32 6 8.65 3.78 
Area 
(cm2) 
Total foot 5 2.88 6 2.40 3 5.97 1.08 
1MPJ 10 12.22 12 11.00 10 12.22 7.37 
2-5digits 9 13.25 12 11.35 10 12.46 7.98 
2-5MPJ 8 7.77 10 6.70 7 8.63 4.18 
Hallux 9 12.45 12 10.65 9 12.45 7.46 
Heel 7 6.99 9 5.82 6 8.02 3.43 
Midfoot 9 13.93 12 11.86 10 13.06 8.23 
Force (N) 
Total foot 5 3.26 6 2.72 4 4.28 1.22 
1MPJ 10 14.59 13 12.64 11 13.79 8.88 
2-5digits 11 17.52 14 15.67 13 16.17 11.67 
2-5MPJ 9 10.39 11 9.18 9 10.39 5.94 
Hallux 10 16.66 13 14.71 12 15.23 10.81 
Heel 8 11.37 11 9.42 8 11.37 6.37 
Midfoot 10 16.27 13 14.24 12 14.78 10.25 
Force-time 
integral 
(N s) 
Total foot 6 4.92 7 4.31 5 5.92 2.18 
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dA/dS<1% dA/dS<0.5% dA/dS50-5% Variable 
n=62 
limbs 
Anatomical  
region Steps Accuracy Steps Accuracy Steps  Accuracy 
50 steps 
Accuracy  
1MPJ 10 16.45 14 13.85 21 12.00 10.16 
2-5digits 10 16.19 13 14.36 19 12.66 10.68 
2-5MPJ 10 20.63 13 18.82 20 12.31 10.56 
Hallux 10 15.89 13 14.12 19 17.09 15.02 
Loading 
begin (%) 
Midfoot 10 17.29 13 15.47 20 13.60 11.77 
1MPJ 3 0.50 3 0.50 2 1.36 0.08 
2-5 Digits 4 1.79 4 1.79 2 5.14 0.68 
2-5MPJ 2 0.63 3 0.24 2 0.63 0.04 
Hallux 3 1.02 3 1.02 2 2.11 0.26 
Heel 7 7.19 9 6.12 6 8.11 3.86 
Midfoot 5 3.99 7 2.90 4 5.27 1.46 
Loading 
end (%) 
Total foot 2 0.39 3 0.15 2 0.39 0.02 
1MPJ 6 4.69 7 4.07 5 5.74 1.94 
2-5digits 8 9.01 10 7.88 7 9.92 5.12 
2-5MPJ 4 2.77 5 2.15 3 4.22 0.87 
Hallux 8 10.58 10 9.23 8 10.58 5.98 
Heel 7 7.23 9 6.16 6 8.15 3.88 
Midfoot 6 4.44 7 3.92 4 6.83 2.08 
Loading 
time (%) 
Total foot 2 0.40 3 0.15 2 0.40 0.02 
1MPJ 7 6.09 9 5.06 6 7.01 2.96 
2-5digits 8 10.35 11 8.55 8 10.35 5.74 
2-5MPJ 6 4.70 7 4.17 4 7.12 2.26 
Hallux 8 11.23 11 9.30 8 11.23 6.29 
Heel 7 8.17 9 6.95 6 9.23 4.37 
Midfoot 7 5.74 8 5.18 6 6.59 2.82 
Loading 
time (ms) 
Total foot 6 4.77 7 4.23 4 7.24 2.29 
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dA/dS<1% dA/dS<0.5% dA/dS50-5% Variable 
n=62 
limbs 
Anatomical  
region Steps Accuracy Steps Accuracy Steps  Accuracy 
50 steps 
Accuracy  
1MPJ 6 4.62 7 4.03 5 5.59 2.00 
2-5digits 6 5.66 8 4.58 5 6.70 2.69 
2-5MPJ 6 4.39 7 3.75 5 5.45 1.68 
Hallux 6 3.67 7 3.19 4 5.96 1.56 
Heel 10 15.78 12 14.52 11 15.08 10.58 
Midfoot 10 17.98 13 15.90 12 16.45 11.75 
Pressure 
instant of 
peak (%) 
Total foot 9 16.07 12 14.14 10 15.27 10.57 
1MPJ 7 6.16 8 5.61 6 6.97 3.25 
2-5digits 7 6.98 8 6.39 6 7.84 3.82 
2-5MPJ 7 5.94 8 5.36 6 6.81 2.94 
Hallux 7 5.97 8 5.40 6 6.81 3.01 
Heel 10 16.65 13 14.90 11 15.94 11.32 
Midfoot 10 19.05 14 16.43 12 17.48 12.59 
Pressure 
instant of 
peak (ms) 
Total foot 10 16.68 12 15.44 11 15.99 11.51 
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Appendix E:   Peak pressure measures of athletic shoes versus 
therapeutic shoes over percentage-normalised stance phase for the 
hallux ulceration sub-population. 
Appendix E  Graphical results of peak pressures over percentage-normalised stance time from 
the hallux ulceration sub-population per anatomical region for the athletic and therapeutic 
shoes. 
Legend: The means are labelled in the legend and the 95% confidence bands (Bstrap) for the 
rocker-soled shoes are the outer dashed lines and the therapeutic shoes are the outer 
continuous lines. 
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Appendix E: Figure  1.  The means and 95% confidence bands (Bstrap) (the outer lines) for 
peak pressure-1MPJ for the hallux ulceration sub-population per shoe type. 
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Appendix E: Figure  2.  The means and 95% confidence bands (Bstrap) (the outer lines) for 
peak pressure-heel for the hallux ulceration sub-population per shoe type. 
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Appendix F:   Peak pressure measures of therapeutic shoes with 
rocker-sole modifications over percentage-normalised stance phase for 
the hallux ulceration sub-population. 
Appendix F  Graphical results of peak pressures (kPa) over percentage-normalised stance 
time from the hallux ulceration sub-population per anatomical region for the therapeutic shoes 
with and without the rocker-sole modifications. 
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Appendix F: Figure  1.  The means and 95% confidence bands (Bstrap) (the outer dashed 
lines) for peak pressure-1MPJ for the hallux ulceration sub-population per shoe type. 
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Appendix F: Figure  2.  The means and 95% confidence bands (Bstrap) (the outer dashed 
lines) for peak pressure-2-5MPJ for the hallux ulceration sub-population per shoe type. 
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Appendix F: Figure  3.  The means and 95% confidence bands (Bstrap) (the outer dashed 
lines) for peak pressure-heel for the hallux ulceration sub-population per shoe type. 
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Appendix G:   Peak pressure measures of athletic shoes versus 
therapeutic shoes over percentage-normalised stance phase for the 
1MPJ ulceration sub-population. 
Appendix G  Graphical results of peak pressures over percentage-normalised stance time 
from the 1MPJ ulceration sub-population per anatomical region for the athletic and 
therapeutic shoes. 
Legend: The means are labelled in the legend and the 95% confidence bands (Bstrap) for the 
rocker-soled shoes are the outer dashed lines and the therapeutic shoes are the outer 
continuous lines. 
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Appendix G: Figure  1.  The means and 95% confidence bands (Bstrap) (the outer lines) for 
peak pressure-hallux for the 1MPJ ulceration sub-population per shoe type. 
 
 	
0
100
200
300
400
500
0 20 40 60 80
Stance phase %
Pe
ak
 
pr
es
su
re
 
-
 
H
ee
l k
Pa Athletic shoe
Therapeutic shoe
 
Appendix G: Figure  2.  The means and 95% confidence bands (Bstrap) (the outer lines) for 
peak pressure-heel for the 1MPJ ulceration sub-population per shoe type. 
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Appendix H:   Peak pressure measures of therapeutic shoes with 
rocker-sole modification over percentage-normalised stance phase for 
the 1MPJ ulceration sub-population. 
Appendix H  Graphical results of peak pressures over percentage-normalised stance time 
from the 1MPJ ulceration sub-population per anatomical region for the therapeutic and 
rocker-soled shoes. 
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Appendix H: Figure  1.  The means and 95% confidence bands (Bstrap) (the outer dashed 
lines) for peak pressure-hallux for the 1MPJ ulceration sub-population per shoe type. 
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Appendix H: Figure  2.  The means and 95% confidence bands (Bstrap) (the outer dashed 
lines) for peak pressure-2-5MPJ for the 1MPJ ulceration sub-population per shoe type. 
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Appendix H: Figure  3.  The means and 95% confidence bands (Bstrap) (the outer dashed 
lines) for peak pressure-heel for the 1MPJ ulceration sub-population per shoe type. 
 
References  
Abu-Faraj, Z. O., Harris, G. F., Abler, J. H., & Wertsch, J. J. (1997). A Holter-type, 
microprocessor-based, rehabilitation instrument for acquisition and storage of plantar pressure 
data. Journal of Rehabilitation Research and Development, 34(2), 187-194. 
Adler, A. I., Boyko, E. J., Ahroni, J. H., & Smith, D. G. (1999). Lower-extremity amputation in 
diabetes:  The independent effects of peripheral vascular disease, sensory neuropathy, and foot 
ulcers. Diabetes Care, 22(Number 7), 1029-1035. 
Adler, A. I., Boyko, E. J., Ahroni, J. H., Stensel, V., Forsberg, R. C., & Smith, D. G. (1997). Risk 
factors for diabetic peripheral sensory neuropathy:  Results of the Seattle prospective diabetic foot 
study. Diabetes Care, 20(Number 7), 1162-1167. 
Ahroni, J. H., Boyko, E. J., & Forsberg, R. C. (1998). Reliability of F-Scan in-shoe measurements 
of plantar pressure. Foot & Ankle International, 19(10), 668-673. 
Albert, S. (1981). A subjective comparison of Spenco and R.P.T. soft tissue supplements used in 
footgear. Orthotics and Prosthetics, 35(3), 17-21. 
Albert, S. F., & Christensen, L. C. (1994). Diabetic foot pressure studies-comparison study of 
patient-selected shoes versus clinician-selected shoes. The Lower Extremity, 1(1), 21-27. 
Albert, S. F., & Rhinoie, C. (1994). Effect of custom orthotics on plantar pressure distribution in 
the pronated diabetic foot. Journal of Foot and Ankle Surgery, 33(6), 598-604. 
Alexander, I. J., Chao, E. Y. S., & Johnson, K. A. (1990). The assessment of dynamic foot-to 
ground contact forces and plantar pressure distribution:  A review of the evolution of current 
techniques and clinical applications. American Orthopaedic Foot and Ankle Society, 11(3), 152-
167. 
American Diabetes Association. (1997a). Diabetes Mellitus and exercise. Diabetes Care, 20(S 1), 
S51. 
American Diabetes Association. (1997b). Foot care in patients with Diabetes Mellitus. Diabetes 
Care, 20 S 1, S31-S32. 
American Diabetes Association. (1997c). Screening for Diabetes. Diabetes Care, 20(S 1), S22-
S23. 
American Diabetes Association. (1999). Preventative foot care in people with diabetes. Diabetes 
Care, 22(S1). 
American Diabetes Association. (2002). Standards of medical care for patients with Diabetes 
Mellitus. Diabetes Care, 25, 213-229. 
Amos, A. F., McCarty, D. J., & Zimmet, P. Z. (1997). The rising global burden of diabetes and its 
complications: Estimates and projections to the year 2010 - Section 1. Diabetes Medicine, 14, S7-
S85. 
Arcan, M., & Brull, M. A. (1976). A fundamental characteristic of the human body and foot, the 
foot-ground pressure pattern. Biomechanics, 9, 453-457. 
 
Armstrong, D. G., & Athanasiou, K. A. (1998). The edge effect:  How and why wounds grow in 
size and depth. Clinics in Podiatric Medicine and Surgery, 15(Number 1), 105-108. 
Armstrong, D. G., Hussain, S. K., Middleton, J., Peters, E. J., Wunderlich, R. P., & Lavery, L. A. 
(1998). Vibration perception threshold: Are multiple sites of testing superior to single site testing 
on diabetic foot examination? Ostomy Wound Management, 44(5), 70-74, 76. 
Armstrong, D. G., & Lavery, L. A. (1998). Evidence-based options for off-loading diabetic foot 
wounds. Healing The Diabetic Wound, 15(Number 1), 95-104. 
Armstrong, D. G., Lavery, L. A., & Harkless, L. B. (1998). Validation of a diabetic wound 
classification system. Diabetes Care, 21(5), 855-859. 
Armstrong, D. G., Lavery, L. A., Vela, S. A., Quebedeaux, T. L., & Fleischli, J. G. (1998). 
Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. 
Archives of Internal Medicine, 158, 289-292. 
Armstrong, D. G., Liswood, P. L., & Todd, W. F. (1995). Potential risks of accommodative 
padding of neuropathic ulcerations. Ostomy Wound Management, 41(7), 44-49. 
Armstrong, D. G., Peters, E. J. G., Athanasiou, K. A., & Lavery, L. A. (1998). Is there a critical 
level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? Journal of 
Foot and Ankle Surgery, 37(4), 303-307. 
Armstrong, D. G., & Stacpoole-Shea, S. J. (1999). Total contact casts and removable cast 
walkers:  Mitigation of plantar heel pressure. Journal of the American Podiatric Medical 
Association, 89(Number 1), 48-53. 
Ashry, H. R., Lavery, L. A., Murdoch, D. P., Frolich, M., & Lavery, D. C. (1997). Effectiveness 
of diabetic insoles to reduce foot pressures. Journal of Foot and Ankle Surgery, 36(4), 268-271. 
Barnett, S. (1998). International protocol guidelines for plantar pressure measurement. The 
Diabetic Foot, 1(4), 137-140. 
Barrett, J. P., & Mooney, V. (1973). Neuropathy and diabetic pressure lesions. Orthopedic Clinics 
of North America, 4, 43. 
Barrnett, C. H. (1954). A plastic pedobarograph. Lancet, 2, 273. 
Bartlett, G., Stewart, J. D., Tamblyn, R., & Abrahamowicz, M. (1998). Normal distributions of 
thermal and vibration sensory thresholds. Muscle and Nerve, 21(3), 367-374. 
Bauman, J. H., Girling, J. P., & Brand, P. W. (1963). Plantar pressures and trophic ulceration - An 
evaluation of footwear. Journal of Bone and Joint Surgery, 45B(4), 652-673. 
Bauman, W., Krabbe, B., & Farkas, R. (1992). The application of in-shoe pressure distribution 
measurements in the controlled therapy of diabetes patients. VDI Berichte, 940, 413-419. 
Baumhauer, J. F., Wervey, R., McWilliams, J., Harris, G. F., & Shereff, M. J. (1997). A 
comparison study of plantar foot pressure in a standardized shoe, total contact cast, and 
prefabricated pneumatic walking brace. Foot & Ankle International, 18(1), 26-33. 
Beckman, J. A., Creager, M. A., & Libby, P. (2002). Diabetes and atherosclerosis: Epidemiology, 
pathophysiology, and management. Journal of the American Medical Association, 287(19), 2570-
2581. 
 	
Benbow, S. J., Chan, A. W., Bowsher, D. R., Williams, G., & Macfarlane, I. A. (1994). The 
prediction of diabetic neuropathic plantar foot ulceration by liquid crystal contact thermography. 
Diabetes Care, 17(8), 835-839. 
Bennett, P. J., Miskewitch, V., & Duplock, L. R. (1996). Quantitative analysis of the effects of 
custom-moulded orthoses. Journal of the American Podiatric Medical Association, 86(7), 307-
310. 
Besser, M. P., Kmieczak, K., Schwartz, L., Snyderman, M., Wasko, J., & Selby-Silverstein, L. 
(1999). Representation of temporal spatial gait parameters using means in adults without 
impairment. Paper presented at the Fourth annual meeting of the North American Society of Gait 
and Clinical Movement Analysis, Dallas, Texas, USA. 
Bild, D. E., Shelby, J. V., Sinnock, P., Browner, W. S., Braveman, P., & Showstock, J. A. (1989). 
Lower extremity amputations in people with diabetes: epidemiology and prevention. Diabetes 
Care, 12, 24-29. 
Birke, J. A., Cornwall, M. W., & Jackson, M. (1988). Relationship between hallux limitus and 
ulceration of the great toe. The Journal of Orthopaedic and Sports Physical Therapy, 10(11), 172-
176. 
Birke, J. A., Franks, D., & Foto, J. G. (1995). First ray joint limitation, pressure, and ulceration of 
the first metatarsal head in diabetes mellitus. Foot Ankle, 16(5), 277-284. 
Birke, J. A., & Sims, D. S. (1986). Plantar sensory threshold in the ulcerative foot. Leprosy 
Review, 57, 261-267. 
Bisquay, H., Freulon, X., de Fouquet, C., & Lajaunie, C. (1999). Multibeam data cleaning using 
geostatistics. Sea Technology, September, 43-51. 
Black, S. A. (2002). Diabetes, diversity, and disparity: What do we do with the evidence? 
American Journal of Public Health, 92(4), 543-548. 
Bloom, S., Till, S., Sönsken, P., & Smith, S. (1984). Use of a biothesiometer to measure 
individual vibration thresholds and their variation in 519 non-diabetic subjects. British Medical 
Journal, 288, 1793-1795. 
Boulton, A. J. M. (1990). The diabetic foot: neuropathic in aetiology? Diabetic Medicine, 6, 852-
858. 
Boulton, A. J. M. (1991). Diabetic neuropathy. In R. Frykberg (Ed.), The high risk foot in diabetes 
mellitus (1st ed., pp. 50-65). New York: Churchill Livingstone. 
Boulton, A. J. M. (1992). Peripheral neuropathy and the diabetic foot. The Foot, 2, 67-72. 
Boulton, A. J. M. (1996). The pathogenesis of diabetic foot problems:  an overview. Diabetic 
Medicine, 13(S1), S12-S16. 
Boulton, A. J. M., Betts, R. P., Franks, C. I., Newrick, P. G., Ward, J. D., & Duckworth, T. 
(1987). Abnormalities of foot pressure in early diabetic neuropathy. Diabetic Medicine, 4, 225-
228. 
Boulton, A. J. M., Bowker, J. H., Gadia, M., Lemerman, R., Caswell, K., Skyler, J. S., et al. 
(1986). Use of plaster casts in the management of diabetic neuropathic foot ulcers. Diabetes Care, 
9(2), 149-152. 
 	
Boulton, A. J. M., Franks, C. I., Betts, R. P., Duckworth, T., & Jard, J. D. (1984). Reduction of 
abnormal foot pressures in diabetic neuropathy using a new polymer insole material. Diabetes 
Care, 7(1), 42-46. 
Boulton, A. J. M., Kubrusly, D. B., Bowker, J. H., Gadia, M. T., Quintero, D. M., Becker, D. M., 
et al. (1986). Impaired vibratory perception and diabetic foot ulceration. Diabetic Medicine, 3, 
335-337. 
Brand, P. W., & Yancey, P. (1993). Pain: The Gift That Nobody Wants. New York: Harper 
Collins Publishers Inc. 
Brandsma, J. W., Robeer, B. G., van den Heuvel, S., Smit, B., Wittens, C. H. A., & Oostendorp, 
R. A. B. (1998). The effect of exercises on walking distance of patients with intermittent 
claudication:  A study of randomized clinical trials. Physical Therapy, 78(3), 278-288. 
Brodsky, J. W., Kourosh, S., Stills, M., & Mooney, V. (1988). Objective evaluation of insert 
material for diabetic and athletic footwear. Foot and Ankle, 9(3), 111-116. 
Brown, D., Wertsch, J. J., Harris, G. F., Klein, J., & Janisse, D. J. (2004). Effect of rocker soles on 
plantar pressures. Archives of Physical Medicine and Rehabilitation, 85, 81-86. 
Brown, M., Rudicel, S., & Esquenazi, A. (1996). Measurement of dynamic pressures at the shoe-
foot interface during normal walking with various foot orthoses using the F-scan system. Foot & 
Ankle International, 17(3), 152-156. 
Burns, S. L., Leese, G. P., & McMurdo, M. E. T. (2002). Older people and ill fitting shoes. 
Postgraduate Medical Journal, 78, 344-346. 
Caro, J. J., Ward, A. J., & O'Brien, J. A. (2002). Lifetime costs of complications resulting from 
type 2 diabetes in the U.S. Diabetes Care, 25(3), 476-481. 
Caselli, A., Pham, H., Giurini, J. M., Armstrong, D. G., & Veves, A. (2002). The forefoot-to-
rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict 
ulceration. Diabetes Care, 25(6), 1066-1071. 
Cavanagh, P. R., Hewitt, F. G. J., & Perry, J. E. (1992). In-shoe plantar pressure measurement:  a 
review. The Foot, 2, 185-194. 
Cavanagh, P. R., Perry, J. E., Ulbrecht, J. S., Derr, J. S., & Pammer, S. E. (1998). Neuropathic 
diabetic patients do not have reduced variability of plantar loading during gait. Gait and Posture, 
7(3), 191-199. 
Cavanagh, P. R., Rodgers, M. M., & Iiboshi, A. (1987). Pressure distribution under symptom-free 
feet during barefoot standing. Foot & Ankle International, 7(5), 262-276. 
Cavanagh, P. R., Simoneau, G. G., & Ulbrecht, J. S. (1993). Ulceration, unsteadiness, and 
uncertainty:  The biomechanical consequences of Diabetes Mellitus. Journal of Biomechanics, 
26(1), 23-40. 
Cavanagh, P. R., Sims, D. S. J., & Sanders, L. J. (1991). Body mass is a poor predictor of peak 
plantar pressure in diabetic men. Diabetes Care, 14(8), 750-755. 
Cavanagh, P. R., Ulbrecht, J. S., & Caputo, G. S. (2001). The biomechanics of the foot in diabetes 
mellitus. In J. H. Bowker & M. A. Pfeifer (Eds.), Levin and O'Neal's The Diabetic Foot (6th. ed., 
pp. 125-196). St. Louis: Mosby Inc. 
 	
Cavanagh, P. R., Ulbrecht, J. S., Caputo, G. S., & Lemmon, D. (1996). Gait analysis and 
prescription Diabetic footwear:  Is there a marriage on the horizon? Biomechanics, III(2), 1-3. 
Chantelau, E., & Gede, A. (2002). Foot dimensions of elderly people with and without diabetes 
mellitus - a data basis for shoe design. Gerontology, 48, 241-244. 
Chantelau, E., Kushner, T., & Spraul, M. (1990). How effective is cushioned therapeutic footwear 
in protecting diabetic feet? A clinical study. Diabetic Medicine, 7(4), 335-339. 
Coleman, W., Brand, P. W., & Birke, J. A. (1984). The total contact cast, a therapy for plantar 
ulceration on insensitive feet. Journal of the American Podiatric Medical Association, 74, 548-
552. 
Coleman, W. C. (1987). Shoe gear for the insensitive foot. The Diabetic Foot, 4(2), 459-470. 
Coleman, W. C. (2001). Footwear for injury prevention: Correlation with risk category. In J. H. 
Bowker & M. A. Pfeifer (Eds.), Levin and O'Neal's The Diabetic Foot (6th ed., pp. 422-438). 
St.Louis: Mosby Inc. 
Conti, S. F., Martin, R. l., Chaytor, E. R., Hughes, C., & Luttrel, L. (1996). Plantar pressure 
measurements during ambulation in weightbearing conventional short leg casts and total contact 
casts. Foot & Ankle International, 17(8), 464-469. 
Courtemache, R., Teasdale, N., Boucher, P., Fleury, M., Lajoie, Y., & Bard, C. (1996). Gait 
problems in diabetic neuropathic patients. Archives of Physical Medicine and Rehabilitation, 
77(9), 849-855. 
Craik, R. L., & Dutterer, L. (1995). Spatial and temporal characteristics of foot fall patterns. In R. 
L. Craik & C. A. Oatis (Eds.), Gait analysis theory and application (pp. 143-158). St. Louis: 
Mosby. 
Cross, H., Sane, S., Dey, A., & Kulkarni, V. N. (1995). The efficacy of podiatric orthoses as an 
adjunct to the treatment of plantar ulceration in leprosy. Leprosy Review, 66, 144-157. 
Ctercteko, G. C., Dhanendran, M., Hutton, W. C., & LeQuesne, L. P. (1981). Vertical forces 
acting on the feet of diabetic patients with neuropathic ulceration. British Journal of Surgery., 68, 
608-614. 
Dahmen, R., Haspels, R., Koomen, B., & Hoeksma, A. F. (2001). Therapeutic footwear for the 
neuropathic foot. An algorithm. Diabetes Care, 24(4), 705-709. 
Dananberg, H. J., Phillips, A. J., & Blaakman, H. E. (1996). A rational approach to the 
nonsurgical treatment of hallux limitus. Advances in Podiatric Medicine and Surgery, 2, 67-86. 
Davis, B. L. (1993). Foot ulceration:  Hypotheses concerning shear and vertical forces acting on 
adjacent regions of skin. Medical Hypotheses, 40, 44-47. 
Davis, B. L., Perry, J. E., Neth, D. C., & Walters, K. C. (1998). A device for simultaneous 
measurement of pressure and shear force distribution of the plantar surface of the foot. Journal of 
Applied Biomechanics, 14, 93-104. 
Davison, A. C., & Hinkley, D. V. (1997). Complex Dependence. In Bootstrap methods and their 
application (pp. 385-428). Cambridge: Cambridge University Press. 
 	
DHAC, & AIHW. (1999). National health priority areas report: diabetes mellitus 1998 (No. 
AIHW Cat. No. PHW 10). Canberra:http://www.aihw.gov.au/publications/cvd/daf02/index.html: 
Commonwealth Department of Health and Aged Care & Australian Institute of Health and 
Welfare. 
Dobinson, J. (1969). Further diffentiation. In Mathematics for technology:2 (pp. 92-96). 
Harmondsworth: Penguin Education. 
Dorland, W. A. N. (2003). Dorland's illustrated medical dictionary (30 ed.). Philadelphia: 
Saunders. 
Duckworth, T., Betts, R. P., Franks, C. I., & Burke, J. (1982). The measurement of pressures 
under the foot. Foot & Ankle, 3(3), 130-141. 
Duckworth, T., Boulton, A. J. M., Betts, R. P., Franks, C. I., & Ward, J. D. (1985). Plantar 
pressure measurements and the prevention of ulceration in the diabetic foot. The Journal of Bone 
and Joint Surgery, 67-B(1), 79-85. 
Dunstan, D. W., Zimmet, P. Z., Welborn, T. A., De Courten, M. P., Cameron, A. J., Sicree, R. A., 
et al. (2002). The raising prevalence of diabetes and impaired glucose tolerance. Diabetes Care, 
25(5), 829-834. 
Dyck, J. B., & Dyck, P. J. (1999). Diabetic Polyneuropathy. In P. J. Dyck & P. K. Thomas (Eds.), 
Diabetic Neuropathy (2nd ed., pp. 255-278). Philedelphia: W. B. Saunders. 
Edmonds, M. E., Blundell, M. P., Morns, M. E., Thomas, E. M., Cotton, L. T., & Watkins, P. J. 
(1986). Improved survival of the diabetic foot: The role of a specialized foot clinic. Quarterly 
Journal of Medicine, 60, 763-771. 
Edmonds, M. E., & Watkins, P. J. (1999). Plantar neuropathic ulcer and charcot joints: Risk 
factors, presentation, and management. In P. J. Dyck & P. K. Thomas (Eds.), Diabetic 
Neuropathy (2nd ed., pp. 398-406). Philadelphia: W. B. Saunders Company. 
Efron, B., & Tibshirani, R. (1993). Better bootstrap confidence intervals. In An introduction to the 
bootstrap (pp. 178-201). New York: Chapman & Hall. 
Elftman, H. (1934). A cinematic study of the distribution of pressure in the human foot. 
Anatomical Records, 59, 481. 
Eliasziw, M., Young, S. L., Woodbury, M. G., & Fryday-Field, K. (1994). Statistical 
methodology for the concurrent assessment of inter-rater and intra-rater reliability: Using 
goniometric measurements as an example. Physical Therapy, 74(8), 777-788. 
Finch, P. M. (1999). Technology in biomedicine: the EMED pedar pressure measurement system. 
The Foot, 9, 1-5. 
Flot, S., Hill, V., Yamada, W., McPoil, T. G., & Cornwall, M. W. (1995). The effect of padded 
hosiery in reducing forefoot plantar pressures. The Lower Extremity, 2(3), 201-205. 
Foto, J. G., & Birke, J. A. (1998). Evaluation of multidensity orthotic materials used in footwear 
for patients with diabetes. Foot & Ankle International, 19(12), 836-841. 
Franks, C. I., Betts, R. P., & Duckworth, T. (1983). A microprocessor-based image processing 
system for dynamic foot pressure studies. Medical Biological Engineering and Computing, 21, 
566. 
 	
Fuller, E. (1994). A review of the biomechanics of shoes. Clinics in Podiatric Medicine and 
Surgery, 11(2), 241-258. 
Fuller, E., Schroeder, S., & Edwards, J. (2001). Reduction of peak pressure on the forefoot with a 
rigid rocker-bottom postoperative shoe. Journal of the American Podiatric Medical Association, 
91(10), 501-507. 
Glatthaar, C., Welborn, T. A., Stenhouse, N. S., & Garcia-Webb, P. (1985). Diabetes and 
impaired glucose tolerance: a prevalence estimate based on the Busselton 1981 survey. Medical 
Journal of Australia, 143, 436-440. 
Graf, P. M. (1993). The Emed system of foot pressure analysis. Clinics in Podiatric Medicine and 
Surgery, 10(3), 445-454. 
Grant, I. A., O'Brien, P., & Dyck, P. J. (1999). Neuropathy tests and normative results. In P. J. 
Dyck & P. K. Thomas (Eds.), Diabetic neuropathy (2nd ed.). Philadelphia: W. B. Saunders 
Company. 
Guzman, B., Fisher, G., Palladino, S. J., & Stavosky, J. W. (1994). Pressure-removing strategies 
in neuropathic ulcer therapy - An alternative to total contact casting. Clinics in Podiatric Medicine 
and Surgery, 11(2), 339-353. 
Hauser, C. J., Klein, S. R., Mehringer, C. M., Appel, P., & Shoemaker, W. C. (1984). Assessment 
of perfusion in the diabetic foot by regional transcutaneous oximetry. Diabetes, 33(June), 527-
531. 
Helm, P. A., Walker, S. C., & Pulliam, G. (1984). Total contact casting in diabetic patients with 
neuropathic foot ulcerations. Archives of Physical Medicine and Rehabilitation, 65, 691-693. 
Holmes, G. B., & Timmerman, L. (1990). A quantitative assessment of the effect of metatarsal 
pads on plantar pressures. Foot and Ankle, 11(3), 141-145. 
Holstein, P., Larsen, K., & Sager, P. (1976). Decompression with the aid of insoles in the 
treatment of diabetic neuropathic ulcers. Acta Orthopaedica Scandinavia, 47(463-468). 
Hughes, J. (1993). The clinical use of pedobarography. Acta Orthopaedica Belgica, 59(1), 10-16. 
Hughes, J., Pratt, L., Linge, K., Clark, P., & Klenerman, L. (1991). Reliability of pressure 
measurements:  the EMED F system. Clinical Biomechanics, 6, 14-18. 
Janisse, D. J. (1995). Prescription insoles and footwear. The Diabetic Foot, 12(1), 41-61. 
Katoulis, E. C., Boulton, A. J. M., & Raptis, S. A. (1996). The role of diabetic neuropathy and 
high plantar pressures in the pathogenesis of foot ulceration. Hormonal and Metabolic Research, 
28, 159-164. 
Kernozek, T. W., LaMott, E. E., & Dancisak, M. J. (1996). Reliability of an in-shoe pressure 
measurement system during treadmill walking. Foot & Ankle International, 17(4), 204-209. 
Kominsky, S. J. (1991). The ambulatory total contact cast. In R. Frykberg (Ed.), The high risk foot 
in diabetes mellitus (1 ed., pp. 449-455). New York: Churchill Livingstone. 
 		
Kumar, S., Fernando, D. J. S., Veves, A., Knowles, E. A., Young, M. J., & Boulton, A. J. M. 
(1991). Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device 
for identifying diabetic patients at risk of foot ulceration. Diabetes Research and Clinical 
Practice, 13, 63-68. 
Lake, M. J. (2000). Determining the protective function of sports footwear. Ergonomics, 43(10), 
1610-1621. 
Landsman, A. S., Meaney, D. F., Cargill, R. S., Macarak, E. J., & Thibault, L. E. (1995). High 
strain rate tissue deformation - A theory on the mechanical etiology of diabetic foot ulceration. 
Journal of the American Podiatric Medical Association, 85(10), 519-527. 
Lavery, L. A., Armstrong, D. G., & Harkless, L. B. (1996). Classification of diabetic foot wounds. 
Journal of Foot and Ankle Surgery, 35(6), 528-531. 
Lavery, L. A., Lavery, D. C., & Quebedeax-Farnham, T. L. (1995). Increased foot pressures after 
great toe amputation in diabetes. Diabetes Care, 18(11), 1460-1462. 
Lavery, L. A., Vela, S. A., Ashry, H. R., Lanctot, D. R., & Athanasiou, K. A. (1997). Novel 
methodology to obtain salient biomechanical characteristics of insole materials. Journal of the 
American Podiatric Medical Association, 87(6), 266-271. 
Lavery, L. A., Vela, S. A., Fleischli, J. G., Armstrong, D. G., & Lavery, D. C. (1997). Reducing 
plantar pressure in the neuropathic foot - A comparison of footwear. Diabetes Care, 20(11), 1706-
1710. 
Lavery, L. A., Vela, S. A., Lavery, D. C., & Quebedeaux, T. L. (1997). Total contact casts:  
Pressure reduction at ulcer sites and the effect on the contralateral foot. Archives of Physical 
Medicine and Rehabilitation, 78(November), 1268-1271. 
Lemmon, D., Shiang, T. Y., Hashmi, A., Ulbrecht, J. S., & Cavanagh, P. R. (1997). The effect of 
insoles in therapeutic footwear - A finite element approach. Journal of Biomechanics, 30(6), 615-
620. 
Lenoff, M. W., Santner, T. J., Otis, J. C., Peterson, M. J., Williams, B. J., & Backus, S. I. (1999). 
Bootstrap prediction and confidence bands: a superior statistical method for analysis of gait data. 
Gait and Posture, 9, 10-17. 
Levin, M. E. (1983). Medical Evaluation and Treatment. In M. E. Levin & L. W. O'Neal (Eds.), 
The Diabetic Foot (3rd ed.). St.Louis: C V Mosby Company. 
Linge, K. (1996). A preliminary objective evaluation of leprosy footwear using in-shoe pressure 
measurement. Acta Orthopaedica Belgica, 62(1), 18-22. 
Litzelman, D. K., Marriott, D. J., & Vinicor, F. (1997). The role of footwear in the prevention of 
foot lesions in patients with NIDDM. Diabetes Care, 20(2), 156-162. 
Lodewick, P. A. (1993). Risk of foot ulceration in diabetic patients with high foot pressure. 
Clinical Diabetes, 118. 
Lord, M., & Hosein, R. (1994). Pressure redistribution by molded inserts in diabetic footwear: A 
pilot study. Journal of Rehabilitation Research and Development, 31(3), 214-221. 
Luo, Z., Berglund, L. J., & An, K. (1998). Validation of F-scan pressure sensor system:  A 
technical note. Journal of Rehabilitation Research and Development, 35(2), 186-191. 
 	

Maluf, K. S., & Mueller, M. J. (2003). Comparison of physical activity and cumulative plantar 
tissue stress among subjects with and without diabetes mellitus and a history of recurrent plantar 
ulcers. Clinical Biomechanics, 18, 567-575. 
Mandato, M. G., & Nester, E. (1999). The effects of increasing heel height on forefoot peak 
pressure. Journal of the American Podiatric Medical Association, 89(2), 75-80. 
Martin, R. L., & Conti, S. F. (1996). Plantar pressure analysis of diabetic rockerbottom deformity 
in total contact casts. Foot & Ankle International, 17(8), 470-472. 
McAllister, D. F., Carver, D., Devarajan, R., Harrison, L., Pietenpol, J. L., & Yang, S.-h. (1991). 
An interactive computer graphics system for the design of molded and orthopedic shoe lasts. 
Journal of Rehabilitation Research and Development, 28(4), 39-46. 
McPoil, T. G., & Cornwall, M. W. (1992). Effect of insole material on force and plantar pressures 
during walking. Journal of the American Podiatric Medical Association, 82(8), 412-416. 
McPoil, T. G., & Cornwall, M. W. (1998). Variability of the center of pressure pattern integral 
during walking. Journal of the American Podiatric Medical Association, 88(6), 259-267. 
McPoil, T. G., Cornwall, M. W., Dupuis, L., & Cornwell, M. (1999). Variability of plantar 
pressure data - A comparison of the two-step and midgait methods. Journal of the American 
Podiatric Medical Association, 89(10), 495-501. 
McPoil, T. G., Cornwall, M. W., & Yamada, W. (1995). A comparison of two in shoe plantar 
pressure measurement systems. Lower Extremity, 2(2), 95-103. 
Menz, H. B., Lord, S. R., Fitzpatrick, R. C., & St George, R. (In Press). Walking stability in older 
people with diabetic peripheral neuropathy. Archives of Physical Medicine and Rehabilitation. 
Meyers-Rice, B., Sugars, L., McPoil, T., & Cornwall, M. W. (1994). Comparison of three 
methods for obtaining plantar pressures in nonpathologic subjects. Journal of the American 
Podiatric Medical Association, 84(10), 499-504. 
Miller, O. F. (1993). Essentials of pressure ulcer treatment - The diabetic experience. Journal of 
Dermatology, Surgery and Oncology, 19, 759-763. 
Mueller, M. J., Minor, S. D., Sahrmann, S. A., Schaaf, J. A., & Strube, M. J. (1994). Differences 
in the gait characteristics of patients with diabetes and peripheral neuropathy compared with age-
matched controls. Physical Therapy, 74(4), 299-308. 
Mueller, M. J., Sinacore, D. R., Hoogstrate, S., & Daly, L. (1994). Hip and ankle walking 
strategies:  Effect on peak plantar pressures and implications for neuropathic ulceration. Archives 
of Physical Medicine and Rehabilitation, 75, 1196-1200. 
Mueller, M. J., & Strube, M. J. (1996). Generalizability of in-shoe peak pressure measures using 
the F-scan system. Clinical Biomechanics, 11(3), 159-164. 
Mueller, M. J., Strube, M. J., & Allen, B. T. (1997). Therapeutic footwear can reduce plantar 
pressures in patients with diabetes and transmetatarsal amputation. Diabetes Care, 20(4), 637-
641. 
Murray, H. J., Veves, A., Young, M. J., Richie, D. H., & Boulton, A. J. M. (1993). Role of 
experimental socks in the care of the high-risk diabetic foot. Diabetes Care, 16(8), 1190-1192. 
 	
Murray, H. J., Young, M. J., Hollis, S., & Boulton, A. J. M. (1996). The association between 
callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabetic Medicine, 
13(11), 979-982. 
Nawoczenski, D. A., Birke, J. A., & Coleman, W. C. (1988). Effect of rocker sole design on 
plantar forefoot pressures. Journal of the American Podiatric Medical Association, 78(9), 455-
460. 
Novel Electronics Incorporated. (1998a). Novel-win scientific analysis software (Version 0.98). 
St. Paul: Novelgmbh, Germany. 
Novel Electronics Incorporated. (1998b). Pedar mobile expert manual (Version 11c97). St Paul: 
Novelgmbh, Germany. 
Novick, A., Birke, J. A., Hoard, A. S., Brasseaux, D. M., Broussard, J. B., & Hawkins, E. S. 
(1991). Rigid orthoses for the insensitive foot: the rigid relief orthosis. Journal of Prosthetics and 
Orthotics, 4(1), 31-40. 
Novick, A., Stone, J., Birke, J., A., Brasseaux, D. M., Broussard, J. B., Hoard, A. S., et al. (1993). 
Reduction of plantar pressure with the rigid relief orthosis. Journal of the American Podiatric 
Medical Association, 83(3), 115-122. 
Ousman, Y., & Sharma, M. (2001). The irrefutable importance of glycemic control. Clinical 
Diabetes, 19(2), 71-72. 
Payne, C. B. (1997). The epidemiology of diabetic foot admissions to hospital. Unpublished PhD, 
University of Otago, Otago. 
Payne, C. B. (2000a). Diabetes Mellitus and the foot. Melbourne: Latrobe University Press. 
Payne, C. B. (2000b). Diabetes-related lower-limb amputations in Australia. Medical Journal of 
Australia, 173, 352-354. 
Payne, C. B., & Dananberg, H. J. (1997). Sagittal plane facilitation of the foot. Journal of the 
American Podiatric Medical Association, 31(1), 7-11. 
Pederson, D. G., & Gore, C. J. (1994). Anthropometry measurement error. In K. I. Norton & T. 
Olds (Eds.), Anthrometry and antropometric profiling (pp. 33-47). Sydney: Nolds Sport 
Scientific. 
Perry, J. E., Hall, J. O., & Davis, B. L. (2002). Simultaneous measurement of plantar pressure and 
shear forces in diabetic individuals. Gait and Posture, 15(1), 101-107. 
Perry, J. E., Ulbrecht, J. S., Derr, J. A., & Cavanagh, P. R. (1995). The use of running shoes to 
reduce plantar pressures in patients who have Diabetes. The Journal of Bone and Joint Surgery, 
77-A(12), 1819-1828. 
Peterson, M. J., Perry, J., & Montgomery, J. (1985). Walking patterns of healthy subjects wearing 
rocker shoes. Physical Therapy, 65(10), 1483-1489. 
Portney, L. G., & Watkins, M. P. (1993). Foundations of Clinical Research Applications to 
Practice. Connecticut: Appleton & Lange. 
Potter, J., & Potter, M. J. (2000). Effect of callus removal on peak plantar pressures. The Foot, 10, 
23-26. 
 	
Praet, S. F. E., & Louwerens, J.-W. K. (2003). The influence of shoe design on plantar pressures 
in neuropathic feet. Diabetes Care, 26(2), 441-445. 
Quaney, B., Meyer, K., Cornwall, M. W., & McPoil, T. G. (1995). A comparison of the dynamic 
pedobarograph and EMED systems for measuring dynamic foot pressures. Foot & Ankle 
International, 16(9), 562-566. 
Quesada, P. M., & Rash, G. S. (2000). Quantitative assessment of simultaneous capacitive and 
resistive plantar pressure measurements during walking. Foot & Ankle International, 21(11), 928-
934. 
Randolph, A. L., Nelson, M., Akkapeddi, S., & Levin, A. (2000). Reliability of measurements of 
pressures applied on the foot during walking by a computerized insole sensor system. Archives of 
Physical Medicine and Rehabilitation, 81(May), 572-578. 
Redmond, A., Lumb, P. S. B., & Landorf, K. (2000). Effect of cast and noncast foot orthoses on 
plantar pressure and force during normal gait. Journal of the American Podiatric Medical 
Association, 90(9), 441-449. 
Reiber, G. E. (1994). Who is at risk of limb loss and what to do about it? Journal of 
Rehabilitation Research and Development, 31, 357-362. 
Reiber, G. E. (1996). The Epidemiology of Diabetic Foot Problems. Diabetic Medicine, 13(S1), 
S6-S11. 
Reiber, G. E. (2001). Epidemiology of foot ulcers and amputations in the diabetic foot. In J. H. 
Bowker & M. A. Pfeifer (Eds.), Levin and O'Neal's The Diabetic Foot (6th ed., pp. 13-32). St. 
Louis, Missouri: Mosby Inc. 
Reiber, G. E., Smith, D. G., Boone, D. A., del Aguila, M., Borchers, R. E., Mathews, D., et al. 
(1997). Design and pilot testing of the DVA/Seattle Footwear System for diabetic patients with 
foot insensitivity. Journal of Rehabilitation Research and development, 34(1), 1-8. 
Reiber, G. E., Smith, D. G., Wallace, C., Sullivan, K., Hayes, S., Vath, C., et al. (2002). Effect of 
therapeutic footwear on foot reulceration in patients with diabetes. A randomized controlled trial. 
Journal of the American Medical Association, 287(19), 2552-2558. 
Rose, N. E., Feiwell, L. A., & Crachiolo, A. (1992). A method for measuring foot pressures using 
a high resolution, computerized insole sensor:  The effect of heel wedges on plantar pressure 
distribution and center of force. Foot & Ankle, 13(5), 263-270. 
Ross, W. F. (1962). Footwear and the prevention of ulcers in leprosy. Leprosy Review, 33, 202-
207. 
Rozema, A., Ulbrecht, J. S., Pammer, S. E., & Cavanagh, P. R. (1996). In-shoe plantar pressures 
during activities of daily living: Implications for therapeutic footwear design. Foot & Ankle 
International, 17(6), 352-359. 
Sanders, J. E., Goldstein, B. S., & Leotta, D. F. (1995). Skin response to mechanical stress:  
Adaptation rather than breakdown - A review of the literature. Journal of Rehabilitation Research 
and Development, 32(3), 214-226. 
Sarnow, M. R., Rosenblum, B. I., Veves, A., Chrzan, J. S., Giurini, J. M., & Habershaw, G. M. 
(1994). In-shoe foot pressure measurements in diabetic patients with at-risk feet and in healthy 
subjects. Diabetes Care, 17(9), 1002-1006. 
 	
Schaff, P. S., & Cavanagh, P. R. (1990). Shoes for the insensitive foot:  The effect of a "rocker 
bottom" shoe modification on plantar pressure distribution. Foot & Ankle, 11(3), 129-140. 
Sekiya, N., Nagasaki, H., Ito, H., & Furuna, T. (1997). Optimal walking in terms of variability in 
step length. Journal of Sports Physical Therapy, 26(5), 266-272. 
Shaw, G. B. (1911). The doctor's dilemma: a tragedy. London: Constable. 
Shaw, J. E., Hsi, W., Ulbrecht, J. S., Norkitis, A., Becker, M. B., & Cavanagh, P. R. (1997). The 
mechanism of plantar unloading in total contact casts:  Implications for design and clinical Use. 
Foot & Ankle International, 18(12), 809-817. 
Sosenko, J. M., Kato, M., Soto, R., & Bild, D. E. (1990). Comparison of quantitative sensory-
threshold measures for their association with foot ulceration in diabetic patients. Diabetes Care, 
13(10), 1057-1061. 
Spittell, P. C., & Brown, R. D. (1999). Cardiovascular disease and diabetes. In P. J. Dyck & P. K. 
Thomas (Eds.), Diabetic Neuropathy (2nd ed.). Philadelphia: W. B. Saunders Company. 
SPSS Incorporated. (1998). SPSS 8.0 for Windows User's Guide (8.0 ed.). Chicago: SPSS Inc. 
Stacpoole-Shea, S. J., Shea, G. A., & Lavery, L. (1999). An examination of plantar pressure 
measurements to identify the location of Diabetic forefoot ulceration. Journal of Foot and Ankle 
Surgery, 38(2), 109-115. 
Stacpoole-Shea, S. J., Walden, J. G., Villarreal, E., Gitter, A., Lavery, L. A., & Armstrong, D. G. 
(1999). Could seamed socks impart unduly high pressure to the diabetic foot? (Abstract). 
Diabetes, 48(S 1), A179. 
Sumiya, T., Suzuki, Y., Kasahara, T., & Ogata, H. (1998). Sensing stability and dynamic response 
of the F-scan in-shoe sensing system:  A technical note. Journal of Rehabilitation Research and 
Development, 35(2), 192-200. 
Taylor, B. V., & Dyck, P. J. (1999). Classification of the diabetic neuropathies. In P. K. Thomas 
& P. J. Dyck (Eds.), Diabetic Neuropathy (2nd ed.). Philadelphia: W. B. Saunders Company. 
Tennant, J. (2002). Podiatry caring for your feet. Melbourne: Diabetes Australia Victoria. 
Tooke, J. E., & Brash, P. D. (1996). Microvascular aspects of diabetic foot disease. Diabetic 
Medicine, 13(S1), S26-S29. 
Trew, M. (1997). Function of the lower limb. In M. Trew & T. Everett (Eds.), Human movement 
An introductory text (3 ed., pp. 158). New York: Churchill Livingstone. 
Uccioli, L., Caselli, A., Giacomozzi, C., Macellari, V., Giurato, L., Lardieri, L., et al. (2001). 
Pattern of abnormal tangential forces in the diabetic neuropathic foot. Clinical Biomechanics, 16, 
446-454. 
Uccioli, L., Faglia, E., Monticone, G., Favales, F., Durola, L., Aldeghi, A., et al. (1995). 
Manufactured shoes in the prevention of diabetic foot ulcers. Diabetes Care, 18(10), 1376-1378. 
Ulbrecht, J., Perry, J., Hewitt, F., & Cavanagh, P. (1994). Controversies in Footwear for the 
Diabetic Foot at Risk. In S. Kominsky (Ed.), Medical and Surgical Management of the Diabetic 
Foot. (pp. 441-453). St. Louis, Missouri: Mosby Year Book Inc. 
 

Van Gheluwe, B., Kirby, K. A., Roosen, P., & Phillips, R. D. (2002). Reliability and accuracy of 
biomechanical measurements of the lower extremities. Journal of the American Podiatric Medical 
Association, 92(6), 317-326. 
VanZant, R. S., McPoil, T. G., & Cornwall, M. W. (2001). Symmetry of plantar pressures and 
vertical forces in healthy subjects during walking. Journal of the American Podiatric Medical 
Association, 91(7), 337-342. 
Veves, A., Masson, E. A., Fernando, D. J. S., & Boulton, A. J. M. (1990). Studies of experimental 
hosiery in diabetic neuropathic patients with high foot pressures. Diabetic Medicine, 7, 324-326. 
Veves, A., Murray, H. J., Young, M. J., & Boulton, A. J. M. (1992). The risk of foot ulceration in 
diabetic patients with high foot pressure:  A prospective study. Diabetologia, 35, 660-663. 
Walker, S. C., Helm, P. A., & Lavery, L. A. (1997). Gait pattern alteration by functional sensory 
substitution in healthy subjects and in diabetic subjects with peripheral neuropathy. Archives of 
Physical Medicine and Rehabilitation, 78, 853-856. 
Walsh, C. H. (1996). A Healed Ulcer:  What Now? Diabetic Medicine, 13(S1), S58-S60. 
Walsh, J. P. (1994). Foot fall measurement technology. In R. L. Craik & C. A. Oatis (Eds.), Gait 
Analysis Theory and Application (pp. 125-142). St Louis: Mosby. 
Wertsch, J. J., Webster, J. G., & Tompkins, W. J. (1992). A portable insole plantar pressure 
measurement system. Journal of Rehabilitation Research and Development, 29(1), 13-18. 
White, J. (1994). Custom shoe therapy - Current concepts, designs, and special considerations. 
Clinics in Podiatric Medicine and Surgery, 11(2), 259-270. 
Winter, D. A. (1991). Kinetics. In The biomechanics and motor control of human gait: Normal, 
elderly and pathological (2nd ed., pp. 35-52). Waterloo: Waterloo Biomechanics. 
Woodburn, J., & Helliwell, P. S. (1996a). Observations on the F-scan in-shoe pressure measuring 
system. Clinical Biomechanics, 11(5), 301-304. 
Woodburn, J., & Helliwell, P. S. (1996b). Relation between heel position and the distribution of 
forefoot plantar pressures and skin callosities in rheumatoid arthritis. Annuals of Rheumatic 
Disease, 55, 806-810. 
Wu, G., & Cavanagh, P. R. (1995). ISB recommendations for standardization in the reporting of 
kinematic data. Journal of Biomechanics, 28(10), 1257-1261. 
Young, C. R. (1993). The F-scan system of foot pressure analysis. Clinics in Podiatric Medicine 
and Surgery, 10(3), 455-461. 
Young, M. J., Breddy, J. L., Veves, A., & Boulton, A. J. M. (1994). The prediction of diabetic 
neuropathic foot ulceration using vibration perception thresholds. Diabetes Care, 16(6), 557-560. 
Young, M. J., Cavanagh, P. R., Thomas, G., Johnson, M. M., Murray, H., & Boulton, A. J. M. 
(1992). The effect of callus removal on dynamic plantar foot pressures in diabetic patients. 
Diabetic Medicine, 9, 55-57. 
Zeman, F. J. (1991). Height-Weight Ratios. In Clinical Nutrition and Dietetics (2nd ed., pp. 480-
481). New York: McMillian Publishing Company. 
 

Zhu, H., Maalej, N., Webster, J. G., Tompkins, W. J., Bach-Y-Rita, P., & Wertsch, J. J. (1990). 
An umbilical data-acquisition system for measuring pressures between the foot and shoe. IEEE 
Transactions on Biomedical Engineering, 37(9), 908-911. 
Zhu, H., Wertsch, J. J., Harris, G. F., & Alba, H. M. (1995). Walking cadence effect on plantar 
pressures. Archives of Physical Medicine and Rehabilitation, 76, 1000-1005. 
Zhu, W. (1997). Making bootstrap statistical inferences: A tutorial. Research Quarterly for 
Exercise and Sport, 68(1), 44-55. 
 
